data_2n2l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n2l _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 . . . . . 0 C--O 1.235 0.323 0 CA-C-O 120.767 0.317 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.9 m -122.1 141.02 51.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.994 0.426 . . . . 0.0 111.113 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -140.62 153.35 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.143 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -119.87 143.47 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.455 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 49.1 m -134.48 142.85 47.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.74 0.305 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.73 150.0 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.94 167.91 40.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.017 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -89.7 138.74 31.22 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.81 127.95 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -126.02 122.13 34.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.093 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 146' ' ' GLY . 50.1 m -118.4 156.72 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.11 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -122.97 128.36 50.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.2 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.454 -179.778 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -63.4 147.14 93.65 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.064 2.51 . . . . 0.0 111.441 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -113.36 140.35 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.285 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -176.4 -174.84 43.25 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.349 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -119.12 147.39 44.22 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 110.591 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -117.09 127.97 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.227 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 tp -112.6 126.08 54.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.977 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 29.2 ttpp -125.06 133.89 52.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.147 0.498 . . . . 0.0 111.621 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -114.36 130.5 56.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.002 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -112.71 128.51 56.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.946 0.403 . . . . 0.0 111.452 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -128.98 120.49 26.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.487 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.25 156.66 42.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 117.021 0.41 . . . . 0.0 110.631 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -134.07 147.77 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.266 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -124.72 123.75 5.17 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -114.94 125.37 53.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.165 0.483 . . . . 0.0 111.759 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -117.11 121.22 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.68 126.98 54.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 0.0 111.646 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.511 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 65.5 tt0 -123.91 117.08 24.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 73.7 p -128.87 156.5 43.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.058 0.456 . . . . 0.0 111.827 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.367 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.9 t80 -139.6 126.95 21.4 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -129.44 141.62 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.553 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 74.3 t80 -133.31 126.53 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.506 ' CE2' ' HG3' ' A' ' 49' ' ' GLN . 95.5 m-85 -124.37 139.96 53.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.895 0.378 . . . . 0.0 110.533 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.68 141.9 45.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.049 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 3.1 p -138.78 120.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.636 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.1 p -135.56 158.38 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.024 0.44 . . . . 0.0 111.877 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.83 157.18 42.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.912 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -172.85 161.31 32.55 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.54 155.19 35.86 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.967 2.445 . . . . 0.0 112.408 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.06 126.65 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.396 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -126.4 128.98 47.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.752 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -77.87 131.49 37.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.697 0.285 . . . . 0.0 110.926 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.4 mt -90.18 -43.22 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.514 0.673 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -138.29 -166.61 2.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.235 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -62.64 -39.65 94.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.622 0.248 . . . . 0.0 111.445 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -122.89 21.75 9.82 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.4 127.96 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 CA-C-N 118.011 0.369 . . . . 0.0 110.095 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.8 m -130.14 144.45 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.764 0.316 . . . . 0.0 111.049 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.6 tp -124.37 135.17 53.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.401 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 51.9 p90 -139.68 156.17 46.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.06 0.457 . . . . 0.0 111.383 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.633 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -108.97 153.16 16.9 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.074 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 134' ' ' SER . 88.9 mt -120.61 127.27 51.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 111.716 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -144.26 138.03 27.68 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . 176.66 -150.23 10.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.875 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.27 156.26 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.45 147.23 16.7 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.665 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -135.75 128.34 30.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 110.838 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.015 179.622 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.233 0.22 0 CA-C-O 121.278 0.561 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.2 p -120.29 148.01 44.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.255 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.8 p -157.28 165.68 35.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.347 . . . . 0.0 111.849 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 138' ' ' SER . 90.4 mt -99.58 137.81 37.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.909 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.46 131.92 54.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.035 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -143.6 137.9 28.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.36 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.65 -163.32 27.7 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.692 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.33 159.58 43.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -136.86 153.52 21.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.265 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.85 138.81 50.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.028 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 51.6 tt0 -129.21 128.38 43.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.612 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -116.49 139.72 50.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.476 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -116.01 85.79 15.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.7 -32.95 7.03 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.207 1.938 . . . . 0.0 111.711 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -134.71 152.71 78.09 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.695 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.8 -38.27 94.64 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 122.664 2.243 . . . . 0.0 114.054 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -104.55 6.07 34.37 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -137.57 122.04 18.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.927 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.64 153.17 36.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.03 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.31 123.83 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.81 130.72 56.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -127.22 120.26 28.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 90' ' ' LEU . 73.3 m -121.65 142.48 50.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.533 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.5 m-85 -122.41 122.54 39.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.113 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 83.8 mt-10 -127.1 135.8 51.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.01 142.07 49.46 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.992 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 57.4 m -115.32 128.02 55.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.12 114.78 29.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.753 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 83.3 mt -118.67 154.72 32.25 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.11 -42.91 95.76 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.55 -33.54 7.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.753 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.1 t -106.42 129.03 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -106.06 126.61 52.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 72.6 t -125.85 126.88 70.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -118.38 137.78 13.25 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 73.9 m -126.88 128.42 46.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.262 0.531 . . . . 0.0 111.086 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -119.8 139.03 52.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 17.8 tmm? -134.42 132.03 38.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.094 0.473 . . . . 0.0 111.567 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.89 127.04 41.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -163.71 -167.65 24.51 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.53 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.9 156.23 48.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.763 0.316 . . . . 0.0 110.709 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -124.95 152.84 17.71 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.679 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -121.24 128.33 52.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.881 0.372 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -93.92 128.25 40.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.71 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -138.59 156.47 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.0 m -145.04 156.02 43.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.63 143.31 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.479 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 50.4 m -134.51 148.34 50.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.708 0.29 . . . . 0.0 111.286 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.9 152.16 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.331 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.24 -179.19 41.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.025 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -103.18 140.81 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.691 0.281 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.81 121.78 45.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -120.43 127.95 52.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.67 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.667 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.5 m -118.01 153.28 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 111.276 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.718 -179.56 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.1 m120 . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.667 ' HD2' ' O ' ' A' ' 13' ' ' SER . 91.5 Cg_endo -80.23 158.87 23.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.747 2.298 . . . . 0.0 111.362 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -111.19 136.49 50.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.554 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.18 -179.86 40.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.574 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.95 154.69 35.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -127.97 126.18 40.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -108.85 136.78 47.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 15.8 ttmm -130.98 136.9 48.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.132 0.491 . . . . 0.0 111.528 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -122.6 127.59 49.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.869 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -113.82 130.63 56.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.0 111.314 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -126.61 122.73 35.88 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.564 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.8 156.61 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.034 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.1 pp -132.41 146.08 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 111.537 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -120.92 125.73 6.33 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 48.1 m -118.09 128.16 54.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 0.0 112.005 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -121.21 120.5 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.354 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.07 129.47 55.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.892 0.377 . . . . 0.0 111.46 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -122.86 115.92 22.78 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.7 p -127.0 155.4 43.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 112.013 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.002 179.852 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t0 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.881 0.372 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -114.79 128.62 56.4 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.931 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -113.92 137.54 51.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.56 123.45 39.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -117.45 137.33 52.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.2 m -127.58 131.97 49.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.852 0.358 . . . . 0.0 111.216 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.03 117.96 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.412 ' OG1' ' HB2' ' A' ' 46' ' ' SER . 74.2 p -132.47 156.96 45.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 111.743 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.581 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.1 156.35 42.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.225 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -173.77 165.02 36.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.104 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.18 155.63 25.71 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.001 2.467 . . . . 0.0 112.364 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.17 127.76 75.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -126.81 125.98 42.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.984 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -77.21 127.61 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.5 mt -75.12 -46.04 40.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -134.29 -97.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.158 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 -31.72 1.36 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.29 3.99 11.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.09 128.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 57.1 m -129.0 148.72 50.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 tt -116.8 136.72 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.225 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.5 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 50.1 p90 -142.04 155.44 45.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.392 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.572 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -109.03 151.86 17.08 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.044 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.1 mt -119.67 125.57 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 0.0 111.503 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -144.58 140.37 28.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.602 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.97 -157.29 27.22 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.65 151.94 51.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.082 0.467 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.17 141.49 17.04 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -127.58 126.09 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.808 0.337 . . . . 0.0 110.39 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.352 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.6 m -115.42 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.7 p -140.54 157.71 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.978 0.418 . . . . 0.0 111.77 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 138' ' ' SER . 69.0 tp -100.56 127.66 46.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.56 130.77 56.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.424 . . . . 0.0 110.953 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -144.56 140.22 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.83 -163.33 27.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.633 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.15 161.27 41.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.5 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -142.1 158.58 26.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.347 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.8 mt -122.56 139.38 53.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.509 -0.346 . . . . 0.0 110.077 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.472 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 52.5 tt0 -118.85 128.49 54.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.169 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.33 142.37 51.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -124.19 82.67 56.92 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.532 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.21 -28.61 33.77 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.477 2.118 . . . . 0.0 112.127 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -131.56 151.29 78.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.546 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.81 -25.57 74.66 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 113.452 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -111.48 13.49 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -140.29 120.89 14.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 110.951 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.5 t -111.43 129.98 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.183 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 51.0 mm -104.64 119.65 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.472 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 88.7 m-20 -114.11 126.48 55.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.991 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.15 124.04 45.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 74.9 m -127.35 143.08 51.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 112.379 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.519 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 51.9 m-85 -124.65 122.96 38.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.102 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -125.59 135.12 51.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -127.39 139.21 53.0 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.871 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 49.6 m -105.99 123.96 48.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -101.36 107.64 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.258 0.552 . . . . 0.0 112.311 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 87.3 mt -119.01 153.0 35.39 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.89 -44.11 97.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -104.9 -32.92 8.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.729 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -106.07 128.36 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -106.19 120.69 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.92 129.19 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.974 0.416 . . . . 0.0 112.091 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.09 138.29 14.64 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.7 m -124.84 129.16 49.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.979 0.418 . . . . 0.0 111.3 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -115.95 136.99 52.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -131.93 127.87 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.96 137.47 53.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.36 -171.59 38.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.571 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.86 157.09 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.94 0.4 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.79 167.19 24.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.738 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -132.86 130.81 40.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.494 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.2 mtm105 -79.04 140.45 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.027 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.937 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -122.94 142.95 50.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.452 . . . . 0.0 111.239 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 155' ' ' ARG . 32.3 m -143.26 154.57 43.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.875 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.3 143.77 32.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.502 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 50.1 m -132.27 141.95 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 pt -127.95 147.56 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.45 -173.22 38.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.042 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.34 142.99 36.27 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.77 114.4 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.266 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -116.77 132.34 56.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.649 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 44.6 m -118.23 165.23 14.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.804 0.335 . . . . 0.0 111.624 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -126.61 121.12 31.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.378 -179.609 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 13' ' ' SER . 30.5 m120 . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 13' ' ' SER . 93.2 Cg_endo -79.67 159.21 25.07 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.797 2.331 . . . . 0.0 110.745 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.01 142.42 27.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.0 169.68 41.01 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.392 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.84 147.64 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 0.0 110.565 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.533 HD22 ' HE2' ' A' ' 32' ' ' LYS . 42.1 t30 -111.09 121.84 46.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.641 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.22 124.09 42.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.102 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.533 ' HE2' HD22 ' A' ' 30' ' ' ASN . 67.5 mttm -127.76 145.39 50.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.436 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -123.34 127.81 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.539 ' NE ' HE22 ' A' ' 122' ' ' GLN . 51.6 mtp180 -109.6 136.48 48.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.902 0.382 . . . . 0.0 111.835 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.64 119.33 16.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.412 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 C--N 1.331 -0.216 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.217 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.0 m -126.75 148.3 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.343 . . . . 0.0 110.818 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.671 ' HB ' ' CE1' ' A' ' 88' ' ' TYR . 78.9 mt -129.37 130.11 67.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.45 136.53 12.74 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -123.22 133.4 54.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.275 0.538 . . . . 0.0 111.865 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -135.93 124.32 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.448 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.08 143.11 49.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.98 0.419 . . . . 0.0 111.201 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -121.51 126.1 48.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 64.8 p -125.7 151.8 46.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.613 -179.504 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -99.48 120.69 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.95 139.02 53.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.235 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.502 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 85.9 t80 -133.78 128.43 34.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.74 135.66 53.7 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.3 m -116.1 123.62 48.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.712 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.38 110.8 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.0 p -135.67 159.3 42.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.051 0.453 . . . . 0.0 111.851 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.29 151.6 32.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.827 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.4 161.54 33.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.901 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.47 160.03 32.2 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.049 2.499 . . . . 0.0 112.688 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 78' ' ' VAL . 9.1 p -130.06 132.49 65.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.227 0.537 . . . . 0.0 110.139 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.49 148.76 50.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.135 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -85.33 127.35 34.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.278 . . . . 0.0 110.705 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.6 mt -89.36 -44.07 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -134.56 -164.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.082 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' O ' ' HD1' ' A' ' 84' ' ' TYR . 98.6 mt-10 -62.05 -40.78 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.457 0.17 . . . . 0.0 111.34 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 83' ' ' GLU . 6.4 m-30 -126.85 28.98 5.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.12 131.41 67.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.3 m -128.9 148.6 50.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.2 tp -112.19 129.75 56.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.671 ' CE1' ' HB ' ' A' ' 44' ' ' ILE . 38.5 t80 -126.99 133.47 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.031 0.443 . . . . 0.0 111.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.514 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -107.7 141.58 15.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.554 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mp -110.06 121.52 45.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 111.486 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.8 tp -135.28 126.81 28.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.562 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.5 -151.15 11.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.869 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.92 155.29 44.69 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.133 0.492 . . . . 0.0 111.553 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.451 ' HA3' ' OH ' ' A' ' 70' ' ' TYR . . . -122.73 144.06 15.66 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.797 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -126.87 126.37 43.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 110.703 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.352 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.374 0.606 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 87.0 m -128.6 133.38 48.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.591 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.3 p -140.12 160.48 39.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.56 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.31 141.87 31.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.177 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.35 133.43 55.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.61 140.04 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.471 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.01 -175.42 38.95 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.734 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.45 154.31 41.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.41 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -148.53 161.71 28.7 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.418 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.17 138.72 50.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.363 -0.418 . . . . 0.0 110.159 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.539 HE22 ' NE ' ' A' ' 34' ' ' ARG . 54.7 tt0 -119.86 130.5 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.999 0.428 . . . . 0.0 110.034 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.03 152.27 33.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.028 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -121.22 82.92 38.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.619 0.247 . . . . 0.0 110.688 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.34 -28.99 14.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.356 2.037 . . . . 0.0 112.248 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 79.5 m80 -130.64 152.93 81.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.737 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -56.28 -36.19 96.64 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.763 2.308 . . . . 0.0 114.287 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -109.57 -4.23 16.37 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 126' ' ' HIS . 68.2 m-85 -121.47 133.51 55.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.68 152.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.084 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.3 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -115.54 114.99 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -114.14 108.97 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.41 ' OG ' ' HA3' ' A' ' 120' ' ' GLY . 54.0 m -128.03 153.13 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -134.48 131.85 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.709 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 149' ' ' MET . 27.2 pt-20 -140.91 161.24 38.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -137.76 159.1 42.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 0.0 111.626 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.453 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 45.2 m -108.59 135.53 49.69 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.912 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -98.67 104.81 16.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 79.2 mt -118.48 153.29 34.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.54 -45.25 93.83 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.2 -32.82 7.64 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.796 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 62.7 t -104.92 130.48 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.44 125.08 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.6 t -121.83 125.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.14 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -113.74 138.17 14.7 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.6 m -124.58 130.98 53.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.443 0.621 . . . . 0.0 111.433 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.7 m-90 -106.24 131.55 53.35 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.41 ' HE3' ' OE2' ' A' ' 136' ' ' GLU . 57.6 mtt -120.63 111.2 17.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.438 . . . . 0.0 111.438 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -123.85 134.41 53.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.612 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 178.39 48.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.378 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.81 150.89 42.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.855 0.359 . . . . 0.0 110.498 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -127.3 155.29 19.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.985 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -118.55 127.77 53.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.764 0.316 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.482 ' HA ' ' OG ' ' A' ' 5' ' ' SER . 80.8 mtp180 -92.82 132.57 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.875 -179.9 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.547 0.213 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -129.04 143.34 50.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.235 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -128.47 143.5 50.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.4 mm -113.77 120.57 63.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 65.7 m -127.33 144.71 51.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.399 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.52 153.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.571 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.17 -174.34 38.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.102 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -109.06 142.61 39.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.26 127.74 54.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 111.416 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -120.97 114.82 22.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.731 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 50.6 m -118.2 159.85 22.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.59 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -126.91 128.87 47.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.169 -178.753 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.731 ' HD2' ' O ' ' A' ' 13' ' ' SER . 72.4 Cg_endo -74.83 157.99 43.14 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.474 2.116 . . . . 0.0 110.72 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -113.92 146.73 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.049 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.66 178.31 48.38 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.431 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.69 148.39 33.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 0.0 110.788 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -124.27 130.05 51.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.948 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.76 136.2 53.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.082 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.7 mttm -124.49 139.95 53.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 111.377 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -132.64 128.3 36.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.069 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.452 ' HD3' HE22 ' A' ' 122' ' ' GLN . 47.0 ttp180 -119.92 133.68 55.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -128.19 125.15 38.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.1 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.26 179.825 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.32 153.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -139.1 138.63 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.36 139.93 12.6 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 m -129.36 136.6 50.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.992 0.425 . . . . 0.0 111.105 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.39 124.85 43.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.821 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.08 120.27 36.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.784 0.326 . . . . 0.0 110.939 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.533 ' OE1' ' HD1' ' A' ' 71' ' ' TYR . 2.8 mm-40 -112.09 106.48 15.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.1 p -125.99 158.04 36.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.119 0.485 . . . . 0.0 112.276 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 179.29 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -99.39 122.76 42.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.645 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -127.79 142.23 51.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.13 123.25 24.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.533 ' HD1' ' OE1' ' A' ' 49' ' ' GLN . 92.1 m-85 -112.79 128.91 56.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.4 m -113.92 127.03 55.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.181 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.9 124.4 70.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -147.15 153.43 39.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.851 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.545 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -153.03 153.43 32.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -167.81 167.37 40.01 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.997 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.56 156.3 40.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.526 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.76 129.71 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.544 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -126.88 126.63 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.996 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -69.94 134.79 48.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 0.0 111.215 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.6 mt -89.62 -45.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.53 0.681 . . . . 0.0 109.777 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.83 -144.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.86 -1.78 52.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.342 -0.224 . . . . 0.0 111.468 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -147.05 9.72 0.99 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.37 142.53 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 68.1 m -138.3 151.35 47.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.049 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tt -116.26 136.93 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -142.75 157.69 44.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 111.335 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.634 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.99 150.52 18.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.845 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.02 129.44 55.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.455 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -142.36 135.66 28.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.8 13.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.903 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.69 152.19 45.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.101 0.477 . . . . 0.0 111.606 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.21 140.81 16.43 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.768 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -119.03 122.42 42.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.592 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.272 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.247 0.546 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -126.8 149.03 49.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.3 t -153.97 148.31 26.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 111.511 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.44 126.94 32.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.64 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.435 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . . . -114.85 132.89 56.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.97 0.414 . . . . 0.0 111.132 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.76 137.7 25.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.291 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.4 -168.38 29.47 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.752 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.06 161.47 41.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.64 161.92 28.95 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.579 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.07 140.76 50.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.047 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.452 HE22 ' HD3' ' A' ' 34' ' ' ARG . 52.7 tt0 -115.4 128.55 56.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -116.18 139.93 49.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.108 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -128.83 82.69 68.19 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -30.06 17.48 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.372 2.048 . . . . 0.0 112.237 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -131.32 152.43 80.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.633 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.16 -35.01 89.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.92 2.413 . . . . 0.0 113.869 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.423 ' O ' ' HD1' ' A' ' 154' ' ' TYR . 2.8 t-20 -109.99 13.7 23.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -130.94 118.57 20.87 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -117.37 131.04 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.341 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.21 122.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -110.77 129.67 55.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.9 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -133.79 125.49 28.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 99.3 p -155.8 165.8 35.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.9 152.64 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.55 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.435 ' OE2' ' HB3' ' A' ' 116' ' ' ALA . 52.5 tt0 -144.42 137.52 27.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -112.75 132.34 55.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 49.3 m -102.89 125.91 49.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -103.25 114.58 28.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 68.1 mt -119.91 153.65 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.16 -43.41 98.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -106.72 -32.06 8.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.756 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.4 t -105.26 130.75 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.91 123.94 48.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -127.7 126.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 112.055 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -114.41 135.01 12.08 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.3 m -119.44 129.18 54.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.52 0.66 . . . . 0.0 111.621 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -111.09 131.44 55.08 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 63.8 mtt -120.71 115.1 22.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.25 136.5 53.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.322 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 -173.25 44.51 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.394 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.66 159.29 43.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.07 -178.23 28.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.596 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.423 ' HD1' ' O ' ' A' ' 128' ' ' ASN . 94.2 m-85 -121.82 144.66 48.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.654 0.264 . . . . 0.0 110.494 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -96.25 126.39 41.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.813 -179.823 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' ARG . 37.3 t -133.88 140.17 46.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 111.134 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.7 m -131.65 149.46 52.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.3 mt -118.56 126.66 75.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.27 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.496 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 62.1 m -117.83 137.22 52.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.299 . . . . 0.0 111.207 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -121.36 129.64 75.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.193 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.93 172.91 31.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.08 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -98.56 145.05 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.81 138.96 52.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.947 0.403 . . . . 0.0 111.429 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' NE1' ' A' ' 148' ' ' TRP . 97.3 mt-30 -127.73 135.03 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.967 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.655 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.6 m -118.82 148.56 42.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.176 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -120.37 123.19 42.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--O 1.223 -0.328 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.465 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.655 ' HD2' ' O ' ' A' ' 13' ' ' SER . 73.5 Cg_endo -76.8 159.48 34.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.632 2.221 . . . . 0.0 110.756 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -116.07 156.35 26.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.903 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -178.63 -153.79 11.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.362 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.12 161.35 38.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 28.1 t-20 -135.26 128.87 32.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' SER . 87.1 mt -104.13 128.15 51.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.986 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 23.0 ttmm -119.74 127.75 53.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.513 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.38 134.52 52.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.614 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 4' ' ' SER . 77.2 ttt-85 -121.78 131.03 53.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 111.733 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -132.36 131.49 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.595 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.9 0.381 . . . . 0.0 110.822 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.3 pp -136.77 150.07 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -130.86 134.1 7.6 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 55.0 m -124.57 135.71 53.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.031 0.415 . . . . 0.0 111.774 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 94.8 m-85 -120.4 111.73 18.11 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.67 127.48 49.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.503 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.512 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 77.4 mt-30 -126.08 123.52 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 77.1 p -128.04 149.45 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.676 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.037 179.608 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t0 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -104.83 130.22 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.769 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -118.03 136.35 53.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.981 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 68.0 t80 -134.45 125.64 27.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.231 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.44 138.16 53.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 109.912 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.7 m -127.92 136.0 50.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.199 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.466 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 63.0 t -124.92 119.63 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.7 p -133.2 156.33 47.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 111.868 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.22 153.01 34.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.042 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.06 164.66 37.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.969 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.19 156.85 29.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.889 2.393 . . . . 0.0 112.64 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.42 129.75 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.382 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -123.13 128.71 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.043 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HD3' ' HB3' ' A' ' 86' ' ' SER . 29.3 mmt180 -78.53 126.31 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 81' ' ' ILE . 44.8 mm -90.97 -42.26 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 110.089 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.0 -167.2 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.04 -38.43 88.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 0.0 111.327 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -128.15 23.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.44 127.48 65.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.64 ' OG ' ' HB3' ' A' ' 122' ' ' GLN . 89.3 p -138.6 151.7 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.7 mt -123.36 145.92 48.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.957 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.456 ' CE2' ' HA3' ' A' ' 120' ' ' GLY . 34.6 p90 -150.89 159.36 44.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 111.714 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.656 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -117.13 149.25 18.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.132 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.65 118.89 36.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.296 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 tp -127.11 125.39 41.17 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . -175.13 -155.03 11.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.855 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.07 153.39 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.613 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.01 141.62 17.0 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.766 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -129.33 130.8 46.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.775 0.321 . . . . 0.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.542 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.09 0.471 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 76.4 p -118.26 149.16 41.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.769 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.4 p -157.4 163.94 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.37 . . . . 0.0 111.759 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.8 mt -98.79 135.41 40.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.064 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.33 130.1 52.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -143.74 138.64 28.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -167.76 -165.05 24.51 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.695 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.18 37.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.456 ' HA3' ' CE2' ' A' ' 88' ' ' TYR . . . -145.28 162.65 28.18 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 113.348 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.0 tp -126.74 138.43 53.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.902 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.64 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 51.6 tt0 -126.75 133.1 50.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.862 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -122.5 151.82 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.574 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -119.35 81.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.23 -34.6 67.37 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.597 2.198 . . . . 0.0 111.483 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.68 155.44 81.26 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.681 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.56 -23.21 74.71 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.844 2.362 . . . . 0.0 113.658 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -117.78 9.51 12.99 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.94 133.93 29.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.69 153.39 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.3 mt -113.22 124.24 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -111.3 126.93 55.42 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -128.6 116.5 19.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.7 m -130.64 153.82 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.504 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 99.0 m-85 -125.58 138.32 53.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.329 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -129.66 144.64 51.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.621 0.248 . . . . 0.0 110.34 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' OH ' ' HD2' ' A' ' 144' ' ' LYS . 90.8 t80 -135.51 129.8 33.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 0.0 111.324 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -101.87 121.8 42.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -102.4 107.02 17.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.716 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 96.2 mt -119.23 153.58 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.68 -43.5 98.75 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.46 -31.88 8.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.716 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.0 t -105.27 128.42 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HD2' ' OH ' ' A' ' 137' ' ' TYR . 34.8 mmtp -105.72 125.36 50.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -126.69 125.67 67.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.4 135.69 12.03 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.9 m -131.29 137.53 48.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.171 0.485 . . . . 0.0 111.667 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.404 ' NE1' ' HB2' ' A' ' 12' ' ' GLN . 34.4 p90 -132.85 148.8 52.3 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm -140.05 149.06 42.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.175 0.512 . . . . 0.0 111.844 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.94 139.0 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.395 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -177.77 -176.0 45.42 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.17 152.24 39.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.457 -0.372 . . . . 0.0 110.517 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.45 152.59 18.4 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.608 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -121.96 130.56 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.489 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -78.52 135.33 37.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.08 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.712 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 . . . . . 0 C--O 1.235 0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.2 p -142.39 156.89 45.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.8 m -136.72 146.61 46.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.0 mt -118.02 125.53 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.2 m -127.21 145.61 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.948 0.404 . . . . 0.0 111.435 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.21 154.28 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.32 176.11 44.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.117 -1.039 . . . . 0.0 113.081 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -94.08 140.4 29.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.13 35.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HB3' HD22 ' A' ' 25' ' ' ASN . 96.0 mt-30 -112.26 118.4 35.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.889 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 64.9 m -118.46 157.5 27.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 111.702 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -127.25 127.57 44.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.372 -179.476 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' SER . 22.6 t-20 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 13' ' ' SER . 37.7 Cg_exo -67.45 148.47 79.2 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.188 2.592 . . . . 0.0 111.006 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -102.96 138.67 39.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -172.76 -177.89 42.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.255 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -121.15 149.48 42.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.272 . . . . 0.0 110.498 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -118.97 126.63 52.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.85 131.09 55.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.982 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -128.47 139.47 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.287 0.565 . . . . 0.0 111.496 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -133.43 129.84 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.277 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -118.53 133.14 56.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -131.77 128.71 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.999 0.428 . . . . 0.0 111.942 -179.129 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.79 156.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.842 0.321 . . . . 0.0 110.877 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 tp -133.52 132.33 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.114 0.483 . . . . 0.0 111.15 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.12 135.66 12.09 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -127.84 134.69 49.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.25 117.95 28.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.404 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 124.93 53.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.83 0.348 . . . . 0.0 111.146 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 10.1 pt20 -131.44 117.52 18.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.901 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 73.6 p -131.6 160.17 36.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.954 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.941 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 120.554 0.216 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -74.73 130.61 39.79 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.602 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.51 139.42 53.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.343 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.43 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.6 m-85 -126.22 127.29 45.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.422 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.482 ' CD1' ' HB3' ' A' ' 49' ' ' GLN . 21.2 t80 -132.18 116.94 17.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.6 m -120.29 136.86 54.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.45 120.22 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.8 p -133.4 157.18 46.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 111.777 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -152.19 155.19 37.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.98 172.71 43.93 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.781 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.98 155.07 43.0 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.943 2.428 . . . . 0.0 112.74 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.03 125.91 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.374 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -127.07 123.69 37.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.964 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -80.24 137.43 36.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.594 0.235 . . . . 0.0 110.746 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.2 mm -88.92 -39.37 12.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.494 0.664 . . . . 0.0 109.776 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -153.51 -155.05 0.56 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.278 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.31 1.81 53.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.622 0.248 . . . . 0.0 111.331 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -144.95 10.7 1.35 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.25 139.24 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.694 0.283 . . . . 0.0 110.651 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -138.65 150.72 46.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.114 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 129.26 54.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.076 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.37 139.75 48.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.736 0.303 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.34 137.37 13.59 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -125.36 126.19 44.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.197 0.499 . . . . 0.0 111.732 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -146.81 136.96 23.52 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.2 -149.76 12.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.869 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.44 151.79 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.482 . . . . 0.0 111.601 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.81 141.13 16.14 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.717 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -124.06 128.51 49.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.295 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.053 179.869 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.2 mttp . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.119 0.485 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 74.3 p -113.37 147.68 37.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.493 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.7 p -155.57 164.64 38.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 0.0 111.709 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.4 mt -98.57 137.32 37.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.828 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.15 132.12 54.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.798 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.16 142.07 26.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.329 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -176.38 -172.98 41.61 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.748 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.9 161.32 42.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.448 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -146.23 165.7 28.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.456 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -126.06 138.89 53.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -119.17 134.54 55.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.388 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -116.47 151.95 35.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -119.67 85.06 32.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.16 -33.35 9.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.192 1.928 . . . . 0.0 111.752 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -136.26 152.64 75.55 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.673 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.9 -30.22 76.93 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.65 2.233 . . . . 0.0 113.745 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.54 10.15 33.21 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -149.11 122.3 8.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.201 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 153' ' ' GLY . 32.9 m -125.63 151.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -122.7 145.17 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -136.14 122.11 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.35 41.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.448 ' OG ' ' HA3' ' A' ' 120' ' ' GLY . 69.3 m -127.98 150.07 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.483 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.8 m-85 -118.38 130.65 56.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -137.06 136.85 38.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -126.72 146.12 50.33 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 55.6 m -112.03 137.41 50.1 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.87 115.51 30.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.815 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 74.7 mt -118.4 154.3 32.65 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.0 -44.73 96.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.48 -33.4 7.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.815 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.5 t -105.65 128.63 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.73 128.95 44.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 65.2 t -125.46 128.07 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.11 0.481 . . . . 0.0 112.099 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -116.83 136.59 12.86 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.5 m -126.8 129.98 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.209 0.504 . . . . 0.0 111.192 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -113.33 133.45 55.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.0 mtt -114.48 117.97 32.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 0.0 111.495 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -125.25 123.36 39.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.314 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.37 -173.48 39.03 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.43 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.04 165.48 27.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.382 . . . . 0.0 110.734 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -153.26 178.47 30.29 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.559 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -131.95 130.92 42.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -80.82 131.25 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.981 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.755 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.687 0.279 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -140.22 159.48 42.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.231 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.2 m -132.25 147.19 52.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.968 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.6 124.2 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.45 ' HA ' ' CA ' ' A' ' 153' ' ' GLY . 56.5 m -120.63 139.73 52.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.436 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.1 mt -123.47 129.16 74.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.004 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 177.86 20.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.313 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -102.58 137.34 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.69 130.52 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.797 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 147' ' ' THR . 72.6 mt-30 -122.34 132.69 54.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 44.2 m -118.35 158.7 24.75 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.455 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -128.97 119.09 23.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.0 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.469 -179.189 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.658 ' HA ' ' O ' ' A' ' 13' ' ' SER . 19.1 p-10 . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 13' ' ' SER . 94.5 Cg_endo -80.12 159.51 23.64 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.569 2.18 . . . . 0.0 110.877 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -91.95 140.5 29.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.573 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -164.53 173.99 40.51 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.259 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.21 152.54 47.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -122.69 132.32 54.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.91 121.1 39.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.071 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.4 mttm -117.9 140.46 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 111.38 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.14 135.98 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.88 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -119.0 129.94 55.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.22 132.2 56.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 -179.077 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.197 0 N-CA-C 112.31 -0.316 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.11 139.83 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.077 0.438 . . . . 0.0 110.624 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.496 HD12 ' CD1' ' A' ' 88' ' ' TYR . 36.8 pt -130.44 158.35 42.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.9 142.65 15.77 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -129.37 123.11 30.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -114.51 122.42 46.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 136.04 54.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -142.16 132.4 24.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.05 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 82.3 p -133.45 158.91 41.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.033 0.444 . . . . 0.0 111.639 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.392 179.163 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.99 126.33 43.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.501 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.11 140.26 51.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.216 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.463 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.3 m-85 -121.34 122.3 39.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.629 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.17 119.51 31.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.1 m -123.89 136.01 54.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.964 0.412 . . . . 0.0 111.155 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.76 121.36 64.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.6 p -130.49 154.97 47.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.067 0.46 . . . . 0.0 111.831 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.99 151.19 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.893 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.04 160.93 31.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.856 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.45 156.3 40.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.862 2.375 . . . . 0.0 112.655 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.21 131.87 70.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 0.0 110.387 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -118.7 125.51 49.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.155 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -70.73 133.82 46.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.533 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.0 mt -84.59 -44.65 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.455 0.645 . . . . 0.0 109.839 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -140.54 -102.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.21 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -125.47 -34.69 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.678 0.275 . . . . 0.0 111.134 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.76 11.73 14.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.08 137.56 48.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -139.12 151.96 47.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.202 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.71 136.12 53.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.135 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 134' ' ' SER . 51.2 p90 -142.61 160.62 39.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 111.281 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.86 152.51 17.31 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.4 mt -112.39 123.32 50.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.331 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.7 tp -136.49 127.33 27.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.604 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.9 -160.48 25.58 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.817 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.86 148.83 52.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 0.0 111.437 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.53 135.75 12.95 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.876 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -124.37 124.81 43.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.037 0.446 . . . . 0.0 110.625 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.158 179.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.03 0.443 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.6 m -120.69 131.44 54.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 81.8 p -145.57 161.24 40.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.01 0.433 . . . . 0.0 111.796 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 138' ' ' SER . 63.8 tp -98.21 126.52 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.82 128.89 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -144.65 140.75 28.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.405 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -173.05 -168.91 34.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.705 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.63 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.6 168.06 32.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.43 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.4 mt -127.35 147.25 50.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.275 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -117.83 137.11 52.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.294 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.83 140.56 52.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.695 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -125.08 83.04 60.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.394 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.06 -27.64 42.07 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.278 1.985 . . . . 0.0 111.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -133.58 153.42 80.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.492 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.48 -37.99 89.86 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.899 2.399 . . . . 0.0 113.692 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -105.63 10.66 32.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.44 121.42 37.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.918 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.26 130.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.306 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.41 123.82 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.37 127.84 56.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.941 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -138.14 123.97 19.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.517 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 99.5 p -150.45 160.87 43.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.0 m-85 -118.34 127.04 53.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.271 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -120.75 126.6 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.52 143.58 51.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.205 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 56.2 m -110.2 128.78 55.68 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.36 105.77 16.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.744 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 90.8 mt -119.15 149.45 41.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.52 -43.8 97.92 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -103.73 -31.92 9.62 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.744 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.5 t -105.82 128.69 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -105.14 120.55 41.79 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 64.0 t -123.31 124.96 71.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.704 -0.398 . . . . 0.0 112.017 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -121.1 130.91 8.41 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 87.3 m -124.96 129.38 50.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.147 0.473 . . . . 0.0 111.484 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.449 ' CD1' ' HD1' ' A' ' 135' ' ' TYR . 52.6 m0 -109.86 133.14 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 74.8 mtm -126.92 126.17 42.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.733 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -140.43 136.33 32.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.395 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.61 -175.7 41.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.821 -1.181 . . . . 0.0 113.538 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.61 152.48 48.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 7' ' ' SER . . . -139.73 165.61 25.82 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.658 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -110.84 130.66 55.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.567 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.31 124.69 36.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.735 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.78 0.324 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.6 p -144.13 156.3 44.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -137.59 146.56 44.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.67 127.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 60.4 m -121.02 138.09 54.33 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.878 0.37 . . . . 0.0 111.221 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.2 mt -125.58 131.31 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.15 -173.16 24.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.18 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.66 147.02 32.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.99 126.27 52.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 111.13 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -117.92 123.31 45.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.882 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.627 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.0 m -118.53 150.88 38.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 111.686 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -127.65 129.28 46.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.707 -179.579 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 . . . . . 0 C--O 1.233 0.216 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 13' ' ' SER . 85.8 Cg_endo -84.16 159.02 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.884 2.389 . . . . 0.0 110.957 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -107.57 149.29 28.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.711 0.291 . . . . 0.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.8 -179.52 42.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.6 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -115.04 147.71 39.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.845 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.492 ' OD1' ' HE1' ' A' ' 149' ' ' MET . 3.3 t30 -122.85 123.77 41.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.266 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -119.59 130.31 55.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HE2' HD22 ' A' ' 30' ' ' ASN . 68.6 mttm -126.87 138.25 53.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.003 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.75 132.87 53.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.751 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -126.04 129.99 50.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.954 0.407 . . . . 0.0 111.46 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.01 134.59 54.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.747 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 111.799 -179.595 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -125.02 131.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.946 0.373 . . . . 0.0 110.842 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 76' ' ' GLY . 18.3 tt -126.56 140.75 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.12 140.17 11.92 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -126.31 139.3 53.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.096 0.474 . . . . 0.0 111.606 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.57 125.26 43.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.642 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.18 126.88 55.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -123.3 107.84 12.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.7 p -128.4 155.22 45.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.972 179.229 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.0 t0 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.845 0.355 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -110.5 122.4 47.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.535 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -102.69 131.49 49.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.124 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -123.77 122.77 38.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -123.43 137.48 54.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.74 0.305 . . . . 0.0 110.217 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.1 m -126.53 136.06 52.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -125.63 120.2 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.0 p -133.34 157.62 45.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.493 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.64 155.35 37.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.174 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -174.43 165.15 36.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.132 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.36 153.9 35.84 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.857 2.372 . . . . 0.0 112.404 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.29 126.68 75.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -122.2 133.47 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.929 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -73.43 137.43 44.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.502 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.1 mt -83.55 -48.57 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.349 0.595 . . . . 0.0 110.34 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -140.88 -84.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.895 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -138.9 -44.92 0.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.66 0.267 . . . . 0.0 111.23 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -109.23 9.67 25.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 m -136.69 142.41 38.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 121.196 -0.202 . . . . 0.0 110.529 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 48.8 m -135.25 149.14 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 111.382 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.3 tp -116.59 129.9 56.43 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -141.85 157.98 44.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.456 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.602 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.68 147.48 18.9 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.749 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.89 118.78 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.74 137.32 54.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.56 -157.43 23.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.797 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.72 154.91 47.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -120.23 139.52 13.8 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -127.12 143.53 51.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.309 179.858 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.234 0.239 0 CA-C-O 121.115 0.483 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.8 m -122.75 132.03 54.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.697 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.1 p -149.18 160.9 42.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.623 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 138' ' ' SER . 91.0 mt -100.49 138.66 37.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.092 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.44 122.66 29.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.744 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -131.64 149.2 52.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.63 -168.3 36.46 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.634 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.07 162.12 38.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -146.0 156.71 27.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.445 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.6 138.99 51.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.879 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.443 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 52.8 tt0 -115.3 124.34 51.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.781 0.324 . . . . 0.0 110.228 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.63 131.47 56.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.977 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.451 ' OD1' HG22 ' A' ' 130' ' ' VAL . 40.6 t30 -126.72 81.11 69.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.421 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.61 -40.17 39.53 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.754 2.303 . . . . 0.0 111.887 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -133.67 154.69 80.76 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.649 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.3 -34.45 70.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.801 2.334 . . . . 0.0 113.817 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -103.19 10.96 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -131.66 112.63 12.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.451 HG22 ' OD1' ' A' ' 124' ' ' ASN . 59.8 t -122.38 130.64 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.22 123.08 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.443 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.8 m-20 -113.82 127.81 56.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.09 115.98 21.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.46 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -136.43 161.96 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.268 0.556 . . . . 0.0 112.462 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -139.29 148.85 43.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.283 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -139.85 148.5 42.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -127.33 128.45 45.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.993 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 66.2 m -100.16 123.95 45.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -101.01 112.76 25.3 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 89.9 mt -119.37 153.91 34.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.84 -44.59 96.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -106.5 -32.49 8.06 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.7 t -105.03 131.19 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -105.64 124.29 49.31 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.5 t -127.27 128.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 112.048 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.49 135.0 11.89 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 85.1 m -123.47 130.15 52.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.241 0.52 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -111.53 136.5 50.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.492 ' HE1' ' OD1' ' A' ' 30' ' ' ASN . 2.8 mmm -119.21 115.58 24.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 0.0 111.194 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.2 133.96 54.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.585 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.73 176.93 46.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.445 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.87 147.24 43.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.651 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.47 160.58 20.84 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.741 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -125.4 130.52 52.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.734 0.302 . . . . 0.0 110.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -76.5 134.12 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.339 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.782 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -138.42 157.0 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 111.264 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -133.54 144.83 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.65 126.77 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.237 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -128.75 144.99 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -127.29 150.68 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.427 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.31 -172.12 36.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.942 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -109.7 156.92 19.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.24 135.34 51.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.859 0.361 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -125.08 129.6 50.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.92 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 57.4 m -116.75 145.95 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -118.71 121.52 40.31 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.536 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 13' ' ' SER . 14.7 p-10 . . . . . 0 CA--C 1.529 0.141 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 13' ' ' SER . 95.9 Cg_endo -79.7 158.45 24.88 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.421 2.08 . . . . 0.0 110.957 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -93.31 146.78 23.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.01 -179.9 40.84 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.433 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -119.61 154.12 34.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.87 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.9 t-20 -126.38 134.42 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.282 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.2 125.66 47.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -121.33 139.32 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.147 0.499 . . . . 0.0 111.6 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.7 129.08 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.114 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -116.57 134.01 55.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.679 0.276 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -128.59 124.83 36.88 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.501 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.007 0.404 . . . . 0.0 110.911 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.94 138.43 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.102 0.477 . . . . 0.0 110.912 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.91 137.42 14.22 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.6 m -124.74 130.11 51.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.019 0.438 . . . . 0.0 111.482 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 97.1 m-85 -115.61 126.49 54.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.685 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.25 115.12 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.826 0.346 . . . . 0.0 110.649 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -123.84 111.46 16.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 77.1 p -125.93 151.8 46.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.716 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.671 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -83.51 124.19 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.894 0.378 . . . . 0.0 110.793 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -114.98 132.29 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.113 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.583 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 78.1 t80 -131.14 121.31 24.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.287 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -134.24 125.55 28.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 110.221 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 m -130.06 146.62 51.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.095 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.72 126.19 64.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.726 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.472 HG21 ' OE1' ' A' ' 136' ' ' GLU . 72.2 p -134.95 157.89 45.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.156 0.503 . . . . 0.0 111.78 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.64 153.86 36.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.96 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -169.85 165.25 38.63 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.936 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.35 154.27 40.75 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.916 2.41 . . . . 0.0 112.722 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.68 127.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.358 . . . . 0.0 110.545 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -127.87 128.55 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.078 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -74.66 128.34 35.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 0.0 111.078 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 86.3 mt -90.36 -42.31 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.12 -165.62 1.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.499 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.75 -39.72 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.548 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -127.21 25.23 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.16 127.54 67.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 66.2 m -128.29 147.25 50.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 111.057 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.9 tp -117.07 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.107 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -142.09 158.77 43.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.068 0.461 . . . . 0.0 111.361 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.558 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -118.7 156.11 15.8 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.052 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.5 mt -115.13 118.48 33.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.31 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.38 131.69 50.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.06 -148.4 10.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.823 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.99 152.23 41.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 136.44 13.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.862 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -120.83 127.46 51.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.656 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.166 179.719 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.14 0.495 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.6 m -125.0 134.68 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 138' ' ' SER . 89.3 p -141.46 162.03 36.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 0.0 111.557 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 138' ' ' SER . 60.7 tp -75.04 129.22 37.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.466 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 137' ' ' TYR . . . -119.69 133.21 55.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.538 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -148.32 159.31 44.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.719 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 174.33 -166.46 38.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.697 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.69 160.48 41.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.34 28.85 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.335 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.57 143.88 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.358 -0.421 . . . . 0.0 109.995 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -127.92 130.11 47.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.846 0.355 . . . . 0.0 110.327 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -123.5 144.36 49.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.843 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.438 ' OD1' HG23 ' A' ' 130' ' ' VAL . 33.7 t30 -127.43 82.14 68.79 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.801 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.48 -40.78 45.2 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.419 2.079 . . . . 0.0 111.848 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -136.03 154.31 77.47 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.9 -34.83 87.42 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.836 2.357 . . . . 0.0 113.761 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -98.94 10.56 41.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -138.66 112.28 8.28 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.438 HG23 ' OD1' ' A' ' 124' ' ' ASN . 67.5 t -116.64 129.78 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.626 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.6 mt -102.54 120.4 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.503 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.2 m-20 -116.65 126.11 52.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.531 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -132.77 135.16 45.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.2 p -155.59 161.01 40.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.382 0.611 . . . . 0.0 112.346 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -138.18 134.09 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.712 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.472 ' OE1' HG21 ' A' ' 74' ' ' THR . 25.9 pt-20 -129.76 147.75 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 83.7 t80 -129.12 135.11 48.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.65 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 67.6 m -107.65 129.36 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -102.04 117.69 35.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.786 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 60.9 mt -119.64 154.29 34.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.97 -44.35 94.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.9 -32.97 7.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.786 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 59.7 t -104.86 130.61 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -103.29 125.15 49.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.0 t -125.83 124.8 67.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.1 138.88 12.88 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.45 ' HB ' ' CG ' ' A' ' 136' ' ' GLU . 85.7 m -125.46 128.97 48.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.405 0.602 . . . . 0.0 111.503 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -114.09 129.51 56.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 70.8 mtm -123.62 139.89 53.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.245 0.545 . . . . 0.0 112.167 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 67.1 tp -136.97 130.43 31.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.039 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.78 173.14 34.48 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.602 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.64 151.73 49.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.433 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.32 -167.18 18.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.436 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -148.15 160.91 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.811 0.339 . . . . 0.0 110.763 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -78.97 141.41 37.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.801 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.525 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 120.709 0.29 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -128.89 143.5 50.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.18 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -129.69 141.92 50.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.693 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.6 mt -116.39 126.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.263 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 51.6 m -124.54 142.17 51.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 0.0 111.184 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -129.4 153.6 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.4 -173.59 37.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.11 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.4 142.31 37.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.09 123.8 51.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -120.38 122.29 40.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.966 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.648 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.7 m -118.97 157.68 27.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.847 0.356 . . . . 0.0 111.264 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -128.13 140.85 51.7 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.771 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.464 -179.669 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 C--O 1.232 0.136 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 13' ' ' SER . 84.6 Cg_endo -78.01 158.47 30.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.706 2.27 . . . . 0.0 111.094 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -114.18 144.78 42.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.31 177.15 43.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.297 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -111.24 144.74 39.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.464 HD22 ' HE2' ' A' ' 32' ' ' LYS . 21.7 t30 -110.69 127.87 55.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.804 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.6 127.07 53.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.229 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HE2' HD22 ' A' ' 30' ' ' ASN . 63.6 mttm -126.61 137.23 53.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.63 135.96 50.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -127.12 130.98 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -114.72 128.36 56.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.544 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.17 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.2 t -121.93 128.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.114 0.457 . . . . 0.0 110.61 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.77 140.56 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.35 141.13 13.11 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -124.99 132.11 53.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.94 0.4 . . . . 0.0 111.364 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.81 118.59 26.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.87 128.18 49.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -124.78 120.55 32.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.7 p -128.62 160.19 33.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.986 0.422 . . . . 0.0 111.695 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.907 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.8 t0 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -100.61 127.08 47.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.72 143.87 48.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.213 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -127.93 118.58 23.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -116.5 128.93 55.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.712 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.0 m -122.46 139.41 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.41 122.31 44.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.613 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.3 p -134.41 159.7 40.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.183 0.516 . . . . 0.0 111.898 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.8 154.2 38.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.094 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.89 165.01 37.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.954 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.5 153.01 30.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.817 2.345 . . . . 0.0 112.389 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.57 128.56 72.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.494 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -119.71 124.12 45.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.998 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -75.6 131.32 39.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.6 mm -90.34 -42.26 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.517 0.675 . . . . 0.0 109.873 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -150.23 -158.15 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.446 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.05 -40.83 91.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -126.2 29.04 5.91 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.71 131.29 15.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 O-C-N 121.953 -0.467 . . . . 0.0 109.836 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.4 m -138.19 152.25 48.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.704 0.288 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mp -124.36 143.22 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.166 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.528 ' CZ ' ' HA3' ' A' ' 120' ' ' GLY . 45.9 p90 -146.18 161.35 40.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.541 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -111.34 146.48 17.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.968 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.1 mt -116.41 123.87 48.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.96 0.41 . . . . 0.0 111.56 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -138.16 137.91 38.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -154.66 16.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.857 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.63 153.07 47.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.998 0.428 . . . . 0.0 111.678 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.39 142.78 17.56 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.71 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -129.67 123.74 31.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.754 179.288 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.147 0.498 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.6 p -109.84 148.75 30.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.711 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -154.93 160.6 41.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.789 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 138' ' ' SER . 85.1 mt -101.25 136.39 41.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.0 133.34 54.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -142.41 139.45 31.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.17 -166.42 29.09 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.777 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.528 ' HA3' ' CZ ' ' A' ' 88' ' ' TYR . . . -134.4 150.27 20.01 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.41 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.04 138.7 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.417 -0.391 . . . . 0.0 109.948 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -124.7 132.12 53.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.898 0.38 . . . . 0.0 110.44 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.518 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -114.8 95.31 40.72 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.355 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.48 -36.22 87.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.522 2.148 . . . . 0.0 111.535 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -130.06 157.17 77.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.767 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.18 -37.34 79.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.874 2.383 . . . . 0.0 113.636 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -105.46 16.35 25.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -126.27 117.03 22.2 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.92 -0.488 . . . . 0.0 110.665 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.1 t -115.32 126.87 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.654 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.4 mm -108.59 126.39 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -123.42 116.82 23.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.997 0.427 . . . . 0.0 111.402 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -122.94 133.33 54.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.6 p -152.22 166.98 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.331 0.586 . . . . 0.0 112.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -141.31 150.68 42.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.633 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -140.18 151.02 44.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -133.92 128.4 34.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.763 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 20.3 m -94.76 124.43 38.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -103.47 102.86 12.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.745 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 97.5 mt -118.62 152.33 36.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.26 -43.86 98.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -105.42 -33.12 8.26 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.745 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.2 t -105.66 125.96 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -105.8 122.64 46.51 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 73.7 t -127.19 129.27 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -117.7 138.83 14.35 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.0 m -127.05 131.71 50.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.244 0.522 . . . . 0.0 111.495 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.9 m-90 -116.8 139.31 50.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 64.3 mtt -127.15 124.33 38.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 0.0 111.992 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.3 mt -127.75 136.67 51.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.112 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.68 -172.37 43.68 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.383 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.97 158.32 44.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.621 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.02 164.4 25.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.816 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -131.32 129.29 41.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 110.177 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -76.37 137.84 40.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 t80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.751 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.088 0.471 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.93 161.03 10.16 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.082 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 -87.24 143.03 27.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.9 m -122.1 141.02 51.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.994 0.426 . . . . 0.0 111.113 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -140.62 153.35 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.143 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -119.87 143.47 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.455 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 49.1 m -134.48 142.85 47.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.74 0.305 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.73 150.0 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.94 167.91 40.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.017 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -89.7 138.74 31.22 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.81 127.95 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -126.02 122.13 34.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.093 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 146' ' ' GLY . 50.1 m -118.4 156.72 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.11 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -122.97 128.36 50.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.21 129.59 74.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.454 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -86.48 108.31 18.47 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.393 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -163.74 147.53 10.2 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.039 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -91.92 108.56 20.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.73 -146.74 6.2 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.576 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.86 145.9 53.31 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HG2' ' NH2' ' A' ' 52' ' ' ARG . 18.6 tptt 74.49 116.54 0.06 Allowed 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.942 0.776 . . . . 0.0 110.324 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.0 tp -61.24 -44.49 97.18 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -86.12 -12.71 49.24 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 41.9 mmtt 49.96 37.59 14.26 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -97.23 111.25 57.59 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 34.7 Cg_exo -63.4 147.14 93.65 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.064 2.51 . . . . 0.0 111.441 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -113.36 140.35 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.285 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -176.4 -174.84 43.25 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.349 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -119.12 147.39 44.22 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 110.591 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -117.09 127.97 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.227 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 tp -112.6 126.08 54.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.977 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 29.2 ttpp -125.06 133.89 52.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.147 0.498 . . . . 0.0 111.621 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -114.36 130.5 56.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.002 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -112.71 128.51 56.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.946 0.403 . . . . 0.0 111.452 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -128.98 120.49 26.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -98.54 119.91 38.06 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -86.29 -16.92 36.02 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.254 0.55 . . . . 0.0 109.914 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -148.0 174.15 12.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.75 -40.07 94.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -111.27 0.99 16.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -127.7 141.21 51.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.093 0.473 . . . . 0.0 111.699 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.86 -179.68 41.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.742 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.25 156.66 42.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 117.021 0.41 . . . . 0.0 110.631 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -134.07 147.77 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.266 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -124.72 123.75 5.17 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -114.94 125.37 53.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.165 0.483 . . . . 0.0 111.759 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -117.11 121.22 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.68 126.98 54.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 0.0 111.646 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.511 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 65.5 tt0 -123.91 117.08 24.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 73.7 p -128.87 156.5 43.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.058 0.456 . . . . 0.0 111.827 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -145.31 162.02 38.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.367 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.465 ' NH2' ' HG2' ' A' ' 21' ' ' LYS . 5.1 tpm_? -62.65 130.31 44.44 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.024 0.44 . . . . 0.0 110.917 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 59.1 5.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.157 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.64 132.34 48.81 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.01 140.92 56.47 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.768 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -71.12 129.06 37.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.05 0.453 . . . . 0.0 111.193 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -131.75 149.01 52.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.668 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.98 118.05 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.641 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -148.36 107.11 3.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.87 18.79 78.48 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.737 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 66.74 27.29 9.32 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.059 0.544 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -131.89 149.79 52.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.799 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -110.29 132.39 54.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.817 0.342 . . . . 0.0 111.216 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -95.75 -54.33 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.639 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 57.83 26.8 13.65 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.18 0.592 . . . . 0.0 112.069 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.58 -17.87 56.51 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.35 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 51.68 39.31 24.93 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 52' ' ' ARG . 94.9 t80 -139.6 126.95 21.4 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -129.44 141.62 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.553 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 74.3 t80 -133.31 126.53 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.506 ' CE2' ' HG3' ' A' ' 49' ' ' GLN . 95.5 m-85 -124.37 139.96 53.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.895 0.378 . . . . 0.0 110.533 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.68 141.9 45.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.049 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 3.1 p -138.78 120.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.636 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.1 p -135.56 158.38 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.024 0.44 . . . . 0.0 111.877 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.83 157.18 42.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.912 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -172.85 161.31 32.55 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.54 155.19 35.86 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.967 2.445 . . . . 0.0 112.408 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.06 126.65 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.396 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -126.4 128.98 47.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.752 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -77.87 131.49 37.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.697 0.285 . . . . 0.0 110.926 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.4 mt -90.18 -43.22 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.514 0.673 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -138.29 -166.61 2.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.235 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -62.64 -39.65 94.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.622 0.248 . . . . 0.0 111.445 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -122.89 21.75 9.82 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.4 127.96 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 CA-C-N 118.011 0.369 . . . . 0.0 110.095 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.8 m -130.14 144.45 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.764 0.316 . . . . 0.0 111.049 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.6 tp -124.37 135.17 53.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.401 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 51.9 p90 -139.68 156.17 46.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.06 0.457 . . . . 0.0 111.383 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.633 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -108.97 153.16 16.9 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.074 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 134' ' ' SER . 88.9 mt -120.61 127.27 51.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 111.716 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -144.26 138.03 27.68 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . 176.66 -150.23 10.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.875 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.27 156.26 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.45 147.23 16.7 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.665 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -135.75 128.34 30.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 110.838 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.11 140.45 12.71 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.015 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -128.66 139.91 52.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.654 0.264 . . . . 0.0 110.985 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.33 136.71 41.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.605 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -125.94 148.83 49.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.375 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -111.71 134.63 53.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.688 0.28 . . . . 0.0 110.57 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.7 m -101.63 114.42 28.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.988 0.423 . . . . 0.0 111.101 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.8 p -162.77 166.96 23.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.454 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.4 mm -99.83 111.92 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.008 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -149.93 160.36 43.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.958 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.7 -39.07 96.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.734 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -116.99 153.46 32.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 0.0 110.355 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.9 m -113.57 150.95 32.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.469 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -143.24 159.46 42.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.945 0.402 . . . . 0.0 111.262 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -156.22 167.6 29.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.097 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -126.73 141.52 51.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.944 0.402 . . . . 0.0 111.29 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.1 m -132.91 137.08 46.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.628 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.05 146.06 50.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.903 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.2 p -120.29 148.01 44.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.255 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.8 p -157.28 165.68 35.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.347 . . . . 0.0 111.849 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 138' ' ' SER . 90.4 mt -99.58 137.81 37.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.909 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.46 131.92 54.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.035 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -143.6 137.9 28.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.36 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.65 -163.32 27.7 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.692 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.33 159.58 43.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -136.86 153.52 21.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.265 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.85 138.81 50.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.028 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 51.6 tt0 -129.21 128.38 43.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.612 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -116.49 139.72 50.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.476 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -116.01 85.79 15.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.7 -32.95 7.03 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.207 1.938 . . . . 0.0 111.711 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -134.71 152.71 78.09 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.695 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.8 -38.27 94.64 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 122.664 2.243 . . . . 0.0 114.054 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -104.55 6.07 34.37 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -137.57 122.04 18.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.927 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.64 153.17 36.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.03 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.31 123.83 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.81 130.72 56.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -127.22 120.26 28.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 90' ' ' LEU . 73.3 m -121.65 142.48 50.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.533 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.5 m-85 -122.41 122.54 39.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.113 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 83.8 mt-10 -127.1 135.8 51.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.01 142.07 49.46 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.992 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 57.4 m -115.32 128.02 55.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.12 114.78 29.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.753 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 83.3 mt -118.67 154.72 32.25 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.11 -42.91 95.76 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.55 -33.54 7.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.753 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.1 t -106.42 129.03 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -106.06 126.61 52.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 72.6 t -125.85 126.88 70.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -118.38 137.78 13.25 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 73.9 m -126.88 128.42 46.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.262 0.531 . . . . 0.0 111.086 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -119.8 139.03 52.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 17.8 tmm? -134.42 132.03 38.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.094 0.473 . . . . 0.0 111.567 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.89 127.04 41.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -163.71 -167.65 24.51 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.53 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.9 156.23 48.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.763 0.316 . . . . 0.0 110.709 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -124.95 152.84 17.71 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.679 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -121.24 128.33 52.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.881 0.372 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -93.92 128.25 40.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.71 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.913 0.387 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.69 74.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.79 148.69 38.26 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 110.464 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -138.59 156.47 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.0 m -145.04 156.02 43.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.63 143.31 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.479 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 50.4 m -134.51 148.34 50.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.708 0.29 . . . . 0.0 111.286 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.9 152.16 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.331 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.24 -179.19 41.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.025 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -103.18 140.81 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.691 0.281 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.81 121.78 45.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -120.43 127.95 52.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.67 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.667 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.5 m -118.01 153.28 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 111.276 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.93 127.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.718 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -85.9 109.82 19.0 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.67 -0.412 . . . . 0.0 109.903 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -155.2 164.67 38.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.335 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -119.01 107.71 13.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.802 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.76 -131.01 2.44 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.511 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.456 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 85.0 m-85 -69.06 150.29 47.78 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 49.0 mttp 69.7 95.84 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.573 0.546 . . . . 0.0 110.595 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.12 -45.16 93.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.723 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 11.3 m-20 -92.13 -14.57 28.96 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 20' ' ' TYR . 57.1 mmtt 50.12 37.24 13.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.444 ' OD1' ' HB3' ' A' ' 23' ' ' ASP . 32.1 m120 -103.43 112.08 65.46 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.667 ' HD2' ' O ' ' A' ' 13' ' ' SER . 91.5 Cg_endo -80.23 158.87 23.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.747 2.298 . . . . 0.0 111.362 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -111.19 136.49 50.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.554 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.18 -179.86 40.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.574 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.95 154.69 35.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -127.97 126.18 40.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -108.85 136.78 47.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 15.8 ttmm -130.98 136.9 48.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.132 0.491 . . . . 0.0 111.528 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -122.6 127.59 49.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.869 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -113.82 130.63 56.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.0 111.314 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -126.61 122.73 35.88 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -97.26 106.17 18.45 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -70.53 -35.32 73.09 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.34 0.59 . . . . 0.0 109.814 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -138.12 176.1 9.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.606 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -62.94 -43.02 99.94 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -109.88 14.04 23.29 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -141.03 130.72 24.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.892 0.377 . . . . 0.0 111.564 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.16 177.37 35.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.016 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.8 156.61 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.034 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.1 pp -132.41 146.08 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 111.537 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -120.92 125.73 6.33 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 48.1 m -118.09 128.16 54.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 0.0 112.005 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -121.21 120.5 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.354 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.07 129.47 55.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.892 0.377 . . . . 0.0 111.46 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -122.86 115.92 22.78 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.7 p -127.0 155.4 43.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 112.013 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -145.28 148.17 33.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.002 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -63.15 138.02 58.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.807 0.336 . . . . 0.0 110.687 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.12 -174.87 49.04 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.863 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -106.08 118.58 36.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.971 0.415 . . . . 0.0 110.68 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 21' ' ' LYS . 42.3 tt0 -135.18 131.55 36.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.516 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -84.85 129.58 34.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.994 0.426 . . . . 0.0 111.062 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.8 m -131.38 149.82 52.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.076 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.6 101.28 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.898 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -158.88 74.42 0.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.778 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.47 5.21 90.13 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.773 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 61.14 32.74 19.57 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.844 0.458 . . . . 0.0 111.333 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -118.09 130.86 56.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.609 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.6 mt -96.73 109.68 22.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.41 . . . . 0.0 110.898 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.43 -31.38 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.089 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.3 t70 69.56 -67.15 0.23 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.308 0.643 . . . . 0.0 111.256 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.17 -42.09 2.04 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.904 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t0 46.45 52.63 10.61 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.841 0.456 . . . . 0.0 111.814 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -114.79 128.62 56.4 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.931 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -113.92 137.54 51.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.56 123.45 39.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -117.45 137.33 52.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.2 m -127.58 131.97 49.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.852 0.358 . . . . 0.0 111.216 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.03 117.96 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.412 ' OG1' ' HB2' ' A' ' 46' ' ' SER . 74.2 p -132.47 156.96 45.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 111.743 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.581 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.1 156.35 42.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.225 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -173.77 165.02 36.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.104 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.18 155.63 25.71 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.001 2.467 . . . . 0.0 112.364 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.17 127.76 75.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -126.81 125.98 42.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.984 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -77.21 127.61 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.5 mt -75.12 -46.04 40.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -134.29 -97.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.158 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 -31.72 1.36 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.29 3.99 11.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.09 128.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 57.1 m -129.0 148.72 50.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 tt -116.8 136.72 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.225 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.5 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 50.1 p90 -142.04 155.44 45.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.392 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.572 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -109.03 151.86 17.08 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.044 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.1 mt -119.67 125.57 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 0.0 111.503 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -144.58 140.37 28.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.602 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.97 -157.29 27.22 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.65 151.94 51.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.082 0.467 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.17 141.49 17.04 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -127.58 126.09 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.808 0.337 . . . . 0.0 110.39 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -116.4 142.06 17.23 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.352 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.43 136.2 54.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.715 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.9 133.14 46.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -128.9 144.5 51.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -104.04 122.71 45.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.8 m -88.56 113.62 24.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.963 0.411 . . . . 0.0 111.492 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.7 p -163.94 165.69 22.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.505 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.68 111.02 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -150.32 162.56 40.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.993 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.16 -39.08 96.64 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.779 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -123.51 150.66 43.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.2 m -120.56 149.95 41.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.724 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -125.39 142.5 51.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.189 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.1 m -132.93 152.73 51.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.934 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -127.33 154.85 44.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 111.638 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.3 p -137.39 152.3 49.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.0 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -131.18 150.88 51.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.6 m -115.42 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.7 p -140.54 157.71 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.978 0.418 . . . . 0.0 111.77 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 138' ' ' SER . 69.0 tp -100.56 127.66 46.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.56 130.77 56.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.424 . . . . 0.0 110.953 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -144.56 140.22 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.83 -163.33 27.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.633 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.15 161.27 41.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.5 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -142.1 158.58 26.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.347 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.8 mt -122.56 139.38 53.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.509 -0.346 . . . . 0.0 110.077 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.472 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 52.5 tt0 -118.85 128.49 54.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.169 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.33 142.37 51.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -124.19 82.67 56.92 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.532 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.21 -28.61 33.77 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.477 2.118 . . . . 0.0 112.127 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -131.56 151.29 78.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.546 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.81 -25.57 74.66 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 113.452 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -111.48 13.49 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -140.29 120.89 14.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 110.951 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.5 t -111.43 129.98 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.183 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 51.0 mm -104.64 119.65 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.472 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 88.7 m-20 -114.11 126.48 55.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.991 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.15 124.04 45.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 74.9 m -127.35 143.08 51.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 112.379 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.519 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 51.9 m-85 -124.65 122.96 38.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.102 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -125.59 135.12 51.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -127.39 139.21 53.0 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.871 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 49.6 m -105.99 123.96 48.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -101.36 107.64 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.258 0.552 . . . . 0.0 112.311 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 87.3 mt -119.01 153.0 35.39 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.89 -44.11 97.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -104.9 -32.92 8.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.729 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -106.07 128.36 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -106.19 120.69 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.92 129.19 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.974 0.416 . . . . 0.0 112.091 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.09 138.29 14.64 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.7 m -124.84 129.16 49.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.979 0.418 . . . . 0.0 111.3 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -115.95 136.99 52.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -131.93 127.87 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.96 137.47 53.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.36 -171.59 38.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.571 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.86 157.09 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.94 0.4 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.79 167.19 24.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.738 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -132.86 130.81 40.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.494 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.2 mtm105 -79.04 140.45 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.027 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.937 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.102 0.477 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.75 -177.68 42.51 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.973 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -87.75 135.85 33.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -122.94 142.95 50.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.452 . . . . 0.0 111.239 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 155' ' ' ARG . 32.3 m -143.26 154.57 43.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.875 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.3 143.77 32.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.502 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 50.1 m -132.27 141.95 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 pt -127.95 147.56 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.45 -173.22 38.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.042 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.34 142.99 36.27 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.77 114.4 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.266 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -116.77 132.34 56.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.649 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 44.6 m -118.23 165.23 14.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.804 0.335 . . . . 0.0 111.624 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -126.61 121.12 31.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 64.6 t -121.22 127.75 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.378 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -67.13 109.22 2.95 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.94 0.4 . . . . 0.0 110.437 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -137.7 154.18 49.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.345 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -123.52 110.04 14.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.423 0.154 . . . . 0.0 110.891 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.79 -90.91 0.31 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.901 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -82.86 160.16 22.23 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.892 -0.181 . . . . 0.0 110.609 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 59.3 81.5 0.17 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.096 0.474 . . . . 0.0 110.781 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.34 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -84.21 -12.19 55.25 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 40.7 mttp 57.8 21.29 7.33 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.185 0.594 . . . . 0.0 112.148 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 13' ' ' SER . 30.5 m120 -106.0 112.85 64.15 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 13' ' ' SER . 93.2 Cg_endo -79.67 159.21 25.07 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.797 2.331 . . . . 0.0 110.745 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.01 142.42 27.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.0 169.68 41.01 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.392 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.84 147.64 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 0.0 110.565 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.533 HD22 ' HE2' ' A' ' 32' ' ' LYS . 42.1 t30 -111.09 121.84 46.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.641 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.22 124.09 42.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.102 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.533 ' HE2' HD22 ' A' ' 30' ' ' ASN . 67.5 mttm -127.76 145.39 50.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.436 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -123.34 127.81 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.539 ' NE ' HE22 ' A' ' 122' ' ' GLN . 51.6 mtp180 -109.6 136.48 48.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.902 0.382 . . . . 0.0 111.835 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.64 119.33 16.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.412 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.86 132.13 44.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.98 -34.24 71.21 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.353 0.597 . . . . 0.0 109.947 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -153.62 174.55 14.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.581 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -80.33 71.27 7.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.651 0.262 . . . . 0.0 110.871 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -164.22 -47.69 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -150.65 160.34 43.89 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.931 0.396 . . . . 0.0 111.3 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.71 -167.12 36.46 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.0 m -126.75 148.3 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.343 . . . . 0.0 110.818 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.671 ' HB ' ' CE1' ' A' ' 88' ' ' TYR . 78.9 mt -129.37 130.11 67.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.45 136.53 12.74 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -123.22 133.4 54.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.275 0.538 . . . . 0.0 111.865 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -135.93 124.32 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.448 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.08 143.11 49.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.98 0.419 . . . . 0.0 111.201 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -121.51 126.1 48.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 64.8 p -125.7 151.8 46.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -157.86 163.27 38.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.613 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -64.85 141.25 58.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.764 0.316 . . . . 0.0 110.608 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.24 165.18 50.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.752 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -108.85 130.7 55.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.854 0.359 . . . . 0.0 111.019 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -127.04 137.42 53.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.993 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -91.54 113.05 25.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.34 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 t -150.86 135.23 17.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.487 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.0 145.32 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.631 0.253 . . . . 0.0 110.896 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -170.54 37.45 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.019 0.437 . . . . 0.0 110.343 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.28 -8.3 77.4 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.337 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -130.1 152.48 49.5 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.561 0.219 . . . . 0.0 110.954 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -107.74 147.19 31.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.946 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.18 142.38 31.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.501 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.9 pt -91.19 -13.2 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.996 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.7 t70 71.98 -41.83 0.52 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.647 0.779 . . . . 0.0 111.925 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.1 -22.19 35.66 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.644 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 97.5 m-20 49.72 46.63 23.74 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -99.48 120.69 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.95 139.02 53.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.235 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.502 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 85.9 t80 -133.78 128.43 34.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.74 135.66 53.7 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.3 m -116.1 123.62 48.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.712 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.38 110.8 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.0 p -135.67 159.3 42.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.051 0.453 . . . . 0.0 111.851 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.29 151.6 32.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.827 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.4 161.54 33.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.901 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.47 160.03 32.2 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.049 2.499 . . . . 0.0 112.688 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 78' ' ' VAL . 9.1 p -130.06 132.49 65.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.227 0.537 . . . . 0.0 110.139 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.49 148.76 50.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.135 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -85.33 127.35 34.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.278 . . . . 0.0 110.705 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.6 mt -89.36 -44.07 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -134.56 -164.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.082 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' O ' ' HD1' ' A' ' 84' ' ' TYR . 98.6 mt-10 -62.05 -40.78 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.457 0.17 . . . . 0.0 111.34 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 83' ' ' GLU . 6.4 m-30 -126.85 28.98 5.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.12 131.41 67.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.3 m -128.9 148.6 50.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.2 tp -112.19 129.75 56.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.671 ' CE1' ' HB ' ' A' ' 44' ' ' ILE . 38.5 t80 -126.99 133.47 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.031 0.443 . . . . 0.0 111.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -107.7 141.58 15.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.554 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mp -110.06 121.52 45.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 111.486 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.8 tp -135.28 126.81 28.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.562 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.5 -151.15 11.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.869 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.92 155.29 44.69 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.133 0.492 . . . . 0.0 111.553 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.451 ' HA3' ' OH ' ' A' ' 70' ' ' TYR . . . -122.73 144.06 15.66 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.797 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -126.87 126.37 43.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 110.703 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -126.27 150.87 17.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.352 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -146.71 151.32 37.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.848 0.356 . . . . 0.0 110.955 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.43 134.61 41.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 61.3 mtpt -128.08 143.22 51.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.246 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -109.59 125.7 52.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.384 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.1 m -102.41 113.52 26.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.055 0.455 . . . . 0.0 110.947 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.8 p -164.19 169.48 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.749 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.39 111.15 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.646 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -150.53 170.8 18.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.919 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.57 -38.22 95.47 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.729 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -141.05 157.03 45.89 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.585 0.231 . . . . 0.0 110.424 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -124.06 148.78 46.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.587 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -126.75 139.34 53.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.813 0.339 . . . . 0.0 111.199 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.0 m -132.65 152.74 51.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -127.49 146.09 50.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.409 . . . . 0.0 111.436 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.5 m -133.87 150.02 51.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.104 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -148.38 148.74 30.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.374 0.606 . . . . 0.0 111.73 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 87.0 m -128.6 133.38 48.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.591 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.3 p -140.12 160.48 39.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.56 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.31 141.87 31.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.177 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.35 133.43 55.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.61 140.04 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.471 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.01 -175.42 38.95 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.734 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.45 154.31 41.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.41 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -148.53 161.71 28.7 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.418 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.17 138.72 50.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.363 -0.418 . . . . 0.0 110.159 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.539 HE22 ' NE ' ' A' ' 34' ' ' ARG . 54.7 tt0 -119.86 130.5 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.999 0.428 . . . . 0.0 110.034 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.03 152.27 33.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.028 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -121.22 82.92 38.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.619 0.247 . . . . 0.0 110.688 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.34 -28.99 14.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.356 2.037 . . . . 0.0 112.248 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 79.5 m80 -130.64 152.93 81.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.737 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -56.28 -36.19 96.64 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.763 2.308 . . . . 0.0 114.287 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -109.57 -4.23 16.37 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 126' ' ' HIS . 68.2 m-85 -121.47 133.51 55.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.68 152.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.084 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.3 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -115.54 114.99 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -114.14 108.97 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.41 ' OG ' ' HA3' ' A' ' 120' ' ' GLY . 54.0 m -128.03 153.13 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -134.48 131.85 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.709 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 149' ' ' MET . 27.2 pt-20 -140.91 161.24 38.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -137.76 159.1 42.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 0.0 111.626 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.453 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 45.2 m -108.59 135.53 49.69 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.912 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -98.67 104.81 16.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 79.2 mt -118.48 153.29 34.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.54 -45.25 93.83 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.2 -32.82 7.64 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.796 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 62.7 t -104.92 130.48 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.44 125.08 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.6 t -121.83 125.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.14 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -113.74 138.17 14.7 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.6 m -124.58 130.98 53.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.443 0.621 . . . . 0.0 111.433 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.7 m-90 -106.24 131.55 53.35 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.41 ' HE3' ' OE2' ' A' ' 136' ' ' GLU . 57.6 mtt -120.63 111.2 17.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.438 . . . . 0.0 111.438 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -123.85 134.41 53.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.612 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 178.39 48.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.378 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.81 150.89 42.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.855 0.359 . . . . 0.0 110.498 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -127.3 155.29 19.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.985 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -118.55 127.77 53.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.764 0.316 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.482 ' HA ' ' OG ' ' A' ' 5' ' ' SER . 80.8 mtp180 -92.82 132.57 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.875 -179.9 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.502 ' HG3' ' OH ' ' A' ' 35' ' ' TYR . 21.8 pt-20 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.157 0.503 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.34 173.59 45.56 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.025 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -88.19 135.24 33.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.547 0.213 . . . . 0.0 110.431 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -129.04 143.34 50.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.235 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -128.47 143.5 50.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.4 mm -113.77 120.57 63.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 65.7 m -127.33 144.71 51.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.399 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.52 153.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.571 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.17 -174.34 38.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.102 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -109.06 142.61 39.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.26 127.74 54.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 111.416 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -120.97 114.82 22.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.731 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 50.6 m -118.2 159.85 22.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.59 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -126.91 128.87 47.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.85 120.3 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.169 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -100.35 110.07 22.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -163.34 174.74 11.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.166 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -84.62 103.25 13.57 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.69 174.37 45.69 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.544 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -92.89 118.09 30.75 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.839 -0.213 . . . . 0.0 111.191 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 38.1 tptt -173.65 127.74 0.41 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.16 -48.17 81.29 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -114.86 -12.51 12.07 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.44 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 36.9 mtmm 59.46 23.26 11.84 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.943 0.497 . . . . 0.0 111.566 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -105.68 112.96 64.49 Favored Pre-proline 0 C--O 1.233 0.207 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.731 ' HD2' ' O ' ' A' ' 13' ' ' SER . 72.4 Cg_endo -74.83 157.99 43.14 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.474 2.116 . . . . 0.0 110.72 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -113.92 146.73 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.049 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.66 178.31 48.38 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.431 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.69 148.39 33.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 0.0 110.788 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -124.27 130.05 51.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.948 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.76 136.2 53.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.082 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.7 mttm -124.49 139.95 53.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 111.377 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -132.64 128.3 36.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.069 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.452 ' HD3' HE22 ' A' ' 122' ' ' GLN . 47.0 ttp180 -119.92 133.68 55.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.502 ' OH ' ' HG3' ' A' ' 1' ' ' GLU . 93.8 t80 -128.19 125.15 38.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.1 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -123.64 133.41 53.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.26 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -97.92 -9.63 25.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.302 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -158.12 163.37 37.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.411 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -82.6 61.19 5.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.564 0.221 . . . . 0.0 111.134 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -169.49 -55.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -119.12 143.78 46.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 111.323 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.77 -174.47 31.69 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.834 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.32 153.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -139.1 138.63 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.36 139.93 12.6 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 m -129.36 136.6 50.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.992 0.425 . . . . 0.0 111.105 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.39 124.85 43.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.821 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.08 120.27 36.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.784 0.326 . . . . 0.0 110.939 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.533 ' OE1' ' HD1' ' A' ' 71' ' ' TYR . 2.8 mm-40 -112.09 106.48 15.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.1 p -125.99 158.04 36.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.119 0.485 . . . . 0.0 112.276 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -152.21 159.72 43.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -83.64 125.97 32.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.756 0.312 . . . . 0.0 110.514 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.11 150.84 20.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.304 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.84 139.13 46.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 111.14 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -74.57 155.49 37.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.458 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -79.91 128.8 33.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.941 0.401 . . . . 0.0 110.851 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p -150.17 163.06 39.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.888 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -96.12 105.04 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.531 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -164.56 54.45 0.14 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.352 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.14 -10.55 73.74 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.729 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 55.88 37.84 29.32 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.146 0.578 . . . . 0.0 111.773 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -110.84 108.47 18.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.801 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.5 mt -119.14 133.44 55.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 111.224 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 pt -94.7 -21.19 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.987 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 t70 68.03 -62.63 0.35 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.439 0.695 . . . . 0.0 111.896 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.91 -19.83 50.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.452 -0.404 . . . . 0.0 112.703 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 53.33 44.42 30.11 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.676 0.391 . . . . 0.0 111.84 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -99.39 122.76 42.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.645 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -127.79 142.23 51.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.13 123.25 24.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.533 ' HD1' ' OE1' ' A' ' 49' ' ' GLN . 92.1 m-85 -112.79 128.91 56.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.4 m -113.92 127.03 55.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.181 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.9 124.4 70.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -147.15 153.43 39.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.851 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -153.03 153.43 32.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -167.81 167.37 40.01 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.997 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.56 156.3 40.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.526 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.76 129.71 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.544 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -126.88 126.63 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.996 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -69.94 134.79 48.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 0.0 111.215 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.6 mt -89.62 -45.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.53 0.681 . . . . 0.0 109.777 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.83 -144.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.86 -1.78 52.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.342 -0.224 . . . . 0.0 111.468 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -147.05 9.72 0.99 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.37 142.53 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 68.1 m -138.3 151.35 47.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.049 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tt -116.26 136.93 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -142.75 157.69 44.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 111.335 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.634 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.99 150.52 18.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.845 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.02 129.44 55.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.455 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -142.36 135.66 28.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.8 13.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.903 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.69 152.19 45.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.101 0.477 . . . . 0.0 111.606 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.21 140.81 16.43 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.768 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.435 ' NE2' ' HD3' ' A' ' 97' ' ' LYS . 75.0 t60 -119.03 122.42 42.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.592 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.88 138.28 14.85 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.272 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HD3' ' NE2' ' A' ' 95' ' ' HIS . 31.2 mmmt -124.27 137.19 54.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.808 0.337 . . . . 0.0 110.832 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.93 130.19 35.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.708 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -127.04 146.25 50.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.187 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -120.87 139.22 53.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.648 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.9 m -103.99 113.95 27.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.015 0.436 . . . . 0.0 110.819 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.4 m -155.25 164.87 38.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.608 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.1 mt -100.45 111.43 30.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.758 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -150.45 171.24 17.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.81 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.1 93.17 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.153 -0.546 . . . . 0.0 111.802 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -133.16 163.57 28.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.618 0.247 . . . . 0.0 110.339 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.0 p -108.96 149.42 29.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.801 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -127.71 153.59 46.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.937 0.398 . . . . 0.0 110.965 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.7 p -150.07 163.66 37.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.817 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -127.01 146.12 50.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.05 0.452 . . . . 0.0 111.58 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -128.78 138.62 52.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.647 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.13 149.48 52.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.247 0.546 . . . . 0.0 111.732 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -126.8 149.03 49.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.3 t -153.97 148.31 26.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 111.511 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.44 126.94 32.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.64 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.435 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . . . -114.85 132.89 56.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.97 0.414 . . . . 0.0 111.132 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.76 137.7 25.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.291 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.4 -168.38 29.47 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.752 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.06 161.47 41.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.64 161.92 28.95 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.579 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.07 140.76 50.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.047 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.452 HE22 ' HD3' ' A' ' 34' ' ' ARG . 52.7 tt0 -115.4 128.55 56.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -116.18 139.93 49.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.108 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -128.83 82.69 68.19 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -30.06 17.48 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.372 2.048 . . . . 0.0 112.237 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -131.32 152.43 80.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.633 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.16 -35.01 89.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.92 2.413 . . . . 0.0 113.869 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.423 ' O ' ' HD1' ' A' ' 154' ' ' TYR . 2.8 t-20 -109.99 13.7 23.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -130.94 118.57 20.87 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -117.37 131.04 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.341 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.21 122.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -110.77 129.67 55.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.9 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -133.79 125.49 28.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 99.3 p -155.8 165.8 35.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.9 152.64 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.55 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.435 ' OE2' ' HB3' ' A' ' 116' ' ' ALA . 52.5 tt0 -144.42 137.52 27.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -112.75 132.34 55.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 49.3 m -102.89 125.91 49.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -103.25 114.58 28.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 68.1 mt -119.91 153.65 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.16 -43.41 98.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -106.72 -32.06 8.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.756 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.4 t -105.26 130.75 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.91 123.94 48.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -127.7 126.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 112.055 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -114.41 135.01 12.08 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.3 m -119.44 129.18 54.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.52 0.66 . . . . 0.0 111.621 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -111.09 131.44 55.08 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 63.8 mtt -120.71 115.1 22.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.25 136.5 53.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.322 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 -173.25 44.51 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.394 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.66 159.29 43.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.07 -178.23 28.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.596 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.423 ' HD1' ' O ' ' A' ' 128' ' ' ASN . 94.2 m-85 -121.82 144.66 48.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.654 0.264 . . . . 0.0 110.494 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -96.25 126.39 41.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.813 -179.823 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.999 0.428 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.62 167.61 50.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.046 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.67 150.57 30.88 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.78 -0.247 . . . . 0.0 110.477 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' ARG . 37.3 t -133.88 140.17 46.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 111.134 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.7 m -131.65 149.46 52.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.3 mt -118.56 126.66 75.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.27 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.496 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 62.1 m -117.83 137.22 52.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.299 . . . . 0.0 111.207 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -121.36 129.64 75.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.193 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.93 172.91 31.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.08 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -98.56 145.05 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.81 138.96 52.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.947 0.403 . . . . 0.0 111.429 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' NE1' ' A' ' 148' ' ' TRP . 97.3 mt-30 -127.73 135.03 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.967 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.655 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.6 m -118.82 148.56 42.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.176 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -120.37 123.19 42.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.86 131.9 72.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -86.14 109.51 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 0.0 110.303 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -145.91 157.01 43.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.227 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -97.43 108.6 21.36 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.79 -147.23 9.28 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.507 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.546 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 90.3 m-85 -72.9 146.79 45.89 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 59.4 mmtt 74.59 110.55 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.579 0.549 . . . . 0.0 109.843 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.82 -40.2 91.82 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -86.99 -14.35 41.91 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt 48.9 38.34 12.02 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -101.56 114.03 65.73 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.655 ' HD2' ' O ' ' A' ' 13' ' ' SER . 73.5 Cg_endo -76.8 159.48 34.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.632 2.221 . . . . 0.0 110.756 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -116.07 156.35 26.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.903 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -178.63 -153.79 11.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.362 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.12 161.35 38.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 28.1 t-20 -135.26 128.87 32.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' SER . 87.1 mt -104.13 128.15 51.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.986 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 23.0 ttmm -119.74 127.75 53.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.513 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.38 134.52 52.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.614 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 4' ' ' SER . 77.2 ttt-85 -121.78 131.03 53.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 111.733 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -132.36 131.49 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -96.22 127.48 42.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -101.21 -16.62 16.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.265 0.555 . . . . 0.0 109.626 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -150.14 177.87 9.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.579 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.95 -46.95 87.04 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -113.94 6.61 16.63 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -124.85 140.45 52.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.02 0.438 . . . . 0.0 111.51 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.17 -177.36 38.77 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.907 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.9 0.381 . . . . 0.0 110.822 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.3 pp -136.77 150.07 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -130.86 134.1 7.6 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 55.0 m -124.57 135.71 53.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.031 0.415 . . . . 0.0 111.774 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 94.8 m-85 -120.4 111.73 18.11 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.67 127.48 49.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.503 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.512 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 77.4 mt-30 -126.08 123.52 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 77.1 p -128.04 149.45 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.676 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -138.69 154.82 48.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.037 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -69.81 139.87 53.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.668 0.271 . . . . 0.0 110.272 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.29 57.04 0.61 Allowed Glycine 0 CA--C 1.517 0.157 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.814 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -110.84 136.85 49.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.706 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.11 134.73 53.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.446 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -90.03 123.78 34.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.009 0.433 . . . . 0.0 111.056 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 m -130.05 152.19 49.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.527 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.4 t -89.66 114.42 27.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.886 0.374 . . . . 0.0 110.815 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -151.37 99.65 2.66 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.627 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.9 10.29 86.32 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.764 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 60.36 37.2 20.26 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.049 0.539 . . . . 0.0 111.293 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -122.3 136.22 54.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.111 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.1 121.64 16.03 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.975 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.7 pt -102.96 -13.83 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.809 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.05 -45.13 93.69 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.414 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.7 -34.12 6.01 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 113.02 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t0 51.46 54.59 10.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 111.645 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -104.83 130.22 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.769 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -118.03 136.35 53.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.981 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 68.0 t80 -134.45 125.64 27.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.231 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.44 138.16 53.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 109.912 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.7 m -127.92 136.0 50.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.199 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.466 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 63.0 t -124.92 119.63 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.7 p -133.2 156.33 47.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 111.868 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.22 153.01 34.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.042 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.06 164.66 37.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.969 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.19 156.85 29.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.889 2.393 . . . . 0.0 112.64 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.42 129.75 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.382 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -123.13 128.71 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.043 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HD3' ' HB3' ' A' ' 86' ' ' SER . 29.3 mmt180 -78.53 126.31 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 81' ' ' ILE . 44.8 mm -90.97 -42.26 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 110.089 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.0 -167.2 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.04 -38.43 88.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 0.0 111.327 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -128.15 23.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.44 127.48 65.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.64 ' OG ' ' HB3' ' A' ' 122' ' ' GLN . 89.3 p -138.6 151.7 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.7 mt -123.36 145.92 48.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.957 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.456 ' CE2' ' HA3' ' A' ' 120' ' ' GLY . 34.6 p90 -150.89 159.36 44.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 111.714 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.656 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -117.13 149.25 18.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.132 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.65 118.89 36.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.296 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 tp -127.11 125.39 41.17 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . -175.13 -155.03 11.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.855 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.07 153.39 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.613 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.01 141.62 17.0 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.766 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -129.33 130.8 46.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.775 0.321 . . . . 0.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -121.76 142.97 15.54 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.542 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -127.35 139.21 53.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.814 0.34 . . . . 0.0 111.074 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.34 127.77 43.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -126.31 142.56 51.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.557 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -109.65 134.11 52.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.339 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.7 p -90.25 115.83 27.76 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.343 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -162.8 164.85 25.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.447 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.6 mt -106.97 111.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -150.7 165.2 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.81 -39.1 97.02 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.742 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -120.29 151.54 39.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.8 p -109.88 150.53 28.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.443 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.59 146.83 50.74 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.755 0.312 . . . . 0.0 111.007 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.1 p -155.82 162.64 40.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.936 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.27 150.03 50.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 111.345 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.3 m -130.23 141.04 50.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.237 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.1 149.17 50.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.09 0.471 . . . . 0.0 111.482 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 76.4 p -118.26 149.16 41.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.769 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.4 p -157.4 163.94 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.37 . . . . 0.0 111.759 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.8 mt -98.79 135.41 40.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.064 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.33 130.1 52.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -143.74 138.64 28.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -167.76 -165.05 24.51 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.695 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.18 37.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.456 ' HA3' ' CE2' ' A' ' 88' ' ' TYR . . . -145.28 162.65 28.18 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 113.348 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.0 tp -126.74 138.43 53.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.902 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.64 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 51.6 tt0 -126.75 133.1 50.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.862 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -122.5 151.82 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.574 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -119.35 81.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.23 -34.6 67.37 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.597 2.198 . . . . 0.0 111.483 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.68 155.44 81.26 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.681 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.56 -23.21 74.71 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.844 2.362 . . . . 0.0 113.658 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -117.78 9.51 12.99 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.94 133.93 29.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.69 153.39 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.3 mt -113.22 124.24 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -111.3 126.93 55.42 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -128.6 116.5 19.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.7 m -130.64 153.82 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.504 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 99.0 m-85 -125.58 138.32 53.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.329 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -129.66 144.64 51.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.621 0.248 . . . . 0.0 110.34 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' OH ' ' HD2' ' A' ' 144' ' ' LYS . 90.8 t80 -135.51 129.8 33.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 0.0 111.324 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -101.87 121.8 42.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -102.4 107.02 17.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.716 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 96.2 mt -119.23 153.58 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.68 -43.5 98.75 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.46 -31.88 8.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.716 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.0 t -105.27 128.42 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HD2' ' OH ' ' A' ' 137' ' ' TYR . 34.8 mmtp -105.72 125.36 50.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -126.69 125.67 67.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.4 135.69 12.03 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.9 m -131.29 137.53 48.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.171 0.485 . . . . 0.0 111.667 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.404 ' NE1' ' HB2' ' A' ' 12' ' ' GLN . 34.4 p90 -132.85 148.8 52.3 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm -140.05 149.06 42.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.175 0.512 . . . . 0.0 111.844 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.94 139.0 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.395 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -177.77 -176.0 45.42 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.17 152.24 39.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.457 -0.372 . . . . 0.0 110.517 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.45 152.59 18.4 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.608 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -121.96 130.56 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.489 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -78.52 135.33 37.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.08 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.712 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.971 0.415 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.96 172.72 40.72 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.848 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -77.32 145.85 37.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.632 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.2 p -142.39 156.89 45.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.8 m -136.72 146.61 46.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.0 mt -118.02 125.53 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.2 m -127.21 145.61 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.948 0.404 . . . . 0.0 111.435 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.21 154.28 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.32 176.11 44.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.117 -1.039 . . . . 0.0 113.081 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -94.08 140.4 29.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.13 35.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HB3' HD22 ' A' ' 25' ' ' ASN . 96.0 mt-30 -112.26 118.4 35.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.889 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 64.9 m -118.46 157.5 27.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 111.702 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -127.25 127.57 44.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.11 125.27 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.372 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -66.29 125.78 26.68 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.982 0.42 . . . . 0.0 110.419 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -130.2 153.48 48.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.332 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -85.71 68.91 10.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.817 0.341 . . . . 0.0 111.356 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.61 0.81 90.32 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.296 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -91.69 134.46 34.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt 71.67 143.89 0.06 Allowed 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.857 0.723 . . . . 0.0 111.393 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.53 -55.59 5.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.292 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -104.05 -13.64 16.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm 51.86 34.46 13.46 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.88 0.472 . . . . 0.0 111.98 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' SER . 22.6 t-20 -104.62 110.04 63.76 Favored Pre-proline 0 C--N 1.332 -0.165 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.851 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 13' ' ' SER . 37.7 Cg_exo -67.45 148.47 79.2 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.188 2.592 . . . . 0.0 111.006 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -102.96 138.67 39.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -172.76 -177.89 42.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.255 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -121.15 149.48 42.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.272 . . . . 0.0 110.498 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -118.97 126.63 52.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.85 131.09 55.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.982 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -128.47 139.47 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.287 0.565 . . . . 0.0 111.496 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -133.43 129.84 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.277 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -118.53 133.14 56.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -131.77 128.71 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.57 134.13 41.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.999 0.428 . . . . 0.0 111.942 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -109.37 -6.49 15.46 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.055 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -154.47 173.57 16.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.578 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.04 -41.9 98.6 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.144 0.277 . . . . 0.0 111.63 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -124.3 34.04 5.13 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.2 t90 -153.1 133.85 13.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.14 -172.47 28.51 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.778 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.79 156.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.842 0.321 . . . . 0.0 110.877 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 tp -133.52 132.33 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.114 0.483 . . . . 0.0 111.15 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.12 135.66 12.09 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -127.84 134.69 49.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.25 117.95 28.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.404 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 124.93 53.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.83 0.348 . . . . 0.0 111.146 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 10.1 pt20 -131.44 117.52 18.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.901 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 73.6 p -131.6 160.17 36.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.954 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.08 163.93 37.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.941 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB3' ' CD2' ' A' ' 54' ' ' PHE . 41.7 mmt180 -71.65 139.5 49.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.882 0.373 . . . . 0.0 110.754 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.3 56.32 4.24 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.753 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 62.8 m-85 -109.96 143.31 40.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.908 0.385 . . . . 0.0 110.896 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -97.36 145.5 26.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.448 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -68.31 138.95 55.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.148 0.499 . . . . 0.0 111.24 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -123.75 146.52 48.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.698 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.2 121.3 66.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.662 0.268 . . . . 0.0 110.946 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -156.77 60.24 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.014 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.27 -11.06 72.27 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.389 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -164.89 147.97 8.51 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -73.04 128.81 36.55 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 111.307 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.56 127.91 54.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 111.097 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.9 pt -114.05 1.16 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.826 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 55.83 34.58 23.77 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.286 0.634 . . . . 0.0 112.414 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.78 -30.19 7.74 Favored Glycine 0 CA--C 1.517 0.187 0 CA-C-N 116.093 -0.503 . . . . 0.0 113.164 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 48.75 54.78 10.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.422 0.289 . . . . 0.0 111.216 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -74.73 130.61 39.79 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.602 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.51 139.42 53.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.343 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.43 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.6 m-85 -126.22 127.29 45.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.422 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' CD1' ' HB3' ' A' ' 49' ' ' GLN . 21.2 t80 -132.18 116.94 17.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.6 m -120.29 136.86 54.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.45 120.22 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.8 p -133.4 157.18 46.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 111.777 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -152.19 155.19 37.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.98 172.71 43.93 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.781 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.98 155.07 43.0 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.943 2.428 . . . . 0.0 112.74 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.03 125.91 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.374 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -127.07 123.69 37.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.964 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -80.24 137.43 36.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.594 0.235 . . . . 0.0 110.746 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.2 mm -88.92 -39.37 12.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.494 0.664 . . . . 0.0 109.776 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -153.51 -155.05 0.56 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.278 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.31 1.81 53.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.622 0.248 . . . . 0.0 111.331 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -144.95 10.7 1.35 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.25 139.24 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.694 0.283 . . . . 0.0 110.651 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -138.65 150.72 46.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.114 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 129.26 54.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.076 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.37 139.75 48.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.736 0.303 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.34 137.37 13.59 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -125.36 126.19 44.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.197 0.499 . . . . 0.0 111.732 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -146.81 136.96 23.52 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.2 -149.76 12.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.869 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.44 151.79 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.482 . . . . 0.0 111.601 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.81 141.13 16.14 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.717 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -124.06 128.51 49.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.295 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -119.23 146.22 18.21 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.053 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -124.53 146.73 48.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.805 0.336 . . . . 0.0 110.884 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.45 146.04 39.58 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.842 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.6 mmtm -122.46 147.68 46.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -116.41 124.77 50.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.818 0.342 . . . . 0.0 110.373 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.4 m -91.34 114.68 27.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.467 . . . . 0.0 111.355 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.8 p -162.78 167.15 23.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.71 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.9 pt -99.11 111.59 29.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.474 0.654 . . . . 0.0 110.151 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -148.68 154.61 39.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.88 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.6 97.36 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.098 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -105.66 173.3 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 110.605 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.3 m -109.83 141.75 42.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -128.45 146.25 50.86 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.829 0.347 . . . . 0.0 111.009 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.6 p -155.61 164.61 38.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -142.54 160.71 39.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.128 0.49 . . . . 0.0 111.35 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.2 p -145.89 157.19 43.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.013 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -133.32 151.49 51.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.119 0.485 . . . . 0.0 111.866 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 74.3 p -113.37 147.68 37.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.493 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.7 p -155.57 164.64 38.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 0.0 111.709 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.4 mt -98.57 137.32 37.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.828 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.15 132.12 54.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.798 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.16 142.07 26.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.329 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -176.38 -172.98 41.61 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.748 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.9 161.32 42.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.448 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -146.23 165.7 28.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.456 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -126.06 138.89 53.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -119.17 134.54 55.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.388 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -116.47 151.95 35.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -119.67 85.06 32.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.16 -33.35 9.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.192 1.928 . . . . 0.0 111.752 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -136.26 152.64 75.55 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.673 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.9 -30.22 76.93 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.65 2.233 . . . . 0.0 113.745 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.54 10.15 33.21 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -149.11 122.3 8.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.201 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 153' ' ' GLY . 32.9 m -125.63 151.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -122.7 145.17 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -136.14 122.11 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.35 41.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.448 ' OG ' ' HA3' ' A' ' 120' ' ' GLY . 69.3 m -127.98 150.07 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.483 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.8 m-85 -118.38 130.65 56.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -137.06 136.85 38.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -126.72 146.12 50.33 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 55.6 m -112.03 137.41 50.1 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.87 115.51 30.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.815 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 74.7 mt -118.4 154.3 32.65 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.0 -44.73 96.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.48 -33.4 7.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.815 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.5 t -105.65 128.63 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.73 128.95 44.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 65.2 t -125.46 128.07 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.11 0.481 . . . . 0.0 112.099 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -116.83 136.59 12.86 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.5 m -126.8 129.98 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.209 0.504 . . . . 0.0 111.192 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -113.33 133.45 55.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.0 mtt -114.48 117.97 32.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 0.0 111.495 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -125.25 123.36 39.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.314 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.37 -173.48 39.03 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.43 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.04 165.48 27.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.382 . . . . 0.0 110.734 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -153.26 178.47 30.29 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.559 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -131.95 130.92 42.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -80.82 131.25 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.981 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.755 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.98 -177.64 48.54 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.02 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.15 150.44 26.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.687 0.279 . . . . 0.0 110.653 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -140.22 159.48 42.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.231 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.2 m -132.25 147.19 52.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.968 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.6 124.2 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.45 ' HA ' ' CA ' ' A' ' 153' ' ' GLY . 56.5 m -120.63 139.73 52.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.436 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.1 mt -123.47 129.16 74.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.004 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 177.86 20.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.313 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -102.58 137.34 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.69 130.52 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.797 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 147' ' ' THR . 72.6 mt-30 -122.34 132.69 54.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 44.2 m -118.35 158.7 24.75 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.455 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -128.97 119.09 23.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.0 t -127.83 129.3 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.469 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -65.36 111.97 3.29 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.05 0.452 . . . . 0.0 110.398 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' H ' ' HE3' ' A' ' 24' ' ' LYS . 69.4 mm-40 -136.81 149.44 47.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.493 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -100.72 105.41 16.75 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.4 -153.95 24.52 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.606 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 85.9 m-85 -73.1 159.94 32.79 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER 75.81 84.37 0.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.703 0.627 . . . . 0.0 109.926 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.93 -34.51 73.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.015 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.28 -17.24 61.9 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HE3' ' H ' ' A' ' 17' ' ' GLU . 2.0 mttp 48.53 35.94 6.73 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.658 ' HA ' ' O ' ' A' ' 13' ' ' SER . 19.1 p-10 -103.52 113.95 65.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 13' ' ' SER . 94.5 Cg_endo -80.12 159.51 23.64 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.569 2.18 . . . . 0.0 110.877 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -91.95 140.5 29.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.573 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -164.53 173.99 40.51 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.259 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.21 152.54 47.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -122.69 132.32 54.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.91 121.1 39.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.071 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.4 mttm -117.9 140.46 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 111.38 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.14 135.98 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.88 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -119.0 129.94 55.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.22 132.2 56.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -103.8 140.97 36.91 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -129.6 169.7 14.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.723 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -79.48 75.05 6.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.528 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -166.59 -172.69 2.23 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.893 0.377 . . . . 0.0 110.737 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.98 -1.78 57.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.882 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -149.85 163.49 37.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.025 0.44 . . . . 0.0 111.372 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.06 -166.54 11.12 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.31 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.11 139.83 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.077 0.438 . . . . 0.0 110.624 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.496 HD12 ' CD1' ' A' ' 88' ' ' TYR . 36.8 pt -130.44 158.35 42.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.9 142.65 15.77 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -129.37 123.11 30.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -114.51 122.42 46.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 136.04 54.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -142.16 132.4 24.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.05 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 82.3 p -133.45 158.91 41.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.033 0.444 . . . . 0.0 111.639 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -132.88 136.93 46.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.392 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -63.15 133.09 53.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.478 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 -178.34 52.35 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.529 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -72.77 106.88 4.93 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 110.625 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -157.65 137.99 12.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.424 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -92.59 128.84 38.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.4 p -97.5 163.8 12.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.234 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.7 102.62 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.146 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -172.99 59.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.42 1.95 90.53 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.822 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 60.0 27.44 16.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.023 0.529 . . . . 0.0 111.58 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -93.92 -7.98 41.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.211 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.25 88.03 2.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.966 0.412 . . . . 0.0 111.138 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 mm -67.02 -43.83 88.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.557 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -119.6 -50.8 2.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.48 -32.3 6.34 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 97.9 m-20 51.08 44.12 28.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.733 0.413 . . . . 0.0 112.08 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.99 126.33 43.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.501 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.11 140.26 51.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.216 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.463 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.3 m-85 -121.34 122.3 39.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.629 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.17 119.51 31.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.1 m -123.89 136.01 54.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.964 0.412 . . . . 0.0 111.155 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.76 121.36 64.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.6 p -130.49 154.97 47.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.067 0.46 . . . . 0.0 111.831 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.99 151.19 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.893 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.04 160.93 31.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.856 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.45 156.3 40.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.862 2.375 . . . . 0.0 112.655 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.21 131.87 70.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 0.0 110.387 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -118.7 125.51 49.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.155 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -70.73 133.82 46.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.533 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.0 mt -84.59 -44.65 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.455 0.645 . . . . 0.0 109.839 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -140.54 -102.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.21 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -125.47 -34.69 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.678 0.275 . . . . 0.0 111.134 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.76 11.73 14.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.08 137.56 48.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -139.12 151.96 47.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.202 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.71 136.12 53.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.135 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 134' ' ' SER . 51.2 p90 -142.61 160.62 39.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 111.281 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.86 152.51 17.31 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.4 mt -112.39 123.32 50.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.331 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.7 tp -136.49 127.33 27.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.604 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.9 -160.48 25.58 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.817 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.86 148.83 52.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 0.0 111.437 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.53 135.75 12.95 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.876 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -124.37 124.81 43.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.037 0.446 . . . . 0.0 110.625 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 111' ' ' SER . . . -109.79 143.96 16.71 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.158 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.39 125.57 29.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 111.032 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.7 133.87 54.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.546 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 68.6 mttm -128.45 143.83 51.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.443 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -109.01 123.73 49.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 m -88.68 113.89 24.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.068 0.461 . . . . 0.0 111.48 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.1 p -163.7 166.05 22.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.587 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 103' ' ' ILE . 19.4 pt -99.45 110.71 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.482 0.658 . . . . 0.0 110.075 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -149.91 157.98 43.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.77 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.67 94.03 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.016 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -115.89 149.57 38.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.758 0.313 . . . . 0.0 110.451 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.7 m -109.76 140.5 43.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.522 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -126.76 147.83 49.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.868 0.366 . . . . 0.0 110.997 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.0 p -152.53 163.53 39.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.928 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -127.19 153.3 46.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.993 0.425 . . . . 0.0 111.358 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 96' ' ' GLY . 88.4 p -138.38 148.82 44.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.868 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -132.06 148.88 52.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 111.638 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.6 m -120.69 131.44 54.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 81.8 p -145.57 161.24 40.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.01 0.433 . . . . 0.0 111.796 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 138' ' ' SER . 63.8 tp -98.21 126.52 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.82 128.89 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -144.65 140.75 28.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.405 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -173.05 -168.91 34.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.705 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.63 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.6 168.06 32.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.43 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.4 mt -127.35 147.25 50.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.275 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -117.83 137.11 52.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.294 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.83 140.56 52.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.695 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -125.08 83.04 60.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.394 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.06 -27.64 42.07 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.278 1.985 . . . . 0.0 111.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -133.58 153.42 80.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.492 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.48 -37.99 89.86 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.899 2.399 . . . . 0.0 113.692 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -105.63 10.66 32.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.44 121.42 37.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.918 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.26 130.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.306 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.41 123.82 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.37 127.84 56.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.941 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -138.14 123.97 19.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.517 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 99.5 p -150.45 160.87 43.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.0 m-85 -118.34 127.04 53.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.271 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -120.75 126.6 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.52 143.58 51.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.205 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 56.2 m -110.2 128.78 55.68 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.36 105.77 16.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.744 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 90.8 mt -119.15 149.45 41.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.52 -43.8 97.92 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -103.73 -31.92 9.62 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.744 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.5 t -105.82 128.69 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -105.14 120.55 41.79 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 64.0 t -123.31 124.96 71.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.704 -0.398 . . . . 0.0 112.017 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -121.1 130.91 8.41 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 87.3 m -124.96 129.38 50.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.147 0.473 . . . . 0.0 111.484 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.449 ' CD1' ' HD1' ' A' ' 135' ' ' TYR . 52.6 m0 -109.86 133.14 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 74.8 mtm -126.92 126.17 42.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.733 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -140.43 136.33 32.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.395 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.61 -175.7 41.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.821 -1.181 . . . . 0.0 113.538 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.61 152.48 48.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 7' ' ' SER . . . -139.73 165.61 25.82 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.658 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -110.84 130.66 55.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.567 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.31 124.69 36.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.735 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.96 -173.83 46.0 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.959 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.2 153.43 22.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 0.0 110.643 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.6 p -144.13 156.3 44.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -137.59 146.56 44.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.67 127.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 60.4 m -121.02 138.09 54.33 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.878 0.37 . . . . 0.0 111.221 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.2 mt -125.58 131.31 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.15 -173.16 24.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.18 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.66 147.02 32.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.99 126.27 52.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 111.13 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -117.92 123.31 45.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.882 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.627 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.0 m -118.53 150.88 38.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 111.686 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -127.65 129.28 46.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.62 127.65 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.707 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -85.02 109.42 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.218 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -155.9 165.73 35.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.2 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -122.13 107.52 12.27 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.805 -0.18 . . . . 0.0 110.752 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 158.62 -138.89 5.94 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.618 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 57.8 t80 -61.62 141.36 57.84 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 63.7 mttp 77.33 90.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.843 0.714 . . . . 0.0 109.747 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.09 -45.56 92.52 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.775 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.12 -15.01 32.47 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.522 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 56.6 mmtt 48.34 36.14 6.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -103.6 111.25 65.02 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 13' ' ' SER . 85.8 Cg_endo -84.16 159.02 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.884 2.389 . . . . 0.0 110.957 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -107.57 149.29 28.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.711 0.291 . . . . 0.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.8 -179.52 42.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.6 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -115.04 147.71 39.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.845 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.492 ' OD1' ' HE1' ' A' ' 149' ' ' MET . 3.3 t30 -122.85 123.77 41.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.266 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -119.59 130.31 55.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HE2' HD22 ' A' ' 30' ' ' ASN . 68.6 mttm -126.87 138.25 53.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.003 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.75 132.87 53.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.751 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -126.04 129.99 50.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.954 0.407 . . . . 0.0 111.46 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.01 134.59 54.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.747 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -116.02 111.12 19.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 111.799 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -102.83 -0.8 30.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.169 0.509 . . . . 0.0 109.867 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -155.52 159.57 39.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.547 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.13 -15.27 41.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 111.366 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.566 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 19.1 t0 -92.59 -28.59 16.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 40' ' ' ASP . 38.7 p90 -152.0 162.25 41.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.042 0.449 . . . . 0.0 111.405 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.63 -178.09 24.28 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.785 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -125.02 131.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.946 0.373 . . . . 0.0 110.842 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 76' ' ' GLY . 18.3 tt -126.56 140.75 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.12 140.17 11.92 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -126.31 139.3 53.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.096 0.474 . . . . 0.0 111.606 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.57 125.26 43.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.642 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.18 126.88 55.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -123.3 107.84 12.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.7 p -128.4 155.22 45.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -133.54 128.62 35.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.972 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.78 160.63 21.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.745 0.307 . . . . 0.0 111.054 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 65' ' ' ASP . . . 80.48 23.41 60.56 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.128 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.1 80.47 0.95 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.066 0.46 . . . . 0.0 111.013 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -130.13 152.02 50.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.169 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -82.88 113.89 20.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.013 0.435 . . . . 0.0 110.901 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.4 m -135.95 150.73 49.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.985 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.24 102.95 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.653 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -167.36 69.41 0.09 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.458 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.85 14.11 82.38 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.957 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 59.03 37.3 24.46 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.912 0.485 . . . . 0.0 111.429 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.65 152.89 44.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.807 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.57 110.86 22.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.125 0.488 . . . . 0.0 111.118 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 pt -112.95 5.6 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.315 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 34.9 t0 -80.05 73.58 6.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.03 -41.52 2.19 Favored Glycine 0 C--O 1.228 -0.225 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.891 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.0 t0 49.52 52.43 14.53 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.687 0.395 . . . . 0.0 111.719 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -110.5 122.4 47.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.535 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -102.69 131.49 49.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.124 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -123.77 122.77 38.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -123.43 137.48 54.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.74 0.305 . . . . 0.0 110.217 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.1 m -126.53 136.06 52.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -125.63 120.2 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.0 p -133.34 157.62 45.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.493 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.64 155.35 37.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.174 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -174.43 165.15 36.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.132 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.36 153.9 35.84 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.857 2.372 . . . . 0.0 112.404 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.29 126.68 75.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -122.2 133.47 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.929 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -73.43 137.43 44.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.502 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.1 mt -83.55 -48.57 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.349 0.595 . . . . 0.0 110.34 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -140.88 -84.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.895 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -138.9 -44.92 0.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.66 0.267 . . . . 0.0 111.23 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -109.23 9.67 25.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 m -136.69 142.41 38.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 121.196 -0.202 . . . . 0.0 110.529 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 48.8 m -135.25 149.14 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 111.382 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.3 tp -116.59 129.9 56.43 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -141.85 157.98 44.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.456 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.602 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.68 147.48 18.9 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.749 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.89 118.78 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.74 137.32 54.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.56 -157.43 23.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.797 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.72 154.91 47.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -120.23 139.52 13.8 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -127.12 143.53 51.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -127.91 150.54 18.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.309 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -134.74 127.45 30.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.62 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.76 128.74 55.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -117.04 129.71 56.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.294 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.9 136.0 44.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.488 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.2 m -103.18 114.86 29.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 111.238 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.3 p -163.25 165.14 24.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.609 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.8 pt -103.88 109.52 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.44 0.638 . . . . 0.0 110.171 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -150.63 163.79 37.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.878 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.94 -38.83 96.08 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.721 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -122.45 151.18 41.54 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.4 p -109.84 152.99 25.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -131.55 150.58 52.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.5 p -153.55 163.11 40.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.844 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -128.51 148.09 50.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.418 . . . . 0.0 111.325 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.9 m -126.03 145.47 50.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.778 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -126.34 147.63 49.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.115 0.483 . . . . 0.0 111.642 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.8 m -122.75 132.03 54.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.697 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.1 p -149.18 160.9 42.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.623 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 138' ' ' SER . 91.0 mt -100.49 138.66 37.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.092 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.44 122.66 29.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.744 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -131.64 149.2 52.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.63 -168.3 36.46 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.634 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.07 162.12 38.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -146.0 156.71 27.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.445 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.6 138.99 51.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.879 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.443 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 52.8 tt0 -115.3 124.34 51.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.781 0.324 . . . . 0.0 110.228 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.63 131.47 56.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.977 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' OD1' HG22 ' A' ' 130' ' ' VAL . 40.6 t30 -126.72 81.11 69.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.421 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.61 -40.17 39.53 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.754 2.303 . . . . 0.0 111.887 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -133.67 154.69 80.76 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.649 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.3 -34.45 70.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.801 2.334 . . . . 0.0 113.817 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -103.19 10.96 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -131.66 112.63 12.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.451 HG22 ' OD1' ' A' ' 124' ' ' ASN . 59.8 t -122.38 130.64 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.22 123.08 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.443 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.8 m-20 -113.82 127.81 56.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.09 115.98 21.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.46 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -136.43 161.96 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.268 0.556 . . . . 0.0 112.462 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -139.29 148.85 43.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.283 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -139.85 148.5 42.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -127.33 128.45 45.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.993 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 66.2 m -100.16 123.95 45.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -101.01 112.76 25.3 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 89.9 mt -119.37 153.91 34.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.84 -44.59 96.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -106.5 -32.49 8.06 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.7 t -105.03 131.19 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -105.64 124.29 49.31 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.5 t -127.27 128.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 112.048 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.49 135.0 11.89 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 85.1 m -123.47 130.15 52.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.241 0.52 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -111.53 136.5 50.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.492 ' HE1' ' OD1' ' A' ' 30' ' ' ASN . 2.8 mmm -119.21 115.58 24.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 0.0 111.194 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.2 133.96 54.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.585 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.73 176.93 46.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.445 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.87 147.24 43.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.651 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.47 160.58 20.84 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.741 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -125.4 130.52 52.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.734 0.302 . . . . 0.0 110.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -76.5 134.12 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.339 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.782 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.94 0.4 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.96 171.05 34.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.025 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -79.34 158.39 27.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.729 0.299 . . . . 0.0 110.539 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -138.42 157.0 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 111.264 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -133.54 144.83 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.65 126.77 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.237 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -128.75 144.99 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -127.29 150.68 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.427 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.31 -172.12 36.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.942 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -109.7 156.92 19.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.24 135.34 51.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.859 0.361 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -125.08 129.6 50.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.92 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 57.4 m -116.75 145.95 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -118.71 121.52 40.31 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.24 130.09 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.536 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.62 108.63 14.42 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.366 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -147.32 156.39 42.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.37 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.24 112.33 24.51 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.766 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.13 -156.36 28.29 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.543 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 73.7 m-85 -69.8 150.38 46.93 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 58.3 mtmt 74.15 93.39 0.08 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.726 0.641 . . . . 0.0 109.344 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.1 tp -58.8 -40.74 84.97 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -82.15 -15.54 52.97 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 48.22 38.98 11.05 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 13' ' ' SER . 14.7 p-10 -101.4 113.62 65.8 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 13' ' ' SER . 95.9 Cg_endo -79.7 158.45 24.88 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.421 2.08 . . . . 0.0 110.957 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -93.31 146.78 23.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.01 -179.9 40.84 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.433 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -119.61 154.12 34.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.87 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.9 t-20 -126.38 134.42 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.282 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.2 125.66 47.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -121.33 139.32 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.147 0.499 . . . . 0.0 111.6 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.7 129.08 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.114 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -116.57 134.01 55.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.679 0.276 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -128.59 124.83 36.88 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -92.21 127.53 37.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -101.55 -9.64 20.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.713 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.5 177.04 11.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.505 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -62.99 -48.23 79.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -112.36 7.29 19.17 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -126.98 142.03 51.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.956 0.408 . . . . 0.0 111.599 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.81 -174.21 37.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.908 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.007 0.404 . . . . 0.0 110.911 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.94 138.43 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.102 0.477 . . . . 0.0 110.912 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.91 137.42 14.22 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.6 m -124.74 130.11 51.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.019 0.438 . . . . 0.0 111.482 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 97.1 m-85 -115.61 126.49 54.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.685 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.25 115.12 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.826 0.346 . . . . 0.0 110.649 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -123.84 111.46 16.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 77.1 p -125.93 151.8 46.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.716 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -158.9 147.44 18.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.671 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.95 124.4 28.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 110.516 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.03 54.85 0.58 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.741 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -109.45 132.05 54.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.733 0.302 . . . . 0.0 110.835 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.71 132.14 47.47 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.277 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 24.1 pm0 -67.91 142.04 56.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.085 0.469 . . . . 0.0 110.917 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.5 m -129.38 149.52 51.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.702 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.76 101.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.998 0.428 . . . . 0.0 110.976 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -164.59 76.98 0.32 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.47 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.19 5.43 90.08 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.759 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 63.25 23.33 13.79 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.154 0.582 . . . . 0.0 111.246 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.14 -9.24 26.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.441 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 92.9 mt -109.25 36.1 3.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.106 0.479 . . . . 0.0 111.026 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' ASP . 42.6 pt -84.43 4.68 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.156 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 35.1 t70 78.69 -52.61 0.47 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.818 0.847 . . . . 0.0 111.273 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.97 -16.63 58.21 Favored Glycine 0 CA--C 1.516 0.106 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.957 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 51.56 49.38 21.02 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.543 0.337 . . . . 0.0 111.734 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -83.51 124.19 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.894 0.378 . . . . 0.0 110.793 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -114.98 132.29 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.113 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.583 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 78.1 t80 -131.14 121.31 24.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.287 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -134.24 125.55 28.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 110.221 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 m -130.06 146.62 51.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.095 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.72 126.19 64.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.726 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.472 HG21 ' OE1' ' A' ' 136' ' ' GLU . 72.2 p -134.95 157.89 45.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.156 0.503 . . . . 0.0 111.78 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.64 153.86 36.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.96 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -169.85 165.25 38.63 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.936 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.35 154.27 40.75 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.916 2.41 . . . . 0.0 112.722 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.68 127.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.358 . . . . 0.0 110.545 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -127.87 128.55 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.078 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -74.66 128.34 35.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 0.0 111.078 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 86.3 mt -90.36 -42.31 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.12 -165.62 1.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.499 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.75 -39.72 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.548 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -127.21 25.23 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.16 127.54 67.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 66.2 m -128.29 147.25 50.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 111.057 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.9 tp -117.07 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.107 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -142.09 158.77 43.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.068 0.461 . . . . 0.0 111.361 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -118.7 156.11 15.8 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.052 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.5 mt -115.13 118.48 33.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.31 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.38 131.69 50.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.06 -148.4 10.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.823 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.99 152.23 41.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 136.44 13.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.862 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -120.83 127.46 51.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.656 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -117.93 141.04 16.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.166 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -130.69 141.83 50.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.59 126.52 42.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.341 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -120.26 126.61 51.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.584 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -97.65 117.72 32.57 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.8 m -91.14 114.33 26.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.994 0.426 . . . . 0.0 111.381 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -164.37 170.82 15.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.643 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.5 mt -101.31 111.41 30.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -150.16 158.31 44.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.875 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.5 -39.62 97.56 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.168 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -115.76 149.74 38.01 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.4 m -110.75 139.57 45.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.498 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -129.16 147.86 51.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.884 0.373 . . . . 0.0 111.04 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 98.5 p -154.43 161.43 41.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.788 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 95.7 mtm-85 -127.5 145.49 50.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.011 0.434 . . . . 0.0 111.49 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.3 m -136.81 147.91 46.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.792 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -146.64 148.66 32.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 111.841 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.6 m -125.0 134.68 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 138' ' ' SER . 89.3 p -141.46 162.03 36.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 0.0 111.557 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 138' ' ' SER . 60.7 tp -75.04 129.22 37.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.466 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 137' ' ' TYR . . . -119.69 133.21 55.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.538 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -148.32 159.31 44.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.719 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 174.33 -166.46 38.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.697 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.69 160.48 41.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.34 28.85 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.335 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.57 143.88 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.358 -0.421 . . . . 0.0 109.995 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -127.92 130.11 47.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.846 0.355 . . . . 0.0 110.327 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -123.5 144.36 49.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.843 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.438 ' OD1' HG23 ' A' ' 130' ' ' VAL . 33.7 t30 -127.43 82.14 68.79 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.801 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.48 -40.78 45.2 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.419 2.079 . . . . 0.0 111.848 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -136.03 154.31 77.47 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.9 -34.83 87.42 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.836 2.357 . . . . 0.0 113.761 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -98.94 10.56 41.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -138.66 112.28 8.28 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.438 HG23 ' OD1' ' A' ' 124' ' ' ASN . 67.5 t -116.64 129.78 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.626 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.6 mt -102.54 120.4 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.503 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.2 m-20 -116.65 126.11 52.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.531 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -132.77 135.16 45.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.2 p -155.59 161.01 40.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.382 0.611 . . . . 0.0 112.346 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -138.18 134.09 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.712 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.472 ' OE1' HG21 ' A' ' 74' ' ' THR . 25.9 pt-20 -129.76 147.75 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 83.7 t80 -129.12 135.11 48.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.65 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 67.6 m -107.65 129.36 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -102.04 117.69 35.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.786 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 60.9 mt -119.64 154.29 34.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.97 -44.35 94.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.9 -32.97 7.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.786 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 59.7 t -104.86 130.61 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -103.29 125.15 49.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.0 t -125.83 124.8 67.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.1 138.88 12.88 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.45 ' HB ' ' CG ' ' A' ' 136' ' ' GLU . 85.7 m -125.46 128.97 48.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.405 0.602 . . . . 0.0 111.503 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -114.09 129.51 56.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 70.8 mtm -123.62 139.89 53.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.245 0.545 . . . . 0.0 112.167 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 67.1 tp -136.97 130.43 31.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.039 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.78 173.14 34.48 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.602 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.64 151.73 49.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.433 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.32 -167.18 18.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.436 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -148.15 160.91 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.811 0.339 . . . . 0.0 110.763 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -78.97 141.41 37.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.801 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.525 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.054 0.454 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.01 172.86 45.84 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.041 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -84.53 149.73 25.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.709 0.29 . . . . 0.0 110.451 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -128.89 143.5 50.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.18 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -129.69 141.92 50.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.693 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.6 mt -116.39 126.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.263 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 51.6 m -124.54 142.17 51.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 0.0 111.184 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -129.4 153.6 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.4 -173.59 37.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.11 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.4 142.31 37.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.09 123.8 51.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -120.38 122.29 40.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.966 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.648 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.7 m -118.97 157.68 27.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.847 0.356 . . . . 0.0 111.264 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -128.13 140.85 51.7 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.771 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -124.63 131.73 72.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.464 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -60.59 134.38 57.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.397 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -123.2 153.61 39.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.41 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -113.67 22.07 14.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.238 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.39 -16.13 5.19 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.681 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 95.2 m-85 -91.98 138.44 31.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 27.8 mmtm 69.24 159.44 0.18 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.463 0.649 . . . . 0.0 111.32 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -88.25 -57.27 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 52.6 p-10 -114.32 -13.69 12.29 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mttt 49.82 36.92 12.17 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.539 ' OD1' ' HB2' ' A' ' 23' ' ' ASP . 34.4 m120 -103.25 112.77 65.93 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 13' ' ' SER . 84.6 Cg_endo -78.01 158.47 30.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.706 2.27 . . . . 0.0 111.094 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -114.18 144.78 42.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.31 177.15 43.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.297 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -111.24 144.74 39.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.464 HD22 ' HE2' ' A' ' 32' ' ' LYS . 21.7 t30 -110.69 127.87 55.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.804 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.6 127.07 53.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.229 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HE2' HD22 ' A' ' 30' ' ' ASN . 63.6 mttm -126.61 137.23 53.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.63 135.96 50.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -127.12 130.98 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -114.72 128.36 56.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -110.0 89.15 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -102.49 -2.41 28.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.156 0.503 . . . . 0.0 110.014 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.584 ' HB3' ' O ' ' A' ' 41' ' ' TRP . 16.3 t-20 -154.45 136.9 15.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.479 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -67.87 -41.1 83.37 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -71.72 -45.65 61.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.584 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 97.8 m95 -128.81 138.47 52.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.943 0.401 . . . . 0.0 112.025 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.54 174.0 18.57 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.928 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.2 t -121.93 128.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.114 0.457 . . . . 0.0 110.61 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.77 140.56 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.35 141.13 13.11 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -124.99 132.11 53.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.94 0.4 . . . . 0.0 111.364 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.81 118.59 26.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.87 128.18 49.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -124.78 120.55 32.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.7 p -128.62 160.19 33.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.986 0.422 . . . . 0.0 111.695 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -153.1 164.39 38.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.907 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.21 146.13 53.66 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.661 0.267 . . . . 0.0 110.75 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.92 172.41 51.33 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.913 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.38 150.54 27.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.727 0.299 . . . . 0.0 110.969 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -135.0 168.08 19.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.914 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.3 pm0 -59.45 138.39 57.69 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.186 0.517 . . . . 0.0 111.109 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.4 m -133.05 159.83 38.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.807 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 m -102.64 161.72 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.781 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -57.73 136.78 56.93 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.99 0.424 . . . . 0.0 110.719 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.14 -8.69 67.48 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.387 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.87 149.63 48.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 111.187 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -105.65 149.8 26.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.051 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 49.66 1.76 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.057 0.455 . . . . 0.0 110.863 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.0 -46.62 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.814 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.3 t0 55.37 29.54 13.25 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.296 0.639 . . . . 0.0 111.768 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.15 -16.09 59.52 Favored Glycine 0 CA--C 1.518 0.225 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.759 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 18.8 t0 49.91 54.73 10.55 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 122.719 0.408 . . . . 0.0 111.865 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -100.61 127.08 47.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.72 143.87 48.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.213 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -127.93 118.58 23.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -116.5 128.93 55.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.712 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.0 m -122.46 139.41 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.41 122.31 44.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.613 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.3 p -134.41 159.7 40.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.183 0.516 . . . . 0.0 111.898 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.8 154.2 38.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.094 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.89 165.01 37.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.954 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.5 153.01 30.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.817 2.345 . . . . 0.0 112.389 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.57 128.56 72.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.494 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 84.6 t80 -119.71 124.12 45.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.998 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -75.6 131.32 39.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.6 mm -90.34 -42.26 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.517 0.675 . . . . 0.0 109.873 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -150.23 -158.15 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.446 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.05 -40.83 91.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -126.2 29.04 5.91 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.71 131.29 15.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 O-C-N 121.953 -0.467 . . . . 0.0 109.836 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.4 m -138.19 152.25 48.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.704 0.288 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mp -124.36 143.22 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.166 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.528 ' CZ ' ' HA3' ' A' ' 120' ' ' GLY . 45.9 p90 -146.18 161.35 40.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.541 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -111.34 146.48 17.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.968 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.1 mt -116.41 123.87 48.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.96 0.41 . . . . 0.0 111.56 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -138.16 137.91 38.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -154.66 16.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.857 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.63 153.07 47.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.998 0.428 . . . . 0.0 111.678 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.39 142.78 17.56 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.71 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -129.67 123.74 31.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.54 138.37 14.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.754 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -128.8 140.66 51.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.893 0.347 . . . . 0.0 111.141 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.14 124.06 26.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.379 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 65.1 tttm -130.76 130.2 43.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -97.32 120.96 38.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.0 m -89.15 115.69 26.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.981 0.419 . . . . 0.0 111.407 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -163.62 170.49 17.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.628 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 tp -106.77 110.69 32.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.686 0.755 . . . . 0.0 110.194 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -150.52 164.04 36.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.876 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.61 -39.6 97.6 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.851 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -132.1 132.09 42.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -112.09 150.28 30.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.523 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -126.07 141.94 51.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.024 0.44 . . . . 0.0 111.203 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.9 m -136.95 159.41 41.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.027 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -136.23 155.66 49.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.079 0.466 . . . . 0.0 111.623 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.8 p -149.04 152.42 36.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.664 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -135.92 149.82 49.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.147 0.498 . . . . 0.0 112.05 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.6 p -109.84 148.75 30.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.711 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -154.93 160.6 41.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.789 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 138' ' ' SER . 85.1 mt -101.25 136.39 41.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.0 133.34 54.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -142.41 139.45 31.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.17 -166.42 29.09 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.777 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.528 ' HA3' ' CZ ' ' A' ' 88' ' ' TYR . . . -134.4 150.27 20.01 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.41 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.04 138.7 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.417 -0.391 . . . . 0.0 109.948 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -124.7 132.12 53.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.898 0.38 . . . . 0.0 110.44 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.518 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -114.8 95.31 40.72 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.355 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.48 -36.22 87.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.522 2.148 . . . . 0.0 111.535 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -130.06 157.17 77.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.767 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.18 -37.34 79.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.874 2.383 . . . . 0.0 113.636 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -105.46 16.35 25.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -126.27 117.03 22.2 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.92 -0.488 . . . . 0.0 110.665 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.1 t -115.32 126.87 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.654 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.4 mm -108.59 126.39 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -123.42 116.82 23.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.997 0.427 . . . . 0.0 111.402 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -122.94 133.33 54.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.6 p -152.22 166.98 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.331 0.586 . . . . 0.0 112.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -141.31 150.68 42.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.633 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -140.18 151.02 44.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -133.92 128.4 34.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.763 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 20.3 m -94.76 124.43 38.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -103.47 102.86 12.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.745 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 97.5 mt -118.62 152.33 36.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.26 -43.86 98.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -105.42 -33.12 8.26 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.745 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.2 t -105.66 125.96 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -105.8 122.64 46.51 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 73.7 t -127.19 129.27 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -117.7 138.83 14.35 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.0 m -127.05 131.71 50.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.244 0.522 . . . . 0.0 111.495 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.9 m-90 -116.8 139.31 50.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 64.3 mtt -127.15 124.33 38.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 0.0 111.992 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.3 mt -127.75 136.67 51.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.112 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.68 -172.37 43.68 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.383 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.97 158.32 44.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.621 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.02 164.4 25.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.816 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -131.32 129.29 41.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 110.177 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -76.37 137.84 40.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 t80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.751 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 . . . . . 0 C--O 1.235 0.323 0 CA-C-O 120.767 0.317 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.9 m -122.1 141.02 51.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.994 0.426 . . . . 0.0 111.113 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -140.62 153.35 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.143 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -119.87 143.47 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.455 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 49.1 m -134.48 142.85 47.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.74 0.305 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.73 150.0 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.94 167.91 40.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.017 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -89.7 138.74 31.22 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -111.81 127.95 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -126.02 122.13 34.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.093 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 146' ' ' GLY . 50.1 m -118.4 156.72 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.11 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -122.97 128.36 50.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.2 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.454 -179.778 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 13' ' ' SER . 34.7 Cg_exo -63.4 147.14 93.65 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.064 2.51 . . . . 0.0 111.441 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -113.36 140.35 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.285 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -176.4 -174.84 43.25 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.349 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -119.12 147.39 44.22 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 110.591 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 3.1 t30 -117.09 127.97 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.227 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 tp -112.6 126.08 54.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.977 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 29.2 ttpp -125.06 133.89 52.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.147 0.498 . . . . 0.0 111.621 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -114.36 130.5 56.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.002 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -112.71 128.51 56.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.946 0.403 . . . . 0.0 111.452 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -128.98 120.49 26.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.487 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.25 156.66 42.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 117.021 0.41 . . . . 0.0 110.631 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -134.07 147.77 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.266 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -124.72 123.75 5.17 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -114.94 125.37 53.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.165 0.483 . . . . 0.0 111.759 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -117.11 121.22 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -115.68 126.98 54.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 0.0 111.646 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.523 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 65.5 tt0 -123.91 117.08 24.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.551 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 73.7 p -128.87 156.5 43.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.058 0.456 . . . . 0.0 111.827 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.367 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.9 t80 -139.6 126.95 21.4 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -129.44 141.62 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.551 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 74.3 t80 -133.31 126.53 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.508 ' CE2' ' HG3' ' A' ' 49' ' ' GLN . 95.5 m-85 -124.37 139.96 53.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.895 0.378 . . . . 0.0 110.533 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 75.4 m -135.68 141.9 45.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.049 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.413 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 3.1 p -138.78 120.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.636 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.1 p -135.56 158.38 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.024 0.44 . . . . 0.0 111.877 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.638 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.83 157.18 42.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.912 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -172.85 161.31 32.55 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.54 155.19 35.86 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.967 2.445 . . . . 0.0 112.408 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 88' ' ' TYR . 61.8 t -120.06 126.65 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.396 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -126.4 128.98 47.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.752 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -77.87 131.49 37.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.697 0.285 . . . . 0.0 110.926 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 87' ' ' LEU . 89.4 mt -90.18 -43.22 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.514 0.673 . . . . 0.0 109.954 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -138.29 -166.61 2.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.235 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -62.64 -39.65 94.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.622 0.248 . . . . 0.0 111.445 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -122.89 21.75 9.82 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.4 127.96 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 CA-C-N 118.011 0.369 . . . . 0.0 110.095 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.8 m -130.14 144.45 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.764 0.316 . . . . 0.0 111.049 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 81' ' ' ILE . 67.6 tp -124.37 135.17 53.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.401 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.522 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 51.9 p90 -139.68 156.17 46.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.06 0.457 . . . . 0.0 111.383 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.635 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -108.97 153.16 16.9 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.074 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 134' ' ' SER . 88.9 mt -120.61 127.27 51.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 111.716 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -144.26 138.03 27.68 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . 176.66 -150.23 10.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.875 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.27 156.26 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.45 147.23 16.7 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.665 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -135.75 128.34 30.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 110.838 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.015 179.622 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.233 0.22 0 CA-C-O 121.278 0.561 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.2 p -120.29 148.01 44.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.255 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 140' ' ' LEU . 92.8 p -157.28 165.68 35.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.347 . . . . 0.0 111.849 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 138' ' ' SER . 90.4 mt -99.58 137.81 37.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.909 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.46 131.92 54.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.035 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -143.6 137.9 28.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.36 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.65 -163.32 27.7 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.692 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.33 159.58 43.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -136.86 153.52 21.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.265 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.85 138.81 50.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.028 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 51.6 tt0 -129.21 128.38 43.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.612 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -116.49 139.72 50.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.476 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -116.01 85.79 15.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 130' ' ' VAL . 58.4 Cg_endo -73.7 -32.95 7.03 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.207 1.938 . . . . 0.0 111.711 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -134.71 152.71 78.09 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.695 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.8 -38.27 94.64 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 122.664 2.243 . . . . 0.0 114.054 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -104.55 6.07 34.37 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -137.57 122.04 18.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.927 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.4 m -127.64 153.17 36.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.03 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.31 123.83 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.81 130.72 56.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -127.22 120.26 28.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.598 ' HB3' HD11 ' A' ' 90' ' ' LEU . 73.3 m -121.65 142.48 50.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.54 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.5 m-85 -122.41 122.54 39.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.113 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 83.8 mt-10 -127.1 135.8 51.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.01 142.07 49.46 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.992 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 57.4 m -115.32 128.02 55.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.12 114.78 29.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.757 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 83.3 mt -118.67 154.72 32.25 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.11 -42.91 95.76 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.55 -33.54 7.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.757 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.1 t -106.42 129.03 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -106.06 126.61 52.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 72.6 t -125.85 126.88 70.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -118.38 137.78 13.25 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 73.9 m -126.88 128.42 46.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.262 0.531 . . . . 0.0 111.086 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -119.8 139.03 52.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 17.8 tmm? -134.42 132.03 38.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.094 0.473 . . . . 0.0 111.567 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.89 127.04 41.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -163.71 -167.65 24.51 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.53 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.9 156.23 48.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.763 0.316 . . . . 0.0 110.709 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -124.95 152.84 17.71 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.679 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -121.24 128.33 52.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.881 0.372 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -93.92 128.25 40.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.71 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -138.59 156.47 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.0 m -145.04 156.02 43.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.63 143.31 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.479 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 50.4 m -134.51 148.34 50.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.708 0.29 . . . . 0.0 111.286 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.9 152.16 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.331 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.24 -179.19 41.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.025 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -103.18 140.81 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.691 0.281 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.81 121.78 45.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -120.43 127.95 52.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.67 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.689 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.5 m -118.01 153.28 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 111.276 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.718 -179.56 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.1 m120 . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 13' ' ' SER . 91.5 Cg_endo -80.23 158.87 23.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.747 2.298 . . . . 0.0 111.362 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -111.19 136.49 50.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.554 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.18 -179.86 40.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.574 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.95 154.69 35.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -127.97 126.18 40.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -108.85 136.78 47.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 15.8 ttmm -130.98 136.9 48.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.132 0.491 . . . . 0.0 111.528 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -122.6 127.59 49.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.869 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -113.82 130.63 56.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.0 111.314 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -126.61 122.73 35.88 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.564 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.8 156.61 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.034 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.1 pp -132.41 146.08 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 111.537 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -120.92 125.73 6.33 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.425 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 48.1 m -118.09 128.16 54.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 0.0 112.005 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -121.21 120.5 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.354 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -118.07 129.47 55.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.892 0.377 . . . . 0.0 111.46 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -122.86 115.92 22.78 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.7 p -127.0 155.4 43.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 112.013 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.002 179.852 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t0 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.881 0.372 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -114.79 128.62 56.4 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.931 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -113.92 137.54 51.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.56 123.45 39.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -117.45 137.33 52.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 66.2 m -127.58 131.97 49.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.852 0.358 . . . . 0.0 111.216 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.03 117.96 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 46' ' ' SER . 74.2 p -132.47 156.96 45.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 111.743 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.1 156.35 42.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.225 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -173.77 165.02 36.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.104 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.18 155.63 25.71 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.001 2.467 . . . . 0.0 112.364 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.17 127.76 75.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -126.81 125.98 42.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.984 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -77.21 127.61 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.698 HD12 HG12 ' A' ' 85' ' ' VAL . 97.5 mt -75.12 -46.04 40.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -134.29 -97.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.158 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 -31.72 1.36 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.29 3.99 11.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.698 HG12 HD12 ' A' ' 81' ' ' ILE . 57.8 t -129.09 128.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 57.1 m -129.0 148.72 50.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 tt -116.8 136.72 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.225 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.501 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 50.1 p90 -142.04 155.44 45.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.392 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.576 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -109.03 151.86 17.08 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.044 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 134' ' ' SER . 83.1 mt -119.67 125.57 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 0.0 111.503 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -144.58 140.37 28.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.602 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.97 -157.29 27.22 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.65 151.94 51.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.082 0.467 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.17 141.49 17.04 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -127.58 126.09 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.808 0.337 . . . . 0.0 110.39 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.352 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.6 m -115.42 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.7 p -140.54 157.71 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.978 0.418 . . . . 0.0 111.77 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 138' ' ' SER . 69.0 tp -100.56 127.66 46.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.56 130.77 56.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.424 . . . . 0.0 110.953 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -144.56 140.22 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.83 -163.33 27.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.633 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.15 161.27 41.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -142.1 158.58 26.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.347 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.8 mt -122.56 139.38 53.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.509 -0.346 . . . . 0.0 110.077 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -118.85 128.49 54.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.169 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.33 142.37 51.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -124.19 82.67 56.92 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.532 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.21 -28.61 33.77 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.477 2.118 . . . . 0.0 112.127 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -131.56 151.29 78.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.546 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.81 -25.57 74.66 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 113.452 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -111.48 13.49 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -140.29 120.89 14.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 110.951 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.5 t -111.43 129.98 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.183 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 51.0 mm -104.64 119.65 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.464 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 88.7 m-20 -114.11 126.48 55.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.991 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.15 124.04 45.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.451 ' HB3' HD11 ' A' ' 90' ' ' LEU . 74.9 m -127.35 143.08 51.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 112.379 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.526 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 51.9 m-85 -124.65 122.96 38.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.102 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -125.59 135.12 51.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -127.39 139.21 53.0 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.871 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 49.6 m -105.99 123.96 48.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -101.36 107.64 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.258 0.552 . . . . 0.0 112.311 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 87.3 mt -119.01 153.0 35.39 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.89 -44.11 97.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -104.9 -32.92 8.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.731 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -106.07 128.36 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -106.19 120.69 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 58.1 t -124.92 129.19 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.974 0.416 . . . . 0.0 112.091 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.09 138.29 14.64 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.7 m -124.84 129.16 49.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.979 0.418 . . . . 0.0 111.3 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -115.95 136.99 52.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -131.93 127.87 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.96 137.47 53.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.36 -171.59 38.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.571 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.86 157.09 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.94 0.4 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.79 167.19 24.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.738 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -132.86 130.81 40.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.494 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.2 mtm105 -79.04 140.45 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.027 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.937 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -122.94 142.95 50.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.452 . . . . 0.0 111.239 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 34' ' ' ARG . 32.3 m -143.26 154.57 43.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.875 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.3 143.77 32.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.502 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 50.1 m -132.27 141.95 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 pt -127.95 147.56 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.45 -173.22 38.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.042 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.34 142.99 36.27 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.77 114.4 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.266 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -116.77 132.34 56.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.674 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 44.6 m -118.23 165.23 14.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.804 0.335 . . . . 0.0 111.624 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -126.61 121.12 31.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.378 -179.609 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 13' ' ' SER . 30.5 m120 . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.674 ' HD2' ' O ' ' A' ' 13' ' ' SER . 93.2 Cg_endo -79.67 159.21 25.07 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.797 2.331 . . . . 0.0 110.745 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.01 142.42 27.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.0 169.68 41.01 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.392 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.84 147.64 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 0.0 110.565 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.551 HD21 ' HE2' ' A' ' 32' ' ' LYS . 42.1 t30 -111.09 121.84 46.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.641 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.22 124.09 42.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.102 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 67.5 mttm -127.76 145.39 50.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.436 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -123.34 127.81 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 5' ' ' SER . 51.6 mtp180 -109.6 136.48 48.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.902 0.382 . . . . 0.0 111.835 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.64 119.33 16.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.412 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 C--N 1.331 -0.216 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.217 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.0 m -126.75 148.3 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.343 . . . . 0.0 110.818 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.681 ' HB ' ' CE1' ' A' ' 88' ' ' TYR . 78.9 mt -129.37 130.11 67.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.45 136.53 12.74 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -123.22 133.4 54.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.275 0.538 . . . . 0.0 111.865 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HD1' HG22 ' A' ' 73' ' ' VAL . 78.7 t80 -135.93 124.32 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.448 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.08 143.11 49.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.98 0.419 . . . . 0.0 111.201 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -121.51 126.1 48.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 64.8 p -125.7 151.8 46.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.613 -179.504 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -99.48 120.69 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.95 139.02 53.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.235 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 85.9 t80 -133.78 128.43 34.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.74 135.66 53.7 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.3 m -116.1 123.62 48.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.712 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.445 HG22 ' HD1' ' A' ' 47' ' ' PHE . 61.6 t -126.38 110.8 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.0 p -135.67 159.3 42.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.051 0.453 . . . . 0.0 111.851 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.29 151.6 32.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.827 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.4 161.54 33.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.901 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.47 160.03 32.2 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.049 2.499 . . . . 0.0 112.688 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.06 132.49 65.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.227 0.537 . . . . 0.0 110.139 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.49 148.76 50.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.135 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -85.33 127.35 34.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.278 . . . . 0.0 110.705 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 87' ' ' LEU . 95.6 mt -89.36 -44.07 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -134.56 -164.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.082 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.469 ' O ' ' HD1' ' A' ' 84' ' ' TYR . 98.6 mt-10 -62.05 -40.78 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.457 0.17 . . . . 0.0 111.34 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.469 ' HD1' ' O ' ' A' ' 83' ' ' GLU . 6.4 m-30 -126.85 28.98 5.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.12 131.41 67.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.3 m -128.9 148.6 50.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.773 ' HB2' HD11 ' A' ' 81' ' ' ILE . 65.2 tp -112.19 129.75 56.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.681 ' CE1' ' HB ' ' A' ' 44' ' ' ILE . 38.5 t80 -126.99 133.47 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.031 0.443 . . . . 0.0 111.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.517 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -107.7 141.58 15.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.554 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 134' ' ' SER . 3.3 mp -110.06 121.52 45.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 111.486 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.8 tp -135.28 126.81 28.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.562 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.5 -151.15 11.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.869 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.92 155.29 44.69 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.133 0.492 . . . . 0.0 111.553 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.456 ' HA3' ' OH ' ' A' ' 70' ' ' TYR . . . -122.73 144.06 15.66 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.797 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -126.87 126.37 43.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 110.703 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.352 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.374 0.606 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 87.0 m -128.6 133.38 48.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.591 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.448 ' HB3' HD21 ' A' ' 140' ' ' LEU . 92.3 p -140.12 160.48 39.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.31 141.87 31.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.177 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.35 133.43 55.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.61 140.04 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.471 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 136' ' ' GLU . . . -170.01 -175.42 38.95 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.734 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.45 154.31 41.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.42 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -148.53 161.71 28.7 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.418 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.17 138.72 50.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.363 -0.418 . . . . 0.0 110.159 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 14.7 tt0 -119.86 130.5 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.999 0.428 . . . . 0.0 110.034 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.03 152.27 33.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.028 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -121.22 82.92 38.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.619 0.247 . . . . 0.0 110.688 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.34 -28.99 14.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.356 2.037 . . . . 0.0 112.248 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 79.5 m80 -130.64 152.93 81.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.737 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -56.28 -36.19 96.64 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.763 2.308 . . . . 0.0 114.287 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -109.57 -4.23 16.37 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 126' ' ' HIS . 68.2 m-85 -121.47 133.51 55.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.68 152.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.084 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.3 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -115.54 114.99 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -114.14 108.97 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.577 ' HB3' HD11 ' A' ' 90' ' ' LEU . 54.0 m -128.03 153.13 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -134.48 131.85 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.709 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.417 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 27.2 pt-20 -140.91 161.24 38.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -137.76 159.1 42.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 0.0 111.626 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 45.2 m -108.59 135.53 49.69 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.912 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -98.67 104.81 16.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.803 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 79.2 mt -118.48 153.29 34.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.54 -45.25 93.83 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.2 -32.82 7.64 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.803 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 62.7 t -104.92 130.48 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.44 125.08 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.6 t -121.83 125.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.14 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -113.74 138.17 14.7 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.6 m -124.58 130.98 53.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.443 0.621 . . . . 0.0 111.433 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.7 m-90 -106.24 131.55 53.35 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.6 mtt -120.63 111.2 17.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.438 . . . . 0.0 111.438 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -123.85 134.41 53.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.612 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 178.39 48.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.378 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.81 150.89 42.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.855 0.359 . . . . 0.0 110.498 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -127.3 155.29 19.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.985 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -118.55 127.77 53.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.764 0.316 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.489 ' HA ' ' OG ' ' A' ' 5' ' ' SER . 80.8 mtp180 -92.82 132.57 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.875 -179.9 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.547 0.213 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -129.04 143.34 50.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.235 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -128.47 143.5 50.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.4 mm -113.77 120.57 63.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 65.7 m -127.33 144.71 51.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.399 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.52 153.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.571 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.17 -174.34 38.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.102 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -109.06 142.61 39.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -108.26 127.74 54.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 111.416 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -120.97 114.82 22.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.739 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 50.6 m -118.2 159.85 22.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.59 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -126.91 128.87 47.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.169 -178.753 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.739 ' HD2' ' O ' ' A' ' 13' ' ' SER . 72.4 Cg_endo -74.83 157.99 43.14 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.474 2.116 . . . . 0.0 110.72 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -113.92 146.73 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.049 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -177.66 178.31 48.38 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.431 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.69 148.39 33.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 0.0 110.788 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 16.4 t30 -124.27 130.05 51.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.948 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.76 136.2 53.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.082 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.7 mttm -124.49 139.95 53.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 111.377 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -132.64 128.3 36.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.069 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.514 ' HD3' HE22 ' A' ' 122' ' ' GLN . 47.0 ttp180 -119.92 133.68 55.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -128.19 125.15 38.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.1 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.26 179.825 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.32 153.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -139.1 138.63 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.36 139.93 12.6 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 m -129.36 136.6 50.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.992 0.425 . . . . 0.0 111.105 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.39 124.85 43.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.821 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.793 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -119.08 120.27 36.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.784 0.326 . . . . 0.0 110.939 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.532 ' OE1' ' HD1' ' A' ' 71' ' ' TYR . 2.8 mm-40 -112.09 106.48 15.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.525 HG22 ' HA3' ' A' ' 28' ' ' GLY . 75.1 p -125.99 158.04 36.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.119 0.485 . . . . 0.0 112.276 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 179.29 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -99.39 122.76 42.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.645 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -127.79 142.23 51.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.13 123.25 24.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.532 ' HD1' ' OE1' ' A' ' 49' ' ' GLN . 92.1 m-85 -112.79 128.91 56.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.793 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 67.4 m -113.92 127.03 55.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.181 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.9 124.4 70.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -147.15 153.43 39.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.851 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -153.03 153.43 32.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -167.81 167.37 40.01 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.997 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.56 156.3 40.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.526 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.76 129.71 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.544 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -126.88 126.63 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.996 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -69.94 134.79 48.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 0.0 111.215 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.631 ' HB ' HG23 ' A' ' 85' ' ' VAL . 95.6 mt -89.62 -45.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.53 0.681 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.83 -144.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.86 -1.78 52.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.342 -0.224 . . . . 0.0 111.468 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -147.05 9.72 0.99 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.631 HG23 ' HB ' ' A' ' 81' ' ' ILE . 3.4 m -140.37 142.53 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 68.1 m -138.3 151.35 47.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.049 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 81' ' ' ILE . 2.7 tt -116.26 136.93 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -142.75 157.69 44.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 111.335 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.635 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.99 150.52 18.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.845 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.02 129.44 55.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.455 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -142.36 135.66 28.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.8 13.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.903 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.69 152.19 45.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.101 0.477 . . . . 0.0 111.606 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.21 140.81 16.43 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.768 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -119.03 122.42 42.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.592 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.272 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.247 0.546 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -126.8 149.03 49.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.428 ' HB2' HD21 ' A' ' 140' ' ' LEU . 39.3 t -153.97 148.31 26.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 111.511 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.44 126.94 32.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.64 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.85 132.89 56.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.97 0.414 . . . . 0.0 111.132 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.76 137.7 25.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.291 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.4 -168.38 29.47 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.752 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.06 161.47 41.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.64 161.92 28.95 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.579 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.07 140.76 50.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.047 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.514 HE22 ' HD3' ' A' ' 34' ' ' ARG . 52.7 tt0 -115.4 128.55 56.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -116.18 139.93 49.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.108 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -128.83 82.69 68.19 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -30.06 17.48 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.372 2.048 . . . . 0.0 112.237 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -131.32 152.43 80.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.633 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.16 -35.01 89.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.92 2.413 . . . . 0.0 113.869 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.419 ' O ' ' HD1' ' A' ' 154' ' ' TYR . 2.8 t-20 -109.99 13.7 23.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -130.94 118.57 20.87 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -117.37 131.04 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.341 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.21 122.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -110.77 129.67 55.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.9 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -133.79 125.49 28.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 99.3 p -155.8 165.8 35.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.9 152.64 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.55 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -144.42 137.52 27.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -112.75 132.34 55.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.455 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 49.3 m -102.89 125.91 49.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -103.25 114.58 28.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.76 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 68.1 mt -119.91 153.65 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.16 -43.41 98.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -106.72 -32.06 8.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.76 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.4 t -105.26 130.75 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.91 123.94 48.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -127.7 126.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 112.055 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -114.41 135.01 12.08 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.3 m -119.44 129.18 54.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.52 0.66 . . . . 0.0 111.621 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -111.09 131.44 55.08 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 63.8 mtt -120.71 115.1 22.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.25 136.5 53.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.322 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 -173.25 44.51 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.394 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.66 159.29 43.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.07 -178.23 28.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.596 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 128' ' ' ASN . 94.2 m-85 -121.82 144.66 48.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.654 0.264 . . . . 0.0 110.494 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -96.25 126.39 41.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.813 -179.823 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 34' ' ' ARG . 37.3 t -133.88 140.17 46.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 111.134 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.7 m -131.65 149.46 52.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.3 mt -118.56 126.66 75.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.27 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.526 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 62.1 m -117.83 137.22 52.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.299 . . . . 0.0 111.207 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -121.36 129.64 75.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.193 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.93 172.91 31.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.08 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -98.56 145.05 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -127.81 138.96 52.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.947 0.403 . . . . 0.0 111.429 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HB2' ' NE1' ' A' ' 148' ' ' TRP . 97.3 mt-30 -127.73 135.03 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.967 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.658 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.6 m -118.82 148.56 42.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.176 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -120.37 123.19 42.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 145' ' ' VAL . 58.2 t . . . . . 0 C--O 1.223 -0.328 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.496 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.658 ' HD2' ' O ' ' A' ' 13' ' ' SER . 73.5 Cg_endo -76.8 159.48 34.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.632 2.221 . . . . 0.0 110.756 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -116.07 156.35 26.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.903 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -178.63 -153.79 11.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.362 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.12 161.35 38.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 28.1 t-20 -135.26 128.87 32.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 46' ' ' SER . 87.1 mt -104.13 128.15 51.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.986 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 23.0 ttmm -119.74 127.75 53.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.513 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.38 134.52 52.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.614 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 4' ' ' SER . 77.2 ttt-85 -121.78 131.03 53.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 111.733 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -132.36 131.49 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.595 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.9 0.381 . . . . 0.0 110.822 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.3 pp -136.77 150.07 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -130.86 134.1 7.6 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 55.0 m -124.57 135.71 53.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.031 0.415 . . . . 0.0 111.774 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 94.8 m-85 -120.4 111.73 18.11 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -102.67 127.48 49.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.503 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.521 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 77.4 mt-30 -126.08 123.52 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 77.1 p -128.04 149.45 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.676 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.037 179.608 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t0 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -104.83 130.22 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.769 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -118.03 136.35 53.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.981 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.513 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 68.0 t80 -134.45 125.64 27.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.231 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.44 138.16 53.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 109.912 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 67.7 m -127.92 136.0 50.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.199 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 63.0 t -124.92 119.63 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.7 p -133.2 156.33 47.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 111.868 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.22 153.01 34.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.042 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.06 164.66 37.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.969 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.19 156.85 29.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.889 2.393 . . . . 0.0 112.64 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 88' ' ' TYR . 57.4 t -123.42 129.75 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.382 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -123.13 128.71 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.043 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.485 ' HD3' ' HB3' ' A' ' 86' ' ' SER . 29.3 mmt180 -78.53 126.31 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.8 mm -90.97 -42.26 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 110.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.0 -167.2 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.04 -38.43 88.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 0.0 111.327 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -128.15 23.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.44 127.48 65.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.645 ' OG ' ' HB3' ' A' ' 122' ' ' GLN . 89.3 p -138.6 151.7 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.7 mt -123.36 145.92 48.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.957 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.508 ' HB3' HG22 ' A' ' 78' ' ' VAL . 34.6 p90 -150.89 159.36 44.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 111.714 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.659 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -117.13 149.25 18.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.132 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 134' ' ' SER . 92.4 mt -112.65 118.89 36.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.296 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 tp -127.11 125.39 41.17 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . -175.13 -155.03 11.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.855 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.07 153.39 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.613 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.01 141.62 17.0 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.766 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -129.33 130.8 46.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.775 0.321 . . . . 0.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.542 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.09 0.471 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 76.4 p -118.26 149.16 41.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.769 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.4 p -157.4 163.94 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.37 . . . . 0.0 111.759 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.8 mt -98.79 135.41 40.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.064 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.33 130.1 52.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -143.74 138.64 28.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -167.76 -165.05 24.51 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.695 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.18 37.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 88' ' ' TYR . . . -145.28 162.65 28.18 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 113.348 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.0 tp -126.74 138.43 53.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.902 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.645 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 51.6 tt0 -126.75 133.1 50.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.862 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -122.5 151.82 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.574 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -119.35 81.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.23 -34.6 67.37 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.597 2.198 . . . . 0.0 111.483 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.68 155.44 81.26 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.681 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.56 -23.21 74.71 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.844 2.362 . . . . 0.0 113.658 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -117.78 9.51 12.99 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.94 133.93 29.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.69 153.39 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.3 mt -113.22 124.24 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -111.3 126.93 55.42 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -128.6 116.5 19.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.59 ' HB3' HD11 ' A' ' 90' ' ' LEU . 67.7 m -130.64 153.82 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 99.0 m-85 -125.58 138.32 53.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.329 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 99.2 mt-10 -129.66 144.64 51.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.621 0.248 . . . . 0.0 110.34 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.434 ' OH ' ' HD2' ' A' ' 144' ' ' LYS . 90.8 t80 -135.51 129.8 33.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 0.0 111.324 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -101.87 121.8 42.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -102.4 107.02 17.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 96.2 mt -119.23 153.58 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.68 -43.5 98.75 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.46 -31.88 8.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.718 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.0 t -105.27 128.42 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HD2' ' OH ' ' A' ' 137' ' ' TYR . 34.8 mmtp -105.72 125.36 50.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -126.69 125.67 67.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.4 135.69 12.03 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 70.9 m -131.29 137.53 48.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.171 0.485 . . . . 0.0 111.667 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 12' ' ' GLN . 34.4 p90 -132.85 148.8 52.3 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm -140.05 149.06 42.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.175 0.512 . . . . 0.0 111.844 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.94 139.0 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.395 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -177.77 -176.0 45.42 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.17 152.24 39.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.457 -0.372 . . . . 0.0 110.517 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.45 152.59 18.4 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.608 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -121.96 130.56 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.489 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -78.52 135.33 37.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.08 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.712 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 . . . . . 0 C--O 1.235 0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.2 p -142.39 156.89 45.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.8 m -136.72 146.61 46.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.0 mt -118.02 125.53 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.2 m -127.21 145.61 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.948 0.404 . . . . 0.0 111.435 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.21 154.28 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.32 176.11 44.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.117 -1.039 . . . . 0.0 113.081 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -94.08 140.4 29.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.13 35.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -112.26 118.4 35.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.889 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 64.9 m -118.46 157.5 27.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 111.702 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -127.25 127.57 44.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.372 -179.476 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 13' ' ' SER . 1.4 t30 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 13' ' ' SER . 37.7 Cg_exo -67.45 148.47 79.2 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.188 2.592 . . . . 0.0 111.006 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -102.96 138.67 39.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -172.76 -177.89 42.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.255 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -121.15 149.48 42.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.272 . . . . 0.0 110.498 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -118.97 126.63 52.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.85 131.09 55.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.982 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -128.47 139.47 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.287 0.565 . . . . 0.0 111.496 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -133.43 129.84 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.277 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -118.53 133.14 56.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -131.77 128.71 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.999 0.428 . . . . 0.0 111.942 -179.129 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.79 156.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.842 0.321 . . . . 0.0 110.877 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 tp -133.52 132.33 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.114 0.483 . . . . 0.0 111.15 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.12 135.66 12.09 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -127.84 134.69 49.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.25 117.95 28.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.404 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 124.93 53.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.83 0.348 . . . . 0.0 111.146 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 10.1 pt20 -131.44 117.52 18.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.901 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 73.6 p -131.6 160.17 36.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.954 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.941 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 120.554 0.216 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -74.73 130.61 39.79 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.602 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.51 139.42 53.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.343 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.442 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.6 m-85 -126.22 127.29 45.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.422 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 49' ' ' GLN . 21.2 t80 -132.18 116.94 17.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.6 m -120.29 136.86 54.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.45 120.22 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.8 p -133.4 157.18 46.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 111.777 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.695 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -152.19 155.19 37.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.98 172.71 43.93 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.781 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.98 155.07 43.0 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.943 2.428 . . . . 0.0 112.74 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.03 125.91 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.374 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -127.07 123.69 37.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.964 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -80.24 137.43 36.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.594 0.235 . . . . 0.0 110.746 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.566 ' HB ' HG23 ' A' ' 85' ' ' VAL . 44.2 mm -88.92 -39.37 12.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.494 0.664 . . . . 0.0 109.776 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -153.51 -155.05 0.56 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.278 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.31 1.81 53.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.622 0.248 . . . . 0.0 111.331 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -144.95 10.7 1.35 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -143.25 139.24 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.694 0.283 . . . . 0.0 110.651 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -138.65 150.72 46.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.114 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 129.26 54.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.076 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.37 139.75 48.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.736 0.303 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.34 137.37 13.59 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -125.36 126.19 44.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.197 0.499 . . . . 0.0 111.732 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -146.81 136.96 23.52 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.2 -149.76 12.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.869 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.44 151.79 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.482 . . . . 0.0 111.601 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.81 141.13 16.14 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.717 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -124.06 128.51 49.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.295 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.053 179.869 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.2 mttp . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.119 0.485 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 74.3 p -113.37 147.68 37.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.493 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.45 ' HB3' HD21 ' A' ' 140' ' ' LEU . 97.7 p -155.57 164.64 38.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 0.0 111.709 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.4 mt -98.57 137.32 37.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.828 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.15 132.12 54.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.798 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.16 142.07 26.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.329 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -176.38 -172.98 41.61 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.748 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.9 161.32 42.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.458 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -146.23 165.7 28.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.456 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -126.06 138.89 53.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -119.17 134.54 55.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.388 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -116.47 151.95 35.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -119.67 85.06 32.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.16 -33.35 9.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.192 1.928 . . . . 0.0 111.752 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -136.26 152.64 75.55 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.673 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.9 -30.22 76.93 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.65 2.233 . . . . 0.0 113.745 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.54 10.15 33.21 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -149.11 122.3 8.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.201 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.63 151.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -122.7 145.17 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -136.14 122.11 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.35 41.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.458 ' OG ' ' HA3' ' A' ' 120' ' ' GLY . 69.3 m -127.98 150.07 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.493 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.8 m-85 -118.38 130.65 56.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -137.06 136.85 38.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -126.72 146.12 50.33 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 55.6 m -112.03 137.41 50.1 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.87 115.51 30.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.821 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 74.7 mt -118.4 154.3 32.65 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.0 -44.73 96.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.48 -33.4 7.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.5 t -105.65 128.63 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.73 128.95 44.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 65.2 t -125.46 128.07 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.11 0.481 . . . . 0.0 112.099 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -116.83 136.59 12.86 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.5 m -126.8 129.98 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.209 0.504 . . . . 0.0 111.192 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -113.33 133.45 55.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.0 mtt -114.48 117.97 32.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 0.0 111.495 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -125.25 123.36 39.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.314 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.37 -173.48 39.03 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.43 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.04 165.48 27.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.382 . . . . 0.0 110.734 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.26 178.47 30.29 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -131.95 130.92 42.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -80.82 131.25 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.981 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.755 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.687 0.279 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -140.22 159.48 42.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.231 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.2 m -132.25 147.19 52.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.968 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.6 124.2 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 56.5 m -120.63 139.73 52.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.436 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.1 mt -123.47 129.16 74.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.004 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 177.86 20.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.313 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -102.58 137.34 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.69 130.52 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.797 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -122.34 132.69 54.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 44.2 m -118.35 158.7 24.75 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.455 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -128.97 119.09 23.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 145' ' ' VAL . 65.0 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.469 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 13' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 13' ' ' SER . 94.5 Cg_endo -80.12 159.51 23.64 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.569 2.18 . . . . 0.0 110.877 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -91.95 140.5 29.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.573 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -164.53 173.99 40.51 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.259 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.21 152.54 47.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -122.69 132.32 54.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.91 121.1 39.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.071 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.4 mttm -117.9 140.46 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 111.38 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.14 135.98 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.88 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.668 ' HA ' HG22 ' A' ' 44' ' ' ILE . 76.5 ttt180 -119.0 129.94 55.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.22 132.2 56.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 -179.077 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.197 0 N-CA-C 112.31 -0.316 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.11 139.83 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.077 0.438 . . . . 0.0 110.624 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 34' ' ' ARG . 36.8 pt -130.44 158.35 42.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.9 142.65 15.77 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -129.37 123.11 30.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -114.51 122.42 46.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 136.04 54.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -142.16 132.4 24.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.05 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.693 HG22 ' HA3' ' A' ' 28' ' ' GLY . 82.3 p -133.45 158.91 41.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.033 0.444 . . . . 0.0 111.639 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.392 179.163 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.99 126.33 43.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.501 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.11 140.26 51.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.216 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.467 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.3 m-85 -121.34 122.3 39.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.629 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.17 119.51 31.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.1 m -123.89 136.01 54.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.964 0.412 . . . . 0.0 111.155 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.76 121.36 64.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.6 p -130.49 154.97 47.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.067 0.46 . . . . 0.0 111.831 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.99 151.19 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.893 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.04 160.93 31.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.856 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.45 156.3 40.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.862 2.375 . . . . 0.0 112.655 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.21 131.87 70.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 0.0 110.387 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -118.7 125.51 49.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.155 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -70.73 133.82 46.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.533 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.711 ' HB ' HG23 ' A' ' 85' ' ' VAL . 84.0 mt -84.59 -44.65 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.455 0.645 . . . . 0.0 109.839 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -140.54 -102.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.21 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -125.47 -34.69 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.678 0.275 . . . . 0.0 111.134 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.76 11.73 14.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 81' ' ' ILE . 2.6 m -136.08 137.56 48.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 122' ' ' GLN . 49.9 m -139.12 151.96 47.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.202 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.71 136.12 53.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.135 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CD1' HD11 ' A' ' 44' ' ' ILE . 51.2 p90 -142.61 160.62 39.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 111.281 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.86 152.51 17.31 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.4 mt -112.39 123.32 50.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.331 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.7 tp -136.49 127.33 27.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.604 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.9 -160.48 25.58 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.817 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.86 148.83 52.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 0.0 111.437 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.53 135.75 12.95 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.876 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -124.37 124.81 43.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.037 0.446 . . . . 0.0 110.625 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.158 179.809 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.03 0.443 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.6 m -120.69 131.44 54.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 81.8 p -145.57 161.24 40.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.01 0.433 . . . . 0.0 111.796 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 138' ' ' SER . 63.8 tp -98.21 126.52 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.82 128.89 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -144.65 140.75 28.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.405 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -173.05 -168.91 34.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.705 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.63 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.6 168.06 32.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.43 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.4 mt -127.35 147.25 50.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.275 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 97.7 mt-30 -117.83 137.11 52.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.294 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.83 140.56 52.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.695 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -125.08 83.04 60.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.394 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.06 -27.64 42.07 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.278 1.985 . . . . 0.0 111.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -133.58 153.42 80.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.492 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.48 -37.99 89.86 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.899 2.399 . . . . 0.0 113.692 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.407 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 33.6 m120 -105.63 10.66 32.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.44 121.42 37.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.918 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.26 130.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.306 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.41 123.82 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.37 127.84 56.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.941 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -138.14 123.97 19.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.52 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 99.5 p -150.45 160.87 43.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.0 m-85 -118.34 127.04 53.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.271 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -120.75 126.6 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.52 143.58 51.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.205 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 56.2 m -110.2 128.78 55.68 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.36 105.77 16.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.748 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 90.8 mt -119.15 149.45 41.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.52 -43.8 97.92 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -103.73 -31.92 9.62 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.748 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.5 t -105.82 128.69 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -105.14 120.55 41.79 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 64.0 t -123.31 124.96 71.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.704 -0.398 . . . . 0.0 112.017 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -121.1 130.91 8.41 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.3 m -124.96 129.38 50.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.147 0.473 . . . . 0.0 111.484 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.451 ' CD1' ' HD1' ' A' ' 135' ' ' TYR . 52.6 m0 -109.86 133.14 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 74.8 mtm -126.92 126.17 42.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.733 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -140.43 136.33 32.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.395 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.61 -175.7 41.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.821 -1.181 . . . . 0.0 113.538 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.61 152.48 48.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 7' ' ' SER . . . -139.73 165.61 25.82 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.658 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 128' ' ' ASN . 93.2 t80 -110.84 130.66 55.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.31 124.69 36.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.735 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.78 0.324 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.6 p -144.13 156.3 44.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -137.59 146.56 44.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.67 127.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 60.4 m -121.02 138.09 54.33 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.878 0.37 . . . . 0.0 111.221 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.2 mt -125.58 131.31 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.15 -173.16 24.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.18 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.66 147.02 32.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.99 126.27 52.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 111.13 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -117.92 123.31 45.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.882 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.649 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.0 m -118.53 150.88 38.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 111.686 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -127.65 129.28 46.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 145' ' ' VAL . 60.2 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.707 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 . . . . . 0 C--O 1.233 0.216 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 13' ' ' SER . 85.8 Cg_endo -84.16 159.02 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.884 2.389 . . . . 0.0 110.957 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -107.57 149.29 28.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.711 0.291 . . . . 0.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -170.8 -179.52 42.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.6 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -115.04 147.71 39.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.845 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.492 HD21 ' HE2' ' A' ' 32' ' ' LYS . 3.3 t30 -122.85 123.77 41.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.266 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -119.59 130.31 55.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.6 mttm -126.87 138.25 53.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.003 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.75 132.87 53.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.751 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -126.04 129.99 50.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.954 0.407 . . . . 0.0 111.46 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.01 134.59 54.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.747 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 111.799 -179.595 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -125.02 131.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.946 0.373 . . . . 0.0 110.842 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 tt -126.56 140.75 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.12 140.17 11.92 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -126.31 139.3 53.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.096 0.474 . . . . 0.0 111.606 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.57 125.26 43.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.642 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -114.18 126.88 55.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -123.3 107.84 12.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.616 HG22 ' HA3' ' A' ' 28' ' ' GLY . 66.7 p -128.4 155.22 45.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.972 179.229 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.0 t0 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.845 0.355 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -110.5 122.4 47.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.535 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -102.69 131.49 49.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.124 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -123.77 122.77 38.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -123.43 137.48 54.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.74 0.305 . . . . 0.0 110.217 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.676 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 64.1 m -126.53 136.06 52.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -125.63 120.2 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.0 p -133.34 157.62 45.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.493 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.64 155.35 37.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.174 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -174.43 165.15 36.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.132 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.36 153.9 35.84 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.857 2.372 . . . . 0.0 112.404 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.29 126.68 75.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -122.2 133.47 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.929 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -73.43 137.43 44.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.502 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.841 ' HB ' HG23 ' A' ' 85' ' ' VAL . 96.1 mt -83.55 -48.57 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.349 0.595 . . . . 0.0 110.34 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -140.88 -84.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.895 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -138.9 -44.92 0.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.66 0.267 . . . . 0.0 111.23 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -109.23 9.67 25.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.841 HG23 ' HB ' ' A' ' 81' ' ' ILE . 7.2 m -136.69 142.41 38.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 121.196 -0.202 . . . . 0.0 110.529 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 48.8 m -135.25 149.14 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 111.382 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.3 tp -116.59 129.9 56.43 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -141.85 157.98 44.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.456 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.604 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.68 147.48 18.9 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.749 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.89 118.78 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.74 137.32 54.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.56 -157.43 23.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.797 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.72 154.91 47.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -120.23 139.52 13.8 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -127.12 143.53 51.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.309 179.858 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.234 0.239 0 CA-C-O 121.115 0.483 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.8 m -122.75 132.03 54.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.697 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.425 ' HB3' HD21 ' A' ' 140' ' ' LEU . 93.1 p -149.18 160.9 42.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.623 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 138' ' ' SER . 91.0 mt -100.49 138.66 37.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.092 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.44 122.66 29.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.744 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -131.64 149.2 52.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.63 -168.3 36.46 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.634 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.07 162.12 38.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -146.0 156.71 27.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.445 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.6 138.99 51.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.879 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.444 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 52.8 tt0 -115.3 124.34 51.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.781 0.324 . . . . 0.0 110.228 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.63 131.47 56.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.977 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.408 ' OD1' HG22 ' A' ' 130' ' ' VAL . 40.6 t30 -126.72 81.11 69.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.421 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.61 -40.17 39.53 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.754 2.303 . . . . 0.0 111.887 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -133.67 154.69 80.76 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.649 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.3 -34.45 70.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.801 2.334 . . . . 0.0 113.817 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -103.19 10.96 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.473 ' CZ ' HD11 ' A' ' 131' ' ' ILE . 22.6 t80 -131.66 112.63 12.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 124' ' ' ASN . 59.8 t -122.38 130.64 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.473 HD11 ' CZ ' ' A' ' 129' ' ' PHE . 49.1 mm -116.22 123.08 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.8 m-20 -113.82 127.81 56.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.09 115.98 21.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.46 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -136.43 161.96 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.268 0.556 . . . . 0.0 112.462 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -139.29 148.85 43.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.283 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -139.85 148.5 42.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -127.33 128.45 45.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.993 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 66.2 m -100.16 123.95 45.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -101.01 112.76 25.3 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.746 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 89.9 mt -119.37 153.91 34.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.84 -44.59 96.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -106.5 -32.49 8.06 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.746 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.7 t -105.03 131.19 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -105.64 124.29 49.31 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 15' ' ' VAL . 62.5 t -127.27 128.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 112.048 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.49 135.0 11.89 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 85.1 m -123.47 130.15 52.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.241 0.52 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -111.53 136.5 50.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 2.8 mmm -119.21 115.58 24.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 0.0 111.194 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.2 133.96 54.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.585 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.73 176.93 46.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.445 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.87 147.24 43.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.651 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.47 160.58 20.84 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.741 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -125.4 130.52 52.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.734 0.302 . . . . 0.0 110.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -76.5 134.12 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.339 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.782 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -138.42 157.0 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 111.264 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -133.54 144.83 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.65 126.77 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.237 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 53.8 m -128.75 144.99 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -127.29 150.68 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.427 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.31 -172.12 36.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.942 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -109.7 156.92 19.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.24 135.34 51.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.859 0.361 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -125.08 129.6 50.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.92 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 57.4 m -116.75 145.95 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -118.71 121.52 40.31 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.536 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 13' ' ' SER . 14.7 p-10 . . . . . 0 CA--C 1.529 0.141 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 13' ' ' SER . 95.9 Cg_endo -79.7 158.45 24.88 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.421 2.08 . . . . 0.0 110.957 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -93.31 146.78 23.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.607 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -168.01 -179.9 40.84 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.433 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -119.61 154.12 34.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.87 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.9 t-20 -126.38 134.42 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.282 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.2 125.66 47.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 60.6 mttp -121.33 139.32 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.147 0.499 . . . . 0.0 111.6 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.7 129.08 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.114 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -116.57 134.01 55.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.679 0.276 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -128.59 124.83 36.88 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.501 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.007 0.404 . . . . 0.0 110.911 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.94 138.43 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.102 0.477 . . . . 0.0 110.912 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -112.91 137.42 14.22 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.6 m -124.74 130.11 51.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.019 0.438 . . . . 0.0 111.482 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 97.1 m-85 -115.61 126.49 54.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.685 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.25 115.12 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.826 0.346 . . . . 0.0 110.649 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -123.84 111.46 16.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.607 HG22 ' HA3' ' A' ' 28' ' ' GLY . 77.1 p -125.93 151.8 46.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.716 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.671 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -83.51 124.19 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.894 0.378 . . . . 0.0 110.793 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -114.98 132.29 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.113 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.581 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 78.1 t80 -131.14 121.31 24.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.287 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -134.24 125.55 28.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 110.221 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 m -130.06 146.62 51.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.095 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.72 126.19 64.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.726 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.2 p -134.95 157.89 45.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.156 0.503 . . . . 0.0 111.78 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.64 153.86 36.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.96 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -169.85 165.25 38.63 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.936 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.35 154.27 40.75 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.916 2.41 . . . . 0.0 112.722 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.599 HG22 ' HB3' ' A' ' 88' ' ' TYR . 60.1 t -123.68 127.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.358 . . . . 0.0 110.545 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -127.87 128.55 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.078 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -74.66 128.34 35.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 0.0 111.078 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 87' ' ' LEU . 86.3 mt -90.36 -42.31 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.12 -165.62 1.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.499 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.75 -39.72 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.548 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -127.21 25.23 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.16 127.54 67.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 66.2 m -128.29 147.25 50.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 111.057 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.703 ' HB2' HD11 ' A' ' 81' ' ' ILE . 64.9 tp -117.07 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.107 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' HB3' HG22 ' A' ' 78' ' ' VAL . 54.6 p90 -142.09 158.77 43.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.068 0.461 . . . . 0.0 111.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.561 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -118.7 156.11 15.8 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.052 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 134' ' ' SER . 88.5 mt -115.13 118.48 33.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.31 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.38 131.69 50.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.06 -148.4 10.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.823 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.99 152.23 41.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 136.44 13.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.862 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -120.83 127.46 51.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.656 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.166 179.719 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.14 0.495 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.6 m -125.0 134.68 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 138' ' ' SER . 89.3 p -141.46 162.03 36.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 0.0 111.557 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 138' ' ' SER . 60.7 tp -75.04 129.22 37.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.466 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 137' ' ' TYR . . . -119.69 133.21 55.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.538 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -148.32 159.31 44.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.719 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 174.33 -166.46 38.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.697 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.69 160.48 41.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.34 28.85 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.335 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.57 143.88 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.358 -0.421 . . . . 0.0 109.995 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -127.92 130.11 47.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.846 0.355 . . . . 0.0 110.327 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -123.5 144.36 49.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.843 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.402 ' OD1' HG22 ' A' ' 130' ' ' VAL . 33.7 t30 -127.43 82.14 68.79 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.801 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.48 -40.78 45.2 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.419 2.079 . . . . 0.0 111.848 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -136.03 154.31 77.47 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.9 -34.83 87.42 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.836 2.357 . . . . 0.0 113.761 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -98.94 10.56 41.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -138.66 112.28 8.28 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG22 ' OD1' ' A' ' 124' ' ' ASN . 67.5 t -116.64 129.78 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.626 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.6 mt -102.54 120.4 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.5 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.2 m-20 -116.65 126.11 52.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.531 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -132.77 135.16 45.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.562 ' HB2' HD11 ' A' ' 90' ' ' LEU . 92.2 p -155.59 161.01 40.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.382 0.611 . . . . 0.0 112.346 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -138.18 134.09 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.712 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.461 ' CG ' ' HB ' ' A' ' 147' ' ' THR . 25.9 pt-20 -129.76 147.75 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 83.7 t80 -129.12 135.11 48.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.65 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 67.6 m -107.65 129.36 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -102.04 117.69 35.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.791 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 60.9 mt -119.64 154.29 34.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.97 -44.35 94.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.9 -32.97 7.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.791 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 59.7 t -104.86 130.61 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -103.29 125.15 49.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.0 t -125.83 124.8 67.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.1 138.88 12.88 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.461 ' HB ' ' CG ' ' A' ' 136' ' ' GLU . 85.7 m -125.46 128.97 48.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.405 0.602 . . . . 0.0 111.503 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -114.09 129.51 56.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 70.8 mtm -123.62 139.89 53.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.245 0.545 . . . . 0.0 112.167 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 67.1 tp -136.97 130.43 31.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.039 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.78 173.14 34.48 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.602 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.64 151.73 49.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.433 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.32 -167.18 18.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.436 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -148.15 160.91 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.811 0.339 . . . . 0.0 110.763 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -78.97 141.41 37.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.801 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.525 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 120.709 0.29 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -128.89 143.5 50.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.18 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -129.69 141.92 50.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.693 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.6 mt -116.39 126.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.263 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 51.6 m -124.54 142.17 51.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 0.0 111.184 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -129.4 153.6 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.4 -173.59 37.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.11 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.4 142.31 37.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.09 123.8 51.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -120.38 122.29 40.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.966 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.661 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.7 m -118.97 157.68 27.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.847 0.356 . . . . 0.0 111.264 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -128.13 140.85 51.7 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.771 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.464 -179.669 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 C--O 1.232 0.136 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 13' ' ' SER . 84.6 Cg_endo -78.01 158.47 30.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.706 2.27 . . . . 0.0 111.094 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -114.18 144.78 42.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -169.31 177.15 43.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.297 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -111.24 144.74 39.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -110.69 127.87 55.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.804 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.6 127.07 53.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.229 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 63.6 mttm -126.61 137.23 53.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.63 135.96 50.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -127.12 130.98 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -114.72 128.36 56.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.544 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.17 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.2 t -121.93 128.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.114 0.457 . . . . 0.0 110.61 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.77 140.56 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.35 141.13 13.11 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -124.99 132.11 53.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.94 0.4 . . . . 0.0 111.364 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.81 118.59 26.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.87 128.18 49.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -124.78 120.55 32.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.47 HG22 ' HA3' ' A' ' 28' ' ' GLY . 62.7 p -128.62 160.19 33.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.986 0.422 . . . . 0.0 111.695 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.907 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.8 t0 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -100.61 127.08 47.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.72 143.87 48.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.213 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -127.93 118.58 23.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -116.5 128.93 55.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.712 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.0 m -122.46 139.41 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.41 122.31 44.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.613 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.3 p -134.41 159.7 40.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.183 0.516 . . . . 0.0 111.898 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.8 154.2 38.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.094 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.89 165.01 37.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.954 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.5 153.01 30.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.817 2.345 . . . . 0.0 112.389 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.57 128.56 72.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.494 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -119.71 124.12 45.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.998 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -75.6 131.32 39.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.804 ' HB ' HG13 ' A' ' 85' ' ' VAL . 47.6 mm -90.34 -42.26 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.517 0.675 . . . . 0.0 109.873 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.414 ' HB3' HG12 ' A' ' 85' ' ' VAL . 2.7 t-20 -150.23 -158.15 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.446 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.05 -40.83 91.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -126.2 29.04 5.91 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.804 HG13 ' HB ' ' A' ' 81' ' ' ILE . 7.7 p -144.71 131.29 15.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 O-C-N 121.953 -0.467 . . . . 0.0 109.836 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.4 m -138.19 152.25 48.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.704 0.288 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 HG13 ' A' ' 81' ' ' ILE . 2.5 mp -124.36 143.22 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.166 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.535 ' CZ ' ' HA3' ' A' ' 120' ' ' GLY . 45.9 p90 -146.18 161.35 40.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.547 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -111.34 146.48 17.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.968 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.408 HD21 ' HE2' ' A' ' 88' ' ' TYR . 79.1 mt -116.41 123.87 48.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.96 0.41 . . . . 0.0 111.56 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -138.16 137.91 38.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -154.66 16.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.857 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.63 153.07 47.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.998 0.428 . . . . 0.0 111.678 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.39 142.78 17.56 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.71 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -129.67 123.74 31.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.754 179.288 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.147 0.498 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.6 p -109.84 148.75 30.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.711 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -154.93 160.6 41.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.789 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 138' ' ' SER . 85.1 mt -101.25 136.39 41.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.0 133.34 54.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -142.41 139.45 31.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.17 -166.42 29.09 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.777 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.535 ' HA3' ' CZ ' ' A' ' 88' ' ' TYR . . . -134.4 150.27 20.01 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.41 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.04 138.7 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.417 -0.391 . . . . 0.0 109.948 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -124.7 132.12 53.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.898 0.38 . . . . 0.0 110.44 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.518 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -114.8 95.31 40.72 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.355 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.48 -36.22 87.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.522 2.148 . . . . 0.0 111.535 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -130.06 157.17 77.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.767 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.18 -37.34 79.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.874 2.383 . . . . 0.0 113.636 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -105.46 16.35 25.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 131' ' ' ILE . 8.4 t80 -126.27 117.03 22.2 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.92 -0.488 . . . . 0.0 110.665 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.1 t -115.32 126.87 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.654 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 129' ' ' PHE . 48.4 mm -108.59 126.39 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -123.42 116.82 23.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.997 0.427 . . . . 0.0 111.402 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -122.94 133.33 54.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.6 p -152.22 166.98 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.331 0.586 . . . . 0.0 112.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -141.31 150.68 42.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.633 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -140.18 151.02 44.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -133.92 128.4 34.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.763 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 20.3 m -94.76 124.43 38.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -103.47 102.86 12.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 97.5 mt -118.62 152.33 36.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.26 -43.86 98.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -105.42 -33.12 8.26 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.749 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.2 t -105.66 125.96 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -105.8 122.64 46.51 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 73.7 t -127.19 129.27 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -117.7 138.83 14.35 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.0 m -127.05 131.71 50.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.244 0.522 . . . . 0.0 111.495 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.9 m-90 -116.8 139.31 50.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 64.3 mtt -127.15 124.33 38.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 0.0 111.992 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.3 mt -127.75 136.67 51.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.112 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.68 -172.37 43.68 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.383 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.97 158.32 44.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.621 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.02 164.4 25.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.816 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -131.32 129.29 41.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 110.177 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -76.37 137.84 40.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 t80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.751 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.088 0.471 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.93 161.03 10.16 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.082 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 -87.24 143.03 27.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.9 m -122.1 141.02 51.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.994 0.426 . . . . 0.0 111.113 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -140.62 153.35 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.143 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -119.87 143.47 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.455 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 49.1 m -134.48 142.85 47.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.74 0.305 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.73 150.0 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.94 167.91 40.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.017 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -89.7 138.74 31.22 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -111.81 127.95 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.403 HE22 ' HG2' ' A' ' 27' ' ' ARG . 50.1 mm-40 -126.02 122.13 34.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.093 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 146' ' ' GLY . 50.1 m -118.4 156.72 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.11 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -122.97 128.36 50.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.21 129.59 74.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.454 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -86.48 108.31 18.47 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.393 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -163.74 147.53 10.2 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.039 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -91.92 108.56 20.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.73 -146.74 6.2 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.576 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.86 145.9 53.31 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG2' ' NH2' ' A' ' 52' ' ' ARG . 18.6 tptt 74.49 116.54 0.06 Allowed 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.942 0.776 . . . . 0.0 110.324 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.0 tp -61.24 -44.49 97.18 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -86.12 -12.71 49.24 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 41.9 mmtt 49.96 37.59 14.26 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -97.23 111.25 57.59 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 13' ' ' SER . 34.7 Cg_exo -63.4 147.14 93.65 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.064 2.51 . . . . 0.0 111.441 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG2' HE22 ' A' ' 12' ' ' GLN . 99.2 mtt180 -113.36 140.35 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.285 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -176.4 -174.84 43.25 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.349 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -119.12 147.39 44.22 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 110.591 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 3.1 t30 -117.09 127.97 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.227 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 tp -112.6 126.08 54.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.977 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 29.2 ttpp -125.06 133.89 52.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.147 0.498 . . . . 0.0 111.621 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -114.36 130.5 56.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.002 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -112.71 128.51 56.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.946 0.403 . . . . 0.0 111.452 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -128.98 120.49 26.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -98.54 119.91 38.06 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -86.29 -16.92 36.02 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.254 0.55 . . . . 0.0 109.914 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -148.0 174.15 12.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.75 -40.07 94.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -111.27 0.99 16.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -127.7 141.21 51.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.093 0.473 . . . . 0.0 111.699 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.86 -179.68 41.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.742 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.25 156.66 42.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 117.021 0.41 . . . . 0.0 110.631 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -134.07 147.77 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.266 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -124.72 123.75 5.17 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -114.94 125.37 53.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.165 0.483 . . . . 0.0 111.759 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -117.11 121.22 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -115.68 126.98 54.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 0.0 111.646 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.523 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 65.5 tt0 -123.91 117.08 24.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.551 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 73.7 p -128.87 156.5 43.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.058 0.456 . . . . 0.0 111.827 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -145.31 162.02 38.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.367 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' NH2' ' HG2' ' A' ' 21' ' ' LYS . 5.1 tpm_? -62.65 130.31 44.44 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.024 0.44 . . . . 0.0 110.917 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 59.1 5.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.157 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.64 132.34 48.81 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.01 140.92 56.47 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.768 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -71.12 129.06 37.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.05 0.453 . . . . 0.0 111.193 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -131.75 149.01 52.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.668 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.98 118.05 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.641 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -148.36 107.11 3.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.87 18.79 78.48 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.737 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 66.74 27.29 9.32 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.059 0.544 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -131.89 149.79 52.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.799 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -110.29 132.39 54.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.817 0.342 . . . . 0.0 111.216 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 66' ' ' GLY . 92.8 mt -95.75 -54.33 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.639 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 57.83 26.8 13.65 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.18 0.592 . . . . 0.0 112.069 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.515 ' H ' HG22 ' A' ' 64' ' ' ILE . . . 92.58 -17.87 56.51 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.35 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 51.68 39.31 24.93 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HB3' ' HB2' ' A' ' 52' ' ' ARG . 94.9 t80 -139.6 126.95 21.4 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -129.44 141.62 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.551 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 74.3 t80 -133.31 126.53 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' CE2' ' HG3' ' A' ' 49' ' ' GLN . 95.5 m-85 -124.37 139.96 53.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.895 0.378 . . . . 0.0 110.533 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 75.4 m -135.68 141.9 45.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.049 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.413 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 3.1 p -138.78 120.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.636 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.1 p -135.56 158.38 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.024 0.44 . . . . 0.0 111.877 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.638 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.83 157.18 42.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.912 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -172.85 161.31 32.55 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.54 155.19 35.86 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.967 2.445 . . . . 0.0 112.408 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 88' ' ' TYR . 61.8 t -120.06 126.65 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.396 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -126.4 128.98 47.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.752 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -77.87 131.49 37.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.697 0.285 . . . . 0.0 110.926 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 87' ' ' LEU . 89.4 mt -90.18 -43.22 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.514 0.673 . . . . 0.0 109.954 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -138.29 -166.61 2.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.235 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -62.64 -39.65 94.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.622 0.248 . . . . 0.0 111.445 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -122.89 21.75 9.82 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.4 127.96 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 CA-C-N 118.011 0.369 . . . . 0.0 110.095 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.8 m -130.14 144.45 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.764 0.316 . . . . 0.0 111.049 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 81' ' ' ILE . 67.6 tp -124.37 135.17 53.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.401 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.522 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 51.9 p90 -139.68 156.17 46.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.06 0.457 . . . . 0.0 111.383 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.635 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -108.97 153.16 16.9 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.074 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 134' ' ' SER . 88.9 mt -120.61 127.27 51.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 111.716 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -144.26 138.03 27.68 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . 176.66 -150.23 10.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.875 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.27 156.26 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.45 147.23 16.7 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.665 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -135.75 128.34 30.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 110.838 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.11 140.45 12.71 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.015 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -128.66 139.91 52.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.654 0.264 . . . . 0.0 110.985 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.33 136.71 41.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.605 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -125.94 148.83 49.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.375 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -111.71 134.63 53.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.688 0.28 . . . . 0.0 110.57 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.7 m -101.63 114.42 28.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.988 0.423 . . . . 0.0 111.101 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.8 p -162.77 166.96 23.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.454 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.4 mm -99.83 111.92 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.008 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -149.93 160.36 43.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.958 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.7 -39.07 96.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.734 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -116.99 153.46 32.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 0.0 110.355 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.9 m -113.57 150.95 32.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.469 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -143.24 159.46 42.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.945 0.402 . . . . 0.0 111.262 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -156.22 167.6 29.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.097 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -126.73 141.52 51.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.944 0.402 . . . . 0.0 111.29 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.1 m -132.91 137.08 46.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.628 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.05 146.06 50.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.903 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.2 p -120.29 148.01 44.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.255 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 140' ' ' LEU . 92.8 p -157.28 165.68 35.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.347 . . . . 0.0 111.849 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 138' ' ' SER . 90.4 mt -99.58 137.81 37.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.909 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.46 131.92 54.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.035 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -143.6 137.9 28.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.36 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.65 -163.32 27.7 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.692 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.33 159.58 43.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -136.86 153.52 21.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.265 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.85 138.81 50.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.028 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 51.6 tt0 -129.21 128.38 43.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.612 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -116.49 139.72 50.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.476 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -116.01 85.79 15.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 130' ' ' VAL . 58.4 Cg_endo -73.7 -32.95 7.03 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.207 1.938 . . . . 0.0 111.711 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -134.71 152.71 78.09 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.695 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.8 -38.27 94.64 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 122.664 2.243 . . . . 0.0 114.054 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -104.55 6.07 34.37 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -137.57 122.04 18.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.927 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.4 m -127.64 153.17 36.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.03 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.31 123.83 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.81 130.72 56.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -127.22 120.26 28.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.598 ' HB3' HD11 ' A' ' 90' ' ' LEU . 73.3 m -121.65 142.48 50.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.54 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.5 m-85 -122.41 122.54 39.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.113 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 83.8 mt-10 -127.1 135.8 51.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.01 142.07 49.46 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.992 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 57.4 m -115.32 128.02 55.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.12 114.78 29.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.757 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 83.3 mt -118.67 154.72 32.25 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.11 -42.91 95.76 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.55 -33.54 7.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.757 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.1 t -106.42 129.03 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -106.06 126.61 52.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 72.6 t -125.85 126.88 70.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -118.38 137.78 13.25 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 73.9 m -126.88 128.42 46.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.262 0.531 . . . . 0.0 111.086 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -119.8 139.03 52.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 17.8 tmm? -134.42 132.03 38.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.094 0.473 . . . . 0.0 111.567 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.89 127.04 41.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -163.71 -167.65 24.51 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.53 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.9 156.23 48.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.763 0.316 . . . . 0.0 110.709 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -124.95 152.84 17.71 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.679 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -121.24 128.33 52.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.881 0.372 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -93.92 128.25 40.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.71 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.913 0.387 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.69 74.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.79 148.69 38.26 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 110.464 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -138.59 156.47 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.0 m -145.04 156.02 43.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.63 143.31 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.479 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 50.4 m -134.51 148.34 50.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.708 0.29 . . . . 0.0 111.286 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.9 152.16 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.331 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.24 -179.19 41.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.025 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -103.18 140.81 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.691 0.281 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.81 121.78 45.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -120.43 127.95 52.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.67 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.689 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.5 m -118.01 153.28 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 111.276 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.93 127.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.718 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -85.9 109.82 19.0 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.67 -0.412 . . . . 0.0 109.903 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -155.2 164.67 38.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.335 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -119.01 107.71 13.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.802 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.76 -131.01 2.44 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.511 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.455 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 85.0 m-85 -69.06 150.29 47.78 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 49.0 mttp 69.7 95.84 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.573 0.546 . . . . 0.0 110.595 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.12 -45.16 93.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.723 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.464 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 11.3 m-20 -92.13 -14.57 28.96 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 20' ' ' TYR . 57.1 mmtt 50.12 37.24 13.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 23' ' ' ASP . 32.1 m120 -103.43 112.08 65.46 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 13' ' ' SER . 91.5 Cg_endo -80.23 158.87 23.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.747 2.298 . . . . 0.0 111.362 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -111.19 136.49 50.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.554 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.18 -179.86 40.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.574 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.95 154.69 35.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -127.97 126.18 40.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -108.85 136.78 47.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 15.8 ttmm -130.98 136.9 48.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.132 0.491 . . . . 0.0 111.528 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -122.6 127.59 49.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.869 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -113.82 130.63 56.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.0 111.314 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -126.61 122.73 35.88 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -97.26 106.17 18.45 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -70.53 -35.32 73.09 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.34 0.59 . . . . 0.0 109.814 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -138.12 176.1 9.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.606 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -62.94 -43.02 99.94 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -109.88 14.04 23.29 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -141.03 130.72 24.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.892 0.377 . . . . 0.0 111.564 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.16 177.37 35.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.016 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.8 156.61 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.034 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.1 pp -132.41 146.08 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 111.537 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -120.92 125.73 6.33 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.425 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 48.1 m -118.09 128.16 54.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 0.0 112.005 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -121.21 120.5 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.354 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -118.07 129.47 55.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.892 0.377 . . . . 0.0 111.46 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -122.86 115.92 22.78 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.7 p -127.0 155.4 43.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 112.013 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -145.28 148.17 33.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.002 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -63.15 138.02 58.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.807 0.336 . . . . 0.0 110.687 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.12 -174.87 49.04 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.863 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -106.08 118.58 36.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.971 0.415 . . . . 0.0 110.68 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 21' ' ' LYS . 42.3 tt0 -135.18 131.55 36.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.516 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -84.85 129.58 34.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.994 0.426 . . . . 0.0 111.062 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.8 m -131.38 149.82 52.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.076 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.6 101.28 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.898 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -158.88 74.42 0.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.778 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.47 5.21 90.13 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.773 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 61.14 32.74 19.57 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.844 0.458 . . . . 0.0 111.333 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -118.09 130.86 56.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.609 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.6 mt -96.73 109.68 22.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.41 . . . . 0.0 110.898 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.43 -31.38 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.089 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.3 t70 69.56 -67.15 0.23 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.308 0.643 . . . . 0.0 111.256 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.17 -42.09 2.04 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.904 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t0 46.45 52.63 10.61 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.841 0.456 . . . . 0.0 111.814 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 98' ' ' ALA . 91.6 t80 -114.79 128.62 56.4 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.931 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -113.92 137.54 51.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.56 123.45 39.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -117.45 137.33 52.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 66.2 m -127.58 131.97 49.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.852 0.358 . . . . 0.0 111.216 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.03 117.96 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 46' ' ' SER . 74.2 p -132.47 156.96 45.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 111.743 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.1 156.35 42.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.225 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -173.77 165.02 36.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.104 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.18 155.63 25.71 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.001 2.467 . . . . 0.0 112.364 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.17 127.76 75.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -126.81 125.98 42.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.984 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -77.21 127.61 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.698 HD12 HG12 ' A' ' 85' ' ' VAL . 97.5 mt -75.12 -46.04 40.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -134.29 -97.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.158 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 -31.72 1.36 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.29 3.99 11.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.698 HG12 HD12 ' A' ' 81' ' ' ILE . 57.8 t -129.09 128.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 57.1 m -129.0 148.72 50.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 tt -116.8 136.72 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.225 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.501 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 50.1 p90 -142.04 155.44 45.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.392 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.576 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -109.03 151.86 17.08 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.044 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 134' ' ' SER . 83.1 mt -119.67 125.57 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 0.0 111.503 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -144.58 140.37 28.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.602 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.97 -157.29 27.22 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.65 151.94 51.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.082 0.467 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.17 141.49 17.04 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -127.58 126.09 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.808 0.337 . . . . 0.0 110.39 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -116.4 142.06 17.23 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.352 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.43 136.2 54.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.715 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . . . -129.9 133.14 46.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -128.9 144.5 51.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -104.04 122.71 45.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.8 m -88.56 113.62 24.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.963 0.411 . . . . 0.0 111.492 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.7 p -163.94 165.69 22.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.505 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.68 111.02 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -150.32 162.56 40.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.993 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.16 -39.08 96.64 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.779 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -123.51 150.66 43.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.2 m -120.56 149.95 41.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.724 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -125.39 142.5 51.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.189 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.1 m -132.93 152.73 51.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.934 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -127.33 154.85 44.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 111.638 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.3 p -137.39 152.3 49.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.0 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -131.18 150.88 51.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.6 m -115.42 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.7 p -140.54 157.71 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.978 0.418 . . . . 0.0 111.77 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 138' ' ' SER . 69.0 tp -100.56 127.66 46.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.56 130.77 56.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.424 . . . . 0.0 110.953 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -144.56 140.22 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.83 -163.33 27.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.633 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.15 161.27 41.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -142.1 158.58 26.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.347 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.8 mt -122.56 139.38 53.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.509 -0.346 . . . . 0.0 110.077 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -118.85 128.49 54.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.169 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.33 142.37 51.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -124.19 82.67 56.92 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.532 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.21 -28.61 33.77 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.477 2.118 . . . . 0.0 112.127 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -131.56 151.29 78.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.546 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.81 -25.57 74.66 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 113.452 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -111.48 13.49 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -140.29 120.89 14.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 110.951 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.5 t -111.43 129.98 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.183 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 51.0 mm -104.64 119.65 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.464 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 88.7 m-20 -114.11 126.48 55.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.991 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.15 124.04 45.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.451 ' HB3' HD11 ' A' ' 90' ' ' LEU . 74.9 m -127.35 143.08 51.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 112.379 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.526 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 51.9 m-85 -124.65 122.96 38.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.102 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -125.59 135.12 51.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -127.39 139.21 53.0 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.871 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 49.6 m -105.99 123.96 48.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -101.36 107.64 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.258 0.552 . . . . 0.0 112.311 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 87.3 mt -119.01 153.0 35.39 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.89 -44.11 97.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -104.9 -32.92 8.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.731 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -106.07 128.36 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -106.19 120.69 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 58.1 t -124.92 129.19 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.974 0.416 . . . . 0.0 112.091 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.09 138.29 14.64 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.7 m -124.84 129.16 49.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.979 0.418 . . . . 0.0 111.3 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -115.95 136.99 52.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -131.93 127.87 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.96 137.47 53.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.36 -171.59 38.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.571 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.86 157.09 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.94 0.4 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.79 167.19 24.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.738 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -132.86 130.81 40.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.494 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.2 mtm105 -79.04 140.45 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.027 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.937 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.102 0.477 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.75 -177.68 42.51 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.973 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -87.75 135.85 33.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -122.94 142.95 50.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.452 . . . . 0.0 111.239 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 34' ' ' ARG . 32.3 m -143.26 154.57 43.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.875 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.3 143.77 32.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.502 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 50.1 m -132.27 141.95 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 pt -127.95 147.56 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.45 -173.22 38.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.042 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.34 142.99 36.27 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.77 114.4 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.266 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -116.77 132.34 56.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.674 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 44.6 m -118.23 165.23 14.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.804 0.335 . . . . 0.0 111.624 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -126.61 121.12 31.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 64.6 t -121.22 127.75 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.378 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -67.13 109.22 2.95 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.94 0.4 . . . . 0.0 110.437 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -137.7 154.18 49.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.345 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -123.52 110.04 14.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.423 0.154 . . . . 0.0 110.891 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.79 -90.91 0.31 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.901 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -82.86 160.16 22.23 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.892 -0.181 . . . . 0.0 110.609 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 59.3 81.5 0.17 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.096 0.474 . . . . 0.0 110.781 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.34 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -84.21 -12.19 55.25 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 40.7 mttp 57.8 21.29 7.33 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.185 0.594 . . . . 0.0 112.148 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 13' ' ' SER . 30.5 m120 -106.0 112.85 64.15 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.674 ' HD2' ' O ' ' A' ' 13' ' ' SER . 93.2 Cg_endo -79.67 159.21 25.07 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.797 2.331 . . . . 0.0 110.745 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.01 142.42 27.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.0 169.68 41.01 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.392 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.84 147.64 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 0.0 110.565 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.551 HD21 ' HE2' ' A' ' 32' ' ' LYS . 42.1 t30 -111.09 121.84 46.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.641 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.22 124.09 42.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.102 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 67.5 mttm -127.76 145.39 50.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.436 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -123.34 127.81 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 5' ' ' SER . 51.6 mtp180 -109.6 136.48 48.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.902 0.382 . . . . 0.0 111.835 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.64 119.33 16.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.412 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.86 132.13 44.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.98 -34.24 71.21 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.353 0.597 . . . . 0.0 109.947 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -153.62 174.55 14.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.581 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -80.33 71.27 7.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.651 0.262 . . . . 0.0 110.871 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -164.22 -47.69 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -150.65 160.34 43.89 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.931 0.396 . . . . 0.0 111.3 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.71 -167.12 36.46 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.0 m -126.75 148.3 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.343 . . . . 0.0 110.818 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.681 ' HB ' ' CE1' ' A' ' 88' ' ' TYR . 78.9 mt -129.37 130.11 67.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.45 136.53 12.74 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -123.22 133.4 54.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.275 0.538 . . . . 0.0 111.865 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HD1' HG22 ' A' ' 73' ' ' VAL . 78.7 t80 -135.93 124.32 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.448 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.08 143.11 49.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.98 0.419 . . . . 0.0 111.201 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -121.51 126.1 48.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 64.8 p -125.7 151.8 46.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -157.86 163.27 38.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.613 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -64.85 141.25 58.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.764 0.316 . . . . 0.0 110.608 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.24 165.18 50.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.752 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -108.85 130.7 55.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.854 0.359 . . . . 0.0 111.019 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -127.04 137.42 53.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.993 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -91.54 113.05 25.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.34 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 t -150.86 135.23 17.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.487 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.0 145.32 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.631 0.253 . . . . 0.0 110.896 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -170.54 37.45 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.019 0.437 . . . . 0.0 110.343 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.28 -8.3 77.4 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.337 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -130.1 152.48 49.5 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.561 0.219 . . . . 0.0 110.954 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -107.74 147.19 31.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.946 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.18 142.38 31.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.501 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.9 pt -91.19 -13.2 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.996 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.7 t70 71.98 -41.83 0.52 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.647 0.779 . . . . 0.0 111.925 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.1 -22.19 35.66 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.644 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 97.5 m-20 49.72 46.63 23.74 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.554 ' HD1' ' HB2' ' A' ' 98' ' ' ALA . 92.0 t80 -99.48 120.69 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.45 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.95 139.02 53.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.235 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 85.9 t80 -133.78 128.43 34.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.74 135.66 53.7 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.3 m -116.1 123.62 48.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.712 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.445 HG22 ' HD1' ' A' ' 47' ' ' PHE . 61.6 t -126.38 110.8 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.0 p -135.67 159.3 42.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.051 0.453 . . . . 0.0 111.851 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.29 151.6 32.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.827 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.4 161.54 33.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.901 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.47 160.03 32.2 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.049 2.499 . . . . 0.0 112.688 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.06 132.49 65.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.227 0.537 . . . . 0.0 110.139 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.49 148.76 50.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.135 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -85.33 127.35 34.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.278 . . . . 0.0 110.705 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 87' ' ' LEU . 95.6 mt -89.36 -44.07 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -134.56 -164.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.082 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.469 ' O ' ' HD1' ' A' ' 84' ' ' TYR . 98.6 mt-10 -62.05 -40.78 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.457 0.17 . . . . 0.0 111.34 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.469 ' HD1' ' O ' ' A' ' 83' ' ' GLU . 6.4 m-30 -126.85 28.98 5.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.12 131.41 67.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.3 m -128.9 148.6 50.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.773 ' HB2' HD11 ' A' ' 81' ' ' ILE . 65.2 tp -112.19 129.75 56.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.681 ' CE1' ' HB ' ' A' ' 44' ' ' ILE . 38.5 t80 -126.99 133.47 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.031 0.443 . . . . 0.0 111.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.517 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -107.7 141.58 15.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.554 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 134' ' ' SER . 3.3 mp -110.06 121.52 45.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 111.486 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.8 tp -135.28 126.81 28.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.562 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.5 -151.15 11.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.869 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.92 155.29 44.69 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.133 0.492 . . . . 0.0 111.553 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.456 ' HA3' ' OH ' ' A' ' 70' ' ' TYR . . . -122.73 144.06 15.66 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.797 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -126.87 126.37 43.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 110.703 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -126.27 150.87 17.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.352 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -146.71 151.32 37.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.848 0.356 . . . . 0.0 110.955 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.554 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . . . -134.43 134.61 41.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 61.3 mtpt -128.08 143.22 51.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.246 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -109.59 125.7 52.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.384 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.1 m -102.41 113.52 26.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.055 0.455 . . . . 0.0 110.947 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.8 p -164.19 169.48 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.749 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.39 111.15 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.646 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -150.53 170.8 18.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.919 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.57 -38.22 95.47 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.729 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -141.05 157.03 45.89 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.585 0.231 . . . . 0.0 110.424 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -124.06 148.78 46.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.587 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -126.75 139.34 53.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.813 0.339 . . . . 0.0 111.199 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.0 m -132.65 152.74 51.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -127.49 146.09 50.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.409 . . . . 0.0 111.436 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.5 m -133.87 150.02 51.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.104 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -148.38 148.74 30.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.374 0.606 . . . . 0.0 111.73 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 87.0 m -128.6 133.38 48.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.591 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.448 ' HB3' HD21 ' A' ' 140' ' ' LEU . 92.3 p -140.12 160.48 39.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.31 141.87 31.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.177 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.35 133.43 55.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.61 140.04 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.471 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 136' ' ' GLU . . . -170.01 -175.42 38.95 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.734 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.45 154.31 41.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -148.53 161.71 28.7 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.418 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.17 138.72 50.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.363 -0.418 . . . . 0.0 110.159 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 14.7 tt0 -119.86 130.5 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.999 0.428 . . . . 0.0 110.034 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.03 152.27 33.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.028 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -121.22 82.92 38.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.619 0.247 . . . . 0.0 110.688 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.34 -28.99 14.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.356 2.037 . . . . 0.0 112.248 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 79.5 m80 -130.64 152.93 81.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.737 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -56.28 -36.19 96.64 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.763 2.308 . . . . 0.0 114.287 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -109.57 -4.23 16.37 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 126' ' ' HIS . 68.2 m-85 -121.47 133.51 55.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.68 152.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.084 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.3 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -115.54 114.99 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -114.14 108.97 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.577 ' HB3' HD11 ' A' ' 90' ' ' LEU . 54.0 m -128.03 153.13 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -134.48 131.85 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.709 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.417 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 27.2 pt-20 -140.91 161.24 38.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -137.76 159.1 42.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 0.0 111.626 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 45.2 m -108.59 135.53 49.69 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.912 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -98.67 104.81 16.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.803 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 79.2 mt -118.48 153.29 34.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.54 -45.25 93.83 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.2 -32.82 7.64 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.803 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 62.7 t -104.92 130.48 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.44 125.08 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.6 t -121.83 125.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.14 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -113.74 138.17 14.7 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.6 m -124.58 130.98 53.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.443 0.621 . . . . 0.0 111.433 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.7 m-90 -106.24 131.55 53.35 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.6 mtt -120.63 111.2 17.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.438 . . . . 0.0 111.438 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -123.85 134.41 53.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.612 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 178.39 48.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.378 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.81 150.89 42.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.855 0.359 . . . . 0.0 110.498 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -127.3 155.29 19.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.985 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -118.55 127.77 53.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.764 0.316 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.489 ' HA ' ' OG ' ' A' ' 5' ' ' SER . 80.8 mtp180 -92.82 132.57 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.875 -179.9 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.509 ' HG3' ' OH ' ' A' ' 35' ' ' TYR . 21.8 pt-20 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.157 0.503 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.34 173.59 45.56 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.025 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -88.19 135.24 33.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.547 0.213 . . . . 0.0 110.431 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -129.04 143.34 50.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.235 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -128.47 143.5 50.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.4 mm -113.77 120.57 63.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 65.7 m -127.33 144.71 51.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.399 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.52 153.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.571 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.17 -174.34 38.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.102 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -109.06 142.61 39.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -108.26 127.74 54.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 111.416 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -120.97 114.82 22.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.739 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 50.6 m -118.2 159.85 22.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.59 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -126.91 128.87 47.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.85 120.3 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.169 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -100.35 110.07 22.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -163.34 174.74 11.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.166 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -84.62 103.25 13.57 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.69 174.37 45.69 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.544 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -92.89 118.09 30.75 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.839 -0.213 . . . . 0.0 111.191 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 38.1 tptt -173.65 127.74 0.41 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.16 -48.17 81.29 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -114.86 -12.51 12.07 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 36.9 mtmm 59.46 23.26 11.84 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.943 0.497 . . . . 0.0 111.566 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -105.68 112.96 64.49 Favored Pre-proline 0 C--O 1.233 0.207 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.739 ' HD2' ' O ' ' A' ' 13' ' ' SER . 72.4 Cg_endo -74.83 157.99 43.14 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.474 2.116 . . . . 0.0 110.72 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -113.92 146.73 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.049 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -177.66 178.31 48.38 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.431 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.69 148.39 33.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 0.0 110.788 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 16.4 t30 -124.27 130.05 51.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.948 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.76 136.2 53.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.082 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.7 mttm -124.49 139.95 53.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 111.377 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -132.64 128.3 36.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.069 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.514 ' HD3' HE22 ' A' ' 122' ' ' GLN . 47.0 ttp180 -119.92 133.68 55.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.509 ' OH ' ' HG3' ' A' ' 1' ' ' GLU . 93.8 t80 -128.19 125.15 38.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.1 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -123.64 133.41 53.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.26 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -97.92 -9.63 25.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.302 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -158.12 163.37 37.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.411 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -82.6 61.19 5.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.564 0.221 . . . . 0.0 111.134 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -169.49 -55.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -119.12 143.78 46.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 111.323 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.77 -174.47 31.69 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.834 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.32 153.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -139.1 138.63 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.36 139.93 12.6 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 m -129.36 136.6 50.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.992 0.425 . . . . 0.0 111.105 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.39 124.85 43.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.821 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.793 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -119.08 120.27 36.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.784 0.326 . . . . 0.0 110.939 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.532 ' OE1' ' HD1' ' A' ' 71' ' ' TYR . 2.8 mm-40 -112.09 106.48 15.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.525 HG22 ' HA3' ' A' ' 28' ' ' GLY . 75.1 p -125.99 158.04 36.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.119 0.485 . . . . 0.0 112.276 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -152.21 159.72 43.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -83.64 125.97 32.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.756 0.312 . . . . 0.0 110.514 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.11 150.84 20.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.304 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.84 139.13 46.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 111.14 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -74.57 155.49 37.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.458 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -79.91 128.8 33.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.941 0.401 . . . . 0.0 110.851 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p -150.17 163.06 39.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.888 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -96.12 105.04 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.531 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -164.56 54.45 0.14 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.352 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.14 -10.55 73.74 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.729 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 55.88 37.84 29.32 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.146 0.578 . . . . 0.0 111.773 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -110.84 108.47 18.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.801 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.5 mt -119.14 133.44 55.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 111.224 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 pt -94.7 -21.19 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.987 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 t70 68.03 -62.63 0.35 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.439 0.695 . . . . 0.0 111.896 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.91 -19.83 50.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.452 -0.404 . . . . 0.0 112.703 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 53.33 44.42 30.11 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.676 0.391 . . . . 0.0 111.84 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -99.39 122.76 42.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.645 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -127.79 142.23 51.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.13 123.25 24.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.532 ' HD1' ' OE1' ' A' ' 49' ' ' GLN . 92.1 m-85 -112.79 128.91 56.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.793 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 67.4 m -113.92 127.03 55.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.181 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.9 124.4 70.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -147.15 153.43 39.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.851 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -153.03 153.43 32.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -167.81 167.37 40.01 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.997 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.56 156.3 40.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.526 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.76 129.71 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.544 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -126.88 126.63 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.996 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -69.94 134.79 48.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 0.0 111.215 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.631 ' HB ' HG23 ' A' ' 85' ' ' VAL . 95.6 mt -89.62 -45.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.53 0.681 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.83 -144.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.86 -1.78 52.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.342 -0.224 . . . . 0.0 111.468 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -147.05 9.72 0.99 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.631 HG23 ' HB ' ' A' ' 81' ' ' ILE . 3.4 m -140.37 142.53 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 68.1 m -138.3 151.35 47.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.049 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 81' ' ' ILE . 2.7 tt -116.26 136.93 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -142.75 157.69 44.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 111.335 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.635 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.99 150.52 18.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.845 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.02 129.44 55.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.455 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -142.36 135.66 28.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.8 13.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.903 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.69 152.19 45.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.101 0.477 . . . . 0.0 111.606 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.21 140.81 16.43 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.768 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.449 ' NE2' ' HD3' ' A' ' 97' ' ' LYS . 75.0 t60 -119.03 122.42 42.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.592 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.88 138.28 14.85 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.272 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD3' ' NE2' ' A' ' 95' ' ' HIS . 31.2 mmmt -124.27 137.19 54.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.808 0.337 . . . . 0.0 110.832 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.93 130.19 35.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.708 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -127.04 146.25 50.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.187 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -120.87 139.22 53.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.648 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.9 m -103.99 113.95 27.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.015 0.436 . . . . 0.0 110.819 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.4 m -155.25 164.87 38.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.608 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.1 mt -100.45 111.43 30.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.758 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -150.45 171.24 17.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.81 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.1 93.17 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.153 -0.546 . . . . 0.0 111.802 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -133.16 163.57 28.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.618 0.247 . . . . 0.0 110.339 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.0 p -108.96 149.42 29.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.801 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -127.71 153.59 46.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.937 0.398 . . . . 0.0 110.965 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.7 p -150.07 163.66 37.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.817 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -127.01 146.12 50.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.05 0.452 . . . . 0.0 111.58 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -128.78 138.62 52.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.647 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.13 149.48 52.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.247 0.546 . . . . 0.0 111.732 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -126.8 149.03 49.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.428 ' HB2' HD21 ' A' ' 140' ' ' LEU . 39.3 t -153.97 148.31 26.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 111.511 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.44 126.94 32.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.64 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.85 132.89 56.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.97 0.414 . . . . 0.0 111.132 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.76 137.7 25.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.291 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.4 -168.38 29.47 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.752 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.06 161.47 41.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.64 161.92 28.95 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.579 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.07 140.76 50.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.047 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.514 HE22 ' HD3' ' A' ' 34' ' ' ARG . 52.7 tt0 -115.4 128.55 56.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -116.18 139.93 49.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.108 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -128.83 82.69 68.19 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -30.06 17.48 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.372 2.048 . . . . 0.0 112.237 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -131.32 152.43 80.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.633 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.16 -35.01 89.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.92 2.413 . . . . 0.0 113.869 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.419 ' O ' ' HD1' ' A' ' 154' ' ' TYR . 2.8 t-20 -109.99 13.7 23.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -130.94 118.57 20.87 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -117.37 131.04 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.341 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.21 122.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -110.77 129.67 55.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.9 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -133.79 125.49 28.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 99.3 p -155.8 165.8 35.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.9 152.64 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.55 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -144.42 137.52 27.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -112.75 132.34 55.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.455 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 49.3 m -102.89 125.91 49.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -103.25 114.58 28.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.76 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 68.1 mt -119.91 153.65 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.16 -43.41 98.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -106.72 -32.06 8.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.76 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.4 t -105.26 130.75 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.91 123.94 48.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -127.7 126.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 112.055 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -114.41 135.01 12.08 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.3 m -119.44 129.18 54.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.52 0.66 . . . . 0.0 111.621 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -111.09 131.44 55.08 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 63.8 mtt -120.71 115.1 22.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.25 136.5 53.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.322 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 -173.25 44.51 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.394 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.66 159.29 43.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.07 -178.23 28.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.596 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 128' ' ' ASN . 94.2 m-85 -121.82 144.66 48.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.654 0.264 . . . . 0.0 110.494 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -96.25 126.39 41.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.813 -179.823 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.999 0.428 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.62 167.61 50.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.046 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.67 150.57 30.88 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.78 -0.247 . . . . 0.0 110.477 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 34' ' ' ARG . 37.3 t -133.88 140.17 46.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 111.134 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.7 m -131.65 149.46 52.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.3 mt -118.56 126.66 75.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.27 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.526 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 62.1 m -117.83 137.22 52.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.299 . . . . 0.0 111.207 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -121.36 129.64 75.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.193 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.93 172.91 31.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.08 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -98.56 145.05 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -127.81 138.96 52.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.947 0.403 . . . . 0.0 111.429 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HB2' ' NE1' ' A' ' 148' ' ' TRP . 97.3 mt-30 -127.73 135.03 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.967 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.658 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.6 m -118.82 148.56 42.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.176 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -120.37 123.19 42.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 145' ' ' VAL . 58.2 t -124.86 131.9 72.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.465 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -86.14 109.51 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 0.0 110.303 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HG3' HG12 ' A' ' 15' ' ' VAL . 95.7 mt-10 -145.91 157.01 43.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.227 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -97.43 108.6 21.36 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.79 -147.23 9.28 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.507 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 90.3 m-85 -72.9 146.79 45.89 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 59.4 mmtt 74.59 110.55 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.579 0.549 . . . . 0.0 109.843 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.82 -40.2 91.82 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -86.99 -14.35 41.91 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt 48.9 38.34 12.02 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -101.56 114.03 65.73 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.658 ' HD2' ' O ' ' A' ' 13' ' ' SER . 73.5 Cg_endo -76.8 159.48 34.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.632 2.221 . . . . 0.0 110.756 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -116.07 156.35 26.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.903 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -178.63 -153.79 11.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.362 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.12 161.35 38.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 28.1 t-20 -135.26 128.87 32.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 46' ' ' SER . 87.1 mt -104.13 128.15 51.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.986 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 23.0 ttmm -119.74 127.75 53.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.513 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.38 134.52 52.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.614 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 4' ' ' SER . 77.2 ttt-85 -121.78 131.03 53.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 111.733 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -132.36 131.49 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -96.22 127.48 42.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -101.21 -16.62 16.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.265 0.555 . . . . 0.0 109.626 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -150.14 177.87 9.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.579 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.95 -46.95 87.04 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -113.94 6.61 16.63 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -124.85 140.45 52.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.02 0.438 . . . . 0.0 111.51 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.17 -177.36 38.77 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.907 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.9 0.381 . . . . 0.0 110.822 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.3 pp -136.77 150.07 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -130.86 134.1 7.6 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 55.0 m -124.57 135.71 53.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.031 0.415 . . . . 0.0 111.774 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 94.8 m-85 -120.4 111.73 18.11 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -102.67 127.48 49.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.503 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.521 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 77.4 mt-30 -126.08 123.52 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 77.1 p -128.04 149.45 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.676 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -138.69 154.82 48.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.037 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -69.81 139.87 53.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.668 0.271 . . . . 0.0 110.272 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.29 57.04 0.61 Allowed Glycine 0 CA--C 1.517 0.157 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.814 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.489 ' HE2' HD12 ' A' ' 64' ' ' ILE . 40.8 t80 -110.84 136.85 49.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.706 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.11 134.73 53.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.446 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -90.03 123.78 34.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.009 0.433 . . . . 0.0 111.056 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.575 ' H ' HD11 ' A' ' 64' ' ' ILE . 67.8 m -130.05 152.19 49.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.527 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.4 t -89.66 114.42 27.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.886 0.374 . . . . 0.0 110.815 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -151.37 99.65 2.66 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.627 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.9 10.29 86.32 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.764 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 60.36 37.2 20.26 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.049 0.539 . . . . 0.0 111.293 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -122.3 136.22 54.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.111 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.1 121.64 16.03 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.975 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.575 HD11 ' H ' ' A' ' 57' ' ' SER . 47.7 pt -102.96 -13.83 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.809 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.05 -45.13 93.69 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.414 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.7 -34.12 6.01 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 113.02 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t0 51.46 54.59 10.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 111.645 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -104.83 130.22 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.769 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -118.03 136.35 53.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.981 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.513 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 68.0 t80 -134.45 125.64 27.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.231 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.44 138.16 53.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 109.912 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 67.7 m -127.92 136.0 50.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.199 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 63.0 t -124.92 119.63 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.7 p -133.2 156.33 47.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 111.868 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.22 153.01 34.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.042 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.06 164.66 37.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.969 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.19 156.85 29.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.889 2.393 . . . . 0.0 112.64 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 88' ' ' TYR . 57.4 t -123.42 129.75 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.382 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -123.13 128.71 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.043 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.485 ' HD3' ' HB3' ' A' ' 86' ' ' SER . 29.3 mmt180 -78.53 126.31 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.8 mm -90.97 -42.26 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 110.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.0 -167.2 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.04 -38.43 88.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 0.0 111.327 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -128.15 23.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.44 127.48 65.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.645 ' OG ' ' HB3' ' A' ' 122' ' ' GLN . 89.3 p -138.6 151.7 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.7 mt -123.36 145.92 48.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.957 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.508 ' HB3' HG22 ' A' ' 78' ' ' VAL . 34.6 p90 -150.89 159.36 44.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 111.714 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.659 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -117.13 149.25 18.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.132 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 134' ' ' SER . 92.4 mt -112.65 118.89 36.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.296 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 tp -127.11 125.39 41.17 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . -175.13 -155.03 11.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.855 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.07 153.39 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.613 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.01 141.62 17.0 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.766 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -129.33 130.8 46.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.775 0.321 . . . . 0.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -121.76 142.97 15.54 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.542 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -127.35 139.21 53.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.814 0.34 . . . . 0.0 111.074 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.34 127.77 43.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -126.31 142.56 51.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.557 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -109.65 134.11 52.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.339 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.7 p -90.25 115.83 27.76 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.343 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -162.8 164.85 25.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.447 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.6 mt -106.97 111.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -150.7 165.2 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.81 -39.1 97.02 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.742 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -120.29 151.54 39.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.8 p -109.88 150.53 28.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.443 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.59 146.83 50.74 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.755 0.312 . . . . 0.0 111.007 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.1 p -155.82 162.64 40.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.936 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.27 150.03 50.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 111.345 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.3 m -130.23 141.04 50.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.237 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.1 149.17 50.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.09 0.471 . . . . 0.0 111.482 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 76.4 p -118.26 149.16 41.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.769 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.4 p -157.4 163.94 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.37 . . . . 0.0 111.759 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.8 mt -98.79 135.41 40.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.064 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.33 130.1 52.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -143.74 138.64 28.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -167.76 -165.05 24.51 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.695 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.18 37.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 88' ' ' TYR . . . -145.28 162.65 28.18 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 113.348 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.0 tp -126.74 138.43 53.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.902 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.645 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 51.6 tt0 -126.75 133.1 50.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.862 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -122.5 151.82 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.574 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -119.35 81.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.23 -34.6 67.37 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.597 2.198 . . . . 0.0 111.483 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.68 155.44 81.26 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.681 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.56 -23.21 74.71 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.844 2.362 . . . . 0.0 113.658 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -117.78 9.51 12.99 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.94 133.93 29.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.69 153.39 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.3 mt -113.22 124.24 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -111.3 126.93 55.42 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -128.6 116.5 19.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.59 ' HB3' HD11 ' A' ' 90' ' ' LEU . 67.7 m -130.64 153.82 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 99.0 m-85 -125.58 138.32 53.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.329 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 99.2 mt-10 -129.66 144.64 51.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.621 0.248 . . . . 0.0 110.34 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.434 ' OH ' ' HD2' ' A' ' 144' ' ' LYS . 90.8 t80 -135.51 129.8 33.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 0.0 111.324 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -101.87 121.8 42.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -102.4 107.02 17.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 96.2 mt -119.23 153.58 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.68 -43.5 98.75 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.46 -31.88 8.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.718 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.0 t -105.27 128.42 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HD2' ' OH ' ' A' ' 137' ' ' TYR . 34.8 mmtp -105.72 125.36 50.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -126.69 125.67 67.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.4 135.69 12.03 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 70.9 m -131.29 137.53 48.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.171 0.485 . . . . 0.0 111.667 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 12' ' ' GLN . 34.4 p90 -132.85 148.8 52.3 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm -140.05 149.06 42.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.175 0.512 . . . . 0.0 111.844 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.94 139.0 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.395 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -177.77 -176.0 45.42 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.17 152.24 39.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.457 -0.372 . . . . 0.0 110.517 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.45 152.59 18.4 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.608 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -121.96 130.56 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.489 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -78.52 135.33 37.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.08 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.712 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.971 0.415 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.96 172.72 40.72 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.848 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -77.32 145.85 37.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.632 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.2 p -142.39 156.89 45.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.8 m -136.72 146.61 46.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.0 mt -118.02 125.53 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.2 m -127.21 145.61 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.948 0.404 . . . . 0.0 111.435 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.21 154.28 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.32 176.11 44.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.117 -1.039 . . . . 0.0 113.081 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -94.08 140.4 29.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.13 35.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -112.26 118.4 35.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.889 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 64.9 m -118.46 157.5 27.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 111.702 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -127.25 127.57 44.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.11 125.27 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.372 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -66.29 125.78 26.68 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.982 0.42 . . . . 0.0 110.419 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -130.2 153.48 48.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.332 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -85.71 68.91 10.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.817 0.341 . . . . 0.0 111.356 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.61 0.81 90.32 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.296 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -91.69 134.46 34.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt 71.67 143.89 0.06 Allowed 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.857 0.723 . . . . 0.0 111.393 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.53 -55.59 5.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.292 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -104.05 -13.64 16.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm 51.86 34.46 13.46 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.88 0.472 . . . . 0.0 111.98 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 13' ' ' SER . 1.4 t30 -104.62 110.04 63.76 Favored Pre-proline 0 C--N 1.332 -0.165 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.851 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 13' ' ' SER . 37.7 Cg_exo -67.45 148.47 79.2 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.188 2.592 . . . . 0.0 111.006 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -102.96 138.67 39.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -172.76 -177.89 42.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.255 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -121.15 149.48 42.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.272 . . . . 0.0 110.498 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -118.97 126.63 52.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.85 131.09 55.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.982 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -128.47 139.47 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.287 0.565 . . . . 0.0 111.496 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -133.43 129.84 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.277 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -118.53 133.14 56.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -131.77 128.71 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.57 134.13 41.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.999 0.428 . . . . 0.0 111.942 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -109.37 -6.49 15.46 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.055 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -154.47 173.57 16.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.578 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.04 -41.9 98.6 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.144 0.277 . . . . 0.0 111.63 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -124.3 34.04 5.13 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.2 t90 -153.1 133.85 13.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.14 -172.47 28.51 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.778 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.79 156.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.842 0.321 . . . . 0.0 110.877 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 tp -133.52 132.33 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.114 0.483 . . . . 0.0 111.15 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.12 135.66 12.09 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -127.84 134.69 49.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.25 117.95 28.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.404 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 124.93 53.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.83 0.348 . . . . 0.0 111.146 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 10.1 pt20 -131.44 117.52 18.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.901 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 73.6 p -131.6 160.17 36.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.954 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.08 163.93 37.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.941 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 68' ' ' PHE . 41.7 mmt180 -71.65 139.5 49.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.882 0.373 . . . . 0.0 110.754 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.3 56.32 4.24 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.753 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 62.8 m-85 -109.96 143.31 40.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.908 0.385 . . . . 0.0 110.896 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -97.36 145.5 26.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.448 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -68.31 138.95 55.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.148 0.499 . . . . 0.0 111.24 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -123.75 146.52 48.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.698 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.2 121.3 66.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.662 0.268 . . . . 0.0 110.946 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -156.77 60.24 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.014 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.27 -11.06 72.27 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.389 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -164.89 147.97 8.51 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -73.04 128.81 36.55 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 111.307 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.56 127.91 54.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 111.097 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 67' ' ' ASP . 36.9 pt -114.05 1.16 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.826 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 55.83 34.58 23.77 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.286 0.634 . . . . 0.0 112.414 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.78 -30.19 7.74 Favored Glycine 0 CA--C 1.517 0.187 0 CA-C-N 116.093 -0.503 . . . . 0.0 113.164 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.473 ' HB2' HD12 ' A' ' 64' ' ' ILE . 30.1 t0 48.75 54.78 10.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.422 0.289 . . . . 0.0 111.216 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 94.9 m-85 -74.73 130.61 39.79 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.602 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.51 139.42 53.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.343 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.442 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.6 m-85 -126.22 127.29 45.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.422 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 49' ' ' GLN . 21.2 t80 -132.18 116.94 17.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.6 m -120.29 136.86 54.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.45 120.22 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.8 p -133.4 157.18 46.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 111.777 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.695 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -152.19 155.19 37.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.98 172.71 43.93 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.781 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.98 155.07 43.0 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.943 2.428 . . . . 0.0 112.74 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.03 125.91 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.374 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -127.07 123.69 37.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.964 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -80.24 137.43 36.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.594 0.235 . . . . 0.0 110.746 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.566 ' HB ' HG23 ' A' ' 85' ' ' VAL . 44.2 mm -88.92 -39.37 12.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.494 0.664 . . . . 0.0 109.776 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -153.51 -155.05 0.56 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.278 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.31 1.81 53.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.622 0.248 . . . . 0.0 111.331 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -144.95 10.7 1.35 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -143.25 139.24 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.694 0.283 . . . . 0.0 110.651 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -138.65 150.72 46.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.114 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 129.26 54.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.076 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.37 139.75 48.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.736 0.303 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.34 137.37 13.59 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -125.36 126.19 44.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.197 0.499 . . . . 0.0 111.732 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -146.81 136.96 23.52 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.2 -149.76 12.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.869 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.44 151.79 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.482 . . . . 0.0 111.601 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.81 141.13 16.14 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.717 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -124.06 128.51 49.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.295 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -119.23 146.22 18.21 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.053 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -124.53 146.73 48.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.805 0.336 . . . . 0.0 110.884 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.45 146.04 39.58 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.842 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.6 mmtm -122.46 147.68 46.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -116.41 124.77 50.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.818 0.342 . . . . 0.0 110.373 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.4 m -91.34 114.68 27.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.467 . . . . 0.0 111.355 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.8 p -162.78 167.15 23.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.71 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 103' ' ' ILE . 17.9 pt -99.11 111.59 29.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.474 0.654 . . . . 0.0 110.151 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -148.68 154.61 39.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.88 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.6 97.36 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.098 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -105.66 173.3 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 110.605 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.3 m -109.83 141.75 42.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -128.45 146.25 50.86 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.829 0.347 . . . . 0.0 111.009 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.6 p -155.61 164.61 38.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -142.54 160.71 39.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.128 0.49 . . . . 0.0 111.35 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.2 p -145.89 157.19 43.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.013 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -133.32 151.49 51.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.119 0.485 . . . . 0.0 111.866 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 74.3 p -113.37 147.68 37.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.493 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.45 ' HB3' HD21 ' A' ' 140' ' ' LEU . 97.7 p -155.57 164.64 38.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 0.0 111.709 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.4 mt -98.57 137.32 37.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.828 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.15 132.12 54.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.798 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.16 142.07 26.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.329 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -176.38 -172.98 41.61 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.748 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.9 161.32 42.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.458 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -146.23 165.7 28.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.456 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -126.06 138.89 53.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -119.17 134.54 55.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.388 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -116.47 151.95 35.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -119.67 85.06 32.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.16 -33.35 9.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.192 1.928 . . . . 0.0 111.752 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -136.26 152.64 75.55 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.673 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.9 -30.22 76.93 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.65 2.233 . . . . 0.0 113.745 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.54 10.15 33.21 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -149.11 122.3 8.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.201 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.63 151.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -122.7 145.17 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -136.14 122.11 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.35 41.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.458 ' OG ' ' HA3' ' A' ' 120' ' ' GLY . 69.3 m -127.98 150.07 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.493 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.8 m-85 -118.38 130.65 56.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -137.06 136.85 38.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -126.72 146.12 50.33 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 55.6 m -112.03 137.41 50.1 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.87 115.51 30.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.821 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 74.7 mt -118.4 154.3 32.65 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.0 -44.73 96.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.48 -33.4 7.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.5 t -105.65 128.63 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.73 128.95 44.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 65.2 t -125.46 128.07 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.11 0.481 . . . . 0.0 112.099 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -116.83 136.59 12.86 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.5 m -126.8 129.98 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.209 0.504 . . . . 0.0 111.192 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -113.33 133.45 55.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.0 mtt -114.48 117.97 32.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 0.0 111.495 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -125.25 123.36 39.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.314 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.37 -173.48 39.03 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.43 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.04 165.48 27.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.382 . . . . 0.0 110.734 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.26 178.47 30.29 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -131.95 130.92 42.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -80.82 131.25 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.981 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.755 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.98 -177.64 48.54 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.02 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.15 150.44 26.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.687 0.279 . . . . 0.0 110.653 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -140.22 159.48 42.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.231 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.2 m -132.25 147.19 52.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.968 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.6 124.2 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 56.5 m -120.63 139.73 52.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.436 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.1 mt -123.47 129.16 74.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.004 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 177.86 20.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.313 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -102.58 137.34 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.69 130.52 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.797 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -122.34 132.69 54.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 44.2 m -118.35 158.7 24.75 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.455 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -128.97 119.09 23.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 145' ' ' VAL . 65.0 t -127.83 129.3 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.469 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -65.36 111.97 3.29 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.05 0.452 . . . . 0.0 110.398 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' H ' ' HE3' ' A' ' 24' ' ' LYS . 69.4 mm-40 -136.81 149.44 47.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.493 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -100.72 105.41 16.75 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.4 -153.95 24.52 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.606 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 85.9 m-85 -73.1 159.94 32.79 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER 75.81 84.37 0.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.703 0.627 . . . . 0.0 109.926 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 22' ' ' LEU . 2.9 mm? -59.93 -34.51 73.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.015 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.28 -17.24 61.9 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HE3' ' H ' ' A' ' 17' ' ' GLU . 2.0 mttp 48.53 35.94 6.73 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 13' ' ' SER . 19.1 p-10 -103.52 113.95 65.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 13' ' ' SER . 94.5 Cg_endo -80.12 159.51 23.64 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.569 2.18 . . . . 0.0 110.877 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -91.95 140.5 29.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.573 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -164.53 173.99 40.51 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.259 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.21 152.54 47.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -122.69 132.32 54.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.91 121.1 39.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.071 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.4 mttm -117.9 140.46 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 111.38 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.14 135.98 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.88 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.668 ' HA ' HG22 ' A' ' 44' ' ' ILE . 76.5 ttt180 -119.0 129.94 55.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.22 132.2 56.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -103.8 140.97 36.91 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.622 ' HE2' HG12 ' A' ' 43' ' ' VAL . 97.2 m-85 -129.6 169.7 14.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.723 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -79.48 75.05 6.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.528 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -166.59 -172.69 2.23 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.893 0.377 . . . . 0.0 110.737 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.98 -1.78 57.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.882 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -149.85 163.49 37.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.025 0.44 . . . . 0.0 111.372 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.06 -166.54 11.12 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.31 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.622 HG12 ' HE2' ' A' ' 37' ' ' PHE . 14.3 p -138.11 139.83 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.077 0.438 . . . . 0.0 110.624 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 34' ' ' ARG . 36.8 pt -130.44 158.35 42.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.9 142.65 15.77 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -129.37 123.11 30.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -114.51 122.42 46.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 136.04 54.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -142.16 132.4 24.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.05 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.693 HG22 ' HA3' ' A' ' 28' ' ' GLY . 82.3 p -133.45 158.91 41.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.033 0.444 . . . . 0.0 111.639 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -132.88 136.93 46.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.392 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -63.15 133.09 53.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.478 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 -178.34 52.35 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.529 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -72.77 106.88 4.93 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 110.625 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -157.65 137.99 12.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.424 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -92.59 128.84 38.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.4 p -97.5 163.8 12.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.234 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.7 102.62 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.146 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -172.99 59.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.42 1.95 90.53 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.822 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 60.0 27.44 16.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.023 0.529 . . . . 0.0 111.58 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -93.92 -7.98 41.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.211 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.25 88.03 2.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.966 0.412 . . . . 0.0 111.138 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 mm -67.02 -43.83 88.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.557 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -119.6 -50.8 2.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.48 -32.3 6.34 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 97.9 m-20 51.08 44.12 28.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.733 0.413 . . . . 0.0 112.08 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.99 126.33 43.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.501 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.11 140.26 51.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.216 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.467 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.3 m-85 -121.34 122.3 39.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.629 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.17 119.51 31.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.1 m -123.89 136.01 54.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.964 0.412 . . . . 0.0 111.155 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.76 121.36 64.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.6 p -130.49 154.97 47.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.067 0.46 . . . . 0.0 111.831 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.99 151.19 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.893 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.04 160.93 31.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.856 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.45 156.3 40.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.862 2.375 . . . . 0.0 112.655 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.21 131.87 70.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 0.0 110.387 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -118.7 125.51 49.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.155 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -70.73 133.82 46.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.533 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.711 ' HB ' HG23 ' A' ' 85' ' ' VAL . 84.0 mt -84.59 -44.65 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.455 0.645 . . . . 0.0 109.839 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -140.54 -102.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.21 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -125.47 -34.69 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.678 0.275 . . . . 0.0 111.134 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.76 11.73 14.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 81' ' ' ILE . 2.6 m -136.08 137.56 48.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 122' ' ' GLN . 49.9 m -139.12 151.96 47.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.202 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.71 136.12 53.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.135 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CD1' HD11 ' A' ' 44' ' ' ILE . 51.2 p90 -142.61 160.62 39.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 111.281 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.86 152.51 17.31 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.4 mt -112.39 123.32 50.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.331 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.7 tp -136.49 127.33 27.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.604 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.9 -160.48 25.58 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.817 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.86 148.83 52.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 0.0 111.437 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.53 135.75 12.95 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.876 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -124.37 124.81 43.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.037 0.446 . . . . 0.0 110.625 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 111' ' ' SER . . . -109.79 143.96 16.71 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.158 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.39 125.57 29.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 111.032 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.7 133.87 54.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.546 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 68.6 mttm -128.45 143.83 51.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.443 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -109.01 123.73 49.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 m -88.68 113.89 24.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.068 0.461 . . . . 0.0 111.48 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.1 p -163.7 166.05 22.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.587 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 103' ' ' ILE . 19.4 pt -99.45 110.71 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.482 0.658 . . . . 0.0 110.075 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -149.91 157.98 43.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.77 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.67 94.03 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.016 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -115.89 149.57 38.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.758 0.313 . . . . 0.0 110.451 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.7 m -109.76 140.5 43.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.522 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -126.76 147.83 49.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.868 0.366 . . . . 0.0 110.997 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.0 p -152.53 163.53 39.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.928 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -127.19 153.3 46.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.993 0.425 . . . . 0.0 111.358 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 96' ' ' GLY . 88.4 p -138.38 148.82 44.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.868 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -132.06 148.88 52.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 111.638 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.6 m -120.69 131.44 54.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 81.8 p -145.57 161.24 40.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.01 0.433 . . . . 0.0 111.796 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 138' ' ' SER . 63.8 tp -98.21 126.52 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.82 128.89 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -144.65 140.75 28.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.405 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -173.05 -168.91 34.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.705 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.63 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.6 168.06 32.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.43 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.4 mt -127.35 147.25 50.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.275 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 97.7 mt-30 -117.83 137.11 52.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.294 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.83 140.56 52.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.695 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -125.08 83.04 60.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.394 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.06 -27.64 42.07 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.278 1.985 . . . . 0.0 111.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -133.58 153.42 80.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.492 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.48 -37.99 89.86 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.899 2.399 . . . . 0.0 113.692 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.407 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 33.6 m120 -105.63 10.66 32.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.44 121.42 37.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.918 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.26 130.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.306 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.41 123.82 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.37 127.84 56.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.941 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -138.14 123.97 19.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.52 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 99.5 p -150.45 160.87 43.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.0 m-85 -118.34 127.04 53.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.271 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -120.75 126.6 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.52 143.58 51.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.205 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 56.2 m -110.2 128.78 55.68 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.36 105.77 16.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.748 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 90.8 mt -119.15 149.45 41.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.52 -43.8 97.92 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -103.73 -31.92 9.62 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.748 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.5 t -105.82 128.69 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -105.14 120.55 41.79 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 64.0 t -123.31 124.96 71.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.704 -0.398 . . . . 0.0 112.017 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -121.1 130.91 8.41 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.3 m -124.96 129.38 50.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.147 0.473 . . . . 0.0 111.484 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.451 ' CD1' ' HD1' ' A' ' 135' ' ' TYR . 52.6 m0 -109.86 133.14 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 74.8 mtm -126.92 126.17 42.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.733 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -140.43 136.33 32.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.395 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.61 -175.7 41.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.821 -1.181 . . . . 0.0 113.538 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.61 152.48 48.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 7' ' ' SER . . . -139.73 165.61 25.82 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.658 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 128' ' ' ASN . 93.2 t80 -110.84 130.66 55.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.31 124.69 36.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.735 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.96 -173.83 46.0 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.959 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.2 153.43 22.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 0.0 110.643 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.6 p -144.13 156.3 44.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -137.59 146.56 44.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.67 127.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 60.4 m -121.02 138.09 54.33 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.878 0.37 . . . . 0.0 111.221 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.2 mt -125.58 131.31 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.15 -173.16 24.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.18 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.66 147.02 32.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.99 126.27 52.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 111.13 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -117.92 123.31 45.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.882 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.649 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.0 m -118.53 150.88 38.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 111.686 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -127.65 129.28 46.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 145' ' ' VAL . 60.2 t -114.62 127.65 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.707 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -85.02 109.42 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.218 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -155.9 165.73 35.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.2 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -122.13 107.52 12.27 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.805 -0.18 . . . . 0.0 110.752 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 158.62 -138.89 5.94 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.618 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 57.8 t80 -61.62 141.36 57.84 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 63.7 mttp 77.33 90.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.843 0.714 . . . . 0.0 109.747 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.09 -45.56 92.52 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.775 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.12 -15.01 32.47 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.522 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 56.6 mmtt 48.34 36.14 6.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -103.6 111.25 65.02 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 13' ' ' SER . 85.8 Cg_endo -84.16 159.02 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.884 2.389 . . . . 0.0 110.957 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -107.57 149.29 28.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.711 0.291 . . . . 0.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -170.8 -179.52 42.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.6 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -115.04 147.71 39.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.845 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.492 HD21 ' HE2' ' A' ' 32' ' ' LYS . 3.3 t30 -122.85 123.77 41.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.266 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -119.59 130.31 55.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.6 mttm -126.87 138.25 53.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.003 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.75 132.87 53.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.751 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -126.04 129.99 50.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.954 0.407 . . . . 0.0 111.46 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.01 134.59 54.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.747 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -116.02 111.12 19.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 111.799 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -102.83 -0.8 30.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.169 0.509 . . . . 0.0 109.867 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -155.52 159.57 39.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.547 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.13 -15.27 41.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 111.366 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 19.1 t0 -92.59 -28.59 16.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.567 ' CE3' ' HB3' ' A' ' 40' ' ' ASP . 38.7 p90 -152.0 162.25 41.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.042 0.449 . . . . 0.0 111.405 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.63 -178.09 24.28 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.785 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -125.02 131.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.946 0.373 . . . . 0.0 110.842 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 tt -126.56 140.75 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.12 140.17 11.92 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -126.31 139.3 53.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.096 0.474 . . . . 0.0 111.606 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.57 125.26 43.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.642 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -114.18 126.88 55.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -123.3 107.84 12.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.616 HG22 ' HA3' ' A' ' 28' ' ' GLY . 66.7 p -128.4 155.22 45.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -133.54 128.62 35.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.972 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.78 160.63 21.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.745 0.307 . . . . 0.0 111.054 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 65' ' ' ASP . . . 80.48 23.41 60.56 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.128 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.1 80.47 0.95 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.066 0.46 . . . . 0.0 111.013 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -130.13 152.02 50.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.169 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -82.88 113.89 20.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.013 0.435 . . . . 0.0 110.901 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.4 m -135.95 150.73 49.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.985 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.24 102.95 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.653 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -167.36 69.41 0.09 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.458 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.85 14.11 82.38 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.957 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 59.03 37.3 24.46 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.912 0.485 . . . . 0.0 111.429 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.65 152.89 44.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.807 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.57 110.86 22.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.125 0.488 . . . . 0.0 111.118 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 pt -112.95 5.6 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.315 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 34.9 t0 -80.05 73.58 6.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.03 -41.52 2.19 Favored Glycine 0 C--O 1.228 -0.225 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.891 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.0 t0 49.52 52.43 14.53 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.687 0.395 . . . . 0.0 111.719 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.424 ' HD1' ' HB2' ' A' ' 98' ' ' ALA . 87.1 t80 -110.5 122.4 47.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.535 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -102.69 131.49 49.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.124 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -123.77 122.77 38.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -123.43 137.48 54.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.74 0.305 . . . . 0.0 110.217 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.676 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 64.1 m -126.53 136.06 52.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -125.63 120.2 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.0 p -133.34 157.62 45.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.493 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.64 155.35 37.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.174 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -174.43 165.15 36.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.132 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.36 153.9 35.84 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.857 2.372 . . . . 0.0 112.404 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.29 126.68 75.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -122.2 133.47 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.929 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -73.43 137.43 44.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.502 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.841 ' HB ' HG23 ' A' ' 85' ' ' VAL . 96.1 mt -83.55 -48.57 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.349 0.595 . . . . 0.0 110.34 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -140.88 -84.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.895 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -138.9 -44.92 0.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.66 0.267 . . . . 0.0 111.23 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -109.23 9.67 25.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.841 HG23 ' HB ' ' A' ' 81' ' ' ILE . 7.2 m -136.69 142.41 38.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 121.196 -0.202 . . . . 0.0 110.529 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 48.8 m -135.25 149.14 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 111.382 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.3 tp -116.59 129.9 56.43 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -141.85 157.98 44.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.456 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.604 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.68 147.48 18.9 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.749 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.89 118.78 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.74 137.32 54.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.56 -157.43 23.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.797 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.72 154.91 47.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -120.23 139.52 13.8 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -127.12 143.53 51.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -127.91 150.54 18.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.309 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -134.74 127.45 30.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.62 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . . . -108.76 128.74 55.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -117.04 129.71 56.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.294 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.9 136.0 44.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.488 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.2 m -103.18 114.86 29.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 111.238 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.3 p -163.25 165.14 24.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.609 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.8 pt -103.88 109.52 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.44 0.638 . . . . 0.0 110.171 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -150.63 163.79 37.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.878 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.94 -38.83 96.08 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.721 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -122.45 151.18 41.54 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.4 p -109.84 152.99 25.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -131.55 150.58 52.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.5 p -153.55 163.11 40.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.844 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -128.51 148.09 50.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.418 . . . . 0.0 111.325 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.9 m -126.03 145.47 50.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.778 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -126.34 147.63 49.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.115 0.483 . . . . 0.0 111.642 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.8 m -122.75 132.03 54.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.697 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.425 ' HB3' HD21 ' A' ' 140' ' ' LEU . 93.1 p -149.18 160.9 42.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.623 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 138' ' ' SER . 91.0 mt -100.49 138.66 37.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.092 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.44 122.66 29.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.744 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -131.64 149.2 52.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.63 -168.3 36.46 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.634 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.07 162.12 38.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -146.0 156.71 27.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.445 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.6 138.99 51.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.879 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.444 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 52.8 tt0 -115.3 124.34 51.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.781 0.324 . . . . 0.0 110.228 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.63 131.47 56.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.977 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.408 ' OD1' HG22 ' A' ' 130' ' ' VAL . 40.6 t30 -126.72 81.11 69.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.421 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.61 -40.17 39.53 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.754 2.303 . . . . 0.0 111.887 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -133.67 154.69 80.76 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.649 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.3 -34.45 70.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.801 2.334 . . . . 0.0 113.817 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -103.19 10.96 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.473 ' CZ ' HD11 ' A' ' 131' ' ' ILE . 22.6 t80 -131.66 112.63 12.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 124' ' ' ASN . 59.8 t -122.38 130.64 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.473 HD11 ' CZ ' ' A' ' 129' ' ' PHE . 49.1 mm -116.22 123.08 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.8 m-20 -113.82 127.81 56.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.09 115.98 21.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.46 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -136.43 161.96 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.268 0.556 . . . . 0.0 112.462 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -139.29 148.85 43.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.283 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -139.85 148.5 42.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -127.33 128.45 45.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.993 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 66.2 m -100.16 123.95 45.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -101.01 112.76 25.3 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.746 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 89.9 mt -119.37 153.91 34.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.84 -44.59 96.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -106.5 -32.49 8.06 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.746 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.7 t -105.03 131.19 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -105.64 124.29 49.31 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 15' ' ' VAL . 62.5 t -127.27 128.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 112.048 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.49 135.0 11.89 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 85.1 m -123.47 130.15 52.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.241 0.52 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -111.53 136.5 50.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 2.8 mmm -119.21 115.58 24.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 0.0 111.194 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.2 133.96 54.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.585 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.73 176.93 46.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.445 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.87 147.24 43.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.651 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.47 160.58 20.84 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.741 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -125.4 130.52 52.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.734 0.302 . . . . 0.0 110.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -76.5 134.12 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.339 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.782 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.94 0.4 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.96 171.05 34.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.025 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -79.34 158.39 27.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.729 0.299 . . . . 0.0 110.539 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -138.42 157.0 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 111.264 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -133.54 144.83 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.65 126.77 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.237 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 53.8 m -128.75 144.99 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -127.29 150.68 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.427 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.31 -172.12 36.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.942 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -109.7 156.92 19.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.24 135.34 51.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.859 0.361 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -125.08 129.6 50.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.92 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 57.4 m -116.75 145.95 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -118.71 121.52 40.31 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.24 130.09 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.536 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.62 108.63 14.42 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.366 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -147.32 156.39 42.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.37 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.24 112.33 24.51 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.766 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.13 -156.36 28.29 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.543 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 73.7 m-85 -69.8 150.38 46.93 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 58.3 mtmt 74.15 93.39 0.08 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.726 0.641 . . . . 0.0 109.344 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.1 tp -58.8 -40.74 84.97 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -82.15 -15.54 52.97 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 48.22 38.98 11.05 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 13' ' ' SER . 14.7 p-10 -101.4 113.62 65.8 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 13' ' ' SER . 95.9 Cg_endo -79.7 158.45 24.88 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.421 2.08 . . . . 0.0 110.957 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -93.31 146.78 23.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.607 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -168.01 -179.9 40.84 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.433 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -119.61 154.12 34.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.87 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.9 t-20 -126.38 134.42 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.282 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.2 125.66 47.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 60.6 mttp -121.33 139.32 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.147 0.499 . . . . 0.0 111.6 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.7 129.08 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.114 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -116.57 134.01 55.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.679 0.276 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -128.59 124.83 36.88 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -92.21 127.53 37.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -101.55 -9.64 20.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.713 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.5 177.04 11.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.505 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -62.99 -48.23 79.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -112.36 7.29 19.17 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -126.98 142.03 51.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.956 0.408 . . . . 0.0 111.599 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.81 -174.21 37.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.908 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.007 0.404 . . . . 0.0 110.911 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.94 138.43 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.102 0.477 . . . . 0.0 110.912 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -112.91 137.42 14.22 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.6 m -124.74 130.11 51.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.019 0.438 . . . . 0.0 111.482 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 97.1 m-85 -115.61 126.49 54.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.685 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.25 115.12 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.826 0.346 . . . . 0.0 110.649 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -123.84 111.46 16.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.607 HG22 ' HA3' ' A' ' 28' ' ' GLY . 77.1 p -125.93 151.8 46.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.716 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -158.9 147.44 18.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.671 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.95 124.4 28.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 110.516 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.03 54.85 0.58 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.741 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -109.45 132.05 54.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.733 0.302 . . . . 0.0 110.835 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.71 132.14 47.47 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.277 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 24.1 pm0 -67.91 142.04 56.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.085 0.469 . . . . 0.0 110.917 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.5 m -129.38 149.52 51.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.702 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.76 101.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.998 0.428 . . . . 0.0 110.976 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -164.59 76.98 0.32 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.47 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.19 5.43 90.08 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.759 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 63.25 23.33 13.79 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.154 0.582 . . . . 0.0 111.246 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.14 -9.24 26.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.441 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 92.9 mt -109.25 36.1 3.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.106 0.479 . . . . 0.0 111.026 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 65' ' ' ASP . 42.6 pt -84.43 4.68 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.156 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 35.1 t70 78.69 -52.61 0.47 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.818 0.847 . . . . 0.0 111.273 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.97 -16.63 58.21 Favored Glycine 0 CA--C 1.516 0.106 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.957 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 51.56 49.38 21.02 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.543 0.337 . . . . 0.0 111.734 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -83.51 124.19 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.894 0.378 . . . . 0.0 110.793 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -114.98 132.29 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.113 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.581 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 78.1 t80 -131.14 121.31 24.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.287 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -134.24 125.55 28.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 110.221 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 m -130.06 146.62 51.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.095 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.72 126.19 64.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.726 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.2 p -134.95 157.89 45.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.156 0.503 . . . . 0.0 111.78 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.64 153.86 36.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.96 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -169.85 165.25 38.63 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.936 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.35 154.27 40.75 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.916 2.41 . . . . 0.0 112.722 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.599 HG22 ' HB3' ' A' ' 88' ' ' TYR . 60.1 t -123.68 127.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.358 . . . . 0.0 110.545 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -127.87 128.55 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.078 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -74.66 128.34 35.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 0.0 111.078 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 87' ' ' LEU . 86.3 mt -90.36 -42.31 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.12 -165.62 1.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.499 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.75 -39.72 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.548 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -127.21 25.23 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.16 127.54 67.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 66.2 m -128.29 147.25 50.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 111.057 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.703 ' HB2' HD11 ' A' ' 81' ' ' ILE . 64.9 tp -117.07 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.107 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' HB3' HG22 ' A' ' 78' ' ' VAL . 54.6 p90 -142.09 158.77 43.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.068 0.461 . . . . 0.0 111.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.561 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -118.7 156.11 15.8 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.052 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 134' ' ' SER . 88.5 mt -115.13 118.48 33.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.31 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.38 131.69 50.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.06 -148.4 10.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.823 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.99 152.23 41.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 136.44 13.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.862 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -120.83 127.46 51.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.656 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -117.93 141.04 16.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.166 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -130.69 141.83 50.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.59 126.52 42.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.341 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -120.26 126.61 51.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.584 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -97.65 117.72 32.57 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.8 m -91.14 114.33 26.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.994 0.426 . . . . 0.0 111.381 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -164.37 170.82 15.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.643 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.5 mt -101.31 111.41 30.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -150.16 158.31 44.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.875 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.5 -39.62 97.56 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.168 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -115.76 149.74 38.01 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.4 m -110.75 139.57 45.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.498 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -129.16 147.86 51.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.884 0.373 . . . . 0.0 111.04 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 98.5 p -154.43 161.43 41.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.788 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 95.7 mtm-85 -127.5 145.49 50.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.011 0.434 . . . . 0.0 111.49 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.3 m -136.81 147.91 46.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.792 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -146.64 148.66 32.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 111.841 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.6 m -125.0 134.68 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 138' ' ' SER . 89.3 p -141.46 162.03 36.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 0.0 111.557 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 138' ' ' SER . 60.7 tp -75.04 129.22 37.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.466 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 137' ' ' TYR . . . -119.69 133.21 55.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.538 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -148.32 159.31 44.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.719 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 174.33 -166.46 38.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.697 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.69 160.48 41.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.34 28.85 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.335 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.57 143.88 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.358 -0.421 . . . . 0.0 109.995 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -127.92 130.11 47.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.846 0.355 . . . . 0.0 110.327 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -123.5 144.36 49.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.843 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.402 ' OD1' HG22 ' A' ' 130' ' ' VAL . 33.7 t30 -127.43 82.14 68.79 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.801 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.48 -40.78 45.2 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.419 2.079 . . . . 0.0 111.848 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -136.03 154.31 77.47 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.9 -34.83 87.42 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.836 2.357 . . . . 0.0 113.761 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -98.94 10.56 41.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -138.66 112.28 8.28 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG22 ' OD1' ' A' ' 124' ' ' ASN . 67.5 t -116.64 129.78 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.626 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.6 mt -102.54 120.4 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.5 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.2 m-20 -116.65 126.11 52.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.531 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -132.77 135.16 45.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.562 ' HB2' HD11 ' A' ' 90' ' ' LEU . 92.2 p -155.59 161.01 40.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.382 0.611 . . . . 0.0 112.346 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -138.18 134.09 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.712 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.461 ' CG ' ' HB ' ' A' ' 147' ' ' THR . 25.9 pt-20 -129.76 147.75 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 83.7 t80 -129.12 135.11 48.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.65 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 67.6 m -107.65 129.36 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -102.04 117.69 35.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.791 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 60.9 mt -119.64 154.29 34.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.97 -44.35 94.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.9 -32.97 7.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.791 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 59.7 t -104.86 130.61 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -103.29 125.15 49.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.0 t -125.83 124.8 67.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.1 138.88 12.88 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.461 ' HB ' ' CG ' ' A' ' 136' ' ' GLU . 85.7 m -125.46 128.97 48.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.405 0.602 . . . . 0.0 111.503 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -114.09 129.51 56.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 70.8 mtm -123.62 139.89 53.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.245 0.545 . . . . 0.0 112.167 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 67.1 tp -136.97 130.43 31.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.039 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.78 173.14 34.48 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.602 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.64 151.73 49.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.433 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.32 -167.18 18.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.436 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -148.15 160.91 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.811 0.339 . . . . 0.0 110.763 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -78.97 141.41 37.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.801 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.525 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.054 0.454 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.01 172.86 45.84 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.041 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -84.53 149.73 25.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.709 0.29 . . . . 0.0 110.451 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -128.89 143.5 50.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.18 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -129.69 141.92 50.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.693 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.6 mt -116.39 126.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.263 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 51.6 m -124.54 142.17 51.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 0.0 111.184 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -129.4 153.6 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.4 -173.59 37.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.11 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.4 142.31 37.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.09 123.8 51.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -120.38 122.29 40.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.966 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.661 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.7 m -118.97 157.68 27.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.847 0.356 . . . . 0.0 111.264 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -128.13 140.85 51.7 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.771 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -124.63 131.73 72.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.464 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -60.59 134.38 57.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.397 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -123.2 153.61 39.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.41 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -113.67 22.07 14.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.238 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.39 -16.13 5.19 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.681 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 95.2 m-85 -91.98 138.44 31.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 27.8 mmtm 69.24 159.44 0.18 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.463 0.649 . . . . 0.0 111.32 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -88.25 -57.27 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.526 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 52.6 p-10 -114.32 -13.69 12.29 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mttt 49.82 36.92 12.17 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 23' ' ' ASP . 34.4 m120 -103.25 112.77 65.93 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 13' ' ' SER . 84.6 Cg_endo -78.01 158.47 30.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.706 2.27 . . . . 0.0 111.094 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -114.18 144.78 42.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -169.31 177.15 43.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.297 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -111.24 144.74 39.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -110.69 127.87 55.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.804 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.6 127.07 53.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.229 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 63.6 mttm -126.61 137.23 53.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.63 135.96 50.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -127.12 130.98 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -114.72 128.36 56.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -110.0 89.15 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -102.49 -2.41 28.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.156 0.503 . . . . 0.0 110.014 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' TRP . 16.3 t-20 -154.45 136.9 15.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.479 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -67.87 -41.1 83.37 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -71.72 -45.65 61.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.589 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 97.8 m95 -128.81 138.47 52.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.943 0.401 . . . . 0.0 112.025 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.54 174.0 18.57 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.928 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.2 t -121.93 128.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.114 0.457 . . . . 0.0 110.61 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.77 140.56 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.35 141.13 13.11 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -124.99 132.11 53.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.94 0.4 . . . . 0.0 111.364 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.81 118.59 26.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.87 128.18 49.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -124.78 120.55 32.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.47 HG22 ' HA3' ' A' ' 28' ' ' GLY . 62.7 p -128.62 160.19 33.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.986 0.422 . . . . 0.0 111.695 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -153.1 164.39 38.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.907 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.21 146.13 53.66 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.661 0.267 . . . . 0.0 110.75 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.92 172.41 51.33 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.913 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.38 150.54 27.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.727 0.299 . . . . 0.0 110.969 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -135.0 168.08 19.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.914 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.3 pm0 -59.45 138.39 57.69 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.186 0.517 . . . . 0.0 111.109 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.4 m -133.05 159.83 38.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.807 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 m -102.64 161.72 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.781 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -57.73 136.78 56.93 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.99 0.424 . . . . 0.0 110.719 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.14 -8.69 67.48 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.387 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.87 149.63 48.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 111.187 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -105.65 149.8 26.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.051 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 49.66 1.76 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.057 0.455 . . . . 0.0 110.863 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.532 HG23 ' HB2' ' A' ' 67' ' ' ASP . 94.4 mt -63.0 -46.62 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.814 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.3 t0 55.37 29.54 13.25 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.296 0.639 . . . . 0.0 111.768 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' H ' HG22 ' A' ' 64' ' ' ILE . . . 91.15 -16.09 59.52 Favored Glycine 0 CA--C 1.518 0.225 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.759 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.532 ' HB2' HG23 ' A' ' 64' ' ' ILE . 18.8 t0 49.91 54.73 10.55 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 122.719 0.408 . . . . 0.0 111.865 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.432 ' HD1' ' HB2' ' A' ' 98' ' ' ALA . 89.1 t80 -100.61 127.08 47.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.72 143.87 48.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.213 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -127.93 118.58 23.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -116.5 128.93 55.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.712 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.0 m -122.46 139.41 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.41 122.31 44.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.613 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.3 p -134.41 159.7 40.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.183 0.516 . . . . 0.0 111.898 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.8 154.2 38.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.094 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.89 165.01 37.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.954 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.5 153.01 30.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.817 2.345 . . . . 0.0 112.389 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.57 128.56 72.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.494 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.41 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 84.6 t80 -119.71 124.12 45.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.998 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -75.6 131.32 39.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.804 ' HB ' HG13 ' A' ' 85' ' ' VAL . 47.6 mm -90.34 -42.26 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.517 0.675 . . . . 0.0 109.873 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.414 ' HB3' HG12 ' A' ' 85' ' ' VAL . 2.7 t-20 -150.23 -158.15 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.446 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.05 -40.83 91.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -126.2 29.04 5.91 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.804 HG13 ' HB ' ' A' ' 81' ' ' ILE . 7.7 p -144.71 131.29 15.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 O-C-N 121.953 -0.467 . . . . 0.0 109.836 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.4 m -138.19 152.25 48.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.704 0.288 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 HG13 ' A' ' 81' ' ' ILE . 2.5 mp -124.36 143.22 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.166 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.535 ' CZ ' ' HA3' ' A' ' 120' ' ' GLY . 45.9 p90 -146.18 161.35 40.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.547 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -111.34 146.48 17.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.968 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.408 HD21 ' HE2' ' A' ' 88' ' ' TYR . 79.1 mt -116.41 123.87 48.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.96 0.41 . . . . 0.0 111.56 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -138.16 137.91 38.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -154.66 16.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.857 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.63 153.07 47.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.998 0.428 . . . . 0.0 111.678 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.39 142.78 17.56 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.71 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -129.67 123.74 31.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.54 138.37 14.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.754 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -128.8 140.66 51.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.893 0.347 . . . . 0.0 111.141 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.432 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . . . -133.14 124.06 26.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.379 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 65.1 tttm -130.76 130.2 43.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -97.32 120.96 38.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.0 m -89.15 115.69 26.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.981 0.419 . . . . 0.0 111.407 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -163.62 170.49 17.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.628 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 tp -106.77 110.69 32.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.686 0.755 . . . . 0.0 110.194 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -150.52 164.04 36.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.876 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.61 -39.6 97.6 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.851 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -132.1 132.09 42.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -112.09 150.28 30.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.523 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -126.07 141.94 51.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.024 0.44 . . . . 0.0 111.203 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.9 m -136.95 159.41 41.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.027 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -136.23 155.66 49.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.079 0.466 . . . . 0.0 111.623 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.8 p -149.04 152.42 36.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.664 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -135.92 149.82 49.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.147 0.498 . . . . 0.0 112.05 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.6 p -109.84 148.75 30.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.711 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -154.93 160.6 41.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.789 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 138' ' ' SER . 85.1 mt -101.25 136.39 41.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.0 133.34 54.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -142.41 139.45 31.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.17 -166.42 29.09 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.777 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.535 ' HA3' ' CZ ' ' A' ' 88' ' ' TYR . . . -134.4 150.27 20.01 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.41 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.04 138.7 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.417 -0.391 . . . . 0.0 109.948 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -124.7 132.12 53.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.898 0.38 . . . . 0.0 110.44 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.518 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -114.8 95.31 40.72 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.355 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.48 -36.22 87.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.522 2.148 . . . . 0.0 111.535 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -130.06 157.17 77.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.767 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.18 -37.34 79.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.874 2.383 . . . . 0.0 113.636 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -105.46 16.35 25.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 131' ' ' ILE . 8.4 t80 -126.27 117.03 22.2 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.92 -0.488 . . . . 0.0 110.665 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.1 t -115.32 126.87 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.654 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 129' ' ' PHE . 48.4 mm -108.59 126.39 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -123.42 116.82 23.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.997 0.427 . . . . 0.0 111.402 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -122.94 133.33 54.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.6 p -152.22 166.98 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.331 0.586 . . . . 0.0 112.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -141.31 150.68 42.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.633 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -140.18 151.02 44.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -133.92 128.4 34.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.763 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 20.3 m -94.76 124.43 38.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -103.47 102.86 12.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 97.5 mt -118.62 152.33 36.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.26 -43.86 98.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -105.42 -33.12 8.26 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.749 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.2 t -105.66 125.96 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -105.8 122.64 46.51 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 73.7 t -127.19 129.27 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -117.7 138.83 14.35 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.0 m -127.05 131.71 50.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.244 0.522 . . . . 0.0 111.495 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.9 m-90 -116.8 139.31 50.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 64.3 mtt -127.15 124.33 38.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 0.0 111.992 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.3 mt -127.75 136.67 51.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.112 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.68 -172.37 43.68 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.383 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.97 158.32 44.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.621 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.02 164.4 25.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.816 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -131.32 129.29 41.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 110.177 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -76.37 137.84 40.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 t80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.751 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 . . . . . 0 C--O 1.235 0.323 0 CA-C-O 120.767 0.317 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.9 m -122.1 141.02 51.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.994 0.426 . . . . 0.0 111.113 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -140.62 153.35 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.143 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -119.87 143.47 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.455 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 49.1 m -134.48 142.85 47.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.74 0.305 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.73 150.0 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.94 167.91 40.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.017 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -89.7 138.74 31.22 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -111.81 127.95 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.403 HE22 ' HG2' ' A' ' 27' ' ' ARG . 50.1 mm-40 -126.02 122.13 34.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.093 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 146' ' ' GLY . 50.1 m -118.4 156.72 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.11 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -122.97 128.36 50.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.2 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.454 -179.778 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 13' ' ' SER . 34.7 Cg_exo -63.4 147.14 93.65 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.064 2.51 . . . . 0.0 111.441 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG2' HE22 ' A' ' 12' ' ' GLN . 99.2 mtt180 -113.36 140.35 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.285 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -176.4 -174.84 43.25 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.349 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -119.12 147.39 44.22 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 110.591 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.575 HD22 ' HB2' ' A' ' 48' ' ' ALA . 24.0 t-20 -117.09 127.97 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.227 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 tp -112.6 126.08 54.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.977 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 29.2 ttpp -125.06 133.89 52.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.147 0.498 . . . . 0.0 111.621 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -114.36 130.5 56.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.002 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -112.71 128.51 56.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.946 0.403 . . . . 0.0 111.452 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -128.98 120.49 26.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.487 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.25 156.66 42.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 117.021 0.41 . . . . 0.0 110.631 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -134.07 147.77 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.266 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -124.72 123.75 5.17 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -114.94 125.37 53.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.165 0.483 . . . . 0.0 111.759 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -117.11 121.22 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -115.68 126.98 54.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 0.0 111.646 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.523 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 65.5 tt0 -123.91 117.08 24.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.551 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 73.7 p -128.87 156.5 43.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.058 0.456 . . . . 0.0 111.827 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.367 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.9 t80 -139.6 126.95 21.4 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -129.44 141.62 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.551 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 74.3 t80 -133.31 126.53 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.508 ' CE2' ' HG3' ' A' ' 49' ' ' GLN . 95.5 m-85 -124.37 139.96 53.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.895 0.378 . . . . 0.0 110.533 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 75.4 m -135.68 141.9 45.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.049 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.413 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 3.1 p -138.78 120.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.636 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.1 p -135.56 158.38 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.024 0.44 . . . . 0.0 111.877 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.638 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.83 157.18 42.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.912 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -172.85 161.31 32.55 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.54 155.19 35.86 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.967 2.445 . . . . 0.0 112.408 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 88' ' ' TYR . 61.8 t -120.06 126.65 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.396 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -126.4 128.98 47.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.752 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -77.87 131.49 37.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.697 0.285 . . . . 0.0 110.926 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 87' ' ' LEU . 89.4 mt -90.18 -43.22 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.514 0.673 . . . . 0.0 109.954 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -138.29 -166.61 2.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.235 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -62.64 -39.65 94.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.622 0.248 . . . . 0.0 111.445 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -122.89 21.75 9.82 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.4 127.96 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 CA-C-N 118.011 0.369 . . . . 0.0 110.095 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.8 m -130.14 144.45 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.764 0.316 . . . . 0.0 111.049 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 81' ' ' ILE . 67.6 tp -124.37 135.17 53.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.401 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.522 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 51.9 p90 -139.68 156.17 46.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.06 0.457 . . . . 0.0 111.383 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.635 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -108.97 153.16 16.9 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.074 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 134' ' ' SER . 88.9 mt -120.61 127.27 51.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 111.716 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -144.26 138.03 27.68 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . 176.66 -150.23 10.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.875 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.27 156.26 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.45 147.23 16.7 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.665 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -135.75 128.34 30.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 110.838 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.015 179.622 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.233 0.22 0 CA-C-O 121.278 0.561 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.2 p -120.29 148.01 44.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.255 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 140' ' ' LEU . 92.8 p -157.28 165.68 35.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.347 . . . . 0.0 111.849 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 138' ' ' SER . 90.4 mt -99.58 137.81 37.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.909 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.46 131.92 54.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.035 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -143.6 137.9 28.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.36 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.65 -163.32 27.7 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.692 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.33 159.58 43.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -136.86 153.52 21.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.265 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.85 138.81 50.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.028 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 51.6 tt0 -129.21 128.38 43.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.612 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -116.49 139.72 50.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.476 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -116.01 85.79 15.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 130' ' ' VAL . 58.4 Cg_endo -73.7 -32.95 7.03 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.207 1.938 . . . . 0.0 111.711 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -134.71 152.71 78.09 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.695 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.8 -38.27 94.64 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 122.664 2.243 . . . . 0.0 114.054 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -104.55 6.07 34.37 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -137.57 122.04 18.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.927 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.4 m -127.64 153.17 36.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.03 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.31 123.83 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.81 130.72 56.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -127.22 120.26 28.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.598 ' HB3' HD11 ' A' ' 90' ' ' LEU . 73.3 m -121.65 142.48 50.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.54 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.5 m-85 -122.41 122.54 39.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.113 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 83.8 mt-10 -127.1 135.8 51.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.01 142.07 49.46 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.992 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 57.4 m -115.32 128.02 55.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.12 114.78 29.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.757 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 83.3 mt -118.67 154.72 32.25 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.11 -42.91 95.76 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.55 -33.54 7.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.757 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.1 t -106.42 129.03 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -106.06 126.61 52.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 72.6 t -125.85 126.88 70.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -118.38 137.78 13.25 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 73.9 m -126.88 128.42 46.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.262 0.531 . . . . 0.0 111.086 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -119.8 139.03 52.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 17.8 tmm? -134.42 132.03 38.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.094 0.473 . . . . 0.0 111.567 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.89 127.04 41.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -163.71 -167.65 24.51 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.53 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.9 156.23 48.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.763 0.316 . . . . 0.0 110.709 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -124.95 152.84 17.71 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.679 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -121.24 128.33 52.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.881 0.372 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -93.92 128.25 40.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.71 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -138.59 156.47 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.0 m -145.04 156.02 43.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.63 143.31 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.479 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 50.4 m -134.51 148.34 50.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.708 0.29 . . . . 0.0 111.286 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.9 152.16 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.331 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.24 -179.19 41.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.025 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -103.18 140.81 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.691 0.281 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.81 121.78 45.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -120.43 127.95 52.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.67 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.689 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.5 m -118.01 153.28 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 111.276 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.718 -179.56 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.1 m120 . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 13' ' ' SER . 91.5 Cg_endo -80.23 158.87 23.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.747 2.298 . . . . 0.0 111.362 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -111.19 136.49 50.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.554 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.18 -179.86 40.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.574 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.95 154.69 35.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.615 HD22 ' HB2' ' A' ' 48' ' ' ALA . 29.3 t-20 -127.97 126.18 40.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -108.85 136.78 47.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 15.8 ttmm -130.98 136.9 48.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.132 0.491 . . . . 0.0 111.528 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -122.6 127.59 49.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.869 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -113.82 130.63 56.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.0 111.314 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -126.61 122.73 35.88 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.564 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.8 156.61 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.034 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.1 pp -132.41 146.08 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 111.537 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -120.92 125.73 6.33 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.425 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 48.1 m -118.09 128.16 54.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 0.0 112.005 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -121.21 120.5 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.354 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.615 ' HB2' HD22 ' A' ' 30' ' ' ASN . . . -118.07 129.47 55.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.892 0.377 . . . . 0.0 111.46 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -122.86 115.92 22.78 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.7 p -127.0 155.4 43.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 112.013 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.002 179.852 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t0 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.881 0.372 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -114.79 128.62 56.4 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.931 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -113.92 137.54 51.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.56 123.45 39.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -117.45 137.33 52.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 66.2 m -127.58 131.97 49.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.852 0.358 . . . . 0.0 111.216 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.03 117.96 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 46' ' ' SER . 74.2 p -132.47 156.96 45.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 111.743 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.1 156.35 42.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.225 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -173.77 165.02 36.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.104 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.18 155.63 25.71 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.001 2.467 . . . . 0.0 112.364 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.17 127.76 75.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -126.81 125.98 42.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.984 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -77.21 127.61 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.698 HD12 HG12 ' A' ' 85' ' ' VAL . 97.5 mt -75.12 -46.04 40.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -134.29 -97.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.158 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 -31.72 1.36 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.29 3.99 11.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.698 HG12 HD12 ' A' ' 81' ' ' ILE . 57.8 t -129.09 128.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 57.1 m -129.0 148.72 50.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 tt -116.8 136.72 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.225 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.501 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 50.1 p90 -142.04 155.44 45.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.392 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.576 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -109.03 151.86 17.08 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.044 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 134' ' ' SER . 83.1 mt -119.67 125.57 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 0.0 111.503 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -144.58 140.37 28.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.602 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.97 -157.29 27.22 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.65 151.94 51.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.082 0.467 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.17 141.49 17.04 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -127.58 126.09 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.808 0.337 . . . . 0.0 110.39 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.352 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.6 m -115.42 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.7 p -140.54 157.71 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.978 0.418 . . . . 0.0 111.77 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 138' ' ' SER . 69.0 tp -100.56 127.66 46.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.56 130.77 56.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.424 . . . . 0.0 110.953 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -144.56 140.22 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.83 -163.33 27.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.633 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.15 161.27 41.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -142.1 158.58 26.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.347 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.8 mt -122.56 139.38 53.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.509 -0.346 . . . . 0.0 110.077 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -118.85 128.49 54.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.169 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.33 142.37 51.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -124.19 82.67 56.92 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.532 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.21 -28.61 33.77 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.477 2.118 . . . . 0.0 112.127 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -131.56 151.29 78.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.546 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.81 -25.57 74.66 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 113.452 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -111.48 13.49 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -140.29 120.89 14.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 110.951 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.5 t -111.43 129.98 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.183 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 51.0 mm -104.64 119.65 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.464 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 88.7 m-20 -114.11 126.48 55.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.991 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.15 124.04 45.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.451 ' HB3' HD11 ' A' ' 90' ' ' LEU . 74.9 m -127.35 143.08 51.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 112.379 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.526 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 51.9 m-85 -124.65 122.96 38.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.102 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -125.59 135.12 51.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -127.39 139.21 53.0 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.871 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 49.6 m -105.99 123.96 48.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -101.36 107.64 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.258 0.552 . . . . 0.0 112.311 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 87.3 mt -119.01 153.0 35.39 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.89 -44.11 97.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -104.9 -32.92 8.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.731 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -106.07 128.36 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -106.19 120.69 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 58.1 t -124.92 129.19 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.974 0.416 . . . . 0.0 112.091 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.09 138.29 14.64 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.7 m -124.84 129.16 49.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.979 0.418 . . . . 0.0 111.3 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -115.95 136.99 52.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -131.93 127.87 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.96 137.47 53.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.36 -171.59 38.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.571 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.86 157.09 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.94 0.4 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.79 167.19 24.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.738 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -132.86 130.81 40.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.494 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.2 mtm105 -79.04 140.45 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.027 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.937 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -122.94 142.95 50.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.452 . . . . 0.0 111.239 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 34' ' ' ARG . 32.3 m -143.26 154.57 43.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.875 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.3 143.77 32.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.502 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 50.1 m -132.27 141.95 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 pt -127.95 147.56 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.45 -173.22 38.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.042 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.34 142.99 36.27 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.77 114.4 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.266 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -116.77 132.34 56.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.674 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 44.6 m -118.23 165.23 14.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.804 0.335 . . . . 0.0 111.624 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -126.61 121.12 31.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.378 -179.609 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 13' ' ' SER . 30.5 m120 . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.674 ' HD2' ' O ' ' A' ' 13' ' ' SER . 93.2 Cg_endo -79.67 159.21 25.07 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.797 2.331 . . . . 0.0 110.745 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.01 142.42 27.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.0 169.68 41.01 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.392 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.84 147.64 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 0.0 110.565 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.551 HD21 ' HE2' ' A' ' 32' ' ' LYS . 42.1 t30 -111.09 121.84 46.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.641 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.22 124.09 42.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.102 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 67.5 mttm -127.76 145.39 50.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.436 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -123.34 127.81 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.58 ' NE ' HE22 ' A' ' 122' ' ' GLN . 51.6 mtp180 -109.6 136.48 48.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.902 0.382 . . . . 0.0 111.835 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.64 119.33 16.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.412 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 C--N 1.331 -0.216 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.217 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.0 m -126.75 148.3 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.343 . . . . 0.0 110.818 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.681 ' HB ' ' CE1' ' A' ' 88' ' ' TYR . 78.9 mt -129.37 130.11 67.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.45 136.53 12.74 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -123.22 133.4 54.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.275 0.538 . . . . 0.0 111.865 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HD1' HG22 ' A' ' 73' ' ' VAL . 78.7 t80 -135.93 124.32 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.448 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.08 143.11 49.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.98 0.419 . . . . 0.0 111.201 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -121.51 126.1 48.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 64.8 p -125.7 151.8 46.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.613 -179.504 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -99.48 120.69 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.95 139.02 53.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.235 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 85.9 t80 -133.78 128.43 34.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.74 135.66 53.7 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.3 m -116.1 123.62 48.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.712 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.445 HG22 ' HD1' ' A' ' 47' ' ' PHE . 61.6 t -126.38 110.8 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.0 p -135.67 159.3 42.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.051 0.453 . . . . 0.0 111.851 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.29 151.6 32.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.827 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.4 161.54 33.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.901 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.47 160.03 32.2 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.049 2.499 . . . . 0.0 112.688 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.06 132.49 65.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.227 0.537 . . . . 0.0 110.139 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.49 148.76 50.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.135 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -85.33 127.35 34.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.278 . . . . 0.0 110.705 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 87' ' ' LEU . 95.6 mt -89.36 -44.07 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -134.56 -164.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.082 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.469 ' O ' ' HD1' ' A' ' 84' ' ' TYR . 98.6 mt-10 -62.05 -40.78 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.457 0.17 . . . . 0.0 111.34 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.469 ' HD1' ' O ' ' A' ' 83' ' ' GLU . 6.4 m-30 -126.85 28.98 5.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.12 131.41 67.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.3 m -128.9 148.6 50.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.773 ' HB2' HD11 ' A' ' 81' ' ' ILE . 65.2 tp -112.19 129.75 56.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.681 ' CE1' ' HB ' ' A' ' 44' ' ' ILE . 38.5 t80 -126.99 133.47 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.031 0.443 . . . . 0.0 111.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.517 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -107.7 141.58 15.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.554 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 134' ' ' SER . 3.3 mp -110.06 121.52 45.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 111.486 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.8 tp -135.28 126.81 28.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.562 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.5 -151.15 11.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.869 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.92 155.29 44.69 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.133 0.492 . . . . 0.0 111.553 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.456 ' HA3' ' OH ' ' A' ' 70' ' ' TYR . . . -122.73 144.06 15.66 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.797 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -126.87 126.37 43.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 110.703 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.352 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.374 0.606 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 87.0 m -128.6 133.38 48.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.591 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.448 ' HB3' HD21 ' A' ' 140' ' ' LEU . 92.3 p -140.12 160.48 39.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.31 141.87 31.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.177 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.35 133.43 55.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.61 140.04 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.471 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 136' ' ' GLU . . . -170.01 -175.42 38.95 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.734 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.45 154.31 41.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.42 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -148.53 161.71 28.7 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.418 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.17 138.72 50.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.363 -0.418 . . . . 0.0 110.159 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.58 HE22 ' NE ' ' A' ' 34' ' ' ARG . 54.7 tt0 -119.86 130.5 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.999 0.428 . . . . 0.0 110.034 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.03 152.27 33.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.028 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -121.22 82.92 38.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.619 0.247 . . . . 0.0 110.688 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.34 -28.99 14.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.356 2.037 . . . . 0.0 112.248 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 79.5 m80 -130.64 152.93 81.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.737 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -56.28 -36.19 96.64 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.763 2.308 . . . . 0.0 114.287 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -109.57 -4.23 16.37 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 126' ' ' HIS . 68.2 m-85 -121.47 133.51 55.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.68 152.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.084 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.3 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -115.54 114.99 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -114.14 108.97 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.577 ' HB3' HD11 ' A' ' 90' ' ' LEU . 54.0 m -128.03 153.13 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -134.48 131.85 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.709 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.417 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 27.2 pt-20 -140.91 161.24 38.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -137.76 159.1 42.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 0.0 111.626 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 45.2 m -108.59 135.53 49.69 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.912 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -98.67 104.81 16.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.803 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 79.2 mt -118.48 153.29 34.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.54 -45.25 93.83 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.2 -32.82 7.64 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.803 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 62.7 t -104.92 130.48 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.44 125.08 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.6 t -121.83 125.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.14 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -113.74 138.17 14.7 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.6 m -124.58 130.98 53.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.443 0.621 . . . . 0.0 111.433 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.7 m-90 -106.24 131.55 53.35 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.6 mtt -120.63 111.2 17.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.438 . . . . 0.0 111.438 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -123.85 134.41 53.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.612 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 178.39 48.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.378 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.81 150.89 42.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.855 0.359 . . . . 0.0 110.498 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -127.3 155.29 19.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.985 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -118.55 127.77 53.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.764 0.316 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.489 ' HA ' ' OG ' ' A' ' 5' ' ' SER . 80.8 mtp180 -92.82 132.57 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.875 -179.9 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.547 0.213 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -129.04 143.34 50.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.235 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -128.47 143.5 50.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.4 mm -113.77 120.57 63.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 65.7 m -127.33 144.71 51.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.399 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.52 153.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.571 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.17 -174.34 38.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.102 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -109.06 142.61 39.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -108.26 127.74 54.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 111.416 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -120.97 114.82 22.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.739 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 50.6 m -118.2 159.85 22.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.59 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -126.91 128.87 47.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.169 -178.753 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.739 ' HD2' ' O ' ' A' ' 13' ' ' SER . 72.4 Cg_endo -74.83 157.99 43.14 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.474 2.116 . . . . 0.0 110.72 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -113.92 146.73 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.049 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -177.66 178.31 48.38 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.431 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.69 148.39 33.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 0.0 110.788 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.1 t-20 -124.27 130.05 51.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.948 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.76 136.2 53.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.082 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.7 mttm -124.49 139.95 53.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 111.377 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -132.64 128.3 36.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.069 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.514 ' HD3' HE22 ' A' ' 122' ' ' GLN . 47.0 ttp180 -119.92 133.68 55.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -128.19 125.15 38.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.1 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.26 179.825 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.32 153.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -139.1 138.63 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.36 139.93 12.6 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 m -129.36 136.6 50.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.992 0.425 . . . . 0.0 111.105 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.39 124.85 43.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.821 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.793 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -119.08 120.27 36.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.784 0.326 . . . . 0.0 110.939 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.532 ' OE1' ' HD1' ' A' ' 71' ' ' TYR . 2.8 mm-40 -112.09 106.48 15.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.525 HG22 ' HA3' ' A' ' 28' ' ' GLY . 75.1 p -125.99 158.04 36.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.119 0.485 . . . . 0.0 112.276 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 179.29 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -99.39 122.76 42.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.645 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -127.79 142.23 51.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.13 123.25 24.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.532 ' HD1' ' OE1' ' A' ' 49' ' ' GLN . 92.1 m-85 -112.79 128.91 56.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.793 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 67.4 m -113.92 127.03 55.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.181 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.9 124.4 70.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -147.15 153.43 39.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.851 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -153.03 153.43 32.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -167.81 167.37 40.01 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.997 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.56 156.3 40.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.526 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.76 129.71 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.544 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -126.88 126.63 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.996 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -69.94 134.79 48.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 0.0 111.215 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.631 ' HB ' HG23 ' A' ' 85' ' ' VAL . 95.6 mt -89.62 -45.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.53 0.681 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.83 -144.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.86 -1.78 52.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.342 -0.224 . . . . 0.0 111.468 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -147.05 9.72 0.99 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.631 HG23 ' HB ' ' A' ' 81' ' ' ILE . 3.4 m -140.37 142.53 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 68.1 m -138.3 151.35 47.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.049 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 81' ' ' ILE . 2.7 tt -116.26 136.93 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -142.75 157.69 44.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 111.335 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.635 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.99 150.52 18.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.845 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.02 129.44 55.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.455 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -142.36 135.66 28.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.8 13.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.903 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.69 152.19 45.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.101 0.477 . . . . 0.0 111.606 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.21 140.81 16.43 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.768 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -119.03 122.42 42.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.592 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.272 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.247 0.546 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -126.8 149.03 49.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.428 ' HB2' HD21 ' A' ' 140' ' ' LEU . 39.3 t -153.97 148.31 26.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 111.511 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.44 126.94 32.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.64 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.85 132.89 56.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.97 0.414 . . . . 0.0 111.132 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.76 137.7 25.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.291 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.4 -168.38 29.47 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.752 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.06 161.47 41.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.64 161.92 28.95 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.579 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.07 140.76 50.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.047 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.514 HE22 ' HD3' ' A' ' 34' ' ' ARG . 52.7 tt0 -115.4 128.55 56.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -116.18 139.93 49.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.108 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -128.83 82.69 68.19 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -30.06 17.48 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.372 2.048 . . . . 0.0 112.237 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -131.32 152.43 80.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.633 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.16 -35.01 89.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.92 2.413 . . . . 0.0 113.869 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.419 ' O ' ' HD1' ' A' ' 154' ' ' TYR . 2.8 t-20 -109.99 13.7 23.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -130.94 118.57 20.87 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -117.37 131.04 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.341 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.21 122.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -110.77 129.67 55.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.9 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -133.79 125.49 28.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 99.3 p -155.8 165.8 35.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.9 152.64 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.55 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -144.42 137.52 27.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -112.75 132.34 55.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.455 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 49.3 m -102.89 125.91 49.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -103.25 114.58 28.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.76 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 68.1 mt -119.91 153.65 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.16 -43.41 98.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -106.72 -32.06 8.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.76 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.4 t -105.26 130.75 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.91 123.94 48.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -127.7 126.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 112.055 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -114.41 135.01 12.08 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.3 m -119.44 129.18 54.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.52 0.66 . . . . 0.0 111.621 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -111.09 131.44 55.08 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 63.8 mtt -120.71 115.1 22.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.25 136.5 53.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.322 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 -173.25 44.51 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.394 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.66 159.29 43.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.07 -178.23 28.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.596 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 128' ' ' ASN . 94.2 m-85 -121.82 144.66 48.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.654 0.264 . . . . 0.0 110.494 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -96.25 126.39 41.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.813 -179.823 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 34' ' ' ARG . 37.3 t -133.88 140.17 46.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 111.134 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.7 m -131.65 149.46 52.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.3 mt -118.56 126.66 75.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.27 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.526 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 62.1 m -117.83 137.22 52.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.299 . . . . 0.0 111.207 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -121.36 129.64 75.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.193 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.93 172.91 31.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.08 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -98.56 145.05 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -127.81 138.96 52.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.947 0.403 . . . . 0.0 111.429 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HB2' ' NE1' ' A' ' 148' ' ' TRP . 97.3 mt-30 -127.73 135.03 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.967 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.658 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.6 m -118.82 148.56 42.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.176 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -120.37 123.19 42.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 145' ' ' VAL . 58.2 t . . . . . 0 C--O 1.223 -0.328 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.658 ' HD2' ' O ' ' A' ' 13' ' ' SER . 73.5 Cg_endo -76.8 159.48 34.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.632 2.221 . . . . 0.0 110.756 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -116.07 156.35 26.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.903 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -178.63 -153.79 11.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.362 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.12 161.35 38.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 28.1 t-20 -135.26 128.87 32.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 46' ' ' SER . 87.1 mt -104.13 128.15 51.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.986 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 23.0 ttmm -119.74 127.75 53.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.513 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.38 134.52 52.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.614 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 4' ' ' SER . 77.2 ttt-85 -121.78 131.03 53.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 111.733 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -132.36 131.49 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.595 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.9 0.381 . . . . 0.0 110.822 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.3 pp -136.77 150.07 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -130.86 134.1 7.6 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 55.0 m -124.57 135.71 53.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.031 0.415 . . . . 0.0 111.774 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 94.8 m-85 -120.4 111.73 18.11 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -102.67 127.48 49.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.503 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.521 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 77.4 mt-30 -126.08 123.52 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 77.1 p -128.04 149.45 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.676 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.037 179.608 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t0 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -104.83 130.22 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.769 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -118.03 136.35 53.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.981 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.513 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 68.0 t80 -134.45 125.64 27.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.231 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.44 138.16 53.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 109.912 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 67.7 m -127.92 136.0 50.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.199 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 63.0 t -124.92 119.63 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.7 p -133.2 156.33 47.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 111.868 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.22 153.01 34.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.042 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.06 164.66 37.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.969 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.19 156.85 29.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.889 2.393 . . . . 0.0 112.64 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 88' ' ' TYR . 57.4 t -123.42 129.75 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.382 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -123.13 128.71 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.043 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.485 ' HD3' ' HB3' ' A' ' 86' ' ' SER . 29.3 mmt180 -78.53 126.31 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.8 mm -90.97 -42.26 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 110.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.0 -167.2 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.04 -38.43 88.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 0.0 111.327 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -128.15 23.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.44 127.48 65.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.645 ' OG ' ' HB3' ' A' ' 122' ' ' GLN . 89.3 p -138.6 151.7 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.7 mt -123.36 145.92 48.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.957 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.508 ' HB3' HG22 ' A' ' 78' ' ' VAL . 34.6 p90 -150.89 159.36 44.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 111.714 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.659 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -117.13 149.25 18.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.132 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 134' ' ' SER . 92.4 mt -112.65 118.89 36.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.296 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 tp -127.11 125.39 41.17 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . -175.13 -155.03 11.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.855 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.07 153.39 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.613 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.01 141.62 17.0 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.766 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -129.33 130.8 46.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.775 0.321 . . . . 0.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.542 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.09 0.471 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 76.4 p -118.26 149.16 41.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.769 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.4 p -157.4 163.94 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.37 . . . . 0.0 111.759 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.8 mt -98.79 135.41 40.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.064 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.33 130.1 52.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -143.74 138.64 28.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -167.76 -165.05 24.51 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.695 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.18 37.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 88' ' ' TYR . . . -145.28 162.65 28.18 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 113.348 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.0 tp -126.74 138.43 53.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.902 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.645 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 51.6 tt0 -126.75 133.1 50.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.862 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -122.5 151.82 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.574 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -119.35 81.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.23 -34.6 67.37 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.597 2.198 . . . . 0.0 111.483 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.68 155.44 81.26 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.681 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.56 -23.21 74.71 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.844 2.362 . . . . 0.0 113.658 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -117.78 9.51 12.99 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.94 133.93 29.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.69 153.39 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.3 mt -113.22 124.24 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -111.3 126.93 55.42 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -128.6 116.5 19.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.59 ' HB3' HD11 ' A' ' 90' ' ' LEU . 67.7 m -130.64 153.82 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 99.0 m-85 -125.58 138.32 53.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.329 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 99.2 mt-10 -129.66 144.64 51.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.621 0.248 . . . . 0.0 110.34 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.434 ' OH ' ' HD2' ' A' ' 144' ' ' LYS . 90.8 t80 -135.51 129.8 33.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 0.0 111.324 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -101.87 121.8 42.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -102.4 107.02 17.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 96.2 mt -119.23 153.58 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.68 -43.5 98.75 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.46 -31.88 8.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.718 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.0 t -105.27 128.42 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HD2' ' OH ' ' A' ' 137' ' ' TYR . 34.8 mmtp -105.72 125.36 50.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -126.69 125.67 67.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.4 135.69 12.03 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 70.9 m -131.29 137.53 48.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.171 0.485 . . . . 0.0 111.667 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 12' ' ' GLN . 34.4 p90 -132.85 148.8 52.3 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm -140.05 149.06 42.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.175 0.512 . . . . 0.0 111.844 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.94 139.0 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.395 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -177.77 -176.0 45.42 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.17 152.24 39.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.457 -0.372 . . . . 0.0 110.517 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.45 152.59 18.4 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.608 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -121.96 130.56 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.489 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -78.52 135.33 37.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.08 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.712 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 . . . . . 0 C--O 1.235 0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.2 p -142.39 156.89 45.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.8 m -136.72 146.61 46.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.0 mt -118.02 125.53 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.2 m -127.21 145.61 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.948 0.404 . . . . 0.0 111.435 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.21 154.28 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.32 176.11 44.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.117 -1.039 . . . . 0.0 113.081 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -94.08 140.4 29.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.13 35.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.499 ' HB3' HD21 ' A' ' 25' ' ' ASN . 96.0 mt-30 -112.26 118.4 35.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.889 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 64.9 m -118.46 157.5 27.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 111.702 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -127.25 127.57 44.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.372 -179.476 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 13' ' ' SER . 22.6 t-20 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 13' ' ' SER . 37.7 Cg_exo -67.45 148.47 79.2 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.188 2.592 . . . . 0.0 111.006 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -102.96 138.67 39.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -172.76 -177.89 42.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.255 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -121.15 149.48 42.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.272 . . . . 0.0 110.498 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -118.97 126.63 52.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.85 131.09 55.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.982 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -128.47 139.47 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.287 0.565 . . . . 0.0 111.496 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -133.43 129.84 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.277 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -118.53 133.14 56.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -131.77 128.71 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.999 0.428 . . . . 0.0 111.942 -179.129 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.79 156.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.842 0.321 . . . . 0.0 110.877 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 tp -133.52 132.33 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.114 0.483 . . . . 0.0 111.15 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.12 135.66 12.09 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -127.84 134.69 49.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.25 117.95 28.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.404 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 124.93 53.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.83 0.348 . . . . 0.0 111.146 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 10.1 pt20 -131.44 117.52 18.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.901 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 73.6 p -131.6 160.17 36.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.954 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.941 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 120.554 0.216 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -74.73 130.61 39.79 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.602 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.51 139.42 53.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.343 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.442 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.6 m-85 -126.22 127.29 45.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.422 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 49' ' ' GLN . 21.2 t80 -132.18 116.94 17.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.6 m -120.29 136.86 54.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.45 120.22 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.8 p -133.4 157.18 46.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 111.777 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.695 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -152.19 155.19 37.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.98 172.71 43.93 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.781 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.98 155.07 43.0 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.943 2.428 . . . . 0.0 112.74 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.03 125.91 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.374 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -127.07 123.69 37.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.964 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -80.24 137.43 36.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.594 0.235 . . . . 0.0 110.746 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.566 ' HB ' HG23 ' A' ' 85' ' ' VAL . 44.2 mm -88.92 -39.37 12.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.494 0.664 . . . . 0.0 109.776 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -153.51 -155.05 0.56 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.278 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.31 1.81 53.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.622 0.248 . . . . 0.0 111.331 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -144.95 10.7 1.35 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -143.25 139.24 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.694 0.283 . . . . 0.0 110.651 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -138.65 150.72 46.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.114 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 129.26 54.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.076 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.37 139.75 48.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.736 0.303 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.34 137.37 13.59 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -125.36 126.19 44.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.197 0.499 . . . . 0.0 111.732 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -146.81 136.96 23.52 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.2 -149.76 12.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.869 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.44 151.79 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.482 . . . . 0.0 111.601 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.81 141.13 16.14 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.717 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -124.06 128.51 49.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.295 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.053 179.869 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.2 mttp . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.119 0.485 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 74.3 p -113.37 147.68 37.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.493 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.45 ' HB3' HD21 ' A' ' 140' ' ' LEU . 97.7 p -155.57 164.64 38.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 0.0 111.709 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.4 mt -98.57 137.32 37.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.828 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.15 132.12 54.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.798 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.16 142.07 26.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.329 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -176.38 -172.98 41.61 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.748 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.9 161.32 42.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.458 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -146.23 165.7 28.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.456 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -126.06 138.89 53.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -119.17 134.54 55.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.388 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -116.47 151.95 35.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -119.67 85.06 32.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.16 -33.35 9.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.192 1.928 . . . . 0.0 111.752 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -136.26 152.64 75.55 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.673 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.9 -30.22 76.93 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.65 2.233 . . . . 0.0 113.745 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.54 10.15 33.21 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -149.11 122.3 8.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.201 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.63 151.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -122.7 145.17 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -136.14 122.11 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.35 41.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.458 ' OG ' ' HA3' ' A' ' 120' ' ' GLY . 69.3 m -127.98 150.07 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.493 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.8 m-85 -118.38 130.65 56.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -137.06 136.85 38.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -126.72 146.12 50.33 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 55.6 m -112.03 137.41 50.1 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.87 115.51 30.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.821 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 74.7 mt -118.4 154.3 32.65 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.0 -44.73 96.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.48 -33.4 7.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.5 t -105.65 128.63 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.73 128.95 44.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 65.2 t -125.46 128.07 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.11 0.481 . . . . 0.0 112.099 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -116.83 136.59 12.86 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.5 m -126.8 129.98 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.209 0.504 . . . . 0.0 111.192 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -113.33 133.45 55.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.0 mtt -114.48 117.97 32.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 0.0 111.495 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -125.25 123.36 39.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.314 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.37 -173.48 39.03 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.43 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.04 165.48 27.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.382 . . . . 0.0 110.734 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.26 178.47 30.29 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -131.95 130.92 42.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -80.82 131.25 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.981 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.755 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.687 0.279 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -140.22 159.48 42.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.231 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.2 m -132.25 147.19 52.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.968 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.6 124.2 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 56.5 m -120.63 139.73 52.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.436 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.1 mt -123.47 129.16 74.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.004 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 177.86 20.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.313 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -102.58 137.34 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.69 130.52 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.797 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -122.34 132.69 54.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 44.2 m -118.35 158.7 24.75 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.455 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -128.97 119.09 23.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 145' ' ' VAL . 65.0 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.469 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 13' ' ' SER . 19.1 p-10 . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 13' ' ' SER . 94.5 Cg_endo -80.12 159.51 23.64 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.569 2.18 . . . . 0.0 110.877 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -91.95 140.5 29.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.573 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -164.53 173.99 40.51 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.259 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.21 152.54 47.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -122.69 132.32 54.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.91 121.1 39.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.071 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.4 mttm -117.9 140.46 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 111.38 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.14 135.98 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.88 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.668 ' HA ' HG22 ' A' ' 44' ' ' ILE . 76.5 ttt180 -119.0 129.94 55.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.22 132.2 56.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 -179.077 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.197 0 N-CA-C 112.31 -0.316 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.11 139.83 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.077 0.438 . . . . 0.0 110.624 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 34' ' ' ARG . 36.8 pt -130.44 158.35 42.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.9 142.65 15.77 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -129.37 123.11 30.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -114.51 122.42 46.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 136.04 54.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -142.16 132.4 24.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.05 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.693 HG22 ' HA3' ' A' ' 28' ' ' GLY . 82.3 p -133.45 158.91 41.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.033 0.444 . . . . 0.0 111.639 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.392 179.163 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.99 126.33 43.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.501 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.11 140.26 51.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.216 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.467 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.3 m-85 -121.34 122.3 39.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.629 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.17 119.51 31.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.1 m -123.89 136.01 54.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.964 0.412 . . . . 0.0 111.155 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.76 121.36 64.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.6 p -130.49 154.97 47.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.067 0.46 . . . . 0.0 111.831 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.99 151.19 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.893 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.04 160.93 31.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.856 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.45 156.3 40.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.862 2.375 . . . . 0.0 112.655 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.21 131.87 70.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 0.0 110.387 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -118.7 125.51 49.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.155 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -70.73 133.82 46.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.533 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.711 ' HB ' HG23 ' A' ' 85' ' ' VAL . 84.0 mt -84.59 -44.65 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.455 0.645 . . . . 0.0 109.839 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -140.54 -102.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.21 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -125.47 -34.69 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.678 0.275 . . . . 0.0 111.134 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.76 11.73 14.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 81' ' ' ILE . 2.6 m -136.08 137.56 48.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 122' ' ' GLN . 49.9 m -139.12 151.96 47.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.202 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.71 136.12 53.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.135 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CD1' HD11 ' A' ' 44' ' ' ILE . 51.2 p90 -142.61 160.62 39.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 111.281 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.86 152.51 17.31 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.4 mt -112.39 123.32 50.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.331 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.7 tp -136.49 127.33 27.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.604 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.9 -160.48 25.58 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.817 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.86 148.83 52.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 0.0 111.437 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.53 135.75 12.95 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.876 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -124.37 124.81 43.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.037 0.446 . . . . 0.0 110.625 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.158 179.809 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.03 0.443 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.6 m -120.69 131.44 54.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 81.8 p -145.57 161.24 40.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.01 0.433 . . . . 0.0 111.796 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 138' ' ' SER . 63.8 tp -98.21 126.52 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.82 128.89 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -144.65 140.75 28.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.405 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -173.05 -168.91 34.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.705 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.63 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.6 168.06 32.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.43 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.4 mt -127.35 147.25 50.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.275 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 97.7 mt-30 -117.83 137.11 52.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.294 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.83 140.56 52.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.695 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.441 ' ND2' HG22 ' A' ' 130' ' ' VAL . 8.4 m120 -125.08 83.04 60.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.394 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.06 -27.64 42.07 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.278 1.985 . . . . 0.0 111.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -133.58 153.42 80.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.492 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.48 -37.99 89.86 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.899 2.399 . . . . 0.0 113.692 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.407 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 33.6 m120 -105.63 10.66 32.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.44 121.42 37.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.918 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.441 HG22 ' ND2' ' A' ' 124' ' ' ASN . 58.8 t -118.26 130.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.306 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.41 123.82 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.37 127.84 56.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.941 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -138.14 123.97 19.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.52 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 99.5 p -150.45 160.87 43.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.0 m-85 -118.34 127.04 53.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.271 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -120.75 126.6 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.52 143.58 51.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.205 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 56.2 m -110.2 128.78 55.68 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.36 105.77 16.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.748 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 90.8 mt -119.15 149.45 41.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.52 -43.8 97.92 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -103.73 -31.92 9.62 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.748 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.5 t -105.82 128.69 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -105.14 120.55 41.79 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 64.0 t -123.31 124.96 71.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.704 -0.398 . . . . 0.0 112.017 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -121.1 130.91 8.41 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.3 m -124.96 129.38 50.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.147 0.473 . . . . 0.0 111.484 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.451 ' CD1' ' HD1' ' A' ' 135' ' ' TYR . 52.6 m0 -109.86 133.14 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 74.8 mtm -126.92 126.17 42.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.733 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -140.43 136.33 32.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.395 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.61 -175.7 41.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.821 -1.181 . . . . 0.0 113.538 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.61 152.48 48.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 7' ' ' SER . . . -139.73 165.61 25.82 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.658 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 128' ' ' ASN . 93.2 t80 -110.84 130.66 55.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.31 124.69 36.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.735 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.78 0.324 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.6 p -144.13 156.3 44.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -137.59 146.56 44.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.67 127.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 60.4 m -121.02 138.09 54.33 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.878 0.37 . . . . 0.0 111.221 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.2 mt -125.58 131.31 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.15 -173.16 24.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.18 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.66 147.02 32.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.99 126.27 52.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 111.13 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -117.92 123.31 45.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.882 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.649 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.0 m -118.53 150.88 38.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 111.686 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -127.65 129.28 46.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 145' ' ' VAL . 60.2 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.707 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 . . . . . 0 C--O 1.233 0.216 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 13' ' ' SER . 85.8 Cg_endo -84.16 159.02 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.884 2.389 . . . . 0.0 110.957 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -107.57 149.29 28.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.711 0.291 . . . . 0.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -170.8 -179.52 42.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.6 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -115.04 147.71 39.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.845 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.492 HD21 ' HE2' ' A' ' 32' ' ' LYS . 3.3 t30 -122.85 123.77 41.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.266 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -119.59 130.31 55.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.6 mttm -126.87 138.25 53.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.003 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.75 132.87 53.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.751 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -126.04 129.99 50.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.954 0.407 . . . . 0.0 111.46 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.01 134.59 54.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.747 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 111.799 -179.595 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -125.02 131.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.946 0.373 . . . . 0.0 110.842 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 tt -126.56 140.75 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.12 140.17 11.92 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -126.31 139.3 53.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.096 0.474 . . . . 0.0 111.606 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.57 125.26 43.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.642 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -114.18 126.88 55.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -123.3 107.84 12.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.616 HG22 ' HA3' ' A' ' 28' ' ' GLY . 66.7 p -128.4 155.22 45.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.972 179.229 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.0 t0 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.845 0.355 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -110.5 122.4 47.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.535 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -102.69 131.49 49.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.124 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -123.77 122.77 38.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -123.43 137.48 54.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.74 0.305 . . . . 0.0 110.217 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.676 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 64.1 m -126.53 136.06 52.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -125.63 120.2 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.0 p -133.34 157.62 45.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.493 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.64 155.35 37.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.174 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -174.43 165.15 36.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.132 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.36 153.9 35.84 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.857 2.372 . . . . 0.0 112.404 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.29 126.68 75.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -122.2 133.47 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.929 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -73.43 137.43 44.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.502 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.841 ' HB ' HG23 ' A' ' 85' ' ' VAL . 96.1 mt -83.55 -48.57 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.349 0.595 . . . . 0.0 110.34 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -140.88 -84.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.895 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -138.9 -44.92 0.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.66 0.267 . . . . 0.0 111.23 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -109.23 9.67 25.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.841 HG23 ' HB ' ' A' ' 81' ' ' ILE . 7.2 m -136.69 142.41 38.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 121.196 -0.202 . . . . 0.0 110.529 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 48.8 m -135.25 149.14 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 111.382 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.3 tp -116.59 129.9 56.43 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -141.85 157.98 44.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.456 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.604 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.68 147.48 18.9 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.749 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.89 118.78 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.74 137.32 54.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.56 -157.43 23.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.797 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.72 154.91 47.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -120.23 139.52 13.8 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -127.12 143.53 51.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.309 179.858 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.234 0.239 0 CA-C-O 121.115 0.483 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.8 m -122.75 132.03 54.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.697 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.425 ' HB3' HD21 ' A' ' 140' ' ' LEU . 93.1 p -149.18 160.9 42.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.623 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 138' ' ' SER . 91.0 mt -100.49 138.66 37.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.092 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.44 122.66 29.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.744 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -131.64 149.2 52.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.63 -168.3 36.46 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.634 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.07 162.12 38.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -146.0 156.71 27.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.445 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.6 138.99 51.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.879 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.444 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 52.8 tt0 -115.3 124.34 51.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.781 0.324 . . . . 0.0 110.228 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.63 131.47 56.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.977 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.408 ' OD1' HG22 ' A' ' 130' ' ' VAL . 40.6 t30 -126.72 81.11 69.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.421 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.61 -40.17 39.53 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.754 2.303 . . . . 0.0 111.887 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -133.67 154.69 80.76 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.649 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.3 -34.45 70.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.801 2.334 . . . . 0.0 113.817 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -103.19 10.96 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.473 ' CZ ' HD11 ' A' ' 131' ' ' ILE . 22.6 t80 -131.66 112.63 12.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 124' ' ' ASN . 59.8 t -122.38 130.64 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.473 HD11 ' CZ ' ' A' ' 129' ' ' PHE . 49.1 mm -116.22 123.08 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.8 m-20 -113.82 127.81 56.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.09 115.98 21.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.46 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -136.43 161.96 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.268 0.556 . . . . 0.0 112.462 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -139.29 148.85 43.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.283 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -139.85 148.5 42.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -127.33 128.45 45.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.993 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 66.2 m -100.16 123.95 45.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -101.01 112.76 25.3 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.746 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 89.9 mt -119.37 153.91 34.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.84 -44.59 96.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -106.5 -32.49 8.06 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.746 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.7 t -105.03 131.19 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -105.64 124.29 49.31 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 15' ' ' VAL . 62.5 t -127.27 128.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 112.048 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.49 135.0 11.89 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 85.1 m -123.47 130.15 52.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.241 0.52 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -111.53 136.5 50.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 2.8 mmm -119.21 115.58 24.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 0.0 111.194 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.2 133.96 54.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.585 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.73 176.93 46.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.445 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.87 147.24 43.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.651 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.47 160.58 20.84 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.741 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -125.4 130.52 52.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.734 0.302 . . . . 0.0 110.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -76.5 134.12 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.339 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.782 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -138.42 157.0 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 111.264 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -133.54 144.83 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.65 126.77 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.237 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 53.8 m -128.75 144.99 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -127.29 150.68 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.427 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.31 -172.12 36.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.942 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -109.7 156.92 19.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.24 135.34 51.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.859 0.361 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -125.08 129.6 50.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.92 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 57.4 m -116.75 145.95 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -118.71 121.52 40.31 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.536 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 13' ' ' SER . 14.7 p-10 . . . . . 0 CA--C 1.529 0.141 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 13' ' ' SER . 95.9 Cg_endo -79.7 158.45 24.88 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.421 2.08 . . . . 0.0 110.957 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -93.31 146.78 23.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.607 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -168.01 -179.9 40.84 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.433 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -119.61 154.12 34.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.87 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.9 t-20 -126.38 134.42 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.282 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.2 125.66 47.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 60.6 mttp -121.33 139.32 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.147 0.499 . . . . 0.0 111.6 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.7 129.08 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.114 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -116.57 134.01 55.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.679 0.276 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -128.59 124.83 36.88 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.501 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.007 0.404 . . . . 0.0 110.911 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.94 138.43 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.102 0.477 . . . . 0.0 110.912 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -112.91 137.42 14.22 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.6 m -124.74 130.11 51.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.019 0.438 . . . . 0.0 111.482 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 97.1 m-85 -115.61 126.49 54.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.685 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.25 115.12 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.826 0.346 . . . . 0.0 110.649 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -123.84 111.46 16.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.607 HG22 ' HA3' ' A' ' 28' ' ' GLY . 77.1 p -125.93 151.8 46.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.716 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.671 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -83.51 124.19 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.894 0.378 . . . . 0.0 110.793 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -114.98 132.29 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.113 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.581 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 78.1 t80 -131.14 121.31 24.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.287 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -134.24 125.55 28.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 110.221 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 m -130.06 146.62 51.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.095 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.72 126.19 64.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.726 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.2 p -134.95 157.89 45.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.156 0.503 . . . . 0.0 111.78 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.64 153.86 36.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.96 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -169.85 165.25 38.63 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.936 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.35 154.27 40.75 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.916 2.41 . . . . 0.0 112.722 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.599 HG22 ' HB3' ' A' ' 88' ' ' TYR . 60.1 t -123.68 127.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.358 . . . . 0.0 110.545 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -127.87 128.55 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.078 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -74.66 128.34 35.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 0.0 111.078 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 87' ' ' LEU . 86.3 mt -90.36 -42.31 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.12 -165.62 1.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.499 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.75 -39.72 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.548 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -127.21 25.23 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.16 127.54 67.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 66.2 m -128.29 147.25 50.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 111.057 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.703 ' HB2' HD11 ' A' ' 81' ' ' ILE . 64.9 tp -117.07 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.107 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' HB3' HG22 ' A' ' 78' ' ' VAL . 54.6 p90 -142.09 158.77 43.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.068 0.461 . . . . 0.0 111.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.561 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -118.7 156.11 15.8 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.052 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 134' ' ' SER . 88.5 mt -115.13 118.48 33.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.31 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.38 131.69 50.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.06 -148.4 10.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.823 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.99 152.23 41.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 136.44 13.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.862 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -120.83 127.46 51.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.656 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.166 179.719 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.14 0.495 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.6 m -125.0 134.68 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 138' ' ' SER . 89.3 p -141.46 162.03 36.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 0.0 111.557 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 138' ' ' SER . 60.7 tp -75.04 129.22 37.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.466 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 137' ' ' TYR . . . -119.69 133.21 55.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.538 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -148.32 159.31 44.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.719 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 174.33 -166.46 38.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.697 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.69 160.48 41.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.34 28.85 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.335 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.57 143.88 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.358 -0.421 . . . . 0.0 109.995 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -127.92 130.11 47.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.846 0.355 . . . . 0.0 110.327 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -123.5 144.36 49.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.843 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.402 ' OD1' HG22 ' A' ' 130' ' ' VAL . 33.7 t30 -127.43 82.14 68.79 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.801 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.48 -40.78 45.2 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.419 2.079 . . . . 0.0 111.848 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -136.03 154.31 77.47 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.9 -34.83 87.42 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.836 2.357 . . . . 0.0 113.761 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -98.94 10.56 41.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -138.66 112.28 8.28 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG22 ' OD1' ' A' ' 124' ' ' ASN . 67.5 t -116.64 129.78 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.626 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.6 mt -102.54 120.4 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.5 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.2 m-20 -116.65 126.11 52.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.531 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -132.77 135.16 45.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.562 ' HB2' HD11 ' A' ' 90' ' ' LEU . 92.2 p -155.59 161.01 40.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.382 0.611 . . . . 0.0 112.346 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -138.18 134.09 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.712 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.461 ' CG ' ' HB ' ' A' ' 147' ' ' THR . 25.9 pt-20 -129.76 147.75 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 83.7 t80 -129.12 135.11 48.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.65 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 67.6 m -107.65 129.36 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -102.04 117.69 35.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.791 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 60.9 mt -119.64 154.29 34.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.97 -44.35 94.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.9 -32.97 7.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.791 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 59.7 t -104.86 130.61 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -103.29 125.15 49.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.0 t -125.83 124.8 67.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.1 138.88 12.88 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.461 ' HB ' ' CG ' ' A' ' 136' ' ' GLU . 85.7 m -125.46 128.97 48.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.405 0.602 . . . . 0.0 111.503 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -114.09 129.51 56.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 70.8 mtm -123.62 139.89 53.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.245 0.545 . . . . 0.0 112.167 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 67.1 tp -136.97 130.43 31.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.039 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.78 173.14 34.48 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.602 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.64 151.73 49.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.433 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.32 -167.18 18.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.436 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -148.15 160.91 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.811 0.339 . . . . 0.0 110.763 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -78.97 141.41 37.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.801 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.525 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 120.709 0.29 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -128.89 143.5 50.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.18 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -129.69 141.92 50.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.693 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.6 mt -116.39 126.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.263 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 51.6 m -124.54 142.17 51.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 0.0 111.184 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -129.4 153.6 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.4 -173.59 37.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.11 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.4 142.31 37.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.09 123.8 51.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -120.38 122.29 40.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.966 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.661 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.7 m -118.97 157.68 27.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.847 0.356 . . . . 0.0 111.264 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -128.13 140.85 51.7 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.771 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.464 -179.669 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 C--O 1.232 0.136 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 13' ' ' SER . 84.6 Cg_endo -78.01 158.47 30.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.706 2.27 . . . . 0.0 111.094 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -114.18 144.78 42.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -169.31 177.15 43.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.297 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -111.24 144.74 39.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.485 HD21 ' HE2' ' A' ' 32' ' ' LYS . 21.7 t30 -110.69 127.87 55.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.804 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.6 127.07 53.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.229 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HE2' HD21 ' A' ' 30' ' ' ASN . 63.6 mttm -126.61 137.23 53.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.63 135.96 50.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -127.12 130.98 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -114.72 128.36 56.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.544 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.17 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.2 t -121.93 128.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.114 0.457 . . . . 0.0 110.61 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.77 140.56 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.35 141.13 13.11 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -124.99 132.11 53.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.94 0.4 . . . . 0.0 111.364 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.81 118.59 26.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.87 128.18 49.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -124.78 120.55 32.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.47 HG22 ' HA3' ' A' ' 28' ' ' GLY . 62.7 p -128.62 160.19 33.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.986 0.422 . . . . 0.0 111.695 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.907 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.8 t0 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -100.61 127.08 47.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.72 143.87 48.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.213 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -127.93 118.58 23.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -116.5 128.93 55.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.712 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.0 m -122.46 139.41 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.41 122.31 44.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.613 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.3 p -134.41 159.7 40.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.183 0.516 . . . . 0.0 111.898 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.8 154.2 38.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.094 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.89 165.01 37.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.954 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.5 153.01 30.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.817 2.345 . . . . 0.0 112.389 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.57 128.56 72.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.494 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -119.71 124.12 45.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.998 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -75.6 131.32 39.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.804 ' HB ' HG13 ' A' ' 85' ' ' VAL . 47.6 mm -90.34 -42.26 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.517 0.675 . . . . 0.0 109.873 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.414 ' HB3' HG12 ' A' ' 85' ' ' VAL . 2.7 t-20 -150.23 -158.15 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.446 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.05 -40.83 91.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -126.2 29.04 5.91 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.804 HG13 ' HB ' ' A' ' 81' ' ' ILE . 7.7 p -144.71 131.29 15.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 O-C-N 121.953 -0.467 . . . . 0.0 109.836 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.4 m -138.19 152.25 48.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.704 0.288 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 HG13 ' A' ' 81' ' ' ILE . 2.5 mp -124.36 143.22 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.166 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.535 ' CZ ' ' HA3' ' A' ' 120' ' ' GLY . 45.9 p90 -146.18 161.35 40.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.547 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -111.34 146.48 17.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.968 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.408 HD21 ' HE2' ' A' ' 88' ' ' TYR . 79.1 mt -116.41 123.87 48.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.96 0.41 . . . . 0.0 111.56 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -138.16 137.91 38.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -154.66 16.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.857 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.63 153.07 47.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.998 0.428 . . . . 0.0 111.678 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.39 142.78 17.56 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.71 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -129.67 123.74 31.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.754 179.288 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.147 0.498 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.6 p -109.84 148.75 30.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.711 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -154.93 160.6 41.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.789 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 138' ' ' SER . 85.1 mt -101.25 136.39 41.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.0 133.34 54.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -142.41 139.45 31.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.17 -166.42 29.09 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.777 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.535 ' HA3' ' CZ ' ' A' ' 88' ' ' TYR . . . -134.4 150.27 20.01 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.41 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.04 138.7 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.417 -0.391 . . . . 0.0 109.948 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -124.7 132.12 53.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.898 0.38 . . . . 0.0 110.44 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.518 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -114.8 95.31 40.72 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.355 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.48 -36.22 87.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.522 2.148 . . . . 0.0 111.535 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -130.06 157.17 77.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.767 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.18 -37.34 79.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.874 2.383 . . . . 0.0 113.636 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -105.46 16.35 25.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 131' ' ' ILE . 8.4 t80 -126.27 117.03 22.2 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.92 -0.488 . . . . 0.0 110.665 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.1 t -115.32 126.87 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.654 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 129' ' ' PHE . 48.4 mm -108.59 126.39 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -123.42 116.82 23.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.997 0.427 . . . . 0.0 111.402 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -122.94 133.33 54.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.6 p -152.22 166.98 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.331 0.586 . . . . 0.0 112.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -141.31 150.68 42.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.633 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -140.18 151.02 44.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -133.92 128.4 34.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.763 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 20.3 m -94.76 124.43 38.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -103.47 102.86 12.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 97.5 mt -118.62 152.33 36.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.26 -43.86 98.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -105.42 -33.12 8.26 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.749 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.2 t -105.66 125.96 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -105.8 122.64 46.51 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 73.7 t -127.19 129.27 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -117.7 138.83 14.35 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.0 m -127.05 131.71 50.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.244 0.522 . . . . 0.0 111.495 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.9 m-90 -116.8 139.31 50.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 64.3 mtt -127.15 124.33 38.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 0.0 111.992 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.3 mt -127.75 136.67 51.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.112 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.68 -172.37 43.68 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.383 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.97 158.32 44.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.621 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.02 164.4 25.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.816 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -131.32 129.29 41.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 110.177 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -76.37 137.84 40.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 t80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.751 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.088 0.471 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.93 161.03 10.16 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.082 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 -87.24 143.03 27.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.9 m -122.1 141.02 51.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.994 0.426 . . . . 0.0 111.113 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -140.62 153.35 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.143 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -119.87 143.47 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.455 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 49.1 m -134.48 142.85 47.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.74 0.305 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 pt -131.73 150.0 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.94 167.91 40.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.017 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -89.7 138.74 31.22 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -111.81 127.95 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.403 HE22 ' HG2' ' A' ' 27' ' ' ARG . 50.1 mm-40 -126.02 122.13 34.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.093 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 146' ' ' GLY . 50.1 m -118.4 156.72 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.11 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -122.97 128.36 50.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.21 129.59 74.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.454 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -86.48 108.31 18.47 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.393 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -163.74 147.53 10.2 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.039 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -91.92 108.56 20.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.73 -146.74 6.2 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.576 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.86 145.9 53.31 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG2' ' NH2' ' A' ' 52' ' ' ARG . 18.6 tptt 74.49 116.54 0.06 Allowed 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.942 0.776 . . . . 0.0 110.324 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.0 tp -61.24 -44.49 97.18 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -86.12 -12.71 49.24 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 41.9 mmtt 49.96 37.59 14.26 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -97.23 111.25 57.59 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 13' ' ' SER . 34.7 Cg_exo -63.4 147.14 93.65 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.064 2.51 . . . . 0.0 111.441 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG2' HE22 ' A' ' 12' ' ' GLN . 99.2 mtt180 -113.36 140.35 48.11 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.285 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -176.4 -174.84 43.25 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.349 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -119.12 147.39 44.22 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 110.591 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.575 HD22 ' HB2' ' A' ' 48' ' ' ALA . 24.0 t-20 -117.09 127.97 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.227 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 tp -112.6 126.08 54.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.977 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 29.2 ttpp -125.06 133.89 52.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.147 0.498 . . . . 0.0 111.621 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -114.36 130.5 56.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.002 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -112.71 128.51 56.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.946 0.403 . . . . 0.0 111.452 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -128.98 120.49 26.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -98.54 119.91 38.06 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -86.29 -16.92 36.02 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.254 0.55 . . . . 0.0 109.914 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -148.0 174.15 12.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.75 -40.07 94.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -111.27 0.99 16.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -127.7 141.21 51.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.093 0.473 . . . . 0.0 111.699 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.86 -179.68 41.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.742 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.25 156.66 42.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 117.021 0.41 . . . . 0.0 110.631 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -134.07 147.77 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.266 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -124.72 123.75 5.17 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -114.94 125.37 53.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.165 0.483 . . . . 0.0 111.759 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -117.11 121.22 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -115.68 126.98 54.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 0.0 111.646 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.523 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 65.5 tt0 -123.91 117.08 24.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.551 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 73.7 p -128.87 156.5 43.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.058 0.456 . . . . 0.0 111.827 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -145.31 162.02 38.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.367 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' NH2' ' HG2' ' A' ' 21' ' ' LYS . 5.1 tpm_? -62.65 130.31 44.44 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.024 0.44 . . . . 0.0 110.917 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 59.1 5.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.157 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.64 132.34 48.81 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.01 140.92 56.47 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.768 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -71.12 129.06 37.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.05 0.453 . . . . 0.0 111.193 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -131.75 149.01 52.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.668 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.98 118.05 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.641 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -148.36 107.11 3.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.87 18.79 78.48 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.737 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 66.74 27.29 9.32 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.059 0.544 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -131.89 149.79 52.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.799 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -110.29 132.39 54.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.817 0.342 . . . . 0.0 111.216 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 66' ' ' GLY . 92.8 mt -95.75 -54.33 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.639 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 57.83 26.8 13.65 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.18 0.592 . . . . 0.0 112.069 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.515 ' H ' HG22 ' A' ' 64' ' ' ILE . . . 92.58 -17.87 56.51 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.35 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 51.68 39.31 24.93 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HB3' ' HB2' ' A' ' 52' ' ' ARG . 94.9 t80 -139.6 126.95 21.4 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -129.44 141.62 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.551 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 74.3 t80 -133.31 126.53 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' CE2' ' HG3' ' A' ' 49' ' ' GLN . 95.5 m-85 -124.37 139.96 53.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.895 0.378 . . . . 0.0 110.533 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 75.4 m -135.68 141.9 45.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.049 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.413 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 3.1 p -138.78 120.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.636 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.1 p -135.56 158.38 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.024 0.44 . . . . 0.0 111.877 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.638 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.83 157.18 42.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.912 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -172.85 161.31 32.55 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.54 155.19 35.86 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.967 2.445 . . . . 0.0 112.408 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 88' ' ' TYR . 61.8 t -120.06 126.65 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.396 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -126.4 128.98 47.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.752 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -77.87 131.49 37.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.697 0.285 . . . . 0.0 110.926 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 87' ' ' LEU . 89.4 mt -90.18 -43.22 14.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.514 0.673 . . . . 0.0 109.954 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -138.29 -166.61 2.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.235 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -62.64 -39.65 94.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.622 0.248 . . . . 0.0 111.445 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -122.89 21.75 9.82 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.4 127.96 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 CA-C-N 118.011 0.369 . . . . 0.0 110.095 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.8 m -130.14 144.45 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.764 0.316 . . . . 0.0 111.049 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 81' ' ' ILE . 67.6 tp -124.37 135.17 53.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.401 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.522 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 51.9 p90 -139.68 156.17 46.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.06 0.457 . . . . 0.0 111.383 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.635 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -108.97 153.16 16.9 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.074 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 134' ' ' SER . 88.9 mt -120.61 127.27 51.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 111.716 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -144.26 138.03 27.68 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . 176.66 -150.23 10.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.875 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.27 156.26 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.45 147.23 16.7 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.665 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -135.75 128.34 30.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 110.838 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.11 140.45 12.71 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.015 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -128.66 139.91 52.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.654 0.264 . . . . 0.0 110.985 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.33 136.71 41.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.605 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -125.94 148.83 49.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.375 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -111.71 134.63 53.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.688 0.28 . . . . 0.0 110.57 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.7 m -101.63 114.42 28.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.988 0.423 . . . . 0.0 111.101 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.8 p -162.77 166.96 23.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.454 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.4 mm -99.83 111.92 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.008 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -149.93 160.36 43.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.958 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.7 -39.07 96.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.734 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -116.99 153.46 32.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 0.0 110.355 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.9 m -113.57 150.95 32.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.469 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -143.24 159.46 42.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.945 0.402 . . . . 0.0 111.262 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -156.22 167.6 29.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.097 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -126.73 141.52 51.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.944 0.402 . . . . 0.0 111.29 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.1 m -132.91 137.08 46.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.628 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.05 146.06 50.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.903 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.2 p -120.29 148.01 44.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.255 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 140' ' ' LEU . 92.8 p -157.28 165.68 35.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.347 . . . . 0.0 111.849 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 138' ' ' SER . 90.4 mt -99.58 137.81 37.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.909 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.46 131.92 54.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.035 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -143.6 137.9 28.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.36 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.65 -163.32 27.7 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.692 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.33 159.58 43.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -136.86 153.52 21.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.993 -1.099 . . . . 0.0 113.265 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.85 138.81 50.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.028 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 51.6 tt0 -129.21 128.38 43.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.612 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -116.49 139.72 50.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.476 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -116.01 85.79 15.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 130' ' ' VAL . 58.4 Cg_endo -73.7 -32.95 7.03 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.207 1.938 . . . . 0.0 111.711 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -134.71 152.71 78.09 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.695 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.8 -38.27 94.64 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 122.664 2.243 . . . . 0.0 114.054 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -104.55 6.07 34.37 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -137.57 122.04 18.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.927 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.4 m -127.64 153.17 36.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.03 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.31 123.83 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.81 130.72 56.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -127.22 120.26 28.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.598 ' HB3' HD11 ' A' ' 90' ' ' LEU . 73.3 m -121.65 142.48 50.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.54 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.5 m-85 -122.41 122.54 39.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.113 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 83.8 mt-10 -127.1 135.8 51.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.01 142.07 49.46 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.992 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 57.4 m -115.32 128.02 55.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.12 114.78 29.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.757 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 83.3 mt -118.67 154.72 32.25 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.11 -42.91 95.76 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.55 -33.54 7.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.757 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.1 t -106.42 129.03 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -106.06 126.61 52.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 72.6 t -125.85 126.88 70.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -118.38 137.78 13.25 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 73.9 m -126.88 128.42 46.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.262 0.531 . . . . 0.0 111.086 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -119.8 139.03 52.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 17.8 tmm? -134.42 132.03 38.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.094 0.473 . . . . 0.0 111.567 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.89 127.04 41.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -163.71 -167.65 24.51 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.53 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.9 156.23 48.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.763 0.316 . . . . 0.0 110.709 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -124.95 152.84 17.71 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.679 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -121.24 128.33 52.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.881 0.372 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -93.92 128.25 40.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.71 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.913 0.387 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.69 74.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.79 148.69 38.26 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 110.464 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -138.59 156.47 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.0 m -145.04 156.02 43.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.63 143.31 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.479 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 50.4 m -134.51 148.34 50.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.708 0.29 . . . . 0.0 111.286 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.9 152.16 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.331 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.24 -179.19 41.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.025 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -103.18 140.81 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.691 0.281 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.81 121.78 45.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -120.43 127.95 52.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.67 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.689 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.5 m -118.01 153.28 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 111.276 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.93 127.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.718 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -85.9 109.82 19.0 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.67 -0.412 . . . . 0.0 109.903 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -155.2 164.67 38.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.335 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -119.01 107.71 13.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.802 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.76 -131.01 2.44 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.511 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.455 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 85.0 m-85 -69.06 150.29 47.78 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 49.0 mttp 69.7 95.84 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.573 0.546 . . . . 0.0 110.595 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.12 -45.16 93.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.723 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.464 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 11.3 m-20 -92.13 -14.57 28.96 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 20' ' ' TYR . 57.1 mmtt 50.12 37.24 13.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 23' ' ' ASP . 32.1 m120 -103.43 112.08 65.46 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 13' ' ' SER . 91.5 Cg_endo -80.23 158.87 23.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.747 2.298 . . . . 0.0 111.362 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -111.19 136.49 50.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.554 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.18 -179.86 40.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.574 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.95 154.69 35.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.615 HD22 ' HB2' ' A' ' 48' ' ' ALA . 29.3 t-20 -127.97 126.18 40.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -108.85 136.78 47.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 15.8 ttmm -130.98 136.9 48.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.132 0.491 . . . . 0.0 111.528 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -122.6 127.59 49.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.869 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -113.82 130.63 56.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.0 111.314 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -126.61 122.73 35.88 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -97.26 106.17 18.45 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -70.53 -35.32 73.09 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.34 0.59 . . . . 0.0 109.814 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -138.12 176.1 9.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.606 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -62.94 -43.02 99.94 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -109.88 14.04 23.29 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -141.03 130.72 24.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.892 0.377 . . . . 0.0 111.564 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.16 177.37 35.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.016 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.8 156.61 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.034 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.1 pp -132.41 146.08 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 111.537 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -120.92 125.73 6.33 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.425 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 48.1 m -118.09 128.16 54.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 0.0 112.005 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -121.21 120.5 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.354 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.615 ' HB2' HD22 ' A' ' 30' ' ' ASN . . . -118.07 129.47 55.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.892 0.377 . . . . 0.0 111.46 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -122.86 115.92 22.78 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.7 p -127.0 155.4 43.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 112.013 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -145.28 148.17 33.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.002 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -63.15 138.02 58.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.807 0.336 . . . . 0.0 110.687 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.12 -174.87 49.04 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.863 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -106.08 118.58 36.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.971 0.415 . . . . 0.0 110.68 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 21' ' ' LYS . 42.3 tt0 -135.18 131.55 36.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.516 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -84.85 129.58 34.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.994 0.426 . . . . 0.0 111.062 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.8 m -131.38 149.82 52.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.076 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.6 101.28 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.898 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -158.88 74.42 0.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.778 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.47 5.21 90.13 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.773 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 61.14 32.74 19.57 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.844 0.458 . . . . 0.0 111.333 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -118.09 130.86 56.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.609 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.6 mt -96.73 109.68 22.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.41 . . . . 0.0 110.898 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.43 -31.38 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.089 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.3 t70 69.56 -67.15 0.23 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.308 0.643 . . . . 0.0 111.256 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.17 -42.09 2.04 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.904 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t0 46.45 52.63 10.61 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.841 0.456 . . . . 0.0 111.814 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 98' ' ' ALA . 91.6 t80 -114.79 128.62 56.4 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.931 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -113.92 137.54 51.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.56 123.45 39.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -117.45 137.33 52.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 66.2 m -127.58 131.97 49.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.852 0.358 . . . . 0.0 111.216 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.03 117.96 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 46' ' ' SER . 74.2 p -132.47 156.96 45.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 111.743 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.1 156.35 42.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.225 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -173.77 165.02 36.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.104 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.18 155.63 25.71 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.001 2.467 . . . . 0.0 112.364 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.17 127.76 75.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -126.81 125.98 42.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.984 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -77.21 127.61 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.698 HD12 HG12 ' A' ' 85' ' ' VAL . 97.5 mt -75.12 -46.04 40.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -134.29 -97.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.158 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 -31.72 1.36 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.29 3.99 11.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.698 HG12 HD12 ' A' ' 81' ' ' ILE . 57.8 t -129.09 128.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 57.1 m -129.0 148.72 50.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 tt -116.8 136.72 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.225 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.501 ' CE1' ' HA3' ' A' ' 120' ' ' GLY . 50.1 p90 -142.04 155.44 45.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.392 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.576 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -109.03 151.86 17.08 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.044 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 134' ' ' SER . 83.1 mt -119.67 125.57 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 0.0 111.503 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -144.58 140.37 28.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.602 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.97 -157.29 27.22 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.65 151.94 51.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.082 0.467 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.17 141.49 17.04 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -127.58 126.09 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.808 0.337 . . . . 0.0 110.39 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -116.4 142.06 17.23 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.352 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.43 136.2 54.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.715 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . . . -129.9 133.14 46.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -128.9 144.5 51.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -104.04 122.71 45.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.8 m -88.56 113.62 24.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.963 0.411 . . . . 0.0 111.492 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.7 p -163.94 165.69 22.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.505 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.68 111.02 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -150.32 162.56 40.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.993 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.16 -39.08 96.64 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.779 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -123.51 150.66 43.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.2 m -120.56 149.95 41.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.724 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -125.39 142.5 51.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.189 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.1 m -132.93 152.73 51.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.934 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -127.33 154.85 44.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 111.638 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.3 p -137.39 152.3 49.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.0 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -131.18 150.88 51.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.6 m -115.42 131.09 57.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.7 p -140.54 157.71 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.978 0.418 . . . . 0.0 111.77 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 138' ' ' SER . 69.0 tp -100.56 127.66 46.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.56 130.77 56.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.424 . . . . 0.0 110.953 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -144.56 140.22 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -174.83 -163.33 27.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.633 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.15 161.27 41.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . -142.1 158.58 26.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.347 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.8 mt -122.56 139.38 53.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.509 -0.346 . . . . 0.0 110.077 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -118.85 128.49 54.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.169 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.33 142.37 51.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -124.19 82.67 56.92 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.532 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.21 -28.61 33.77 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.477 2.118 . . . . 0.0 112.127 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -131.56 151.29 78.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.546 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.81 -25.57 74.66 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 113.452 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -111.48 13.49 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -140.29 120.89 14.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 110.951 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 75.5 t -111.43 129.98 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.183 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 51.0 mm -104.64 119.65 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.464 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 88.7 m-20 -114.11 126.48 55.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.991 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.15 124.04 45.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.451 ' HB3' HD11 ' A' ' 90' ' ' LEU . 74.9 m -127.35 143.08 51.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 112.379 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.526 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 51.9 m-85 -124.65 122.96 38.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.102 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -125.59 135.12 51.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -127.39 139.21 53.0 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.871 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 49.6 m -105.99 123.96 48.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -101.36 107.64 19.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.258 0.552 . . . . 0.0 112.311 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 87.3 mt -119.01 153.0 35.39 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.89 -44.11 97.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -104.9 -32.92 8.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.731 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -106.07 128.36 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -106.19 120.69 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 58.1 t -124.92 129.19 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.974 0.416 . . . . 0.0 112.091 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.09 138.29 14.64 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.7 m -124.84 129.16 49.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.979 0.418 . . . . 0.0 111.3 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -115.95 136.99 52.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -131.93 127.87 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.96 137.47 53.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.36 -171.59 38.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.571 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.86 157.09 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.94 0.4 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.79 167.19 24.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.738 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -132.86 130.81 40.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.494 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.2 mtm105 -79.04 140.45 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.027 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.937 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.102 0.477 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.75 -177.68 42.51 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.973 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -87.75 135.85 33.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -122.94 142.95 50.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.452 . . . . 0.0 111.239 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 34' ' ' ARG . 32.3 m -143.26 154.57 43.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.875 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.3 143.77 32.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.502 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 50.1 m -132.27 141.95 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 pt -127.95 147.56 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.517 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.45 -173.22 38.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.042 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.34 142.99 36.27 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.77 114.4 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.266 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -116.77 132.34 56.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.674 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 44.6 m -118.23 165.23 14.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.804 0.335 . . . . 0.0 111.624 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -126.61 121.12 31.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 64.6 t -121.22 127.75 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.378 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -67.13 109.22 2.95 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.94 0.4 . . . . 0.0 110.437 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -137.7 154.18 49.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.345 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -123.52 110.04 14.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.423 0.154 . . . . 0.0 110.891 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.79 -90.91 0.31 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.901 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -82.86 160.16 22.23 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.892 -0.181 . . . . 0.0 110.609 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 59.3 81.5 0.17 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.096 0.474 . . . . 0.0 110.781 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.34 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -84.21 -12.19 55.25 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 40.7 mttp 57.8 21.29 7.33 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.185 0.594 . . . . 0.0 112.148 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 13' ' ' SER . 30.5 m120 -106.0 112.85 64.15 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.674 ' HD2' ' O ' ' A' ' 13' ' ' SER . 93.2 Cg_endo -79.67 159.21 25.07 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.797 2.331 . . . . 0.0 110.745 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -93.01 142.42 27.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.0 169.68 41.01 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.392 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.84 147.64 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 0.0 110.565 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.551 HD21 ' HE2' ' A' ' 32' ' ' LYS . 42.1 t30 -111.09 121.84 46.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.641 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.22 124.09 42.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.102 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 67.5 mttm -127.76 145.39 50.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.436 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -123.34 127.81 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.687 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.58 ' NE ' HE22 ' A' ' 122' ' ' GLN . 51.6 mtp180 -109.6 136.48 48.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.902 0.382 . . . . 0.0 111.835 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.64 119.33 16.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.412 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.86 132.13 44.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.98 -34.24 71.21 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.353 0.597 . . . . 0.0 109.947 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -153.62 174.55 14.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.581 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -80.33 71.27 7.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.651 0.262 . . . . 0.0 110.871 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -164.22 -47.69 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -150.65 160.34 43.89 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.931 0.396 . . . . 0.0 111.3 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.71 -167.12 36.46 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.0 m -126.75 148.3 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.343 . . . . 0.0 110.818 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.681 ' HB ' ' CE1' ' A' ' 88' ' ' TYR . 78.9 mt -129.37 130.11 67.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.45 136.53 12.74 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -123.22 133.4 54.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.275 0.538 . . . . 0.0 111.865 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HD1' HG22 ' A' ' 73' ' ' VAL . 78.7 t80 -135.93 124.32 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.448 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.08 143.11 49.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.98 0.419 . . . . 0.0 111.201 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -121.51 126.1 48.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 64.8 p -125.7 151.8 46.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -157.86 163.27 38.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.613 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -64.85 141.25 58.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.764 0.316 . . . . 0.0 110.608 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.24 165.18 50.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.752 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -108.85 130.7 55.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.854 0.359 . . . . 0.0 111.019 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -127.04 137.42 53.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.993 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -91.54 113.05 25.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.34 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 t -150.86 135.23 17.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.487 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.0 145.32 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.631 0.253 . . . . 0.0 110.896 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -170.54 37.45 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.019 0.437 . . . . 0.0 110.343 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.28 -8.3 77.4 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.337 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -130.1 152.48 49.5 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.561 0.219 . . . . 0.0 110.954 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -107.74 147.19 31.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.946 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.18 142.38 31.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.501 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.9 pt -91.19 -13.2 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.996 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.7 t70 71.98 -41.83 0.52 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.647 0.779 . . . . 0.0 111.925 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.1 -22.19 35.66 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.644 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 97.5 m-20 49.72 46.63 23.74 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.554 ' HD1' ' HB2' ' A' ' 98' ' ' ALA . 92.0 t80 -99.48 120.69 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.45 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.95 139.02 53.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.235 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 85.9 t80 -133.78 128.43 34.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.74 135.66 53.7 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.3 m -116.1 123.62 48.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.712 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.445 HG22 ' HD1' ' A' ' 47' ' ' PHE . 61.6 t -126.38 110.8 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.0 p -135.67 159.3 42.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.051 0.453 . . . . 0.0 111.851 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.29 151.6 32.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.827 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.4 161.54 33.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.901 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.47 160.03 32.2 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.049 2.499 . . . . 0.0 112.688 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.06 132.49 65.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.227 0.537 . . . . 0.0 110.139 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.49 148.76 50.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.135 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -85.33 127.35 34.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.278 . . . . 0.0 110.705 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 87' ' ' LEU . 95.6 mt -89.36 -44.07 15.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -134.56 -164.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.082 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.469 ' O ' ' HD1' ' A' ' 84' ' ' TYR . 98.6 mt-10 -62.05 -40.78 96.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.457 0.17 . . . . 0.0 111.34 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.469 ' HD1' ' O ' ' A' ' 83' ' ' GLU . 6.4 m-30 -126.85 28.98 5.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.12 131.41 67.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 70.3 m -128.9 148.6 50.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.773 ' HB2' HD11 ' A' ' 81' ' ' ILE . 65.2 tp -112.19 129.75 56.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.681 ' CE1' ' HB ' ' A' ' 44' ' ' ILE . 38.5 t80 -126.99 133.47 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.031 0.443 . . . . 0.0 111.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.517 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -107.7 141.58 15.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.554 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 134' ' ' SER . 3.3 mp -110.06 121.52 45.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 111.486 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.8 tp -135.28 126.81 28.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.562 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.5 -151.15 11.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.869 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.92 155.29 44.69 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.133 0.492 . . . . 0.0 111.553 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.456 ' HA3' ' OH ' ' A' ' 70' ' ' TYR . . . -122.73 144.06 15.66 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.797 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -126.87 126.37 43.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 110.703 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -126.27 150.87 17.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.352 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -146.71 151.32 37.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.848 0.356 . . . . 0.0 110.955 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.554 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . . . -134.43 134.61 41.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 61.3 mtpt -128.08 143.22 51.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.246 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -109.59 125.7 52.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.384 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.1 m -102.41 113.52 26.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.055 0.455 . . . . 0.0 110.947 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.8 p -164.19 169.48 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.749 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.39 111.15 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.646 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -150.53 170.8 18.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.919 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.57 -38.22 95.47 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.729 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -141.05 157.03 45.89 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.585 0.231 . . . . 0.0 110.424 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -124.06 148.78 46.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.587 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -126.75 139.34 53.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.813 0.339 . . . . 0.0 111.199 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.0 m -132.65 152.74 51.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -127.49 146.09 50.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.409 . . . . 0.0 111.436 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.5 m -133.87 150.02 51.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.104 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -148.38 148.74 30.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.374 0.606 . . . . 0.0 111.73 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 87.0 m -128.6 133.38 48.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.591 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.448 ' HB3' HD21 ' A' ' 140' ' ' LEU . 92.3 p -140.12 160.48 39.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.31 141.87 31.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.177 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.35 133.43 55.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.61 140.04 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.471 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 136' ' ' GLU . . . -170.01 -175.42 38.95 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.734 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.45 154.31 41.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -148.53 161.71 28.7 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.418 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.17 138.72 50.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.363 -0.418 . . . . 0.0 110.159 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.58 HE22 ' NE ' ' A' ' 34' ' ' ARG . 54.7 tt0 -119.86 130.5 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.999 0.428 . . . . 0.0 110.034 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.03 152.27 33.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.028 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -121.22 82.92 38.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.619 0.247 . . . . 0.0 110.688 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.34 -28.99 14.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.356 2.037 . . . . 0.0 112.248 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 79.5 m80 -130.64 152.93 81.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.737 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -56.28 -36.19 96.64 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.763 2.308 . . . . 0.0 114.287 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -109.57 -4.23 16.37 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 126' ' ' HIS . 68.2 m-85 -121.47 133.51 55.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.68 152.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.084 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.3 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -115.54 114.99 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -114.14 108.97 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.577 ' HB3' HD11 ' A' ' 90' ' ' LEU . 54.0 m -128.03 153.13 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -134.48 131.85 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.709 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.417 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 27.2 pt-20 -140.91 161.24 38.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -137.76 159.1 42.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 0.0 111.626 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 45.2 m -108.59 135.53 49.69 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.912 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -98.67 104.81 16.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.803 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 79.2 mt -118.48 153.29 34.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.54 -45.25 93.83 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -107.2 -32.82 7.64 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.803 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 62.7 t -104.92 130.48 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.44 125.08 50.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.6 t -121.83 125.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.14 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -113.74 138.17 14.7 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 89.6 m -124.58 130.98 53.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.443 0.621 . . . . 0.0 111.433 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.7 m-90 -106.24 131.55 53.35 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.6 mtt -120.63 111.2 17.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.438 . . . . 0.0 111.438 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -123.85 134.41 53.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.612 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 178.39 48.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.378 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.81 150.89 42.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.855 0.359 . . . . 0.0 110.498 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -127.3 155.29 19.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.985 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -118.55 127.77 53.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.764 0.316 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.489 ' HA ' ' OG ' ' A' ' 5' ' ' SER . 80.8 mtp180 -92.82 132.57 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.875 -179.9 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.509 ' HG3' ' OH ' ' A' ' 35' ' ' TYR . 21.8 pt-20 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.157 0.503 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.34 173.59 45.56 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.025 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -88.19 135.24 33.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.547 0.213 . . . . 0.0 110.431 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -129.04 143.34 50.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.235 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -128.47 143.5 50.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.4 mm -113.77 120.57 63.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 65.7 m -127.33 144.71 51.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.399 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.52 153.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.571 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.17 -174.34 38.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.102 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -109.06 142.61 39.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -108.26 127.74 54.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 111.416 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -120.97 114.82 22.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.739 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 50.6 m -118.2 159.85 22.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.59 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -126.91 128.87 47.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.85 120.3 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.539 0.209 . . . . 0.0 111.169 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -100.35 110.07 22.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -163.34 174.74 11.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.166 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -84.62 103.25 13.57 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.69 174.37 45.69 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.544 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -92.89 118.09 30.75 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.839 -0.213 . . . . 0.0 111.191 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 38.1 tptt -173.65 127.74 0.41 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.16 -48.17 81.29 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -114.86 -12.51 12.07 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 36.9 mtmm 59.46 23.26 11.84 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.943 0.497 . . . . 0.0 111.566 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -105.68 112.96 64.49 Favored Pre-proline 0 C--O 1.233 0.207 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.739 ' HD2' ' O ' ' A' ' 13' ' ' SER . 72.4 Cg_endo -74.83 157.99 43.14 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.474 2.116 . . . . 0.0 110.72 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -113.92 146.73 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.049 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -177.66 178.31 48.38 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.431 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.69 148.39 33.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 0.0 110.788 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.1 t-20 -124.27 130.05 51.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.948 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.76 136.2 53.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.082 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.7 mttm -124.49 139.95 53.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 111.377 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -132.64 128.3 36.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.069 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.514 ' HD3' HE22 ' A' ' 122' ' ' GLN . 47.0 ttp180 -119.92 133.68 55.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.509 ' OH ' ' HG3' ' A' ' 1' ' ' GLU . 93.8 t80 -128.19 125.15 38.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.1 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -123.64 133.41 53.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.26 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -97.92 -9.63 25.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.302 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -158.12 163.37 37.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.411 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -82.6 61.19 5.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.564 0.221 . . . . 0.0 111.134 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -169.49 -55.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -119.12 143.78 46.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.944 0.402 . . . . 0.0 111.323 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.77 -174.47 31.69 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.834 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.32 153.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -139.1 138.63 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.36 139.93 12.6 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 m -129.36 136.6 50.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.992 0.425 . . . . 0.0 111.105 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.39 124.85 43.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.821 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.793 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -119.08 120.27 36.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.784 0.326 . . . . 0.0 110.939 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.532 ' OE1' ' HD1' ' A' ' 71' ' ' TYR . 2.8 mm-40 -112.09 106.48 15.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.525 HG22 ' HA3' ' A' ' 28' ' ' GLY . 75.1 p -125.99 158.04 36.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.119 0.485 . . . . 0.0 112.276 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -152.21 159.72 43.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -83.64 125.97 32.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.756 0.312 . . . . 0.0 110.514 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.11 150.84 20.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.304 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.84 139.13 46.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 111.14 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -74.57 155.49 37.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.458 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -79.91 128.8 33.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.941 0.401 . . . . 0.0 110.851 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p -150.17 163.06 39.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.888 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -96.12 105.04 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.531 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -164.56 54.45 0.14 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.352 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.14 -10.55 73.74 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.729 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 55.88 37.84 29.32 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.146 0.578 . . . . 0.0 111.773 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -110.84 108.47 18.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.801 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.5 mt -119.14 133.44 55.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 111.224 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 pt -94.7 -21.19 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.987 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 t70 68.03 -62.63 0.35 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.439 0.695 . . . . 0.0 111.896 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.91 -19.83 50.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.452 -0.404 . . . . 0.0 112.703 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 53.33 44.42 30.11 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.676 0.391 . . . . 0.0 111.84 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -99.39 122.76 42.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.645 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -127.79 142.23 51.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.13 123.25 24.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.532 ' HD1' ' OE1' ' A' ' 49' ' ' GLN . 92.1 m-85 -112.79 128.91 56.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.793 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 67.4 m -113.92 127.03 55.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.181 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.9 124.4 70.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -147.15 153.43 39.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.851 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -153.03 153.43 32.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.064 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -167.81 167.37 40.01 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.997 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.56 156.3 40.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.526 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.76 129.71 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.544 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -126.88 126.63 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.996 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -69.94 134.79 48.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 0.0 111.215 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.631 ' HB ' HG23 ' A' ' 85' ' ' VAL . 95.6 mt -89.62 -45.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.53 0.681 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.83 -144.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.86 -1.78 52.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.342 -0.224 . . . . 0.0 111.468 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -147.05 9.72 0.99 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.631 HG23 ' HB ' ' A' ' 81' ' ' ILE . 3.4 m -140.37 142.53 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 68.1 m -138.3 151.35 47.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.049 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 81' ' ' ILE . 2.7 tt -116.26 136.93 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -142.75 157.69 44.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 111.335 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.635 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.99 150.52 18.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.845 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.02 129.44 55.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.455 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -142.36 135.66 28.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.8 13.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.903 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.69 152.19 45.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.101 0.477 . . . . 0.0 111.606 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.21 140.81 16.43 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.768 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.449 ' NE2' ' HD3' ' A' ' 97' ' ' LYS . 75.0 t60 -119.03 122.42 42.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.592 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.88 138.28 14.85 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.272 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD3' ' NE2' ' A' ' 95' ' ' HIS . 31.2 mmmt -124.27 137.19 54.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.808 0.337 . . . . 0.0 110.832 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.93 130.19 35.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.708 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -127.04 146.25 50.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.187 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -120.87 139.22 53.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.648 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.9 m -103.99 113.95 27.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.015 0.436 . . . . 0.0 110.819 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.4 m -155.25 164.87 38.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.608 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.1 mt -100.45 111.43 30.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.758 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -150.45 171.24 17.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.81 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.1 93.17 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.153 -0.546 . . . . 0.0 111.802 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -133.16 163.57 28.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.618 0.247 . . . . 0.0 110.339 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.0 p -108.96 149.42 29.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.801 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -127.71 153.59 46.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.937 0.398 . . . . 0.0 110.965 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.7 p -150.07 163.66 37.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.817 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -127.01 146.12 50.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.05 0.452 . . . . 0.0 111.58 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -128.78 138.62 52.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.647 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.13 149.48 52.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.247 0.546 . . . . 0.0 111.732 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -126.8 149.03 49.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.428 ' HB2' HD21 ' A' ' 140' ' ' LEU . 39.3 t -153.97 148.31 26.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 111.511 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.44 126.94 32.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.64 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.85 132.89 56.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.97 0.414 . . . . 0.0 111.132 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -145.76 137.7 25.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.291 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.4 -168.38 29.47 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.752 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.06 161.47 41.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.64 161.92 28.95 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.579 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.07 140.76 50.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.047 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.514 HE22 ' HD3' ' A' ' 34' ' ' ARG . 52.7 tt0 -115.4 128.55 56.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -116.18 139.93 49.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.108 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -128.83 82.69 68.19 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -30.06 17.48 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.372 2.048 . . . . 0.0 112.237 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -131.32 152.43 80.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.633 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.16 -35.01 89.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.92 2.413 . . . . 0.0 113.869 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.419 ' O ' ' HD1' ' A' ' 154' ' ' TYR . 2.8 t-20 -109.99 13.7 23.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -130.94 118.57 20.87 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -117.37 131.04 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.341 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.21 122.47 62.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -110.77 129.67 55.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.921 0.391 . . . . 0.0 111.9 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -133.79 125.49 28.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 99.3 p -155.8 165.8 35.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -139.9 152.64 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.55 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -144.42 137.52 27.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -112.75 132.34 55.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.455 ' HB2' ' HB ' ' A' ' 145' ' ' VAL . 49.3 m -102.89 125.91 49.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -103.25 114.58 28.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.76 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 68.1 mt -119.91 153.65 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.16 -43.41 98.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -106.72 -32.06 8.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.76 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.4 t -105.26 130.75 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.91 123.94 48.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -127.7 126.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 112.055 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -114.41 135.01 12.08 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.3 m -119.44 129.18 54.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.52 0.66 . . . . 0.0 111.621 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -111.09 131.44 55.08 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 63.8 mtt -120.71 115.1 22.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.25 136.5 53.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.322 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.56 -173.25 44.51 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.394 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.66 159.29 43.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.07 -178.23 28.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.596 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 128' ' ' ASN . 94.2 m-85 -121.82 144.66 48.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.654 0.264 . . . . 0.0 110.494 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -96.25 126.39 41.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.813 -179.823 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.999 0.428 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.62 167.61 50.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.046 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.67 150.57 30.88 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.78 -0.247 . . . . 0.0 110.477 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 34' ' ' ARG . 37.3 t -133.88 140.17 46.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 111.134 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.7 m -131.65 149.46 52.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.3 mt -118.56 126.66 75.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.27 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.526 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 62.1 m -117.83 137.22 52.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.299 . . . . 0.0 111.207 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -121.36 129.64 75.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.193 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.93 172.91 31.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.08 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -98.56 145.05 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -127.81 138.96 52.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.947 0.403 . . . . 0.0 111.429 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HB2' ' NE1' ' A' ' 148' ' ' TRP . 97.3 mt-30 -127.73 135.03 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.967 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.658 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.6 m -118.82 148.56 42.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.176 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -120.37 123.19 42.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 145' ' ' VAL . 58.2 t -124.86 131.9 72.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.465 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -86.14 109.51 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 0.0 110.303 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HG3' HG12 ' A' ' 15' ' ' VAL . 95.7 mt-10 -145.91 157.01 43.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.227 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -97.43 108.6 21.36 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.79 -147.23 9.28 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.507 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 90.3 m-85 -72.9 146.79 45.89 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 59.4 mmtt 74.59 110.55 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.579 0.549 . . . . 0.0 109.843 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.82 -40.2 91.82 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -86.99 -14.35 41.91 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt 48.9 38.34 12.02 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -101.56 114.03 65.73 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.658 ' HD2' ' O ' ' A' ' 13' ' ' SER . 73.5 Cg_endo -76.8 159.48 34.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.632 2.221 . . . . 0.0 110.756 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -116.07 156.35 26.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.903 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -178.63 -153.79 11.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.362 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.12 161.35 38.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 28.1 t-20 -135.26 128.87 32.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 46' ' ' SER . 87.1 mt -104.13 128.15 51.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.986 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 23.0 ttmm -119.74 127.75 53.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.513 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.38 134.52 52.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.614 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 4' ' ' SER . 77.2 ttt-85 -121.78 131.03 53.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 111.733 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -132.36 131.49 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -96.22 127.48 42.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -101.21 -16.62 16.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.265 0.555 . . . . 0.0 109.626 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -150.14 177.87 9.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.579 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.95 -46.95 87.04 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -113.94 6.61 16.63 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -124.85 140.45 52.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.02 0.438 . . . . 0.0 111.51 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.17 -177.36 38.77 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.907 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.9 0.381 . . . . 0.0 110.822 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.3 pp -136.77 150.07 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -130.86 134.1 7.6 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 55.0 m -124.57 135.71 53.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.031 0.415 . . . . 0.0 111.774 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 94.8 m-85 -120.4 111.73 18.11 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -102.67 127.48 49.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.503 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.521 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 77.4 mt-30 -126.08 123.52 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 70' ' ' TYR . 77.1 p -128.04 149.45 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.676 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -138.69 154.82 48.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.037 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -69.81 139.87 53.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.668 0.271 . . . . 0.0 110.272 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.29 57.04 0.61 Allowed Glycine 0 CA--C 1.517 0.157 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.814 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.489 ' HE2' HD12 ' A' ' 64' ' ' ILE . 40.8 t80 -110.84 136.85 49.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.706 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.11 134.73 53.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.446 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -90.03 123.78 34.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.009 0.433 . . . . 0.0 111.056 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.575 ' H ' HD11 ' A' ' 64' ' ' ILE . 67.8 m -130.05 152.19 49.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.527 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.4 t -89.66 114.42 27.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.886 0.374 . . . . 0.0 110.815 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -151.37 99.65 2.66 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.627 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.9 10.29 86.32 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.764 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 60.36 37.2 20.26 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.049 0.539 . . . . 0.0 111.293 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -122.3 136.22 54.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.111 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.1 121.64 16.03 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.975 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.575 HD11 ' H ' ' A' ' 57' ' ' SER . 47.7 pt -102.96 -13.83 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.809 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.05 -45.13 93.69 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.414 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.7 -34.12 6.01 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 113.02 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t0 51.46 54.59 10.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 111.645 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -104.83 130.22 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.769 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -118.03 136.35 53.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.981 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.513 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 68.0 t80 -134.45 125.64 27.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.231 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -126.44 138.16 53.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 109.912 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 67.7 m -127.92 136.0 50.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.199 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 63.0 t -124.92 119.63 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.7 p -133.2 156.33 47.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 111.868 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.22 153.01 34.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.042 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.06 164.66 37.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.969 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.19 156.85 29.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.889 2.393 . . . . 0.0 112.64 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 88' ' ' TYR . 57.4 t -123.42 129.75 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.382 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -123.13 128.71 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.043 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.485 ' HD3' ' HB3' ' A' ' 86' ' ' SER . 29.3 mmt180 -78.53 126.31 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.8 mm -90.97 -42.26 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 110.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.0 -167.2 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.04 -38.43 88.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 0.0 111.327 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -128.15 23.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.44 127.48 65.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.645 ' OG ' ' HB3' ' A' ' 122' ' ' GLN . 89.3 p -138.6 151.7 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.7 mt -123.36 145.92 48.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.957 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.508 ' HB3' HG22 ' A' ' 78' ' ' VAL . 34.6 p90 -150.89 159.36 44.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 111.714 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.659 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -117.13 149.25 18.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.132 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 134' ' ' SER . 92.4 mt -112.65 118.89 36.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.296 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 tp -127.11 125.39 41.17 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 73' ' ' VAL . . . -175.13 -155.03 11.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.855 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.07 153.39 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.613 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.01 141.62 17.0 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.766 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -129.33 130.8 46.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.775 0.321 . . . . 0.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -121.76 142.97 15.54 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.542 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -127.35 139.21 53.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.814 0.34 . . . . 0.0 111.074 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.34 127.77 43.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -126.31 142.56 51.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.557 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -109.65 134.11 52.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.339 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.7 p -90.25 115.83 27.76 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.343 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.3 p -162.8 164.85 25.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.447 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.6 mt -106.97 111.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -150.7 165.2 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.81 -39.1 97.02 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.742 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -120.29 151.54 39.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.8 p -109.88 150.53 28.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.443 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.59 146.83 50.74 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.755 0.312 . . . . 0.0 111.007 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.1 p -155.82 162.64 40.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.936 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.27 150.03 50.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 111.345 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.3 m -130.23 141.04 50.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.237 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.1 149.17 50.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.09 0.471 . . . . 0.0 111.482 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 76.4 p -118.26 149.16 41.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.769 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.4 p -157.4 163.94 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.37 . . . . 0.0 111.759 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.8 mt -98.79 135.41 40.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.064 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.33 130.1 52.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -143.74 138.64 28.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -167.76 -165.05 24.51 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.695 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.18 37.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 88' ' ' TYR . . . -145.28 162.65 28.18 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 113.348 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.0 tp -126.74 138.43 53.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.902 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.645 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 51.6 tt0 -126.75 133.1 50.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.862 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -122.5 151.82 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.574 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -119.35 81.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.23 -34.6 67.37 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.597 2.198 . . . . 0.0 111.483 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.68 155.44 81.26 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.681 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.56 -23.21 74.71 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.844 2.362 . . . . 0.0 113.658 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -117.78 9.51 12.99 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.94 133.93 29.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 111.181 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.69 153.39 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.3 mt -113.22 124.24 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -111.3 126.93 55.42 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -128.6 116.5 19.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.59 ' HB3' HD11 ' A' ' 90' ' ' LEU . 67.7 m -130.64 153.82 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 99.0 m-85 -125.58 138.32 53.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.329 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 147' ' ' THR . 99.2 mt-10 -129.66 144.64 51.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.621 0.248 . . . . 0.0 110.34 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.434 ' OH ' ' HD2' ' A' ' 144' ' ' LYS . 90.8 t80 -135.51 129.8 33.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.062 0.458 . . . . 0.0 111.324 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -101.87 121.8 42.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -102.4 107.02 17.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 96.2 mt -119.23 153.58 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.68 -43.5 98.75 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.46 -31.88 8.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.718 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 60.0 t -105.27 128.42 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HD2' ' OH ' ' A' ' 137' ' ' TYR . 34.8 mmtp -105.72 125.36 50.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 62.0 t -126.69 125.67 67.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.4 135.69 12.03 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 136' ' ' GLU . 70.9 m -131.29 137.53 48.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.171 0.485 . . . . 0.0 111.667 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 12' ' ' GLN . 34.4 p90 -132.85 148.8 52.3 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm -140.05 149.06 42.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.175 0.512 . . . . 0.0 111.844 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.94 139.0 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.395 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -177.77 -176.0 45.42 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.17 152.24 39.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.457 -0.372 . . . . 0.0 110.517 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.45 152.59 18.4 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.608 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -121.96 130.56 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.489 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -78.52 135.33 37.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.08 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.712 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.971 0.415 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.96 172.72 40.72 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.848 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -77.32 145.85 37.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.632 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.2 p -142.39 156.89 45.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.8 m -136.72 146.61 46.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.0 mt -118.02 125.53 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.2 m -127.21 145.61 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.948 0.404 . . . . 0.0 111.435 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.21 154.28 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.32 176.11 44.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.117 -1.039 . . . . 0.0 113.081 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -94.08 140.4 29.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.13 35.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.499 ' HB3' HD21 ' A' ' 25' ' ' ASN . 96.0 mt-30 -112.26 118.4 35.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.889 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 64.9 m -118.46 157.5 27.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 111.702 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -127.25 127.57 44.61 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.11 125.27 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.372 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -66.29 125.78 26.68 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.982 0.42 . . . . 0.0 110.419 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -130.2 153.48 48.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.332 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -85.71 68.91 10.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.817 0.341 . . . . 0.0 111.356 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.61 0.81 90.32 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.296 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -91.69 134.46 34.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt 71.67 143.89 0.06 Allowed 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.857 0.723 . . . . 0.0 111.393 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.53 -55.59 5.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.292 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -104.05 -13.64 16.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm 51.86 34.46 13.46 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.88 0.472 . . . . 0.0 111.98 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 13' ' ' SER . 22.6 t-20 -104.62 110.04 63.76 Favored Pre-proline 0 C--N 1.332 -0.165 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.851 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 13' ' ' SER . 37.7 Cg_exo -67.45 148.47 79.2 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.188 2.592 . . . . 0.0 111.006 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -102.96 138.67 39.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 49' ' ' GLN . . . -172.76 -177.89 42.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.255 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -121.15 149.48 42.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.272 . . . . 0.0 110.498 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -118.97 126.63 52.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.85 131.09 55.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.982 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -128.47 139.47 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.287 0.565 . . . . 0.0 111.496 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -133.43 129.84 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.277 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -118.53 133.14 56.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -131.77 128.71 39.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.57 134.13 41.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.999 0.428 . . . . 0.0 111.942 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -109.37 -6.49 15.46 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.055 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -154.47 173.57 16.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.578 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.04 -41.9 98.6 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.144 0.277 . . . . 0.0 111.63 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -124.3 34.04 5.13 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.2 t90 -153.1 133.85 13.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.14 -172.47 28.51 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.778 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.79 156.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.842 0.321 . . . . 0.0 110.877 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 tp -133.52 132.33 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.114 0.483 . . . . 0.0 111.15 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.12 135.66 12.09 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -127.84 134.69 49.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -121.25 117.95 28.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.404 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 124.93 53.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.83 0.348 . . . . 0.0 111.146 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 10.1 pt20 -131.44 117.52 18.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.901 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 73.6 p -131.6 160.17 36.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.954 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.08 163.93 37.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.941 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 68' ' ' PHE . 41.7 mmt180 -71.65 139.5 49.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.882 0.373 . . . . 0.0 110.754 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.3 56.32 4.24 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.753 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 62.8 m-85 -109.96 143.31 40.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.908 0.385 . . . . 0.0 110.896 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -97.36 145.5 26.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.448 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -68.31 138.95 55.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.148 0.499 . . . . 0.0 111.24 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -123.75 146.52 48.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.698 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.2 121.3 66.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.662 0.268 . . . . 0.0 110.946 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -156.77 60.24 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.014 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.27 -11.06 72.27 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.389 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -164.89 147.97 8.51 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -73.04 128.81 36.55 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 111.307 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.56 127.91 54.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 111.097 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 67' ' ' ASP . 36.9 pt -114.05 1.16 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.826 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 55.83 34.58 23.77 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.286 0.634 . . . . 0.0 112.414 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.78 -30.19 7.74 Favored Glycine 0 CA--C 1.517 0.187 0 CA-C-N 116.093 -0.503 . . . . 0.0 113.164 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.473 ' HB2' HD12 ' A' ' 64' ' ' ILE . 30.1 t0 48.75 54.78 10.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.422 0.289 . . . . 0.0 111.216 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 94.9 m-85 -74.73 130.61 39.79 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.602 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.51 139.42 53.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.343 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.442 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.6 m-85 -126.22 127.29 45.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.422 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 49' ' ' GLN . 21.2 t80 -132.18 116.94 17.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.6 m -120.29 136.86 54.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.983 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.45 120.22 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.8 p -133.4 157.18 46.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 111.777 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.695 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -152.19 155.19 37.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.98 172.71 43.93 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.781 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.98 155.07 43.0 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.943 2.428 . . . . 0.0 112.74 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.03 125.91 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.374 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -127.07 123.69 37.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.964 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -80.24 137.43 36.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.594 0.235 . . . . 0.0 110.746 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.566 ' HB ' HG23 ' A' ' 85' ' ' VAL . 44.2 mm -88.92 -39.37 12.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.494 0.664 . . . . 0.0 109.776 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -153.51 -155.05 0.56 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.278 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.31 1.81 53.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.622 0.248 . . . . 0.0 111.331 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -144.95 10.7 1.35 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -143.25 139.24 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.694 0.283 . . . . 0.0 110.651 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -138.65 150.72 46.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.114 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 129.26 54.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.076 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.37 139.75 48.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.736 0.303 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.34 137.37 13.59 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -125.36 126.19 44.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.197 0.499 . . . . 0.0 111.732 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -146.81 136.96 23.52 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.2 -149.76 12.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.869 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.44 151.79 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.482 . . . . 0.0 111.601 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.81 141.13 16.14 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.717 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -124.06 128.51 49.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.295 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -119.23 146.22 18.21 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.053 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -124.53 146.73 48.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.805 0.336 . . . . 0.0 110.884 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.45 146.04 39.58 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.842 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.6 mmtm -122.46 147.68 46.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -116.41 124.77 50.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.818 0.342 . . . . 0.0 110.373 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.4 m -91.34 114.68 27.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.467 . . . . 0.0 111.355 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.8 p -162.78 167.15 23.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.71 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 103' ' ' ILE . 17.9 pt -99.11 111.59 29.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.474 0.654 . . . . 0.0 110.151 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -148.68 154.61 39.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.88 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.6 97.36 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.098 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -105.66 173.3 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 110.605 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.3 m -109.83 141.75 42.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -128.45 146.25 50.86 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.829 0.347 . . . . 0.0 111.009 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.6 p -155.61 164.61 38.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -142.54 160.71 39.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.128 0.49 . . . . 0.0 111.35 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.2 p -145.89 157.19 43.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.013 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -133.32 151.49 51.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.119 0.485 . . . . 0.0 111.866 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 74.3 p -113.37 147.68 37.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.493 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.45 ' HB3' HD21 ' A' ' 140' ' ' LEU . 97.7 p -155.57 164.64 38.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 0.0 111.709 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 138' ' ' SER . 88.4 mt -98.57 137.32 37.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.828 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.15 132.12 54.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.798 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.16 142.07 26.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.329 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -176.38 -172.98 41.61 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.748 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.9 161.32 42.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.458 ' HA3' ' OG ' ' A' ' 134' ' ' SER . . . -146.23 165.7 28.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.456 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -126.06 138.89 53.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -119.17 134.54 55.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.388 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -116.47 151.95 35.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -119.67 85.06 32.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.16 -33.35 9.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.192 1.928 . . . . 0.0 111.752 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -136.26 152.64 75.55 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.673 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.9 -30.22 76.93 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.65 2.233 . . . . 0.0 113.745 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.54 10.15 33.21 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -149.11 122.3 8.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.201 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.63 151.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -122.7 145.17 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -136.14 122.11 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.35 41.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.458 ' OG ' ' HA3' ' A' ' 120' ' ' GLY . 69.3 m -127.98 150.07 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.493 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.8 m-85 -118.38 130.65 56.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -137.06 136.85 38.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -126.72 146.12 50.33 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 55.6 m -112.03 137.41 50.1 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.87 115.51 30.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.821 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 74.7 mt -118.4 154.3 32.65 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.0 -44.73 96.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.48 -33.4 7.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.5 t -105.65 128.63 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.73 128.95 44.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 65.2 t -125.46 128.07 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.11 0.481 . . . . 0.0 112.099 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -116.83 136.59 12.86 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.5 m -126.8 129.98 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.209 0.504 . . . . 0.0 111.192 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -113.33 133.45 55.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.0 mtt -114.48 117.97 32.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 0.0 111.495 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -125.25 123.36 39.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.314 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.37 -173.48 39.03 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.43 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.04 165.48 27.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.382 . . . . 0.0 110.734 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.26 178.47 30.29 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -131.95 130.92 42.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -80.82 131.25 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.981 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.755 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.98 -177.64 48.54 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.02 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.15 150.44 26.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.687 0.279 . . . . 0.0 110.653 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -140.22 159.48 42.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.231 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.2 m -132.25 147.19 52.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.968 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.6 124.2 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 56.5 m -120.63 139.73 52.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.436 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.1 mt -123.47 129.16 74.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.004 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 177.86 20.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.313 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -102.58 137.34 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.69 130.52 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.797 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -122.34 132.69 54.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 44.2 m -118.35 158.7 24.75 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.455 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -128.97 119.09 23.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 145' ' ' VAL . 65.0 t -127.83 129.3 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.469 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -65.36 111.97 3.29 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.05 0.452 . . . . 0.0 110.398 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' H ' ' HE3' ' A' ' 24' ' ' LYS . 69.4 mm-40 -136.81 149.44 47.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.493 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -100.72 105.41 16.75 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.4 -153.95 24.52 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.606 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 85.9 m-85 -73.1 159.94 32.79 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER 75.81 84.37 0.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.703 0.627 . . . . 0.0 109.926 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 22' ' ' LEU . 2.9 mm? -59.93 -34.51 73.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.015 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.28 -17.24 61.9 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HE3' ' H ' ' A' ' 17' ' ' GLU . 2.0 mttp 48.53 35.94 6.73 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 13' ' ' SER . 19.1 p-10 -103.52 113.95 65.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 13' ' ' SER . 94.5 Cg_endo -80.12 159.51 23.64 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.569 2.18 . . . . 0.0 110.877 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -91.95 140.5 29.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.573 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -164.53 173.99 40.51 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.259 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.21 152.54 47.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -122.69 132.32 54.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.91 121.1 39.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.071 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.4 mttm -117.9 140.46 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 0.0 111.38 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.14 135.98 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.88 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.668 ' HA ' HG22 ' A' ' 44' ' ' ILE . 76.5 ttt180 -119.0 129.94 55.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.22 132.2 56.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -103.8 140.97 36.91 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.622 ' HE2' HG12 ' A' ' 43' ' ' VAL . 97.2 m-85 -129.6 169.7 14.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.723 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -79.48 75.05 6.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.528 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -166.59 -172.69 2.23 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.893 0.377 . . . . 0.0 110.737 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.98 -1.78 57.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.882 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -149.85 163.49 37.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.025 0.44 . . . . 0.0 111.372 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.06 -166.54 11.12 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.31 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.622 HG12 ' HE2' ' A' ' 37' ' ' PHE . 14.3 p -138.11 139.83 41.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.077 0.438 . . . . 0.0 110.624 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 34' ' ' ARG . 36.8 pt -130.44 158.35 42.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.9 142.65 15.77 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -129.37 123.11 30.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -114.51 122.42 46.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 136.04 54.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -142.16 132.4 24.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.05 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.693 HG22 ' HA3' ' A' ' 28' ' ' GLY . 82.3 p -133.45 158.91 41.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.033 0.444 . . . . 0.0 111.639 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -132.88 136.93 46.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.392 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -63.15 133.09 53.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.478 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 -178.34 52.35 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.529 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -72.77 106.88 4.93 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 110.625 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -157.65 137.99 12.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.424 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -92.59 128.84 38.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.4 p -97.5 163.8 12.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.234 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.7 102.62 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.146 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -172.99 59.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.42 1.95 90.53 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.822 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 60.0 27.44 16.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.023 0.529 . . . . 0.0 111.58 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -93.92 -7.98 41.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.211 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.25 88.03 2.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.966 0.412 . . . . 0.0 111.138 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 mm -67.02 -43.83 88.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.557 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -119.6 -50.8 2.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.48 -32.3 6.34 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 97.9 m-20 51.08 44.12 28.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.733 0.413 . . . . 0.0 112.08 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.99 126.33 43.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.501 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.11 140.26 51.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.216 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.467 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 98.3 m-85 -121.34 122.3 39.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.629 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.17 119.51 31.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.1 m -123.89 136.01 54.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.964 0.412 . . . . 0.0 111.155 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.76 121.36 64.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.6 p -130.49 154.97 47.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.067 0.46 . . . . 0.0 111.831 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.99 151.19 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.893 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.04 160.93 31.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.856 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.45 156.3 40.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.862 2.375 . . . . 0.0 112.655 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.21 131.87 70.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 0.0 110.387 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -118.7 125.51 49.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.155 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -70.73 133.82 46.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.533 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.711 ' HB ' HG23 ' A' ' 85' ' ' VAL . 84.0 mt -84.59 -44.65 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.455 0.645 . . . . 0.0 109.839 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -140.54 -102.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.21 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -125.47 -34.69 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.678 0.275 . . . . 0.0 111.134 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.76 11.73 14.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 81' ' ' ILE . 2.6 m -136.08 137.56 48.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 122' ' ' GLN . 49.9 m -139.12 151.96 47.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.202 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.71 136.12 53.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.135 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CD1' HD11 ' A' ' 44' ' ' ILE . 51.2 p90 -142.61 160.62 39.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 111.281 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.86 152.51 17.31 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.4 mt -112.39 123.32 50.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.331 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.7 tp -136.49 127.33 27.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.604 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.9 -160.48 25.58 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.817 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.86 148.83 52.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 0.0 111.437 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.53 135.75 12.95 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.876 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -124.37 124.81 43.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.037 0.446 . . . . 0.0 110.625 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 111' ' ' SER . . . -109.79 143.96 16.71 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.158 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.39 125.57 29.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 111.032 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.7 133.87 54.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.546 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 68.6 mttm -128.45 143.83 51.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.443 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -109.01 123.73 49.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 m -88.68 113.89 24.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.068 0.461 . . . . 0.0 111.48 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.1 p -163.7 166.05 22.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.587 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 103' ' ' ILE . 19.4 pt -99.45 110.71 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.482 0.658 . . . . 0.0 110.075 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -149.91 157.98 43.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.77 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.67 94.03 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.016 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -115.89 149.57 38.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.758 0.313 . . . . 0.0 110.451 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.7 m -109.76 140.5 43.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.522 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -126.76 147.83 49.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.868 0.366 . . . . 0.0 110.997 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.0 p -152.53 163.53 39.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.928 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -127.19 153.3 46.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.993 0.425 . . . . 0.0 111.358 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 96' ' ' GLY . 88.4 p -138.38 148.82 44.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.868 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -132.06 148.88 52.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 111.638 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.6 m -120.69 131.44 54.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 81.8 p -145.57 161.24 40.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.01 0.433 . . . . 0.0 111.796 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 138' ' ' SER . 63.8 tp -98.21 126.52 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.82 128.89 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -144.65 140.75 28.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.405 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 135' ' ' TYR . . . -173.05 -168.91 34.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.705 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.63 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.6 168.06 32.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.43 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.4 mt -127.35 147.25 50.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.275 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 97.7 mt-30 -117.83 137.11 52.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.294 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.83 140.56 52.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.695 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.441 ' ND2' HG22 ' A' ' 130' ' ' VAL . 8.4 m120 -125.08 83.04 60.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.394 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.06 -27.64 42.07 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.278 1.985 . . . . 0.0 111.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -133.58 153.42 80.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.492 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.48 -37.99 89.86 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.899 2.399 . . . . 0.0 113.692 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.407 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 33.6 m120 -105.63 10.66 32.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.44 121.42 37.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.918 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.441 HG22 ' ND2' ' A' ' 124' ' ' ASN . 58.8 t -118.26 130.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.306 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.41 123.82 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.37 127.84 56.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.941 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -138.14 123.97 19.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.52 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 99.5 p -150.45 160.87 43.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 118' ' ' GLY . 92.0 m-85 -118.34 127.04 53.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.271 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -120.75 126.6 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.52 143.58 51.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.205 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 56.2 m -110.2 128.78 55.68 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.36 105.77 16.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.748 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 90.8 mt -119.15 149.45 41.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.52 -43.8 97.92 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -103.73 -31.92 9.62 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.748 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.5 t -105.82 128.69 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -105.14 120.55 41.79 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 64.0 t -123.31 124.96 71.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.704 -0.398 . . . . 0.0 112.017 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -121.1 130.91 8.41 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.3 m -124.96 129.38 50.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.147 0.473 . . . . 0.0 111.484 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.451 ' CD1' ' HD1' ' A' ' 135' ' ' TYR . 52.6 m0 -109.86 133.14 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 74.8 mtm -126.92 126.17 42.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.733 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -140.43 136.33 32.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.395 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.61 -175.7 41.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.821 -1.181 . . . . 0.0 113.538 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.61 152.48 48.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 7' ' ' SER . . . -139.73 165.61 25.82 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.658 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 128' ' ' ASN . 93.2 t80 -110.84 130.66 55.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.31 124.69 36.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.735 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.96 -173.83 46.0 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.959 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.2 153.43 22.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 0.0 110.643 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.6 p -144.13 156.3 44.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -137.59 146.56 44.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.67 127.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 60.4 m -121.02 138.09 54.33 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.878 0.37 . . . . 0.0 111.221 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.2 mt -125.58 131.31 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.15 -173.16 24.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.18 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.66 147.02 32.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.99 126.27 52.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.781 0.324 . . . . 0.0 111.13 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -117.92 123.31 45.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.882 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.649 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.0 m -118.53 150.88 38.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 111.686 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -127.65 129.28 46.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 145' ' ' VAL . 60.2 t -114.62 127.65 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.707 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -85.02 109.42 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.218 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -155.9 165.73 35.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.2 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -122.13 107.52 12.27 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.805 -0.18 . . . . 0.0 110.752 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 158.62 -138.89 5.94 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.618 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 57.8 t80 -61.62 141.36 57.84 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 63.7 mttp 77.33 90.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.843 0.714 . . . . 0.0 109.747 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.09 -45.56 92.52 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.775 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.12 -15.01 32.47 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.522 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 56.6 mmtt 48.34 36.14 6.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -103.6 111.25 65.02 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 13' ' ' SER . 85.8 Cg_endo -84.16 159.02 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.884 2.389 . . . . 0.0 110.957 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -107.57 149.29 28.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.711 0.291 . . . . 0.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -170.8 -179.52 42.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.6 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -115.04 147.71 39.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.845 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.492 HD21 ' HE2' ' A' ' 32' ' ' LYS . 3.3 t30 -122.85 123.77 41.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.266 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -119.59 130.31 55.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 68.6 mttm -126.87 138.25 53.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.003 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.75 132.87 53.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.751 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -126.04 129.99 50.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.954 0.407 . . . . 0.0 111.46 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.01 134.59 54.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.747 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -116.02 111.12 19.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 111.799 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -102.83 -0.8 30.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.169 0.509 . . . . 0.0 109.867 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -155.52 159.57 39.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.547 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.13 -15.27 41.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 111.366 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 19.1 t0 -92.59 -28.59 16.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.567 ' CE3' ' HB3' ' A' ' 40' ' ' ASP . 38.7 p90 -152.0 162.25 41.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.042 0.449 . . . . 0.0 111.405 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.63 -178.09 24.28 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.785 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -125.02 131.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.946 0.373 . . . . 0.0 110.842 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 tt -126.56 140.75 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.12 140.17 11.92 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -126.31 139.3 53.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.096 0.474 . . . . 0.0 111.606 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.57 125.26 43.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.642 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 72' ' ' SER . . . -114.18 126.88 55.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -123.3 107.84 12.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.616 HG22 ' HA3' ' A' ' 28' ' ' GLY . 66.7 p -128.4 155.22 45.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -133.54 128.62 35.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.972 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.78 160.63 21.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.745 0.307 . . . . 0.0 111.054 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 65' ' ' ASP . . . 80.48 23.41 60.56 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.128 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.1 80.47 0.95 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.066 0.46 . . . . 0.0 111.013 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -130.13 152.02 50.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.169 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -82.88 113.89 20.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.013 0.435 . . . . 0.0 110.901 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.4 m -135.95 150.73 49.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.985 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.24 102.95 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.653 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -167.36 69.41 0.09 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.458 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.85 14.11 82.38 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.957 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 59.03 37.3 24.46 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.912 0.485 . . . . 0.0 111.429 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.65 152.89 44.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.807 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.57 110.86 22.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.125 0.488 . . . . 0.0 111.118 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 pt -112.95 5.6 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.315 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 34.9 t0 -80.05 73.58 6.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.03 -41.52 2.19 Favored Glycine 0 C--O 1.228 -0.225 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.891 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.0 t0 49.52 52.43 14.53 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.687 0.395 . . . . 0.0 111.719 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.424 ' HD1' ' HB2' ' A' ' 98' ' ' ALA . 87.1 t80 -110.5 122.4 47.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.535 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -102.69 131.49 49.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.124 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -123.77 122.77 38.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -123.43 137.48 54.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.74 0.305 . . . . 0.0 110.217 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.676 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 64.1 m -126.53 136.06 52.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -125.63 120.2 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.0 p -133.34 157.62 45.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.493 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.64 155.35 37.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.174 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -174.43 165.15 36.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.132 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.36 153.9 35.84 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.857 2.372 . . . . 0.0 112.404 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.29 126.68 75.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -122.2 133.47 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.929 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -73.43 137.43 44.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.502 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.841 ' HB ' HG23 ' A' ' 85' ' ' VAL . 96.1 mt -83.55 -48.57 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.349 0.595 . . . . 0.0 110.34 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -140.88 -84.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.895 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -138.9 -44.92 0.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.66 0.267 . . . . 0.0 111.23 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -109.23 9.67 25.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.841 HG23 ' HB ' ' A' ' 81' ' ' ILE . 7.2 m -136.69 142.41 38.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 121.196 -0.202 . . . . 0.0 110.529 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 48.8 m -135.25 149.14 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 111.382 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.3 tp -116.59 129.9 56.43 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -141.85 157.98 44.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.456 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.604 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -116.68 147.48 18.9 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.749 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.89 118.78 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.74 137.32 54.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.56 -157.43 23.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.797 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.72 154.91 47.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -120.23 139.52 13.8 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -127.12 143.53 51.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -127.91 150.54 18.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.309 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -134.74 127.45 30.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.62 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . . . -108.76 128.74 55.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -117.04 129.71 56.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.294 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.9 136.0 44.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.488 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.2 m -103.18 114.86 29.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 111.238 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.3 p -163.25 165.14 24.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.609 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.8 pt -103.88 109.52 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.44 0.638 . . . . 0.0 110.171 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -150.63 163.79 37.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.878 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.94 -38.83 96.08 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.721 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -122.45 151.18 41.54 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.4 p -109.84 152.99 25.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.911 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -131.55 150.58 52.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.5 p -153.55 163.11 40.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.844 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -128.51 148.09 50.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.418 . . . . 0.0 111.325 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.9 m -126.03 145.47 50.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.778 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -126.34 147.63 49.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.115 0.483 . . . . 0.0 111.642 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.8 m -122.75 132.03 54.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.697 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.425 ' HB3' HD21 ' A' ' 140' ' ' LEU . 93.1 p -149.18 160.9 42.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.623 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 138' ' ' SER . 91.0 mt -100.49 138.66 37.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.092 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.44 122.66 29.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.744 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -131.64 149.2 52.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.63 -168.3 36.46 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.634 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.07 162.12 38.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -146.0 156.71 27.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.445 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.6 138.99 51.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.879 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.444 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 52.8 tt0 -115.3 124.34 51.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.781 0.324 . . . . 0.0 110.228 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.63 131.47 56.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.977 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.408 ' OD1' HG22 ' A' ' 130' ' ' VAL . 40.6 t30 -126.72 81.11 69.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.421 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.61 -40.17 39.53 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.754 2.303 . . . . 0.0 111.887 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -133.67 154.69 80.76 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.649 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.3 -34.45 70.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.801 2.334 . . . . 0.0 113.817 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -103.19 10.96 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.473 ' CZ ' HD11 ' A' ' 131' ' ' ILE . 22.6 t80 -131.66 112.63 12.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 124' ' ' ASN . 59.8 t -122.38 130.64 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.473 HD11 ' CZ ' ' A' ' 129' ' ' PHE . 49.1 mm -116.22 123.08 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.8 m-20 -113.82 127.81 56.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 111.688 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.09 115.98 21.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.46 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -136.43 161.96 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.268 0.556 . . . . 0.0 112.462 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -139.29 148.85 43.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.283 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -139.85 148.5 42.19 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -127.33 128.45 45.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.993 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 66.2 m -100.16 123.95 45.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -101.01 112.76 25.3 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.746 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 89.9 mt -119.37 153.91 34.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.84 -44.59 96.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -106.5 -32.49 8.06 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.746 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 63.7 t -105.03 131.19 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -105.64 124.29 49.31 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 15' ' ' VAL . 62.5 t -127.27 128.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 112.048 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.49 135.0 11.89 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 85.1 m -123.47 130.15 52.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.241 0.52 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -111.53 136.5 50.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 2.8 mmm -119.21 115.58 24.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 0.0 111.194 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.2 133.96 54.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.585 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -173.73 176.93 46.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.445 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.87 147.24 43.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.651 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -126.47 160.58 20.84 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.741 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -125.4 130.52 52.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.734 0.302 . . . . 0.0 110.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -76.5 134.12 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.339 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.782 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.94 0.4 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.96 171.05 34.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.025 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -79.34 158.39 27.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.729 0.299 . . . . 0.0 110.539 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -138.42 157.0 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 111.264 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -133.54 144.83 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.65 126.77 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.237 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 53.8 m -128.75 144.99 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -127.29 150.68 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.427 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.31 -172.12 36.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.942 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -109.7 156.92 19.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.24 135.34 51.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.859 0.361 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -125.08 129.6 50.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.92 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 57.4 m -116.75 145.95 43.14 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -118.71 121.52 40.31 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.24 130.09 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.536 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.62 108.63 14.42 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.366 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -147.32 156.39 42.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.37 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.24 112.33 24.51 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.766 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.13 -156.36 28.29 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.543 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 73.7 m-85 -69.8 150.38 46.93 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 58.3 mtmt 74.15 93.39 0.08 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.726 0.641 . . . . 0.0 109.344 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.1 tp -58.8 -40.74 84.97 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -82.15 -15.54 52.97 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 48.22 38.98 11.05 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 13' ' ' SER . 14.7 p-10 -101.4 113.62 65.8 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 13' ' ' SER . 95.9 Cg_endo -79.7 158.45 24.88 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.421 2.08 . . . . 0.0 110.957 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -93.31 146.78 23.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.607 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -168.01 -179.9 40.84 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.433 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -119.61 154.12 34.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 110.87 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.9 t-20 -126.38 134.42 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.282 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.2 125.66 47.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 60.6 mttp -121.33 139.32 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.147 0.499 . . . . 0.0 111.6 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.7 129.08 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.114 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -116.57 134.01 55.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.679 0.276 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -128.59 124.83 36.88 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -92.21 127.53 37.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -101.55 -9.64 20.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.713 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.5 177.04 11.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.505 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -62.99 -48.23 79.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -112.36 7.29 19.17 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -126.98 142.03 51.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.956 0.408 . . . . 0.0 111.599 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.81 -174.21 37.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.908 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.007 0.404 . . . . 0.0 110.911 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.94 138.43 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.102 0.477 . . . . 0.0 110.912 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' LYS . . . -112.91 137.42 14.22 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.6 m -124.74 130.11 51.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.019 0.438 . . . . 0.0 111.482 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 97.1 m-85 -115.61 126.49 54.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.685 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.25 115.12 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.826 0.346 . . . . 0.0 110.649 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -123.84 111.46 16.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.607 HG22 ' HA3' ' A' ' 28' ' ' GLY . 77.1 p -125.93 151.8 46.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.716 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -158.9 147.44 18.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.671 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.95 124.4 28.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 110.516 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.03 54.85 0.58 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.741 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -109.45 132.05 54.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.733 0.302 . . . . 0.0 110.835 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.71 132.14 47.47 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.277 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 24.1 pm0 -67.91 142.04 56.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.085 0.469 . . . . 0.0 110.917 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.5 m -129.38 149.52 51.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.702 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.76 101.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.998 0.428 . . . . 0.0 110.976 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -164.59 76.98 0.32 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.47 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.19 5.43 90.08 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.759 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 63.25 23.33 13.79 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.154 0.582 . . . . 0.0 111.246 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.14 -9.24 26.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.441 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 92.9 mt -109.25 36.1 3.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.106 0.479 . . . . 0.0 111.026 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 65' ' ' ASP . 42.6 pt -84.43 4.68 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.156 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 35.1 t70 78.69 -52.61 0.47 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.818 0.847 . . . . 0.0 111.273 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.97 -16.63 58.21 Favored Glycine 0 CA--C 1.516 0.106 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.957 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 51.56 49.38 21.02 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.543 0.337 . . . . 0.0 111.734 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -83.51 124.19 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.894 0.378 . . . . 0.0 110.793 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -114.98 132.29 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.113 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.581 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 78.1 t80 -131.14 121.31 24.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.287 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -134.24 125.55 28.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 110.221 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.9 m -130.06 146.62 51.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.095 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.72 126.19 64.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.726 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.2 p -134.95 157.89 45.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.156 0.503 . . . . 0.0 111.78 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.64 153.86 36.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.96 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -169.85 165.25 38.63 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.936 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.35 154.27 40.75 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.916 2.41 . . . . 0.0 112.722 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.599 HG22 ' HB3' ' A' ' 88' ' ' TYR . 60.1 t -123.68 127.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.358 . . . . 0.0 110.545 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -127.87 128.55 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.078 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -74.66 128.34 35.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 0.0 111.078 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 87' ' ' LEU . 86.3 mt -90.36 -42.31 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.12 -165.62 1.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.499 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.75 -39.72 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.548 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -127.21 25.23 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.16 127.54 67.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 122' ' ' GLN . 66.2 m -128.29 147.25 50.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 111.057 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.703 ' HB2' HD11 ' A' ' 81' ' ' ILE . 64.9 tp -117.07 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.107 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' HB3' HG22 ' A' ' 78' ' ' VAL . 54.6 p90 -142.09 158.77 43.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.068 0.461 . . . . 0.0 111.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.561 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -118.7 156.11 15.8 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.052 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 134' ' ' SER . 88.5 mt -115.13 118.48 33.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.31 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.38 131.69 50.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.06 -148.4 10.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.823 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.99 152.23 41.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 136.44 13.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.862 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -120.83 127.46 51.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.656 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -117.93 141.04 16.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.166 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -130.69 141.83 50.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.59 126.52 42.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.341 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -120.26 126.61 51.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.584 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -97.65 117.72 32.57 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.8 m -91.14 114.33 26.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.994 0.426 . . . . 0.0 111.381 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -164.37 170.82 15.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.643 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.5 mt -101.31 111.41 30.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -150.16 158.31 44.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.875 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.5 -39.62 97.56 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.168 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -115.76 149.74 38.01 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.4 m -110.75 139.57 45.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.498 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -129.16 147.86 51.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.884 0.373 . . . . 0.0 111.04 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 98.5 p -154.43 161.43 41.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.788 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 95.7 mtm-85 -127.5 145.49 50.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.011 0.434 . . . . 0.0 111.49 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.3 m -136.81 147.91 46.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.792 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -146.64 148.66 32.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 111.841 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.6 m -125.0 134.68 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.693 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 138' ' ' SER . 89.3 p -141.46 162.03 36.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 0.0 111.557 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 138' ' ' SER . 60.7 tp -75.04 129.22 37.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.466 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 137' ' ' TYR . . . -119.69 133.21 55.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.538 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -148.32 159.31 44.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.719 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 174.33 -166.46 38.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.697 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.69 160.48 41.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.62 162.34 28.85 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.335 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.57 143.88 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.358 -0.421 . . . . 0.0 109.995 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 52.5 tt0 -127.92 130.11 47.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.846 0.355 . . . . 0.0 110.327 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -123.5 144.36 49.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.843 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.402 ' OD1' HG22 ' A' ' 130' ' ' VAL . 33.7 t30 -127.43 82.14 68.79 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.801 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.48 -40.78 45.2 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.419 2.079 . . . . 0.0 111.848 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -136.03 154.31 77.47 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.9 -34.83 87.42 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.836 2.357 . . . . 0.0 113.761 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -98.94 10.56 41.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -138.66 112.28 8.28 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG22 ' OD1' ' A' ' 124' ' ' ASN . 67.5 t -116.64 129.78 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.626 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.6 mt -102.54 120.4 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.5 ' OD1' ' HG3' ' A' ' 122' ' ' GLN . 99.2 m-20 -116.65 126.11 52.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.531 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -132.77 135.16 45.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.562 ' HB2' HD11 ' A' ' 90' ' ' LEU . 92.2 p -155.59 161.01 40.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.382 0.611 . . . . 0.0 112.346 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -138.18 134.09 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.712 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.461 ' CG ' ' HB ' ' A' ' 147' ' ' THR . 25.9 pt-20 -129.76 147.75 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 83.7 t80 -129.12 135.11 48.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.982 0.42 . . . . 0.0 111.65 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 67.6 m -107.65 129.36 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -102.04 117.69 35.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.791 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 60.9 mt -119.64 154.29 34.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.97 -44.35 94.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.9 -32.97 7.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.791 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 59.7 t -104.86 130.61 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -103.29 125.15 49.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.0 t -125.83 124.8 67.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.1 138.88 12.88 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.461 ' HB ' ' CG ' ' A' ' 136' ' ' GLU . 85.7 m -125.46 128.97 48.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.405 0.602 . . . . 0.0 111.503 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -114.09 129.51 56.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 70.8 mtm -123.62 139.89 53.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.245 0.545 . . . . 0.0 112.167 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 67.1 tp -136.97 130.43 31.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.039 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.78 173.14 34.48 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.602 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.64 151.73 49.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.433 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.32 -167.18 18.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.436 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -148.15 160.91 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.811 0.339 . . . . 0.0 110.763 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -78.97 141.41 37.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.801 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.525 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.054 0.454 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.01 172.86 45.84 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.041 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -84.53 149.73 25.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.709 0.29 . . . . 0.0 110.451 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -128.89 143.5 50.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.18 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -129.69 141.92 50.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.693 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.6 mt -116.39 126.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.263 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 153' ' ' GLY . 51.6 m -124.54 142.17 51.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 0.0 111.184 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.9 pt -129.4 153.6 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.408 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.4 -173.59 37.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.11 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.4 142.31 37.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.09 123.8 51.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -120.38 122.29 40.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.966 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.661 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 49.7 m -118.97 157.68 27.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.847 0.356 . . . . 0.0 111.264 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -128.13 140.85 51.7 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.771 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -124.63 131.73 72.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.464 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -60.59 134.38 57.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.397 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -123.2 153.61 39.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.41 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -113.67 22.07 14.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.238 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.39 -16.13 5.19 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.681 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 95.2 m-85 -91.98 138.44 31.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 27.8 mmtm 69.24 159.44 0.18 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.463 0.649 . . . . 0.0 111.32 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -88.25 -57.27 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.526 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 52.6 p-10 -114.32 -13.69 12.29 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mttt 49.82 36.92 12.17 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 23' ' ' ASP . 34.4 m120 -103.25 112.77 65.93 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 13' ' ' SER . 84.6 Cg_endo -78.01 158.47 30.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.706 2.27 . . . . 0.0 111.094 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -114.18 144.78 42.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -169.31 177.15 43.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.297 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -111.24 144.74 39.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.485 HD21 ' HE2' ' A' ' 32' ' ' LYS . 21.7 t30 -110.69 127.87 55.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.804 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.6 127.07 53.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.229 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HE2' HD21 ' A' ' 30' ' ' ASN . 63.6 mttm -126.61 137.23 53.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.63 135.96 50.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -127.12 130.98 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -114.72 128.36 56.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -110.0 89.15 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -102.49 -2.41 28.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.156 0.503 . . . . 0.0 110.014 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' TRP . 16.3 t-20 -154.45 136.9 15.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.479 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -67.87 -41.1 83.37 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -71.72 -45.65 61.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.589 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 97.8 m95 -128.81 138.47 52.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.943 0.401 . . . . 0.0 112.025 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.54 174.0 18.57 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.928 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.2 t -121.93 128.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.114 0.457 . . . . 0.0 110.61 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.77 140.56 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.35 141.13 13.11 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -124.99 132.11 53.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.94 0.4 . . . . 0.0 111.364 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.81 118.59 26.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.87 128.18 49.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -124.78 120.55 32.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.47 HG22 ' HA3' ' A' ' 28' ' ' GLY . 62.7 p -128.62 160.19 33.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.986 0.422 . . . . 0.0 111.695 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -153.1 164.39 38.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.907 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.21 146.13 53.66 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.661 0.267 . . . . 0.0 110.75 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.92 172.41 51.33 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.913 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.38 150.54 27.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.727 0.299 . . . . 0.0 110.969 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -135.0 168.08 19.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.914 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.3 pm0 -59.45 138.39 57.69 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.186 0.517 . . . . 0.0 111.109 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.4 m -133.05 159.83 38.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.807 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 m -102.64 161.72 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.781 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -57.73 136.78 56.93 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.99 0.424 . . . . 0.0 110.719 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.14 -8.69 67.48 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.387 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.87 149.63 48.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 111.187 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -105.65 149.8 26.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.051 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 49.66 1.76 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.057 0.455 . . . . 0.0 110.863 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.532 HG23 ' HB2' ' A' ' 67' ' ' ASP . 94.4 mt -63.0 -46.62 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.814 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.3 t0 55.37 29.54 13.25 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.296 0.639 . . . . 0.0 111.768 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' H ' HG22 ' A' ' 64' ' ' ILE . . . 91.15 -16.09 59.52 Favored Glycine 0 CA--C 1.518 0.225 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.759 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.532 ' HB2' HG23 ' A' ' 64' ' ' ILE . 18.8 t0 49.91 54.73 10.55 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 122.719 0.408 . . . . 0.0 111.865 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.432 ' HD1' ' HB2' ' A' ' 98' ' ' ALA . 89.1 t80 -100.61 127.08 47.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.72 143.87 48.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.213 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -127.93 118.58 23.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -116.5 128.93 55.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.712 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.0 m -122.46 139.41 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.41 122.31 44.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.613 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.3 p -134.41 159.7 40.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.183 0.516 . . . . 0.0 111.898 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 91' ' ' LEU . . . -149.8 154.2 38.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.094 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 89' ' ' GLY . . . -171.89 165.01 37.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.954 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.5 153.01 30.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.817 2.345 . . . . 0.0 112.389 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.57 128.56 72.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.494 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.41 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 84.6 t80 -119.71 124.12 45.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.998 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -75.6 131.32 39.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.804 ' HB ' HG13 ' A' ' 85' ' ' VAL . 47.6 mm -90.34 -42.26 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.517 0.675 . . . . 0.0 109.873 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.414 ' HB3' HG12 ' A' ' 85' ' ' VAL . 2.7 t-20 -150.23 -158.15 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.446 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.05 -40.83 91.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -126.2 29.04 5.91 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.804 HG13 ' HB ' ' A' ' 81' ' ' ILE . 7.7 p -144.71 131.29 15.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 O-C-N 121.953 -0.467 . . . . 0.0 109.836 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.4 m -138.19 152.25 48.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.704 0.288 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 HG13 ' A' ' 81' ' ' ILE . 2.5 mp -124.36 143.22 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.166 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.535 ' CZ ' ' HA3' ' A' ' 120' ' ' GLY . 45.9 p90 -146.18 161.35 40.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.547 ' O ' ' HA3' ' A' ' 76' ' ' GLY . . . -111.34 146.48 17.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.968 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.408 HD21 ' HE2' ' A' ' 88' ' ' TYR . 79.1 mt -116.41 123.87 48.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.96 0.41 . . . . 0.0 111.56 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -138.16 137.91 38.1 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -154.66 16.8 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.857 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.63 153.07 47.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.998 0.428 . . . . 0.0 111.678 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.39 142.78 17.56 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.71 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -129.67 123.74 31.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.54 138.37 14.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.754 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -128.8 140.66 51.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.893 0.347 . . . . 0.0 111.141 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.432 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . . . -133.14 124.06 26.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.379 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 65.1 tttm -130.76 130.2 43.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -97.32 120.96 38.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.0 m -89.15 115.69 26.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.981 0.419 . . . . 0.0 111.407 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -163.62 170.49 17.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.628 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 tp -106.77 110.69 32.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.686 0.755 . . . . 0.0 110.194 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -150.52 164.04 36.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.876 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.61 -39.6 97.6 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.851 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -132.1 132.09 42.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -112.09 150.28 30.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.523 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -126.07 141.94 51.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.024 0.44 . . . . 0.0 111.203 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.9 m -136.95 159.41 41.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.027 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -136.23 155.66 49.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.079 0.466 . . . . 0.0 111.623 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 93.8 p -149.04 152.42 36.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.664 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -135.92 149.82 49.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.147 0.498 . . . . 0.0 112.05 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.6 p -109.84 148.75 30.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.711 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -154.93 160.6 41.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.789 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 138' ' ' SER . 85.1 mt -101.25 136.39 41.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.0 133.34 54.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -142.41 139.45 31.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.17 -166.42 29.09 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.777 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.535 ' HA3' ' CZ ' ' A' ' 88' ' ' TYR . . . -134.4 150.27 20.01 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.41 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.04 138.7 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.417 -0.391 . . . . 0.0 109.948 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -124.7 132.12 53.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.898 0.38 . . . . 0.0 110.44 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.518 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -114.8 95.31 40.72 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.355 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.48 -36.22 87.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.522 2.148 . . . . 0.0 111.535 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -130.06 157.17 77.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.767 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.18 -37.34 79.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.874 2.383 . . . . 0.0 113.636 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -105.46 16.35 25.67 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 131' ' ' ILE . 8.4 t80 -126.27 117.03 22.2 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.92 -0.488 . . . . 0.0 110.665 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.1 t -115.32 126.87 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.654 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 129' ' ' PHE . 48.4 mm -108.59 126.39 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -123.42 116.82 23.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.997 0.427 . . . . 0.0 111.402 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -122.94 133.33 54.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.6 p -152.22 166.98 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.331 0.586 . . . . 0.0 112.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -141.31 150.68 42.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.633 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -140.18 151.02 44.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -133.92 128.4 34.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.763 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 115' ' ' LEU . 20.3 m -94.76 124.43 38.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -103.47 102.86 12.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 97.5 mt -118.62 152.33 36.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.26 -43.86 98.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -105.42 -33.12 8.26 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.749 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 58.2 t -105.66 125.96 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -105.8 122.64 46.51 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 73.7 t -127.19 129.27 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . -117.7 138.83 14.35 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.0 m -127.05 131.71 50.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.244 0.522 . . . . 0.0 111.495 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 31.9 m-90 -116.8 139.31 50.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 64.3 mtt -127.15 124.33 38.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 0.0 111.992 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.3 mt -127.75 136.67 51.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.112 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.68 -172.37 43.68 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.383 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.97 158.32 44.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.621 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 7' ' ' SER . . . -137.02 164.4 25.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.816 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -131.32 129.29 41.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 110.177 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -76.37 137.84 40.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 t80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.751 -179.935 . . . . . . . . 0 0 . 1 stop_ save_